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Abstract 
Amyotrophic Lateral Sclerosis is a devastating neurological disease with no known cure.  
In 1993, a genetic link was established between ALS and mutant forms of Cu, Zn-superoxide 
dismutase (SOD1), an antioxidant enzyme that catalyzes the dismutation of the damaging free 
radical superoxide anion (O
2-
) to hydrogen peroxide (H2O2) and dioxygen (O2).  The inheritable 
form of ALS (fALS) accounts for ~10% of all ALS cases and so SOD1 mutations comprise ~1.5-
2% of all ALS cases, but nevertheless represent a major known cause of the disease.  
Furthermore, the clinical symptoms of fALS and sALS are similar, although fALS patients with 
SOD1 mutations have an earlier age of disease onset than sALS (by ~10 years).  A major 
hypothesis in the field of ALS research is that mutations decrease the stability and increase the 
aggregation propensity of SOD1, causing motor neuron degeneration.  Attempts to identify 
relationships between the effects of the mutations and ALS characteristics have shown that these 
effects are highly complex and not correlated with disease characteristics in a simple way.  
SOD1 undergoes various in vivo modifications (notably disulfide bond formation and metal 
binding) and the form of SOD1 that is relevant to ALS toxicity is unknown.  Recently, attention 
has focused on the immature forms of SOD1, which lack metal and/or disulfide bonds, because 
these forms are more destabilized by ALS-associated mutations compared to the mature, metal-
bound, disulfide oxidize (holoSS) form.   
A powerful approach to uncovering the mechanisms of SOD1 misfolding and 
aggregation is to investigate the how mutations affect the global and local stability of SOD1 
under physiological conditions.  Here, the stability of disulfide-oxidized (SS), metal free (apo) 
SOD1 has been investigated by combining isothermal titration and differential scanning 
calorimetry techniques (ITC and DSC, respectively) to break down changes in global stability 
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into dimer interface and monomer stability components.  First, ITC was used to assess the 
thermodynamics of dimer dissociation for pWT and 13 ALS-associated mutants and the results 
were confirmed using size exclusion chromatography (SEC).  Together these experiments reveal 
that all mutations investigated, even those far removed from the interface, promote dissociation.  
Furthermore, apo SOD1 dissociation is characterized by large ∆Cp, ∆H and ∆S changes, far 
larger than expected based on theoretical calculations of surface area changes estimated from the 
crystal structure.  This finding suggests that large conformation changes accompany dissociation 
and that monomeric apo SOD1 is fairly malleable, a finding that suggests dimerization may play 
an important role in the maturation of SOD1, by preventing the buildup of partially unfolded, 
aggregation-protein species. Subsequent to these studies, total unfolding (ie. folded dimer to 
unfolded monomer) for the same set of mutants was characterized using DSC, and the data fit to 
a 3-state folding mechanism with monomer intermediate.  Due to the complexity of this model, 
numerous DSC experiments for the same mutant were globally fit, with the energetics of the first 
transition fixed to values obtained by ITC, thus reducing the uncertainty in the fitted parameters 
that define monomer unfolding.  The results from this approach reveal that mutations have 
variable effects on apoSS monomer stability.  In most cases, apoSS monomers are only 
marginally stable; accordingly, mutations greatly elevate the levels of unfolded protein under 
physiological conditions.  In contrast, two mutations, while decreasing dimer interface stability, 
actually increase monomer stability.  These experiments show that mutations have markedly 
different effects on the populations of folded and unfolded monomers in vivo and disclose 
important implications for disease-relevant aggregation.   
We have also characterized the stability of the most immature form of SOD1 (apoSH 
SOD1), which lacks both disulfide bonds and metals.  This form of the protein is mainly 
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monomeric, with marginal stability that is greatly affected by ALS-associated mutations.  
Surprisingly however, we find that this form of SOD1 is remarkably resistant to aggregation 
under physiological-like conditions.  Static and dynamic light scattering (SLS and DLS, 
respectively) as well as analytical ultracentrifugation (AUC) reveal higher-order interactions are 
present, but of the 12 mutants invested, only one showed evidence of aggregate formation.  
Increased protein concentrations or the addition of salt promote aggregation of some SOD1 
mutants and the mechanism(s) of aggregation have been characterized using light scattering, 
atomic force microscopy (AFM), and Thioflavin-T (ThT) binding.  Under conditions that 
enhance aggregation, DLS and AFM experiments reveal that some mutants form small fibrils 
ranging from ~20-100 nm in length, or ~2-100 monomers.  Other mutants aggregate less, but the 
aggregates that do form are longer (greater than 1000 nm).  Furthermore, ThT binding 
experiments suggest that the aggregates contain different degrees of β-structure.  Mutations 
appear to have complex effects on the energy landscape of apoSH SOD1, promoting different 
aggregation pathways.  This complexity may help explain the different disease phenotypes 
associated with different mutants.   
By characterizing both folding and aggregation of different forms of immature SOD1, we 
have employed a powerful approach to untangling the role of toxic aggregation in the syndrome 
of ALS. 
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1.1 Amyotrophic Lateral Sclerosis 
Amyotrophic lateral sclerosis (ALS) is a heterogeneous disorder characterized as either a 
proteinopathy, ribopathy, or both (3).  ALS affects upper motor neurons in the motor cortex as 
well as lower motor neurons in the brainstem and spinal cord, leading to muscle weakness, 
atrophy, spasticity, and involuntary muscle contraction (3–5), with eventual failure of the 
respiratory muscles underlying the fatal event in most cases (5, 6).  In 1993, a genetic link was 
established between ALS and mutant forms of Cu, Zn-superoxide dismutase (SOD1) (7, 8), and 
since then ALS-linked mutations have been found in more than 25 genes affecting many 
different aspects of protein homeostasis and RNA processing (3, 6, 9).  Like many other 
neurodegenerative diseases (10), the majority of ALS cases are not inherited (ie., sporadic 
(sALS)), and a small proportion (~10%) are familial (fALS) (8).  It is now believed that ALS-
linked mutations disrupt normal cellular function through both gain-of-function and loss-of-
function mechanisms that ultimately lead to progressive failure of the motor neuron, 
characterized by protein aggregation, mitochondria stress, endoplasmic reticulum (ER) and Golgi 
malfunction, and disruption in axon transport, eventually leading to axon retraction and 
denervation of the lower motor neurons and muscles (3, 6, 11, 12).  Similar to other 
neurodegenerative diseases, ALS pathogenesis progresses from an initial region to adjacent sites 
through mechanisms not well understood (10).  The onset and duration of disease is highly 
variable, even among patients with the same mutation, indicating that multiple factors may 
modulate disease (3, 13).  The onset of symptoms is typically during middle age and juvenile 
ALS is very rare; thus, ALS is thought to be associated with aging (3).  It has been proposed that 
the natural decline of proteostatic mechanisms associated with aging plays a role in increasing 
the propensity of proteins to accumulate and aggregate (14, 15).  Disease symptoms become 
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evident during the first stage of motor neuron death, at which point axon connections are 
disrupted due to axon retraction.  Initially, denervation can be compensated for by a process 
referred to as “sprouting,” whereby axons from motor neurons more resistant to degeneration in 
the surrounding area re-establish lost connections.  Over time however, this mechanism is not 
sufficient to prevent disease progression, which is usually rapid (~2-5 years) (3).  The factors 
that contribute to motor neuron vulnerability and degeneration are not well understood but relate 
to the cell’s response to stress, regeneration potential, and susceptibility to glutamate-induced 
exocitotoxicity (3, 16, 17).  Furthermore, what defines the actual onset of disease, referred to as 
the biological onset, is unknown, but is likely determined within the motor neuron.  Disease 
duration may depend on other factors, such as the neuroinflammatory response to degeneration 
(3), and/or the mechanism by which motor neuron pathology is spread (10, 14).  It is possible 
that the disease may start early in life, perhaps during embryonic development, and become 
apparent only later in life.   
Recent research has increasingly recognized distinguishing pathological features among 
subsets of patients, but also overlapping symptoms with other neurodegenerative disorders as 
disease progresses (3, 18, 19).  Neurons in the prefrontal and temporal cortex can be affected to 
varying extents in ALS, resulting in simultaneous development of frontal temperal dementia 
(FTD), referred to as ALS with frontotemporal lobe degeneration (ALS-FTLD) (3).  Thus, it has 
been proposed that ALS and FTD exhibit two ends of a single-disease spectrum.  Furthermore, 
numerous genes have been linked to ALS, and there is evidence for differences in pathology 
related to both genetic and environmental factors (3, 20).  Therefore, ALS may best be described 
as a syndrome and not as a single disease (20).  
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While the cause or causes of ALS remain unknown, a leading hypothesis is that toxic 
protein misfolding plays a role, as is the case in other neurodegenerative diseases (21).  While 
many misfolding diseases involve the formation of a particular type of fibrillar aggregate known 
as amyloid, it is not clear to what extent protein aggregation in ALS resembles amyloid 
formation (22).  Amyloidoses are characterized histopathologically using the dye Congo Red, 
which exhibits green-gold birefringence upon binding to unbranched amyloid fibres containing a 
highly protease resistant cross-β-structure core, with  β-strands oriented perpendicular to the 
fibre axis (23) (refer to section 1.2.1).  Congo Red birefringence is not observed in ALS (22); 
nevertheless, the observations of fibrillar aggregates and a proximal pattern of cell death (3, 24–
26) suggest that ALS has similar disease mechanisms to amyloidoses.   
SOD1 mutations comprise ~1.5-2% of all ALS cases, but nevertheless represent a major 
known cause of the disease (3, 6).  Furthermore, the clinical symptoms of fALS and sALS are 
similar; yet, fALS patients with SOD1 mutations have an earlier age of disease onset than sALS 
(by ~10 years) (4).  Misfolded SOD1 is targeted for degradation via the ubiquitin pathway, and 
mutations in SOD1 may disrupt this process and in turn impair the proteasomal degradation 
pathway (27, 28).  As these regulatory systems fail, protein oligomers and then aggregates can 
accumulate in the cytosol, causing cellular stress and eventual death.  Mutant SOD1 is the main 
component of intracellular aggregates found in fALS patients with SOD1 mutations (29).  These 
SOD1 aggregates have been classified morphologically as Lewy-body-like hyaline inclusions 
which are composed of granule coated fibrils 15-25 nm in diameter (26).  Other components 
include ubiquitin (30), phosphorylated neurofilaments (31), the copper chaperone for SOD1 
(CCS) (32), and other folding chaperones (17, 29).  While it was originally thought that 
aggregation of SOD1 was limited to fALS (22), other studies have shown that aggregated SOD1 
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is present in some sALS aggregates as well (19, 33).  The differences in the reported detection of 
aggregated SOD1 may be accounted for by differences in the binding properties of different anti-
SOD1 antibodies.  It is possible, therefore, that loss of stabilizing post-translational 
modifications or aberrant covalent modifications may induce conformational changes in wild 
type SOD1, similar to the effects of mutations, that result in harm to the cell (19, 33–35), and 
that SOD1 may serve as a link between a subset of sALS and fALS cases (33). 
In ALS and a number of diseases such as Parkinson’s, Alzheimer’s, and Huntington’s, 
neurodegeneration spreads through interconnected regions of the central nervous system (10, 
15).  This phenomenon may be explained by the discovery that a diverse number of misfolded 
and/or aggregated proteins released from one cell via exocytosis or cell lysis can penetrate 
neighbouring cells and form a structural template (ie. an aggregate “seed”) for aggregation of the 
endogenous protein (10, 14, 24, 36).  This finding has led to the hypothesis that the pathogenic 
mechanism observed in prion diseases may be more pervasive than previously thought (24).  In 
prion diseases, the infectious agent, a misfolded protein, can spread from cell to cell and induce 
misfolding and aggregation of the endogenous protein (37).  The key difference between prion 
diseases and other protein misfolding diseases, however, lies in the potency of induced 
aggregation (14).  Currently, there is no evidence, with the exception of prion proteins, that 
misfolded protein can be spread between animals and/or humans; and thus, protein misfolding 
diseases where infectivity has not been demonstrated are now classified as prion-like diseases or 
prioniods (24). 
Like many other misfolded proteins associated with neurodegenerative diseases, SOD1 
has been shown to exhibit seeded aggregation in vitro and in vivo (14, 36, 38–40).  SOD1 is 
largely present in the cytoplasm (70%) (41); however, both wild type and mutants have been 
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detected in the cerebrospinal fluid of healthy individuals as well as fALS patients (42, 43).  
Formerly, it was suggested that secretion of SOD1 may be a cellular protective mechanism, 
preventing intracellular inclusion formation; it now appears more likely that this process is 
harmful to the central nervous system as a whole (36).  It has been shown that SOD1 can be 
excreted via a variety of distinct pathways, one of which is through association with 
chromogranins, the major components of secretory granules.  This association is specific to 
mutant SOD1, and can trigger cell death (44).  Furthermore, immunization targeting extracellular 
SOD1 was found to increase the lifespan of transgenic mice expressing mutant SOD1 (45).  
Once transported to the extracellular environment, misfolded SOD1 conformers and/or SOD1 
aggregates less than 0.4 μm in diameter (10, 40) can be taken up by neighbouring cells and seed 
aggregation of endogenous wildtype and mutant SOD1 (39).  Differences in the rate of cell to 
cell transfer of these aggregate seeds may underlie the rate of disease progression and partially 
account for the differences in pathology observed (40).  Interestingly, human SOD1 seeds are 
only able to induce aggregation of human SOD1.  Expression of human SOD1 in murine models 
does not cause aggregation of mouse SOD1, perhaps owing to differences in the N-terminal 
region of the proteins (39).  Thus, seeded aggregation of SOD1 is highly sequence and perhaps 
structurally specific.   
A remaining challenge for ALS research lies in uncovering the initial event(s) that lead to 
disease and the toxic species, misfolded or oligomeric protein, responsible for disease onset.  
While ALS may best be described as a syndrome, similar disease mechanisms likely underlie 
sporadic and familial cases, and discovering the common links between different versions of the 
disease will have a powerful impact on the therapeutic approaches to fighting and eventually 
curing the disease. 
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1.2 Protein Folding and Misfolding and Aggregation 
Since 1961, when it was discovered that proteins could fold in the absence of the cellular 
environment, it has been known that a protein’s primary sequence contains all the necessary 
information for protein folding (46); yet predicting the pathway by which proteins fold into their 
respective functional, native states remains a central problem in molecular biology, despite 
decades of progress.  Because the number of possible conformations a polypeptide can adopt is 
so large, it would take an extremely long time for folding to occur if the polypeptide were to 
sample all possible arrangements in a systemic process prior to finding the native structure.  
Instead, it is believed that the inherent fluctuations of an unfolded protein allow it to make many 
initial contacts, enabling regions of the sequence to come together (47).  In general, native-like 
interactions tend to be more stable than non-native interactions, and so lower the energy of the 
system once they form (48).  Eventually, through these stochastic conformational fluctuations, 
the native state is found, a process that has been shown to be highly efficient for proteins that 
have survived evolution (47).  In general, protein folding can be described by a nucleation-
condensation mechanism, whereby the protein undergoes a series of conformational changes that 
eventually lead to compaction of the polypeptide chain and sequestration of the hydrophobic 
residues within the protein core.  In this compact state, the polypeptide can sample fewer 
conformations, eventually acquiring a native-like structure that can serve as the folding nucleus 
around which the rest of the structure condenses to form the lowest energy native state (47, 49).  
The lowest energy state is not a static conformation, however, and local structural fluctuations 
are common for most protein folds (50).  It is often assumed that the functional state of a protein 
is the most stable state under biological conditions (51), yet recent work has shown that most if 
not all proteins are able to form amyloid fibrils, structures that have even higher stability (52, 
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53).  During folding, a polypeptide chain may encounter a number of energetic barriers caused 
by topology, proteins with large contact order fold more slowly, polypeptide inflexibility, 
improper disulfide bond formation, and aberrant intramolecular or intermolecular interactions 
(51).  The native state, therefore, may reflect the conformation energetically accessible from the 
unfolded state and low enough in energy to be highly populated. 
When proteins fold in an aqueous environment, roughly 85 percent of the non-polar side 
chains become buried in the core (54).  These hydrophobic interactions are believed to be the 
driving force behind protein folding (55).  When a protein is unfolded in an aqueous 
environment, the water molecules form hydration shells around the hydrophobic regions of the 
polypeptide (56).  When favourable hydrophobic interactions within the core of a protein are 
formed, these structures are disrupted and water is released to the surrounding environment, an 
entropically favourable process despite the reduced conformational freedom of the polypeptide 
chain (57, 58).  Mutations that introduce a cavity within the hydrophobic core of the protein 
decrease the number of van der Waals interactions and can largely reduce protein stability (54, 
59).  Hydrogen bonds also make very important contributions.  In the native state, approximately 
1.1 hydrogen bonds are formed per residue; 65 percent of those bonds occur between peptide 
groups, 23 percent occur between peptide groups and amino acid side chains, and only 11 
percent occur between side chains (54).  Thus, the polypeptide backbone forms the majority of 
the stabilizing hydrogen bonds in the native state.  Hydrogen bonds and electrostatic interactions 
have also been found in the core of proteins, where they are stronger due to the lower dielectric 
constant in the hydrophobic core.  In such cases, the residues involved in these interactions tend 
to be highly conserved (54).   
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A central aspect in understanding protein misfolding diseases is knowledge of the protein 
structural states that are relevant to pathology and their respective stabilities and mechanisms of 
formation.  The populations of different states are determined by their relative stabilities.  Protein 
stability can be thought of in two ways: thermodynamic and kinetic stability.  Thermodynamic 
stability defines the populations of different states at equilibrium, while kinetic stability 
describes the rates of interconversion between states (Fig. 1.2A).  Thus, thermodynamic and 
kinetic measurements provide complementary approaches for determining the conformations a 
protein is likely to adopt.  Decreased protein stability is associated with increased unfolding, 
either from folded to less folded states, or within the ensemble of conformers that comprise a 
given state.  Different conformers can vary greatly in their propensity to form aggregates (53).  
For the purposes of interpreting this work, the focus of this introduction will be on 
thermodynamic stability. 
Thermodynamic stability, or the Gibbs free energy of folding (∆G), is defined as the 
difference in energy between the unfolded and folded states when the system has reached 
equilibrium.  
∆𝐺 = 𝐺𝑢 − 𝐺𝑓 (Eq. 1.1) 
Thermodynamic stability (∆G) is also related to both the change in enthalpy (∆H) and 
entropy (∆S) with temperature (T) by the Gibbs-Helmholtz equation (equation 1.2).   
∆𝐺 =  ∆𝐻 − 𝑇∆𝑆 (Eq. 1.2) 
Favourable reactions, such as protein folding, proceed spontaneously with negative (∆G) values, 
while processes that are not energetically favourable have positive (∆G) values.  The 
thermodynamic stability (∆G), enthalpy (∆H), and entropy (∆S), must always be determined with 
respect to a reference state according to the following equations. 
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∆𝐻 =  ∆𝐻𝑟𝑒𝑓 +  ∆𝐶𝑝(𝑇 − 𝑇𝑟𝑒𝑓) (Eq. 1.3) 
∆𝑆 =  ∆𝑆𝑟𝑒𝑓 + ∆𝐶𝑝ln (
𝑇
𝑇𝑟𝑒𝑓
) (Eq. 1.4) 
∆Href and ∆Sref refer to the enthalpy and entropy at the reference temperature (Tref), respectively, 
and ∆Cp refers to the change in specific heat capacity for the process.  Once these three values 
are known, the ∆G of folding/unfolding can be determined at all temperatures according to 
equation 1.5, which is a combination of equations 1.2, 1.3 and 1.4.   
∆𝐺 =  ∆𝐻𝑟𝑒𝑓 − 𝑇∆𝑆𝑟𝑒𝑓 +  ∆𝐶𝑝(𝑇 − 𝑇𝑟𝑒𝑓 − 𝑇𝑙𝑛(
𝑇
𝑇𝑟𝑒𝑓
) (Eq. 1.5) 
Extrapolating ∆G, ∆H, and ∆S from the reference temperature requires an accurate ∆Cp.  The 
first models of protein folding assumed no change in ∆Cp upon protein folding (ie., ∆Cp = 0), 
implying that ∆H and ∆S are temperature independent variables.  Given that protein folding 
involves the sequestration of hydrophobic residues, and that the heat capacity of a solution 
increases with hydrophobic hydration (58, 60), it is now believed that this early assumption is 
inaccurate (61).  For protein folding/unfolding, the temperature dependence of ∆H and ∆S is in 
fact quite large (Fig. 1.1A).  Furthermore, the ∆Cp for thermal denaturation of most proteins is 
positive, and usually can be considered constant for a given temperature range (56, 59).  Given 
these characteristics, the ∆G of protein folding/unfolding varies non-linearly with temperature, 
and is referred to as a stability curve (Fig. 1.1).  Owing to the curvature of this plot, there is a 
characteristic temperature range where ∆G is positive (ie., Gu > Gf and protein unfolding is not 
favourable) and a temperature where the protein is most stable.  The temperatures where the 
stability curve crosses the x-axis, corresponds to the melting temperatures of the protein.  In most 
cases, there are two melting temperatures; the lower melting temperature is often below the 
freezing point of water and is usually not observed.  Furthermore, the larger the ∆Cp, the larger 
the curvature, and the smaller the temperature range where ∆G is positive (59) (Fig. 1.1B).   
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Figure 1.1 Protein Stability Curves.  The stability curves represented here were constructed 
using data obtained for SOD1 mutant V148I in the fully metallated, holo, state (holoSS) (Broom 
and Meiering, unpublished data).  (A) ∆G versus temperature is a non-linear function with 
negative curvature.  T1 and T2 indicate the melting temperatures of the protein (ie., where ∆G=0, 
and for monomeric proteins that unfold/fold via a 2-state pathway, where half the protein is 
unfolded).  Tmax indicates the temperature of maximum stability (ie., where ∆S=0).  (B) The 
magnitude of ∆Cp determines the curvature of the ∆G versus temperature function.  If the ∆Cp is 
small, the temperature of maximum stability is not well defined (red curve), and the stability 
curve approaches linearity.  As ∆Cp increases, the curvature of the function increases and cold-
unfolding occurs at higher temperatures (ie. T1 increases).  For holo SOD1, ∆Cp is 2.75 kcal mol-
1 °C-1 (black curve) (60).  The red and blue lines were constructed with differing ∆Cp values: 1 
kcal mol
-1
 °C-1 (red curve), 3.5 kcal mol-1 °C-1 (solid blue curve), 5 kcal mol-1 °C-1 (dashed blue 
curve), and 7.5 kcal mol
-1 °C-1 (dotted blue curve).  Both Fig. 1.1A and 1.1B are adapted from 
Becktel and Schellman, 1987 (59).   
 
12 
 
Destabilization of proteins by chemical modifications or by mutations favours an increase 
in the population of partially folded species that may possess a higher degree of aggregation 
propensity owing to the exposure of the hydrophobic groups, or hydrogen bonding ligands, that 
are normally buried in the protein core (Fig. 1.2B).  This exposure can promote the formation of 
non-native intermolecular contacts between proteins which leads to formation of aggregates.  
Thus, the propensity of a given globular protein to aggregate depends on how energetically 
feasible it is for the protein to access locally, partially, or fully unfolded aggregation-prone 
state(s) (Fig. 1.2B).  Interestingly, subtle decreases in global protein stability are often 
accompanied by local destabilization, which may only subtly alter the protein structure but 
nevertheless increase the aggregation propensity of the protein.  As more light is shed on the 
various aggregation mechanisms, it is clear that there is evidence of aggregate formation from 
native-like species that have undergone much more restricted unfolding (53, 62).  Examples of 
aggregate formation from native-like states include various proteins associated with disease such 
as mutant lysozyme (53), β2-microglobulin (53), and SOD1 (63).  Various mechanisms of 
protein aggregation have been proposed, including formation of a cross-β spine, end to end 
stacking, and domain swapping, and in some cases protein aggregation may involve more than 
one of these mechanisms (64).  These mechanisms will be explored further in sections 1.2.1 and 
1.2.2, as they relate to amyloid and non-amyloid aggregation. 
In addition to protein stability and structure, many other factors, such as physicochemical 
properties of amino acids within a protein sequence and solution conditions, can affect protein 
aggregation.  Hydrophobicity, β-sheet propensity, and charge of a polypeptide sequence have 
been shown to modulate the formation of amyloid aggregates by unfolded proteins (65).  
Interestingly, these properties are also important for facilitating correct protein folding, 
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suggesting that while similar forces contribute to both processes, different key residues are 
involved in forming the initial contacts that drive native protein folding and aggregation (66).  In 
many cases, the overall aggregation propensity of a protein increases if the primary sequence 
contains short stretches of amino acids with properties that favour aggregation, for example low 
net charge, extensive hydrophobicity, and/or a tendency to form a β-sheet over an α-helix (67).  
Taken together, these studies indicate that aggregation is at least partially controlled by the 
physicochemical properties of amino acid residues within a polypeptide sequence (65, 67). 
Solution conditions are another important factor that can modulate the stability, 
conformation, and the intermolecular interactions of a protein, and thereby influence the rate of 
protein aggregation and the type of aggregate structure formed (68, 69).  Importantly, variations 
in solution conditions can cause the same protein to aggregate by fundamentally different 
mechanisms (70–72).  Temperature, pH, macromolecular crowding, agitation, and ionic strength 
are all variables that can influence both the type of aggregation observed (amorphous versus 
fibrillar) and the extent to which this process occurs (68, 69, 73, 74).  A number of studies have 
used different solution conditions (increased temperature, decreased pH, increased ionic strength, 
sonication or agitation) to promote the formation of fibrillar amyloid aggregates by various 
forms of SOD1 (75–78).  Other studies have demonstrated soluble oligomer and small aggregate 
formation by various forms of SOD1 in quiescent, physiologically relevant solution conditions 
(63, 79).  Thus, it is becoming increasingly evident that multiple factors can greatly influence 
protein folding and aggregation and that these factors must be considered when investigating the 
molecular mechanisms of protein aggregation and the relevance of these mechanisms to disease. 
  
14 
 
 
Figure 1.2 Reaction Coordinate Diagrams for Protein Folding.  (A) Thermodynamic stability 
is defined as the energy difference between the folded native state (N) and the unfolded state (U).  
The higher the stability, the more populated the N state at equilibrium.  Kinetic stability is 
defined as the difference in energy between the folded, native state (N) and the transition state 
(TS), which represents the main energetic barrier to folding.  For proteins with high kinetic 
stability, the transition state is less energetically accessible, and proteins will spend more time in 
the native conformation.  (B) The effects of native state (N) destabilization by mutation on the 
population of locally unfolded, native-like (N*), partially folded intermediate (I), and fully 
unfolded (U) states are shown.  Aggregation may occur from N*, I or U, and the morphology of 
the aggregates formed may depend on the conformation of the protein prior to aggregation. 
Mutations that destabilize N (destabilization is indicated by the red arrow), decrease the energy 
difference between the N and the more unfolded states (N*, I or U), and thereby promote 
aggregation. Note that destabilization of N, does not necessarily imply destabilization of I.  
Mutations that destabilize N may stabilize or destabilize I, resulting in a large increase or 
decrease, respectively, in the population of I compared to levels observed in the native folding 
pathway. Panel B was obtained from Broom et al., 2011 (1), and originally adapted from Chiti 
and Dobson 2009 (53). 
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1.2.1 Amyloid Aggregates 
Amyloid has traditionally been defined by pathologists as extracellular fibrils that give rise 
to a cross-β X-ray diffraction pattern and cause green birefringence upon binding congo red (23, 
62, 64, 80).  Currently, extracellular deposition of classical amyloid aggregates has been 
identified in approximately 25 syndromes defined clinically as amyloidosis (81).  The definition 
of amyloid however, is evolving and has become controversial, as fibrils resembling amyloid 
have been discovered intracellularly, in diseases not traditionally considered amyloidosis (23, 64, 
82), and numerous biophysical studies have identified structural heterogeneity in amyloid fibrils 
(23, 82, 83).   
From a biophysical perspective, the fundamental feature of amyloid fibrils is the cross-β 
spine core; yet, these fibrils can differ widely, in the size of the fibril spine (ie., how much of the 
protein forms the amyloid core), the arrangement of β-strands (parallel or antiparallel) and the 
degree to which these β-strands align (23, 62, 84).  Despite these differences, the β-sheet is the 
strongest repeating unit of the amyloid fibril.  Most structural studies of amyloid fibrils have 
revealed that the β-strands run perpendicular to the fibril axis, stabilized by hydrogen bonds 
between main chain atoms arranged parallel to the fibril axis, and the side chains face above and 
below the sheet (23).  Other structural studies of amyloid fibrils formed from out-of-register β-
sheets have revealed that the β-strands are arranged at an angle, with repeating weak and strong 
interfaces, stabilized by two and six hydrogen bonds, respectively.  The stability of these fibrils 
is lower than that of fibrils formed from in-register β-sheets, possibly due to hydrogen bonding 
donor and acceptor groups left unsatisfied at the ends of the β-strands (84).  Each β-sheet is 
typically referred to as a protofibril, and the number and orientation of the protofibrils add 
further variation to the amyloid theme.  The protofibrils can be oriented face to face, or face to 
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back, and they can pack together with the same or opposite edge strands at each end.  The 
amyloid core is referred to as a dry steric zipper due to the highly packed side chains and the 
release of water upon formation.  Due to this release of water, the hydrophobic effect contributes 
stability to the fibril (23). 
Most of what is known about the amyloid structure derives from structural studies of small 
amyloidogenic peptides that form the amyloid core through side-chain interactions of self-
complementary sequences (62, 82).  One example is the peptide GNNQQNY, derived from the 
yeast prion protein Sup35p (Fig. 1.3A).  In the amyloid state, the peptide side chains interact in 
the core such that the glutamine (Q) and asparagine (N) are tightly interlocked (80).  More 
complex cores can form from sequences that are not self-complementary, but nevertheless 
interact in favourable ways.  Remarkably, several different amyloid forming proteins have been 
shown to form numerous distinct dry steric zippers, most notably the amyloid-β peptide, which 
can form diverse fibrils with 13 different dry steric zippers under different solution conditions 
(23, 62, 85). 
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Figure 1.3 Modes of Amyloid Formation.  (A) The amyloidogenic peptide GNNQQNY, 
derived from the yeast prion protein Sup35p, is shown interacting with an identical peptide.  The 
polypeptide backbone carbon atoms are shown in grey, the side chain carbon atoms in cyan, 
oxygen atoms in red, and nitrogen atoms in blue.  Interactions between side chain residues form 
the steric zipper amyloid core.  As peptides add to the fibril, the growing β-sheet extends from 
the page, as shown on the right.  Panels B through D depict β2-microglobulin misfolding and 
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run-away domain-swapping leading to dimerization and formation of amyloid fibrils.  In each 
panel, the different subunits within the domain-swapped structure are coloured either blue or 
pink.  These panels were recreated from Liu et. al., 2011 (83).  (B) The native structure of 
monomeric β2-microglobulin forms a β-sandwich that is stabilized by one disulfide bond that 
links the two sheets formed by strands A, B, D, E and C, F, G.  A schematic representation of the 
native state fold is shown on the left, while the crystal structure is shown on the right (PDB code 
1LDS) (86).  (C) A domain swapped dimer forms when the disulfide is reduced and β-strands E, 
F, and G are exchanged between the subunits, creating two new intermolecular interfaces.  One 
is identical to the original contacts made in the monomer, while the other interface is formed by 
the hinge loop, corresponding to the original loop 4, which connects the swapped domains.  This 
hinge loop region contains an amyloidogenic sequence and can form the steric zipper amyloid 
core.  Disulfide shuffling also accompanies dimer formation, where the original intramolecular 
disulfide bond becomes an intermolecular disulfide bond, adding stability to the dimer structure.  
A schematic representation of the domain-swapped dimer is shown on the left, while two views 
of the crystal structure are shown on the right.  The higher and lower images show the frontal 
and top-down views of the domain-swapped dimer (PDB code 3LOW) (83).  (D) Run-away 
polymerization of β2-microglobulin can occur if domain swapping is not reciprocal.  Disulfide 
reduction can promote dimerization and oligomerization, and the self-association of the hinge 
loop region transforms the oligomers into amyloid fibrils.  Disulfide bonds reformed between the 
interacting subunits promote aggregation (83).  
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It is generally believed that most proteins can form amyloid under destabilizing conditions, 
which exposes sites within the protein that can interact non-natively; yet, it is becoming 
increasingly evident that amyloid formation can arise from states that closely resemble the native 
state (53, 64, 83, 87).  In fact, it was recently demonstrated that protein activity was preserved 
within an amyloid fibril, indicating that the active site is mainly intact despite fibrillation of the 
protein (64, 88).  For proteins with extensive β-sheet secondary structure, amyloid formation 
may arise from subtle changes to the protein fold that expose edges of the native β-sheets, 
allowing for end-to-end stacking of the protein (64, 89).  Such a mechanism has been proposed 
for SOD1; however, it is unclear whether these aggregates are truly amyloid (90).  Amyloid 
formation can also be promoted by domain swapping between proteins (23, 64, 83, 89).  Domain 
swapping can be reciprocal, where no unsatisfied domains are exposed, or it can be open-ended, 
where at least one or more unsatisfied domains exist at each end, resulting in propagation of a 
domain-swapped oligomer (Fig. 1.3B-D).  In the latter case, interdomain interactions are 
identical to those found in the native state; thus, aggregation can be promoted by exposure of any 
segment free to interact with an identical partner (64, 83).  Some amyloidogenic proteins, 
notably prion proteins, contain frustrated regions, where residues do not adopt the most favoured 
β-strand secondary structure.  Domain swapping causes structural changes that alleviate this 
frustration (64, 91).  Domain swapping can also facilitate non-amyloid fibrillation, as discussed 
in the following section. 
Amyloid fibrils form via nucleation-dependent kinetics characterized by a lag phase 
corresponding to the time required to form the initial nucleus, the template upon which 
aggregates can grow (87, 92).  For fibrils formed from small amyloidogenic peptides, 
approximately three peptides are required to form the template (93).  Once formed, additional 
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peptides can join the fibril by exposing sequences that can interact with the template (23, 94).  
Due to the specific rotamer conformations the side chains must adopt in the fibril core, β-sheets 
within each protofibril form faster than the protofibrils can pair.  For small peptides, the loss of 
entropy in the side chains creates a barrier to fibril formation (80).  For full length proteins, 
however, the barrier may mainly be due to local and/or global unfolding processes that expose 
amyloidogenic side chains and/or the backbone amide N-H and C=O groups, which can form 
non-native hydrogen-bonding interactions (23, 87).   
It can be seen, therefore, that the term amyloid can refer to a variety of fibrils with a 
similar core motif, but with a great deal of variety and structural complexity.  Numerous studies 
reveal that amino acid sequences are not the singular determinant of fibril structure, as specific 
amyloidogenic sequences can form fibrils that differ in, for example, diameter, twist period, and 
stability (82); and it has been proposed that the heterogeneity observed in amyloid structures may 
account for the phenotypic diversity observed in amyloid-associated diseases (10).  Furthermore, 
the observation that certain amyloid seeds can induce aggregation of some amyloidogenic 
proteins but not others may depend on, for instance, sequence complementarity, the size of the 
amyloid core, and the number of protofibrils wound together (23).  In general, it is believed that 
the larger the amyloidogenic sequence, the more complex the aggregation pathway, and the more 
difficult it may be to determine which species are toxic (95).  It was recently demonstrated that 
two distinct amyloid fibrils, formed from the same protein, displayed different degrees of 
toxicity.  Furthermore,  the toxicity of one fibril was increased after fragmentation, while the 
toxicity of the other decreased, thus indicating the smaller aggregates are not always more toxic 
(96).  In another study, it was shown that fibrils formed from out-of-register β-sheets were more 
toxic than those formed from in-register β-sheets, owing to the former’s lower stability and 
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increased likelihood of fragmentation (84).  The cellular response to different amyloid 
conformations is highly complex; it is becoming increasingly clear that the pathways that lead to 
protein aggregation are highly diverse (95).  Biophysical studies of amyloid fibrils are important, 
given that amyloid architecture appears to underlie fibril toxicity (97).  Many studies of amyloid 
structure and formation have helped to explain why amyloid fibrils are associated with so many 
diseases and to distinguish the particular biophysical properties of the toxic fibrils from the 
benign ones. 
 
1.2.2 Non-amyloid Aggregates 
Non-amyloid protein aggregation has been observed in a number of protein conformational 
diseases, as well as in vitro (64, 98–105), albeit in general this type of protein aggregation is less 
well characterized than amyloid aggregation.  Examples of disease-relevant proteins that form 
non-amyloid aggregates include hemoglobin, in cases of sickle-cell anemia, members of the 
superfamily of serine protease inhibitors (serpins), in a number of diseases generalized as the 
serpinopathies, and the crystallins, associated with the onset of cataracts.  In the first example, 
hemoglobin forms ordered helical fibrils (Fig. 1.4A, B), while the serpins form an assembly of β-
sheets that differ from amyloid in that they lack the characteristic cross-β spine (Fig. 1.4 C) (64).  
In the final example, it is currently believed that aggregation of crystallin results in the formation 
of non-structured aggregates referred to as amorphous (104, 106). 
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Figure 1.4 Modes of Non-amyloid Aggregation.  Here two different modes of non-amyloid 
aggregation are shown.  (A) Mutant hemoglobin (HgS) forms helical aggregates via a double 
nucleation mechanism whereby fibrils form de novo, through homogeneous nucleation, and 
grow by addition of monomers to a preformed fibril, through heterogeneous nucleation.  In each 
case, the critical nucleus represents the thermodynamic turning point in the aggregation pathway 
whereby further aggregate growth becomes favourable.  This figure was obtained from Ferrone, 
2004 (103).  (B) The HgS fibril is composed of double stranded HgS polymers that associated 
via interactions between β6 valine and the hydrophobic pocket of an additional HgS monomer.  
In this schematic representation, β6 valine is depicted as a protruding triangle.  Interactions 
between β6 valine residues are not reciprocal and facilitate further higher order assembly of HgS 
molecules.  A secondary interaction site exists between HgS monomers within the fibril, 
indicated by the black circle; however, these interactions are not well characterized.  This figure 
was adapted from Wang et. al., 2013 (107).  (C) Domain swapping underlies aggregation of α1-
antitrypsin, a member of the serpin superfamily.  A common cause of α1-antitrypsin deficiency 
arises when individuals inherit the Z allele of the gene, which contains a mutation at the 
beginning of the reactive centre loop (RCL, the location of this mutation is indicated by a Z).  
The RCL loop is indicated in red.  Others inherit mutations in β-sheet A, indicated in blue, 
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referred to as the shutter region, and indicated by a red circle.  These inherited mutations disrupt 
β-sheet A, promoting formation of an aggregation-prone native-like state (M*), which allows the 
insertion of the RCL into β-sheet A, adding an additional strand.  If this process occurs 
intramolecularly, α1-antitrypsin forms a more stable latent monomer (L), but if the RCL of one 
molecule inserts into the β-sheet of another, dimerization (D) and later polymerization can occur.  
This figure was obtained from Lomas, 2013 (100).       
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Aggregation of mutant hemoglobin (HbS) underlies the pathology of sickle cell anemia 
(108).  Hemoglobin contains four subunits, two denoted as α, and two as β.  Individuals with 
sickle cell anemia contain mutations at the sixth position within the two β chains, that replace a 
glutamic acid with a valine, resulting in the introduction of two hydrophobic residues at the 
surface of the protein (109).  When hemoglobin is in the deoxygenated state, the β6 valine 
residue can interact with a hydrophobic pocket within the β-chain of an adjacent molecule, 
leading to polymerization at high enough concentrations (Fig. 1.4A, B) (102, 103, 110).  A salt 
bridge situated within this hydrophobic pocket underlies the pH dependence of HbS 
polymerization (103).  The β6 valine contact site, which lies at a diagonal with respect to the 
fibril axis and is referred to as the lateral interaction site, combined with a secondary contact site, 
which does not contain the site of mutation and lies along the fibril axis, form the important 
interactions that underlie the double stranded fibril that is the fundamental unit of the helical 
polymer.  The polymer structure has been shown to contain seven of these fibril pairs (111, 112).  
As the HbS fibrils grow, they distort the structure of the red blood cell, causing it to move more 
slowly through the venous capillaries, resulting in damage that is associated with the clinical 
symptoms of sickle cell anemia (110).   
Aggregation of HbS proceeds through a double nucleation mechanism (Fig. 1.4A) (103).  
The initial contacts made between HbS molecules are not favourable and form only through 
stochastic structural fluctuations that lead to temporary association between HbS molecules (103, 
110).  The critical nucleus is thought to consist of a small segment of the 14-strand polymer; 
however, the structural details of this species are unclear.  The nucleus is considered to be the 
thermodynamic turning point, and its properties may vary with HbS concentration and pH, as 
well as other variables (103).  Once the critical nucleus forms, polymer growth becomes 
25 
 
thermodynamically favourable.  Additionally, the surface of the polymer supports further 
nucleation, forming branching sites where additional HbS molecules can add on to the fibril 
(103, 110). 
The serpin superfamily includes a large number of proteins, approximately 1500, with 
varied functions (113, 114).  Members of the serpin superfamily include serine and cysteine 
protease inhibitors, dual class inhibitors, as well as non-inhibitory proteins.  These proteins are 
important regulators of proteolysis, and play key roles in coagulation, inflammation, and 
fibrinolysis (100, 113, 115).  While the primary sequences of serpin proteins differ, these 
proteins share a core structure composed of approximately 400 amino acids (113, 114).  This 
core consists of three β-sheets and nine α-helices, conventionally named A-C and A-I 
respectively (100, 113).  The most common and thoroughly studied member of the serpin 
superfamily is α1-antitrypsin (α1AT), which functions as an inhibitor of neutrophil elastase 
(NE), a protease involved in the inflammatory response (116).  Through a combination of loss-
of-function and gain-of-function mechanisms, mutations in α1AT cause α1AT deficiency, and 
result in increased levels of NE, in turn leading to emphysema, and intracellular aggregation of 
α1AT, causing liver disease (100, 113, 115).  The general mechanism by which serpin inhibitors 
carry out their function demands a great deal of structural flexibility; thus, these proteins are only 
marginally stable in their native conformations (101, 113, 114).  In the native state, these 
proteins expose a large loop, designated the reactive centre loop (RCL), which contains the 
cleavage site for the target protease.  Following proteolytic cleavage, the RCL inserts into β-
sheet A, a more stable conformation, adding an additional β-strand.  Because the target protease 
is covalently bound to the RCL, this movement drags the protease from one end of the protein to 
the other, inactivating both the serpin and protease.  Because the inactive state is more stable 
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than the native state, the energy gained from insertion of the RCL into β-sheet A provides a 
driving force for inactivation (101, 113–115). 
A number of disease-associated mutations have been identified in cases of α1AT 
deficiency (100, 113, 116).  Mutations destabilize the protein, resulting in slower folding into a 
native state that contains an opening in β-sheet A, and an unraveled α-helix F.  These structural 
alterations predispose the protein to forming an expanded β-sheet A, as the reactive loop can then 
insert into the middle of β-sheet A.  This conformational change can result in the formation of an 
inactive monomer, if the RCL inserts into its own β-sheet A, or an inactive domain-swapped 
dimer, if the RCL from another monomer inserts into β-sheet A.  Propagation of this dimer leads 
to polymerization (100, 101, 113–115).  It was originally believed that polymerization of the 
serpin proteins occurred via a unified mechanism, but it is now well established that the reactive 
loop can insert into different positions within β-sheet A, or even add to another β-sheet, 
depending on the solution conditions (115).  In some cases, the aggregates formed were identical 
to those observed in disease; in other cases, they were only observed in vitro (117). 
Protein association can also involve formation of aggregates that are far less structured and 
this type of aggregation is referred to as amorphous.  Amorphous protein aggregation is 
associated with a number of processes, such as production of wine haze and the development of 
cataracts, and is a common problem during purification of recombinant proteins  (118, 119),  
frequently observed when proteins are incubated at their isoelectric pH (120).  In cataracts, 
proteins within the ocular lens accumulate age-related damage, due to oxidative stress and 
exposure to UV light, resulting in protein destabilization and consequently aggregation.  These 
aggregates scatter light and cause blurred vision and eventually blindness if left untreated (121).  
This process is believed to begin with the crystallin proteins, notably α-crystallin, which 
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functions as a folding chaperone, binding to proteins in the molten globule state to prevent 
aggregation, though in later stages of the disease other cytoskeletal proteins are also recruited 
(104, 106, 121).  These aggregates are resistant to 8 M urea, yet are dissolved with the addition 
of reducing agent and thus are enriched in cross-linked protein (122).  Cross-linking is thought to 
occur between cysteine residues; lens proteins undergo cysteine, methionine and tryptophan 
oxidation over time, but can also occur through non-disulfide covalent bonds involving 
dehydroalanine for example (104, 106, 123).  It is important to note that the structure of 
aggregates formed within the ocular lens during cataract development remains controversial; 
both amyloid and amorphous aggregation of crystalline proteins has been observed under 
different conditions (124).  
Few mathematical models exist to describe the mechanism of amorphous aggregation; yet, 
it has been characterized as a disordered process whereby monomers add to a growing aggregate 
in any direction.  As the surface area of the aggregate grows, so does the rate of aggregation 
(125).  Various modes of amorphous aggregation may differ, however, depending on the initial 
conformation of the aggregating protein and the degree of residual structure within the aggregate.   
While other modes of protein assembly exist, these examples reflect how multifaceted 
protein aggregation processes are.  Furthermore, single mutations have the potential to 
significantly alter the aggregation mechanism of many proteins.  It may not be surprising, given 
the complexity and diversity of native protein structures, that various modes of protein assembly 
are possible; and with further progress being made each year toward uncovering the mechanisms 
and structural characteristics of protein aggregates, more strategies will be developed to combat 
protein aggregation in cases where it is inconvenient or toxic. 
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1.3 Cu, Zn-Superoxide Dismutase 
1.3.1 Cu, Zn-Superoxide Dismutase Structure 
Cu, Zn-Superoxide Dismutase (SOD1) is a paradigm for understanding protein structure 
and function as well as folding and misfolding in disease, and has been studied extensively (1, 2, 
126).  Human SOD1 is a member of the SOD family of proteins, which all function as 
antioxidant metalloenzymes, yet differ in their cellular localization, quaternary structure, and 
active site metal (127).  SOD1 is a homodimer, while SOD2 and SOD3 are homotetramers; 
however, all catalyze the dismutation of superoxide to form hydrogen peroxide and oxygen (see 
section 1.3.2).  SOD1 is located mainly in the cytosol and to a small extent in the intermembrane 
space of the mitochondria, whereas SOD2 and SOD3 are located in the mitochondria matrix and 
the extracellular space, respectively (127).  To date, only SOD1 has been implicated in ALS 
pathogenesis (3, 33). 
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Figure 1.5 Structures of human SOD1 and variants associated with ALS.  The structures of 
two different forms of SOD1 highlight how post-translational modifications have major effects 
on the structure of the protein.  FALS-associated mutations are located throughout the protein 
and may promote misfolding in different ways.  (A) Crystal structure of holoSS SOD1 (pdb 
1HL5) with the protein backbone represented as a ribbon.  HoloSS is a homodimer of 153 amino 
acid subunits, which adopt a Greek key β-barrel structure consisting of 8 β-strands and 
connecting loops.   Each subunit binds one zinc (black sphere) and one copper (orange sphere), 
contains a highly conserved intramolecular disulfide bond between Cys 57 and 146 (red ball and 
stick), and is naturally N-acetylated (not shown).  SOD1 also contains two free cysteines at 
positions 6 and 111 (pink ball and stick).   The longest loops are the zinc-binding loop (Loop IV, 
yellow) and the electrostatic loop (Loop VII, blue).  The zinc-binding loop contains residues that 
form the Zn-binding site, as well as one of the cysteines involved in the intrasubunit disulfide 
bond, which attaches this loop to β-strand 8.  In addition, the zinc-binding loop contains residues 
involved in forming the dimer interface.  Zinc binding, disulfide bond formation, and 
dimerization constrain the flexibility of the zinc-binding loop and markedly increase protein 
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stability.  (B) Solution structure of apoSS monomer variant of SOD1 (PDB 1RK7).  The colour 
scheme is identical to Panel A.  The structure of the monomer is less defined than in mature 
holoSS.  (C) Crystal structure of holoSS SOD1 (PDB 1HL5) with metal binding ligands shown 
in cyan.  Zinc is coordinated by four histidines, His 63, 71, and 80, as well as Asp 83, while 
copper is coordinated by His 46, 48, 63 and 120, as well as one water molecule (not shown).  
The colour scheme for the rest of the molecule is identical to panels A and B.  (D) Primary 
sequence of the SOD1 monomer and mis-sense mutations associated with fALS (adapted from 
Broom et al., 2014 (2).  The secondary structural elements are listed above the primary sequence 
and coloured as in A and B.  FALS-associated mutations are listed vertically in red below the 
wild type amino acid in black. The black and orange spheres indicate zinc and copper-
coordinating residues, respectively. 
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The fully mature, holo form of SOD1 (holoSS) has a melting temperature of ~92 °C (128) 
and can maintain enzymatic activity in strongly denaturing conditions (129).  The high stability 
of holoSS can be attributed to the highly compact dimeric structure (Fig. 1.5A, C), composed of 
two identical monomers, each consisting of 153 amino acid residues that bind one copper and 
one zinc ion, contain one intramolecular disulfide bond between Cys 57 and 146, and two free 
cysteines at positions 6 and 111.  Each monomer folds into a Greek key β-barrel, consisting of 
two, four-stranded antiparallel β-sheets, connected by 7 loops of differing size.  These two β-
sheets are oriented in a cross conformation, such that the four strands of each β-sheet lie at an 
angle with respect to one another (130).  The longest loops, the zinc-binding loop (Loop IV) and 
the electrostatic loop (Loop VII), are highly important for SOD1 stability and function (126).  
The zinc-binding loop contains residues that form the zinc-binding site, as well as one of the 
cysteines involved in the intrasubunit disulfide bond, which attaches this loop to β-strand 8.  In 
addition, the zinc-binding loop contains residues involved in forming the dimer interface  (126, 
130).  Thus, zinc binding, disulfide bond formation, and dimerization constrain the flexibility of 
the zinc binding loop and markedly increase protein stability (131).  The electrostatic loop is 
composed of charged residues that are essential for guiding the superoxide anion from the 
surface of the protein into the active site where the redox active copper ion sits (132, 133).  Both 
zinc-binding and electrostatic loops contain more hydrogen bonding and hydrophilic side chain 
interactions than the β-barrel, and these interactions are thought to play an essential role in 
stabilizing the loop conformations by providing a network of connections between the loops and 
the metal binding sites (130).  Furthermore, the zinc and copper-binding sites are linked by His 
63, functioning as a ligand for both metals, as well as by Aso 124 within the electrostatic loop, 
which forms hydrogen bonds with copper-ligand His 46 and zinc-ligand His 71 (126, 130). 
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 Metal free disulfide oxidized (apoSS) and disulfide reduced (apoSH) SOD1 have 
markedly reduced stability, and melt at 60 °C and 48 °C, respectively  (98, 131, 134).  When the 
disulfide bond is formed, metal free SOD1 (apoSS) is a dimer (135).  While the long loops have 
increased conformational flexibility (90, 136–139), the disulfide bond fixes the zinc-binding loop 
to the β-barrel, thereby ensuring that many of the dimer interface residues are in place.  When the 
disulfide bond is reduced, dimerization is much less favourable, and the monomer remains the 
only populated form of SOD1 under physiological conditions (Fig. 1.5B) (98, 140). 
In summary, each holoSS monomer consists of a β-barrel scaffold with two large loops 
projecting from this scaffold, forming the functional regions of the protein.  The network of 
stabilizing interactions that forms when both metals are bound to SOD1 constrains the motion of 
the zinc-binding and electrostatic loops, the result of which is a highly stable, compact structure.  
In the absence of metal, SOD1 is much less stable (98, 131, 134), and the large loops gain 
conformational freedom.  Therefore, the functional regions of SOD1 may be the Achilles heel of 
the protein, enabling aberrant interactions to take place if metal binding is compromised (see 
section 1.3.6). 
Over 170, predominantly missense, mutations are associated with ALS, giving rise to 
~20% of fALS cases (http://alsod.iop.kcl.ac.uk/).  The mutations are associated with 
characteristic average disease durations, which vary greatly, for example from ~1 year for the 
dimer interface mutation A4V, the most common mutation in North America, to ~18 years for 
H46R, a metal binding mutant.  Over the years, a great deal of attention has been focused on 
elucidating the structural characteristics of different SOD1 variants to account for differing 
disease phenotypes.  While the most abundant form of SOD1 in vivo is generally holoSS (126), 
conditions such as mutation or aging may promote increased population of undermetalled or 
33 
 
disulfide reduced, less stable forms of the protein; and the form(s) of SOD1 most relevant to 
pathology in different ALS cases remain(s) unknown. 
   
1.3.2 Pseudo-WT Cu,Zn-Superoxide Dismutase 
In recent years, systematic analyses of the effects of fALS-associated mutations on the 
stability and folding of various forms of SOD1 have been reported (1, 2).  Human SOD1 
contains two free cysteine residues at amino acid positions 6 and 111 (Fig. 1.5A), and these free 
cysteine residues inhibit reversible unfolding of SOD1 in vitro by forming intramolecular and 
intermolecular non-native disulfide bonds, which promote SOD1 aggregation (141, 142).  
Reversible unfolding is a prerequisite for thermodynamic analysis, and so to overcome this 
limitation, pseudo-wild type (pWT) constructs lacking these free cysteines have been used 
extensively for in vitro studies of SOD1.  In the most widely used pWT construct, the free 
cysteines are mutated to alanine and serine at positions 6 and 111, respectively (1, 98, 128, 134, 
141, 143–146); however, other mutations at these positions have also been used (most notably 
C6A and C111A) (147–149).  Not only are these chemically and structurally conservative 
mutations, but a serine at position 111 is found in most other mammalian SOD1, and alanine at 
position 6 is observed in other non-mammalian organisms (150).  Mutating the free cysteines 
results in highly reversible unfolding of pWT, while having very minimal effects on structure, 
function, and stability (98, 130, 141, 142).  The pWT construct also makes it easier to study 
modes of aggregation not catalyzed by cysteine oxidation.  The use of pWT SOD1 constructs has 
provided valuable insights into the mechanism of SOD1 folding and misfolding and aggregation.  
Unless otherwise stated, all SOD1 variants studied in this work contain C6A and C111S 
mutations. 
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1.3.3 Cu, Zn-Superoxide Dismutase Function 
The zinc and copper ions lie in close proximity and share the metal binding residue, His 63 
(Fig. 1.5C).  This interaction is essential since it limits the redox activity of the copper ion, 
preventing harmful reactions from damaging essential cellular molecules.  Zinc is coordinated by 
His 63, 71, 80, and Asp 83, while copper is coordinated by His 46, 48, 63, and 120 and one water 
molecule (126, 130).  The mechanism by which superoxide is converted to hydrogen peroxide 
and oxgyen is performed through oxidation and reduction cycles between the substrate and the 
catalytic copper ion.  The first step of the SOD1 catalyzed reaction is superoxide reduction, 
immediately followed by reduction of a second superoxide molecule and reoxidation of copper.  
This two-step reaction is presented below: 
Step 1: 𝑂2
− + 𝐶𝑢2+ → 𝑂2 + 𝐶𝑢
1+
  
Step 2:  𝑂2
− + 2𝐻+ + 𝐶𝑢1+ → 𝐻2𝑂2 + 𝐶𝑢
2+ 
Overall: 2𝑂2
− + 2𝐻+  → 𝑂2 + 𝐻2𝑂2 
Upon reduction, the copper ion shifts 1.3 Å and releases His 63 and the water ligand.  This 
release changes the conformation of the copper-binding site from a five-coordinated structure to 
a trigonal planar, three-coordinated arrangement, while the arrangement of zinc-coordinating 
residues remains unchanged.  Reoxidation of the copper ion regenerates the five-coordinated 
structure of the copper-binding site (126). 
 
1.3.4 Cu, Zn-Superoxide Dismutase Maturation In Vivo 
SOD1 requires a number of posttranslational modifications before achieving full activity; 
and these modifications are regulated by oxygen and copper levels in a many Eukaryote cells 
(151–154).  It has been shown that SOD1 activity rapidly increases in yeast cells grown under 
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anaerobic conditions with increases in copper and oxygen concentrations (154), and similar 
results were mirrored in animal models (155).  Studies in yeast also suggest that regulation of 
SOD1 activity occurs at both the transcription and translation levels (153, 154, 156).  It has been 
proposed that the first response to increased oxidative stress involves rapid activation of a pre-
existing pool of immature SOD1, followed by increased expression of antioxidant enzymes (153, 
157).  The metal content of immature SOD1 awaiting activation, and whether or not this 
mechanism is relevant in more complex organisms, remains unknown.  It appears possible, 
though, that SOD1 can exist in a number of different states within the cell, depending on 
different conditions  (151).  In addition to metal binding, intrasubunit disulfide bond formation, 
and dimerization, the polypeptide undergoes methionine cleavage at the N-terminus followed by 
acetylation of the adjacent alanine residue (126). 
The most immature form of the polypeptide is the apo reduced form (apoSH), which lacks 
all modifications.  While the mechanism(s) of zinc acquisition in vivo remain unknown, the steps 
that facilitate copper binding to SOD1 have been the focus of numerous studies over the past 
decade and are now understood in greater detail.  Copper can be harmful to cellular components; 
therefore, homeostatic levels are under tight regulatory control and virtually no free copper exists 
in Eukaryote cells (158).  Copper acquisition and distribution to various cellular compartments 
and copper chaperones involves a highly complex set of metabolic pathways which are still the 
focus of extensive investigation (159, 160).  It is believed that copper enters the cell in the Cu
1+
 
state through high affinity copper transporters or specific, lower affinity permeases, and is 
subsequently passed to copper chaperones responsible for delivery to cytosolic enzymes or to 
membrane transports for delivery to other cellular compartments.  Transport from one site to 
another is facilitated by specific protein-protein interactions and increasing copper-affinity 
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gradients (160).  Human SOD1 acquires its copper cofactor mainly through direct interaction 
with the copper chaperone for superoxide dismutase (CCS), a homodimeric protein composed of 
monomers consisting of three unique domains (151, 152, 161, 162).  SOD1 can also acquire 
copper through a CCS-independent pathway through interaction between electrostatic residues in 
Loop VI with glutathione (163).  This mechanism is poorly understood, but likely plays only a 
minor role in SOD1 activation (158, 162).  Most studies on CCS have focused on the yeast and 
human forms of CCS, which differ slightly in sequence, quaternary structure, and metal binding 
capabilities, but nevertheless likely activate SOD1 through a similar mechanism, since it has 
been shown that human CCS can activate yeast SOD1 (151, 152, 162, 164).  As the focus of this 
thesis is human SOD1, only what is known about human CCS will be discussed in detail. 
The first domain of human CCS is homologous to the family of Atx1 metallochaperones, 
forming a βαββαβ ferrodoxin fold that contains a highly conserved MXCXXC copper binding 
domain located in a surface exposed loop (165).  In general, Atx1 metallochaperons interact with 
their targets through structural complementarity, either electrostatic or hydrophobic interactions, 
facilitating target recognition and correct orientation of the copper-coordinating residues (166).  
Copper is transferred from Atx1 chaperones to their target proteins through a series of two and 
then three-coordinate intermediates that involve the Atx1 copper-coordinating cysteines and a 
pair of reduced cysteines close to or within the target recognition site (Fig. 1.6A) (166).  While 
SOD1 is not a typical binding partner for Atx1 metallochaperones, domain one of CCS is 
accessible to SOD1 Cys 57 and 146 upon heterodimer formation (161, 165).  It is of further note 
that SOD1 constructs with alanine mutations at residues 57 and 146 showed decreased ability to 
become activated by CCS; therefore, Cys 47 and 146 may mediate delivery of copper from 
domain one of CCS to the SOD1 active site (165).  While previous studies showed that domain 
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one was only essential for activation of SOD1 when copper was limiting (162, 164), more 
recently it has been demonstrated that the absence of domain one abolishes the ability of CCS to 
transfer copper to SOD1 (161).  In the current model, therefore, domain one is considered the 
copper-delivery domain; however, it is possible that domain three may also bind copper either 
independently or through interactions with domain one under certain conditions.  It has been 
shown that CCS from various species can bind more than one equivalent of copper (158), and 
may adopt different conformations to protect the copper binding site during transfer to SOD1, as 
has been previously proposed (162).  Transfer from the cysteine ligands within CCS to the 
histidine ligands within Cu,Zn-SOD also suggests a change in the copper redox state from Cu
+1
 
to Cu
+2
, since nitrogen donor ligands more readily bind Cu
2+
 than Cu
1+
, while the opposite is true 
for sulphur donating ligands (159).  Therefore, a change in copper redox state may enable a 
change in copper ligand.  It has been shown that SOD1 CCS-dependent activation relies on the 
presence of oxygen (153, 154), suggesting that oxygen may play a role in the oxidation of 
copper, in turn facilitating ligand switching. 
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Figure 1.6 Maturation of SOD1.  (A) A schematic representation of copper transfer from an 
Atx1 chaperone to its target protein through a series of two and then three-coordinate 
intermediates that involve the Atx1 copper-coordinating cysteines and a pair of reduced cysteines 
close to or within the target recognition site.  It is possible that copper transfer from CCS domain 
one to SOD1 occurs through a similar interaction between cysteine residues.  This figure was 
adapted from Bertini et al. 2007 (166).  (B) A proposed mechanism of SOD1 maturation.  Here 
SOD1 is indicated in grey and CCS in blue.  Copper and zinc are shown as orange and black 
spheres respectively.  Disulfide status is indicated as SH for reduced and S-S for oxidized.  The 
three CCS domains are labelled D1, D2, and D3.  Heterodimer formation between CCS and 
SOD1 is facilitated by interactions between the native SOD1 interface and the SOD1-like 
interface within CCS domain two.  Copper transfer involves domain one and disulfide oxidation 
domain three.  Following copper transfer and disulfide oxidation, SOD1 is released from CCS 
and can dimerize, forming the active enzyme.  This figure was adapted from Banci et al., 2012 
(161). 
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Domain two resembles monomeric SOD1, both structurally and in terms of sequence.  It 
forms a Greek-key β-barrel with both large loops corresponding to the zinc-binding and 
electrostatic loops, as well as six of the seven metal binding residues found in SOD1 (167).  
Human CCS binds one zinc ion, which is required for function (168), at the site analogous to the 
SOD1 zinc binding site, while being unable to bind copper as it is missing one of the metal-
binding histidine residues (167).  It has been proposed, therefore, that domain two is not involved 
in copper transfer to SOD1, but rather is involved in target recognition (151, 152, 161, 169, 170).  
The similarity of CCS domain two and SOD1 suggests that the SOD1-CCS heterodimer may 
form through interactions of residues important for homodimerization, and in fact the crystal 
structure of yeast CCS-SOD1 heterodimers reveals that the heterodimer interface is very similar 
to the homodimer interface (170).  Furthermore, mutations introduced into the dimer interface 
abolish CCS activation of SOD1 in yeast (157).  Zinc binding to SOD1 likely precedes 
interaction with CCS, as it has been shown to be a requirement for copper transfer from CCS to 
SOD1 (161, 169), although heterodimer formation is possible with apo SOD1 and CCS (161).  
This discovery indicates that the conformational changes of some key residues, notably disulfide 
bonding region, which occur upon zinc-binding to SOD1 and subsequent stabilization of the 
zinc-binding loop, are a prerequisite for copper transfer (161).  If heterodimer formation between 
SOD1 and CCS is facilitated by interactions between residues in the homodimer interfaces, 
efficient transfer of copper from SOD1 to CCS would require significant population of 
monomeric forms of both proteins.  Interestingly, disulfide oxidation of SOD1, which would 
promote dimerization, has been reported to inhibit CCS-dependent activation, further suggesting 
that the SOD1 dimer is not a well-matched target for CCS (161).  It is worth noting, however, 
that other Greek key β-barrel dimers can rapidly exchange monomers under physiological 
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conditions (171).  Given the similarity between CCS domain two and SOD1, it is possible that 
heterodimer formation is under kinetic control (162). 
The third domain of CCS is a short polypeptide, ~40 amino acids in length, with little 
secondary structure and a highly conserved CXC copper-binding motif (151, 170).   Previous 
work has shown that copper can bind to both domains 1 and 3; but, only domain 3 is able to 
deliver copper to the SOD1 active site (162, 164).  More recently however, experiments with 
different CCS constructs, missing one or two of the three domains, have revealed that copper 
transfer to the SOD1 active site is possible in the absence of domain 3.  It is now generally 
believed that domain 3 is primarily responsible for SOD1 disulfide bond formation, which can 
only occur when domains one and two are present (161).  Disulfide bond formation between 
SOD1 Cys 57 and 146 involves an oxygen-dependent disulfide shuffle, which begins with the 
formation of an intermolecular disulfide bond between CCS Cys 244 and SOD1 Cys 57, which is 
subsequently transferred to SOD1, resulting in oxidation of Cys 57 and 146 (151–153).  
There are still questions regarding the mechanism of SOD1 CCS-dependent activation.  It 
is unclear how copper is oxidized to Cu
2+
, how the disulfide shuffle is initiated, and how these 
step(s) are regulated by oxygen levels.  The emerging model for CCS-dependent activation of 
SOD1 involves a series of stages that require coordination of all three CCS domains.  First, zinc 
binding occurs, possibly-independent of CCS, followed by heterodimer formation between CCS 
and SOD1.  This step facilitates copper transfer, mediated by SOD1 Cys 57 and 146, and transfer 
of the intersubunit disulfide bond between CCS domain 3 and SOD1 to the intrasubunit disulfide 
bond within SOD1.  The final step of SOD1 activation is dimerization, which has been shown to 
be regulated by COMMD1, which acts downstream of CCS, inhibiting dimerization when there 
is excess copper and CCS (156).  It appears, therefore, that each post-translational modification 
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of SOD1 is regulated by the demands of the cell, ensuring that there is no excess of activated 
SOD1. 
 
1.3.5 Cu, Zn-Superoxide Dismutase Stability and Folding 
As discussed at the beginning of this introduction (section 1.2), protein folding can depend 
very strongly on solution conditions, in particular protein concentration, denaturant 
concentration, and temperature, and these can be varied to characterize different structural 
transitions  (2, 172, 173).  Most proteins in nature, including SOD1, consist of more than one 
subunit, and as a consequence their folding inherently depends on protein concentration (173).  
Denaturant- and temperature-induced unfolding of SOD1 have been fit to 2- or 3-state 
mechanisms.  For monomeric apoSH, reversible unfolding fits a 2-state transition between folded 
(M) and unfolded (U) monomers (M ↔ U).  At low protein concentrations, dimeric apoSS and 
holoSS exhibit 3-state equilibrium transitions between folded dimers (N2), M and U (N2 ↔ 2M 
↔ 2U). Increasing protein concentration decreases the proportion of M such that only a net 2-
state process (N2 ↔ 2U) is observed at equilibrium, although inter-conversion among all 3 states 
may still be observed kinetically.   
In its most immature form, apoSH, pseudo wild-type (pWT) SOD1 adopts a folded, but 
highly dynamic monomeric structure (Chapters 4 and 5) (174).  This form of SOD1 has marginal 
stability, with ~95% of the protein being folded at physiological temperature and pH.   Kinetic 
studies further show that disulfide reduction decreases stability by increasing the rate of 
unfolding (147).  Accordingly, the stability of apoSH is relatively low compared to other 
globular proteins (1), and far lower than more mature forms of SOD1.  In general, mutations 
have the largest effects on the stability of the apoSH form, ranging from slightly increasing to, 
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more often, greatly decreasing its melting temperature to below 37 °C.  Thus, mutations can 
markedly alter the populations of folded and unfolded conformations (98).  
Disulfide bond formation stabilizes both the folded monomer and the dimer interface of 
SOD1, such that 3-state folding can be analyzed by equilibrium chemical (134) and in some 
cases thermal denaturation (refer to Chapter 2), as well as by kinetics.  In contrast to apoSH, 
pWT and mutant apoSS are very predominantly folded under physiological conditions (98, 134).  
Nevertheless, based on equilibrium denaturation and molecular dynamics simulations, it has 
been proposed that the effects of mutations propagate extensively through the protein structure 
and disrupt the dimer interface (98, 175).  Kinetic experiments have shown that mutations can 
increase the rate of dissociation and/or monomer unfolding (176, 177).  Thus, in apoSS, 
mutations generally have destabilizing effects, resulting in increased native-state structural 
fluctuations and small increases in population of folded and unfolded monomers.  Until now, 
however, the dimer interface stability has not been calculated directly (refer to Chapter 2). 
Metal binding strongly stabilizes SOD1 and reduces its dynamics. The overwhelming 
majority of mutations characterized to date decrease the stability of holoSS (1, 143, 146), but 
because the folded dimer is extremely stable, the absolute increases in the amounts of unfolded 
species (M and U) are extremely small, and hence are unlikely to directly impact aggregation.  
Rather, increased local structural fluctuations tend to promote metal loss and/or disruption of the 
dimer interface, and so expose regions that are normally buried (99).  Various covalent 
modifications have similar destabilizing effects.  For example, oxidation of active site histidine 
residues destabilizes holoSS, promotes monomerization, increases exposure of hydrophobic 
residues, and leads to metal loss (178).  Metal binding also increases the kinetic stability of 
SOD1; pWT holoSS unfolds extremely slowly via formation of a folded monomer, which has 
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weakened metal binding compared to the dimer (146).  Various mutations increase the unfolding 
rates of holoSS, and increase the accessibility of misfolded species, notably mis-metallated 
monomers.  Collectively, these studies have revealed that mutations and covalent modifications 
increase structural fluctuations and misfolding in the otherwise extremely stable holoSS. 
 
1.3.6 Modes of Cu,Zn-Superoxide Dismutase Aggregation 
A key theme emerging from the folding studies of SOD1 is that mutations have differing 
effects on the amounts of unfolded and misfolded species that may be populated in disease.  This 
suggests that aggregation may arise from multiple, very different initial conformations.  
Enhanced aggregation has been reported for many species of SOD1, including mutant and/or 
modified protein, with formation of diverse structures, ranging from amorphous to various kinds 
of fibrils (Fig. 1.7).  It must be emphasized that varying experimental conditions strongly 
influence observed aggregation mechanisms and structures, which have different aberrant 
interactions, for example between the edges of the β-barrel, exposed hydrophobic groups, and 
improper loop interactions. 
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Figure 1.7 Mechanisms of SOD1 aggregation.  Some of the many reported 
misfolded/aggregated structures of SOD1 are illustrated schematically (A-K). These structures 
may depend strongly on the conformation of the various possible precursor SOD1 species. 
Soluble, natively folded SOD1 is represented by grey spheres.  Copper and zinc ions are 
indicated by orange and black spheres respectively and disulfide status is indicated as SH for 
reduced and S-S for oxidized.  (A) Under agitation, apoSH forms a nucleus containing 
intermolecular disulfide bonds involving Cys 57 and Cys 146, which then recruit more stable apo 
and part metallated SS forms of SOD1.  The resulting fibres bind the fluorescent dye, Thioflavin-
T (ThT), and exhibit twisted morphologies by atomic force microscopy (AFM) (76).  (B)  
Destabilizing and/or agitation conditions result in fibres with features of classic amyloid (75, 
179, 180), as is frequently observed when proteins aggregate from a globally unfolded state 
(179).  Such “classic” fibrils have a protease-resistent cross-β spine, cause large enhancements in 
ThT fluorescence, exhibit green-gold birefringence upon binding the dye Congo Red, and have 
fibril diameters of ~5-20 nm (75, 179).  (C-E)  Amyloid-like aggregates showing polymorphism 
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due to a protease-resistant fibril core (shaded shapes) are formed by different fragments of the 
SOD1 sequence, such as the N-terminal ~60 amino acids (C), centre of the protein forms the 
core (D), C-terminal region (E). Protease sensitive parts are shown as grey coils. The structures 
of the cores are not known and may include cross β-strands (181).  (F) Dimers of apoSS linked 
through disulfide linkages, which involve normally reduced Cys 6 and Cys 111  (182, 183).  (G, 
H) Amyloid-like fibrils formed as a result of non-native interactions between apoSS dimers (90, 
137, 138).  Exposure of the edge of the β-barrel in apoSS due to disorder in the zinc-binding and 
electrostatic loops results in a zig-zag packing of dimers when the edge is partially exposed (G) 
or  linear packing when the edge  is fully exposed  (H).  (I, J) Different types of amorphous 
aggregates formed by structured (I) and unstructured (J) protein respectively (35, 99).  (K)  
Amyloid pores formed by zinc-bound SS dimers.  The zinc-binding loop, indicated in yellow, of 
one dimer interacts with the β-barrel of another dimer at angle.  The zinc-binding loop forms an 
additional β-strand, the result of which is an extended β-sheet that spirals around the long axis 
(90). 
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In recent years, there has been extensive research on the aggregation of apoSH, as this 
unstable form of SOD1 has been proposed to be particularly likely to aggregate in disease (1, 98, 
131).  In vitro, the extent and type of aggregation for apoSH varies greatly with experimental 
conditions (Fig. 1.7).  Thermal denaturation has been shown to be highly reversible for apoSH 
pWT and some mutants, suggesting resistance to aggregation from partially or fully unfolded 
states, although other mutations show evidence of misfolding and aggregation (98).  In contrast, 
other conditions strongly enhance aggregation of even wild type (WT) apoSH.  Agitation of both 
WT and mutant apoSH solutions can cause formation of various amyloid-like fibres (76, 184).  
Mutations modulate the structural features of the fibres, resulting in distinct, or common, 
protease-resistant cores under different conditions (181, 185).  Intriguingly, such structural 
polymorphisms may be analogous to different “strains” observed in prion aggregation (23).  
Furthermore, under agitation conditions, small amounts of apoSH can seed the aggregation of 
more stable forms of SOD1 (76, 185).  It is well established that amyloid can form quite readily 
from highly unfolded sections of proteins.  Also, agitation induces aggregation of many proteins 
through mechanisms that are not well understood but may involve unfolding at air-water or 
water-solid interfaces and/or disulfide shuffling (186, 187).  Recent studies have shown that 
various forms of metal-free SOD1 can make amyloid-like fibres with smooth, unbranched 
morphologies under agitation conditions; and this occurs from the globally unfolded rather than 
the folded state (188).  In contrast, under quiescent solution conditions, both WT and pWT 
apoSH show little tendency to aggregate, and different apoSH mutants form different sizes of 
aggregates at different rates (98) (refer to Chapter 5).  These varying results suggest that the 
mode(s) of apoSH aggregation are particularly diverse, and sensitive to varying conditions, due 
to the marginal stability, and hence easily altered conformational properties. 
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Due to the higher stability of apoSS compared to apoSH, more strongly destabilizing 
and/or disulfide oxidizing/shuffling conditions are generally required to induce aggregation on 
an experimentally tractable time scale (75, 78, 144, 182, 189).  For apoSS, different destabilizing 
conditions result in multiple aggregate structures, ranging from amorphous to non-amyloid and 
amyloid fibrils, in varying proportions (75, 144).  Destabilization of apoSS can also cause 
disulfide shuffling between the normally reduced free cysteines (Cys 6 and 111) and those 
normally forming the disulfide bond (Cys 57 and 146) (Fig. 1.5) (189).  Furthermore, under non-
destabilizing, oxidizing conditions, aberrant disulfide bonding involving the free cysteines is 
required for the formation of amyloid-like fibrils (Fig. 1.7) (182).  The roles of aberrant disulfide 
bonding for misfolding and aggregation are complex and not fully clear in both in vitro and in 
vivo studies; in disease models, early roles are uncertain, but they are likely to be significant as 
disease progresses due to increasingly oxidizing cellular conditions (190).  Alternatively, apoSS 
can form other amyloid-like fibres, without aberrant disulfide bonds.  These fibres are composed 
of native-like dimers undergoing local unfolding, forming non-native intermolecular interactions 
involving the zinc-binding and electrostatic loops and exposed β-barrel edge strands (90, 138).  
Crystallographic studies of undermetallated and mismetallated SOD1 variants have revealed 
numerous structural changes that occur upon metal loss that enable formation of these assemblies 
of SOD1 dimers.  Various interactions between the zinc binding and electrostatic loops are lost 
in the absence of metal, the result of which is increased disorder in these loops (90, 136–138).  
When zinc is bound in its proper site, His 46 (a copper binding ligand) and 71 (a zinc binding 
ligand) form hydrogen bonds with Asp 124 in the electrostatic loop (136, 191).  Zinc binding 
further stabilizes the electrostatic loop by capping the negatively charged end of the short α-helix 
within this loop, which sits above the zinc binding site (Fig. 1.5) (191).  When the zinc binding 
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and electrostatic large loops are in place, charged residues Asp 76 and Glu 77 act as 
“gatekeepers,” preventing exposure of the β-barrel edge strands; but when the conformation of 
these loops is lost, the edge strands are exposed and SOD1 dimers can assemble in a linear or 
zig-zag fashion, depending on the degree of loop disorder (90).  These structural studies show 
that the SOD1 dimer is finely tuned for proper metal binding, and the conformational freedom of 
zinc binding and electrostatic loops is highly influenced by the numerous interactions formed in 
the presence of metal.  Consequently, aggregation of apoSS may progress from various locally or 
globally unfolded conformations, with or without aberrant disulfide linkages. 
The highly stable holoSS form of SOD1 is generally thought to be highly resistant to 
aggregation (35, 76, 144, 192).  Nevertheless, agitation of holoSS, in combination with strongly 
destabilizing solution conditions, results in fibril formation (76, 78); prolonged quiescent 
incubation of both WT and mutant holoSS under physiological temperature and pH, eventually 
results in formation of amorphous aggregates (99).  Lag phases are characteristic of unfavourable 
nucleation-rapid elongation aggregation mechanisms, and have been observed for many disease-
linked amyloid-forming proteins.  Similar to these proteins, for SOD1 various mutations may 
decrease the length of the lag phase, possibly due to enhanced metal loss and/or dimer 
dissociation (99, 193).  In cells, these structural changes may in turn promote disulfide reduction 
(194).  Increased population of various misfolded forms of SOD1 due to these changes could 
also contribute to aggregation in ALS.  Of note, loss of all bound metals was not required for 
amorphous aggregation (99), and crystallographic studies found that part-metallated SS SOD1 
can form helical fibrils via non-native loop and β-barrel interactions (90). In addition, the 
oxidation of various residues has been implicated in misfolding/aggregation.  For example, 
oxidation of active site histidine residues promotes amorphous aggregation of metallated SS 
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SOD1 (178).  Thus, mutation and/or other covalent changes to holoSS can also give rise to 
misfolded, aggregation-prone species.  Taken together, the above-described findings provide 
evidence for multiple possible aggregation processes, which may play various contributive roles 
in disease. 
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1.4 Research Objectives 
 A long standing theory in the field of ALS research is that the immature, metal free, 
forms of SOD1 are the most relevant to disease due to their lower stability, and consequently 
heightened aggregation propensity (52).  There has been a great deal of speculation that these 
species, notability apoSH, represent the common denominator in various cases of familial and 
sporadic ALS (76, 135, 147, 180, 184, 195).  Monitoring SOD1 aggregation is difficult however, 
and many of these studies were performed in vitro, under non-physiological conditions, in order 
to accelerate the rate of aggregation to aid with experimental tractability.  Interpreting these 
results in relation to disease characteristics is therefore difficult. 
 Previous studies in the Meiering lab have focused on characterizing the stability of 
various apoSS SOD1 variants (128, 134).  The work presented herein is an elaboration of these 
studies.  In particular, using a combination of isothermal titration calorimetry (ITC) and 
differential scanning calorimetry (DSC), instead of reporting on just total dimer stability, the 
thermodynamics of apoSS dimer dissociation and monomer unfolding have been separately 
characterized (Chapter 2 and 3).  Using this approach, we have found that the common effect of 
all fALS-associated mutations investigated is that they weaken the dimer interface, while 
exerting different effects on the stability of the apoSS monomer.  Our experiments also reveal 
that dimer dissociation is accompanied by extensive unraveling of the structure resulting in the 
formation of poorly packed and malleable monomers.  These findings provide key information 
for understanding the mechanisms and energetics underlying normal maturation of SOD1, as 
well as toxic SOD1 misfolding pathways associated with disease. 
Earlier DSC experiments in the Meiering lab also revealed that fALS-associated mutations 
have the largest effects on the stability of apoSH, in some cases decreasing the melting 
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temperature of the protein to below 37 °C; thus, a significant fraction of the protein is unfolded at 
physiological temperature (174).  Whether or not this decrease in stability promotes aggregation 
under physiological conditions was largely unknown.  Here we have expanded these studies to 
additional apoSH variants to more fully appreciate how the different structural contexts of the 
mutations impact the thermodynamics of unfolding.  We have also characterized how fALS-
associated mutations impact the aggregation propensity of apoSH under physiological conditions 
(Chapter 4).  Aggregation was assessed using a combination of complimentary biophysical 
techniques, such as light scattering, atomic force microscopy (AFM), and Thioflavin-T (ThT) 
binding, with the goal of reporting on aggregation behaviour, not induced by extreme conditions 
that cause the marginally stable apoSH form to unfold.  We also accounted for the effects of 
removing the free cysteines (Cys 6 and 111) on the folding and aggregation behaviour of apoSH 
(Chapter 4).  We find that under physiological conditions, apoSH is fairly resistant to 
aggregation.  Low levels of small oligomers do form, but the concentration of these oligomers 
remains too low to support extensive aggregation.  We therefore explored other mild conditions 
that enhance the intermolecular interactions between apoSH and encourage aggregation.  
Interestingly, at higher protein concentration and/or in the presence of salt, we observe very 
different aggregation propensities of diverse apoSH variants that do not appear to correlate with 
differences in stability (Chapter 5).   
The goal of these in depth biophysical analysis of metal free stability and aggregation 
propensity has been to provide valuable insight into various ways metal free SOD1 may misfold 
and aggregate and inevitably contribute to disease. 
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Chapter 2 
Destabilization of the dimer interface  
is a common consequence of  
diverse ALS-associated mutations in metal free SOD1 
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Overview 
Neurotoxic misfolding of Cu,Zn-superoxide dismutase (SOD1) is implicated in causing 
amyotrophic lateral sclerosis, a devastating and incurable neurodegenerative disease.  Disease-
linked mutations have been proposed to promote misfolding and aggregation by decreasing 
SOD1 stability and increasing the proportion of less folded forms of the protein.  Here we report 
direct measurement of the thermodynamic effects of chemically and structurally diverse 
mutations on the stability of the dimer interface for metal free (apo) SOD1 using isothermal 
titration calorimetry and size exclusion chromatography.  Remarkably, all mutations, even ones 
that are distant from the dimer interface, decrease interface stability and increase the population 
of monomeric SOD1.  The thermodynamic analyses show that substantial structural 
perturbations accompany dimer dissociation, resulting in formation of poorly packed and 
malleable dissociated monomers.  These findings provide key information for understanding the 
mechanisms and energetics underlying normal maturation of SOD1, as well as toxic SOD1 
misfolding pathways associated with disease. 
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2.1 Introduction 
Amyotrophic lateral sclerosis (ALS) is a common, rapidly progressive motor neuron 
disease, for which there is no cure, and treatment options are very limited (3).  Mutations in 
homodimeric Cu, Zn superoxide dismutase (SOD1) (Fig. 2.1) account for ~20% of familial and 
3-5% of sporadic ALS cases (fALS and sALS, respectively) (3),  and an increasing body of 
research suggests a role also for the wild-type SOD1 in disease (33).  Clinical symptoms are 
similar in fALS and sALS (3);  thus, studies on SOD1 are critical for understanding the 
molecular mechanisms of disease.   
Many, predominantly missense, mutations distributed throughout SOD1 have been 
associated with fALS (http://alsod.iop.kcl.ac.uk/home.aspx), and confer a toxic gain-of-function 
to the protein (3).  A characteristic feature of ALS is the formation of protein aggregates in motor 
neurons (21), and SOD1 is a component of aggregates in SOD1-linked fALS and in some sALS 
cases (26), as well as in animal models of the disease (196).  Thus, a prominent hypothesis is that 
ALS is caused by protein misfolding and aggregation, analogous to toxic misfolding of other 
proteins in various neurodegenerative diseases such as Huntington’s, Alzheimer’s and prion 
disorders (52).  The mechanisms by which SOD1 forms aggregates, however, remain poorly 
understood (2). 
Extensive research indicates that an increased population of unmetallated (apo) 
monomeric forms of SOD1 may promote toxic aggregation (134, 143, 175, 193, 197–199).  
Folding and thermodynamic stability measurements of SOD1 can reveal if and how mutations 
create instability and so favour misfolding and aggregation (2).  In previous studies, we observed  
moderately destabilizing effects of several mutations on the highly stable metal-bound (holo) 
SOD1, owing mainly to decreases in monomer stability, and mutations that weaken metal 
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binding tend to have the largest destabilizing effects on holo monomers (143).  For the apo 
protein, the mutations tend to decrease both dimer interface and monomer stability to a larger 
extent than for the holo protein (134).  Measurements of the kinetics of unfolding and refolding 
have similarly indicated that some mutations weaken the apo SOD1 dimer interface; however, 
these experiments have high uncertainties due to long extrapolations (176, 177, 200), and the 
assumption of invariance in the underlying rate constant for dimer association (176, 200).  
Molecular dynamic simulations have also predicted that the large majority of mutations weaken 
the dimer interface of apo SOD1 (175, 201, 202).  Collectively, these studies suggest that some 
fALS-associated mutations weaken the apo SOD1 dimer interface, but until now direct 
experimental measurement of these effects has been very limited and further experimental 
studies are needed to ascertain the effects of mutations on dimerization. 
Here, we report direct quantitative measurements of the thermodynamics of dimer 
dissociation for 13 chemically and structurally diverse ALS-associated mutations distributed 
throughout the SOD1 structure (Fig. 2.1) by isothermal titration calorimetry (ITC) and size 
exclusion chromatography (SEC).  ITC is a powerful, yet little explored, tool for characterizing 
the thermodynamics of protein-protein association using measurements of the heat changes that 
accompany binding (203).  A single ITC experiment can define the dissociation equilibrium 
constant (Kd) and enthalpy (∆Hd), from which the Gibbs free energy (∆Gd) and entropy of 
dissociation (∆Sd) can be determined.  In addition, using measurements of ∆Hd as a function of 
temperature, the change in the specific heat capacity for dissociation (∆Cp,d) can be obtained.  
Using ITC to analyze the thermodynamics of apo SOD1 dimer dissociation at physiological 
temperature and pH, as well as parallel measurements of dissociation using SEC, we obtain the 
striking result that diverse mutations decrease dimer interface stability and increase formation of 
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structurally disrupted monomers.  The ITC and SEC give valuable information on the energetics 
and mechanism of SOD1 subunit association for understanding natural protein maturation and 
disease. 
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Figure 2.1 Structural features of apo SOD1.  SOD1 is a homodimeric metalloenzyme.  Each 
monomer forms a Greek key β-barrel and contains a single disulfide bond (orange).  In the 
absence of bound metals, loops IV (green) and VII (blue) are disordered and the structure is 
more flexible than the metal-bound (holo) protein (135, 136).  The sites of ALS-associated 
mutations characterized herein are shown in red sticks (PDB code 1HL4). 
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2.2 Materials and Methods 
2.2.1 Recombinant SOD1 expression and purification   
The human pWT SOD1 (pseudo wild-type with nonconserved Cys 6 and Cys 111 
replaced by Ala and Ser, respectively) (1, 98, 141) and mutant SOD1 were expressed using the 
plasmid vector pHSOD1ASlacI1 (204) in E. coli cells, purified and demetallated by dialysis 
against ethylenediaminetetraacetic acid (EDTA) as described previously (128, 205).  Protein 
concentration was determined by absorbance at 280 nm using an extinction coefficient of 10,800 
M
-1
 cm
-1
 for the SOD1 dimer (206).   
 
2.2.2 Isothermal titration calorimetry (ITC)   
ITC experiments measuring the heat of dissociation of the apo SOD1 dimer (N2) to folded 
monomers (M), N2↔2M, governed by the dissociation constant (Kd), were performed as 
described (207, 208) using a Microcal Isothermal Titration Calorimetry 200 instrument 
(Microcal Inc, Northampton, MA, USA).  Measurements were performed at 37 °C, where 
dissociation is increased compared to previous measurements at lower temperatures (134, 177, 
193, 197), and below the transition temperature of thermal denaturation experiments (128, 134).  
Highly concentrated apoSS SOD1 (0.35-1 mM total dimer), buffered in 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.8, was diluted into the identical 
buffer in the ITC reaction cell in successive small volume (0.3-0.5 μL) injections.  Dilution 
artefacts were minimized by injecting the protein directly into flow-through collected during 
concentration by ultrafiltration of the high protein concentration solution.  The heat associated 
with each injection (qi) was determined by integrating the power versus time trace.  Data were fit 
to a dimer dissociation model (207, 208) according to Eq. 2.1:  
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𝑞
𝑖
= 𝑉∆𝐻𝑑 ([𝑀𝑖] −  [𝑀𝑖−1] (1 −
𝑣
𝑉
) −  𝑓
𝑚
[𝑀𝑜]
𝑣
𝑉
) +  𝑞
𝑑𝑖𝑙
 (Eq. 2.1) 
where ΔHd is the enthalpy change of dissociation from native dimer to two monomers, calculated 
per mol monomer.  [M]o is the total concentration of apo SOD1 (monomer units) in the syringe, 
[Mi] and [Mi-1] are the concentrations of apo SOD1 monomer in the ITC cell after injection i and 
i-1, respectively, v is the volume of each injection, V is the ITC reaction cell volume, qdil is a 
correction factor for the heat associated with sample dilution unrelated to dissociation, and fm is 
the fraction of protein in the syringe that exists as free monomer, which can be expressed as: 
𝑓
𝑚
=
1
4[𝑀0]
(−𝐾𝑑 +  √𝐾𝑑
2 + 8𝐾𝑑[𝑀𝑜]) (Eq. 2.2) 
The data were fit using Microcal Origin 7.0 (Microcal Inc, Northampton, MA, USA) with ΔHd, 
Kd and qdil as floating parameters.  At the experimental temperature, Texp, ∆Gd(Texp) was 
calculated from Kd(Texp) using Eq. 2.3: 
∆𝐺𝑑(𝑇𝑒𝑥𝑝) =  −𝑅𝑇𝑒𝑥𝑝𝑙𝑛𝐾𝑑(𝑇𝑒𝑥𝑝) (Eq. 2.3) 
where R is the universal gas constant.  ITC experiments were performed at temperatures ranging 
from 18 to 37 °C to obtain the temperature dependence of ΔHd, the ΔCp,d, for mutants where 
dissociation was measureable at lower temperatures (Fig. 2.3A).  Values of ΔGd(T) at other 
temperatures can be calculated using Eq. 2.4 (128). 
∆𝐺𝑑(𝑇) =  [∆𝐻𝑑,𝑒𝑥𝑝 +  ∆𝐶𝑝,𝑑(𝑇 − 𝑇𝑒𝑥𝑝)] − 𝑇 [∆𝑆𝑑,𝑒𝑥𝑝 + ∆𝐶𝑝,𝑑ln (
𝑇
𝑇𝑒𝑥𝑝
)] (Eq. 2.4) 
 
2.2.3 Size Exclusion Chromatography (SEC)   
SEC was performed on a Bio-Rad BioLogic DuoFlow system with a prepacked Superose 
12 10/300 GL (GE Healthcare) analytical gel filtration column.  The mobile phase was 20 mM 
HEPES, 150 mM NaCl, pH 7.8, with a flow rate of 1 mL min
-1
.  Experiments were conducted at 
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ambient temperature (~23 °C) and sample injection volumes were 25 µL.  Linear calibration 
curves of elution time versus log of molecular weight were obtained using standards: bovine 
serum albumin (66 kDa), myoglobin (16.9 kDa), and cytochrome C (12.6 kDa).  Dilution of the 
sample on the column was determined once daily by using the peak width at half height of the 
myoglobin standard (~800 µL) and dividing by the volume loaded (25 µL).  This dilution factor 
(~32) was used to calculate the total concentration of the SOD1 when eluted from the column.   
The elution volume of each sample (Ve) plotted against total protein concentration in 
dimer equivalents [N2]o was fit to Eqs. 2.5 and 2.6 (209) using Origin Software: 
𝑉𝑒 =  𝑉𝑀 −  [
(𝑉𝑀− 𝑉𝑁2)(log(
1+% 𝑁2
100
) )
𝑙𝑜𝑔2
] (Eq. 2.5) 
% 𝑁2 =  [
(8[𝑁2]𝑜+ 𝐾𝑑)− √𝐾𝑑
2+16𝐾𝑑[𝑁2]𝑜
0.08[𝑁2]𝑜
] (Eq. 2.6) 
where % N2 = [N2]/[N2]o*100 and VM and VN
2 
are the elution volumes of the monomer and dimer, 
respectively.  For dimers with a Kd in the range of 1 to 10 μM, the data could be fit to Eqs. 2.5 
and 2.6 to obtain parameters VM , VN
2
 and Kd (210).  On average, the fitted VM  was 1.2 mL 
greater than VN
2
 indicating the hydrodynamic volume of the dissociated monomers is increased ~ 
10% relative to the associated monomers (211).  For dimers with a Kd in the range of 0.001 to 
0.01 μM, values of VN
2 
were well defined by the data; detection limits at 280 nm precluded 
obtaining Ve at lower protein concentrations for determination of VM and so this was set to a 
value based on the dimers with larger Kd values.  Linear transformations of the data were 
generated using Ve and fitted values according to Eqs. 2.7-2.10: 
% 𝑁2 = 100 ×  2
𝑉𝑀  −𝑉𝑒  
𝑉𝑀  −𝑉𝑁2    - 1 (Eq. 2.7) 
𝐾𝑑 =
0.04[𝑁2]𝑜(100−%𝑁2)
2
%𝑁2
 (Eq. 2.8) 
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log [
%𝑁2
0.04(100−%𝑁2)2
] = log[𝑁2]𝑜 − log[𝐾𝑑] (Eq. 2.9) 
𝑌 =  
%𝑁2
 0.04(100−%𝑁2)
2 
 (Eq. 2.10) 
A plot of log Y versus log [N2]o yields a straight line with a slope of 1; when Y = 1, Kd = [N2]o 
(Fig. 2.4). 
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2.3 Results and Discussion 
2.3.1 Apo SOD1 dissociation is endothermic and strongly dependent on temperature   
ITC experiments were conducted for pWT (pseudo wild-type) apoSS SOD1 and fALS-
associated mutants (Figs. 2.1, 2.2), yielding Kd and associated thermodynamic properties (Fig. 
2.2C, Table 2.1).  Previous measurements by analytical ultracentrifugation (AUC), SEC and 
chemical denaturation conducted at lower than physiological temperature found that the wild-
type apo SOD1 dimer is quite stable (e.g. Kd ~1 nM at neutral pH, temperature range 5-25 °C) 
(134, 177, 193, 197).  Here, we report measurements at a physiological temperature of 37 °C, 
where we find dissociation is markedly increased, with Kd values larger than ~67 nM (Figs. 
2.2C, S2.1).  Furthermore, SOD1 dissociation is endothermic (Figs. 2.3A, C, vide infra), with a 
large positive ∆Cp,d (Fig. 2.3A).  Thus, the dissociation enthalpy is strongly temperature-
dependent, and dissociation is increasingly favorable and measurable by ITC at higher 
temperature due to the increased heat of dissociation.  Owing to relatively larger heats of 
dissociation being observed for some mutants (A4V, H43R, I113T and V148G), their 
dissociation is also measurable at 25 °C (Figs. 2.3A, B).  Measurements of Kd using SEC (Figs. 
2.4, S2.2) are in excellent agreement with ITC (Fig. 2.3B and Table 2.1). 
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Figure 2.2 Isothermal titration calorimetry reveals decreased dimer stability for SOD1 
mutants.  (A) Raw ITC data for I113T mutant at 37 °C.  Each peak corresponds to the heat 
measured for a small volume injection of protein solution into the ITC sample cell.  The 
endothermic heats of dissociation decrease for successive injections due to the increase in protein 
concentration in the cell and the accompanying shift of the equilibrium towards native dimer.  
(B) Integrated heats at 37 °C for each injection (diamonds) are shown for pWT (black), E100G 
(blue), I113T (green), A4V (orange) and V148G (red), in order of increasing values of Kd.  The 
dashed lines are the fits of the data to a dimer dissociation model (Eq. 2.1) with fitted values 
shown in Figs. 2.2C, 2.3 and summarized in Table 2.1.  (C) For all mutants, the Kd is increased 
relative to the pWT as measured by ITC at 37 °C.   
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2.3.2 fALS-associated mutations weaken the apo SOD1 dimer interface   
The ITC and SEC measurements clearly demonstrate a common effect of weakening of 
the apo SOD1 dimer interface by diverse ALS-associated mutations that are distributed 
throughout the protein structure (Fig. 2.1).  The ITC data for all the apo SOD1 variants are well 
fit by a 2-state dimer dissociation model (N2↔2M) (see Experimental Procedures, Fig. 2.2B).  
The ΔHd and Kd values from the fits and the corresponding ΔGd values are summarized in Figs. 
2.2C, 2.3B, C, and Table 2.1.  At 37 °C, the pWT apo SOD1 dimer interface still has a relatively 
high affinity, with a Kd of 67 nM and ΔGd of 10.3 kcal (mol dimer)
-1
.  All mutations increase the 
Kd at 25 and 37 °C but to different extents (Figs. 2.2C, S2.1), corresponding to decreases in 
interface stability of 1.3-4.3 kcal (mol dimer)
-1
 at 37 °C (Fig. 2.3B, Table 2.1). 
Notably, the effects of mutations on the integrity of the dimer interface cannot be 
predicted readily based on the different structural contexts of the mutations (Fig. 2.1).  The dimer 
interface stability is considerably weaker at 37 °C than measured previously at lower temperature 
and the mutations are more destabilizing at 37 °C resulting in a significant proportion of 
monomer at physiological temperature and protein concentration (~ 40 µM (212); ~2% for pWT 
to ~50% for V148G).  In general, mutations in or near the dimer interface, such as A4V, I113T 
and V148G, tend to be the most destabilizing, but distant mutations, notably G93R, can also 
markedly weaken the interface (Figs. 2.1, 2.2C).  Thus, a key finding here is that the effects of 
fALS-associated mutations commonly propagate through the protein and weaken the dimer 
interface of apo SOD1.  Additional support for the generality of this result is provided by 
simulations of additional mutants and more limited experimental measurements of stability under 
non-physiological conditions (134, 175–177).  Similar long range effects of mutations on 
interfaces have been reported for some other oligomeric proteins (213–215).  Notably, inherited 
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mutations in transthyretin (TTR) are proposed to cause familial amyloid polyneuropathy (FAP) 
by inducing conformational changes that promote dissociation of the native tetramer, leading to 
formation of partially folded monomers that can self-assemble into amyloid fibrils (215).  For 
SOD1, the finding that all the mutations studied destabilize the interface is especially significant 
in light of antibody binding studies that identified exposure of the SOD1 dimer interface in 
aggregates from ALS patients (22, 216), implicating dimer dissociation as a common occurrence 
in disease. 
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Figure 2.3 Thermodynamics of apo SOD1 dimer dissociation.  (A) Kirchoff plot of ∆Hd 
versus temperature.  The ΔCp,d is determined from the temperature dependence of ∆Hd and is 
similar for diverse mutants.  For V148G (red circles), A4V (orange squares), I113T (green 
diamonds), and H43R (purple triangles), the ΔCp,d  is 1.1 ± 0.1, 0.8 ± 0.1, 0.7 ± 0.2, and 0.8 ± 0.2 
kcal (mol monomer)
-1
 °C-1, respectively.  Thus, the average ΔCp,d  is ~0.9 kcal (mol monomer)
-1
 
°C-1 (1.7 ± 0.2 (kcal (mol dimer)-1 °C-1)).  (B) ∆Gd determined by ITC at 37 °C and 25 °C (left 
bar, grey; middle, dark blue, respectively), and by SEC at ~23 °C (right, light blue).  The 
expected difference in ∆Gd at 25 and 23 °C calculated using Eq. 2.4 (Experimental Procedures) is 
less than 0.1 kcal (mol dimer)
-1
.  (C) ∆Hd (red) and T∆Sd (blue) determined by fitting heats of 
dissociation at 37 °C.  Error bars reflect the standard deviation of multiple (3-10) ITC 
experiments.  The determined values are summarized in Table 2.1.  
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Table 2.1 Dimer interface stability of apo SOD1 variants measured by ITC and SEC. 
SOD1 variant 
∆Hd 
(kcal (mol 
dimer)
-1
)) 
ITC (37 °C)a 
Kd 
(µM) 
 
ITC (37 °C)a 
∆Gd 
(kcal (mol 
dimer)
-1
)) 
ITC (37 °C)a,b 
∆∆Gd 
(kcal (mol 
dimer)
-1
)) 
ITC (37 °C)c 
∆Gd 
(kcal (mol 
dimer)
-1
)) 
ITC (25 °C)a,b 
∆Gd 
(kcal (mol 
dimer)
-1
)) 
SEC (23 °C)b,d 
pWT 30.8 ± 8.8 0.067 ± 0.050 10.3 ± 0.5 na nd 11.0 ± 0.4 
V148I 11.4 ± 2.2 0.5 ± 0.2 8.9 ± 0.2 1.3 nd nd 
G93S 17.6 ± 4.6 1.3 ± 0.5 8.4 ± 0.3 1.8 nd nd 
H46R 16.2 ± 4.4 1.4 ± 1.1 8.4 ± 0.4 1.9 nd 10.3 ± 0.3 
E100G 16.0 ± 4.8 2.6 ± 1.7 8.0 ± 0.4 2.3 nd nd 
G37R 7.8 ± 1.8 5.0 ± 1.9 7.6 ± 0.2 2.7 nd nd 
H43R 23.0 ± 1.4 5.7 ± 0.4 7.5 ± 0.0 2.7 9.7 ± 0.1 10.2 ± 0.1 
G93A 14.0 ± 2.0 8.4 ± 3.5 7.2 ± 0.3 3.0 nd 10.4 ± 0.3 
I113T 30.2 ± 2.5 10.2 ± 3.0 7.1 ± 0.2 3.1 8.4 ± 1.1 9.5 ± 0.6 
A4T 39.2 ± 3.8 10.6 ± 3.3 7.1 ± 0.2 3.1 nd nd 
A4S 9.0 ± 2.6 10.9 ± 0.2 7.0 ± 0.0 3.1 nd nd 
G93R 45.6 ± 1.8 20.0 ± 4.1 6.7 ± 0.1 3.5 nd nd 
A4V 37.2 ± 3.8 34.2 ± 13.3 6.4 ± 0.3 3.8 7.9 ± 0.7 7.2 ± 0.2 
V148G 50.6 ± 1.4 76.8 ± 34.0 5.9 ± 0.3 4.3 7.3 ± 0.1 7.0 ± 0.1 
na = not applicable.  
nd = not determined. 
a
Values for each mutant are derived from fitting integrated raw ITC data to a dimer dissociation 
model (Eq. 2.1, Fig. 2.2B)  and are an average and standard deviation of 3-10 experiments. 
b∆Gd values were obtained from Kd values using Eq. 2.3. 
cΔΔGd = ΔGd,pWT – ΔGd,mutant; positive values indicate a decrease in interface stability for the 
mutant relative to pWT. 
d
Data obtained by SEC.  For pWT, G93A and H46R, heats of dissociation at 25 °C were too 
small to be measurable by ITC, thus Kd at this temperature was measurable only by SEC.  Values 
are the average of 3-6 experiments and error bars represent the 95% confidence intervals. 
SEC data was obtained and analyzed by Jessica A. O. Rumfeldt. 
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2.3.3 Thermodynamics show that apo SOD1 dimer dissociation is accompanied by extensive 
disruption of structure and explain the particular sensitivity of the dimer interface to mutation  
The thermodynamic data provide insights into structural changes accompanying apo 
SOD1 dissociation.  The measured enthalpies (Fig. 2.3C, Table 2.1) are much (up to 20-fold) 
larger than expected values calculated using empirical models based on surface area changes 
between the crystal structure of the SOD1 dimer and its constituent monomer  (217, 218).  In 
addition, the value of ΔCp,d (1.7 ± 0.2 kcal (mol dimer)
-1
 °C-1, Fig. 2.3A) is relatively large; the 
large values of ΔHd and ΔCp,d indicate a substantial increase in exposure of hydrophobic residues 
upon dissociation (219).  For protein folding, ΔCp can be calculated fairly accurately based on 
changes in solvent accessible surface area (217, 218).  Applying this approach, and assuming no 
structural change in the monomer upon dissociation, the estimated ΔCp,d for SOD1 is ~0.5 kcal 
(mol dimer)
-1
 °C-1, again, much lower than the experimental value.  Notably, large ΔHd and ΔCp,d 
values have been reported for some other proteins, and were explained by significant 
conformational changes and/or changes in solvent binding upon dissociation (203, 218, 220).  
The total ΔCp for unfolding of the apo SOD1 dimer to unfolded monomers, ΔCp,N
2
↔2U, has been 
measured previously as 3.3 ± 0.8 kcal (mol dimer)
-1 °C-1 (128); combining this value with ΔCp,d, 
the change in heat capacity for monomer unfolding, ΔCp,M↔U  (= ΔCp,N
2
↔2U - ΔCp,d )/2), can be 
calculated as 0.8 ± 0.4 kcal (mol monomer)
-1
 °C-1.  These values of ΔCp,d and ΔCp,M↔U are 
consistent with measurements of the denaturant-dependence of dimer dissociation and monomer 
unfolding for apo SOD1 which, similar to changes in heat capacity, are roughly correlated with 
changes in solvent exposed surface area (134).  Thus, the relatively large ΔCp,d and small 
ΔCp,M↔U reveal significant disruption of the compact structure of the apo SOD1 dimer upon 
dissociation to form less well packed monomers (discussed further below).    
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Additional mechanistic insights into the process of consolidation of the dimer interface 
during SOD1 maturation may be obtained from further consideration of the dissociation 
thermodynamics combined with structural and folding studies.  For all the SOD1 variants, dimer 
dissociation is enthalpically unfavorable and entropically driven at 37 °C (Fig. 2.3C), suggesting 
increased protein entropy upon dissociation overcomes the loss of solvent entropy due to 
increased exposure of hydrophobic residues (221).  The solution NMR structure of an engineered 
monomeric apo SOD1 variant containing multiple mutations in the interface that abolish 
dimerization shows substantial disruption of structure compared to the dimer (222).  Also, 
chemical denaturation m values indicate that the pWT apo SOD1 monomer involves lower than 
typical burial of solvent exposed surface area upon folding, and the monomer becomes 
considerably more compact in the presence of stabilizing Na2SO4 (134).  Moreover, most of the 
substantial stability of dimeric apo SOD1 originates from the formation of the dimer interface, 
which is only slightly less stable than in the holo form of the protein (134, 143).  Other indirect 
measures using chemical denaturants found the isolated apo SOD1 monomer has only marginal 
thermodynamic stability (134, 177).  Thus, the direct measurements of thermodynamics of 
dissociation determined here are consistent with previous results obtained under non-
physiological conditions, and provide strong evidence for extensive structural disruption upon 
dissociation of apo SOD1.  The thermodynamic results also provide information on the 
mechanisms underlying the natural maturation of SOD1.  Due to the loose packing of the apo 
monomer, dimerization confers strong stabilization as well as protection against aggregation by 
structuring regions of the protein that are highly dynamic in the monomer. 
The particular sensitivity of the SOD1 dimer interface to disruption by mutations as 
demonstrated here is consistent with the structural and dynamic features of the interface.  The 
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SOD1 interface is not evolutionarily conserved (223), is relatively small (~10% of monomer 
surface area) and has high hydrophobicity (~80% nonpolar residues) (173).  The small size and 
high hydrophobicity of the interface suggest a low extent and selectivity of monomer-monomer 
interaction so that association may be easily perturbed by mutation.  Indeed, significant changes 
in the interface were observed in structural studies of A4V and I113T (198).  Furthermore, due to 
the small size of the interface there may be little variation possible for stable orientations of 
monomers (224).  Computational studies have shown that the dimer interface and metal binding 
sites in SOD1 are highly connected (225),  and have identified coupled motion between SOD1 
monomers that is lost in A4V, G37R and H46R dimers (226, 227).  Taken together, these 
computational studies point to long-range structural effects caused by mutations that may disrupt 
proper interface contacts.  Furthermore, the network of stabilizing interactions that form when 
metals are bound to SOD1 constrains the flexibility of loops IV and VII (Fig. 2.1); but, in the 
absence of metal these loops gain conformational freedom (135, 136, 165),  and have been 
proposed to create energetic frustration in the apo form of the protein (148).  These regions of 
enhanced dynamics, notably in Loop IV which forms part of the dimer interface, may be easily 
perturbed by mutations leading to compromised dimer interface stability.  Thus, the common 
weakening of the dimer interface of apo SOD1 with temperature and mutation as characterized 
here rationalizes a range of experimental and computational results and demonstrates the 
susceptibility of the interface to disruption by modest changes in the covalent structure of the 
protein.  This disruption may occur not only due to fALS-associated mutations but also upon 
covalent modifications of wild-type SOD1 observed in sALS (19).  
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Figure 2.4 Size exclusion chromatography reveals decreased dimer stability for SOD1 
mutants.  SEC data were measured as a function of total dimer concentration, [N2]o.  The linear 
transformation of the data (Experimental Procedures, Eq. 2.9) gives the fitted Kd values (Table 
2.1) at  Y=1 as indicated by the arrows.  Symbols with error bars represent the average and 95% 
confidence intervals for 3-6 SEC measurements.  SEC data was obtained and analyzed by Jessica 
A. O. Rumfeldt. 
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2.3.4 Conclusions 
In summary, we report here ITC and SEC measurements that reveal common 
destabilization of apo SOD1 caused by diverse mutations whose effects manifest at the dimer 
interface.  To date, relatively few homodimeric proteins have been characterized by ITC, and 
predicting the energetics and mechanisms of protein binding remains challenging (203, 218, 
220).  Such predictions are particularly difficult when association also involves significant 
protein conformational changes (228).  The results here show how quantitative analysis of 
protein interface stability by ITC can provide valuable data both for fundamental understanding 
and modelling of protein-protein interactions and for understanding disease. 
Many studies have attempted to correlate various properties of mutant SOD1 with ALS 
characteristics.  A correlation between total protein stability (i.e. combined monomer and dimer 
interface stability) and disease duration has been reported; however, the data are very scattered 
(200, 229, 230).  Thus, mutational effects on total stability are only part of the story.  Our results 
show that dimerization and monomer stabilities are additional key characteristics to consider for 
unravelling the origins of toxic effects of SOD1 in ALS.  
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2.4 Supplementary Information 
 
 
Figure S2.1 Change in dimer interface affinity with increasing temperature.  The grey bars 
represent the increase in the Kd at 37 °C relative to 25 °C (Kd = Kd(37) - Kd(25)).  SEC and ITC 
experiments at ~23 °C and 25 °C, respectively, were performed for H43R, I113T, A4V, and 
V148G.  Extrapolating ∆Gd(25) values determined by ITC to ∆Gd(23) using Eq. 2.4 and a ΔCp,d 
of 1.7 kcal (mol dimer)
-1
 °C-1 results in very little change in ∆Gd  (0.03-0.09 kcal (mol dimer)
-1
) 
and Kd (0.02-0.6 μM), which are smaller than the experimental uncertainties.  Thus, the Kd(25) 
values were calculated as the average of the ITC and SEC values.  For pWT, H46R, and G93A, 
the heat of dissociation was too small at 25 °C to be measurable by ITC, and so the SEC values 
were used.  Error bars reflect the standard deviation of multiple measurements of Kd(37) and 
Kd(25). 
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Figure S2.2 Decreased dimer stability of SOD1 mutants measured by SEC at ambient 
temperature (23 °C).  (A) SEC elution profile for pWT (black), I113T (green), and V148G (red) 
at 0.9 and 0.2 μM dimer, shown as solid and dotted lines, respectively.  (B) Percent native dimer 
(N2) as a function of protein concentration (M dimer).  Data points are calculated from 
experimental elution volumes and fitted parameters using Eq. 2.7.  Solid lines were generated 
using Eq. 2.6 and fitted values of Kd (Table 2.1). 
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Chapter 3 
Combined calorimetry techniques reveal complex effects of fALS-associated 
mutations on the stability of metal free SOD1 
 
Author Contributions 
This chapter will be submitted for publication with the following authors: Helen R. 
Broom, Kenrick A. Vassall, Jessica A.O. Rumfeldt, Ming Sze Tong, Julia M. Bonner, and 
Elizabeth M. Meiering.  The manuscript was written mainly by Helen R. Broom with 
contributions from Kenrick A. Vassall, Jessica A.O. Rumfeldt, and Elizabeth M. Meiering.  The 
ITC data were obtained by Helen R. Broom (Chapter 2); the DSC data were obtained by Helen 
R. Broom, Kenrick A. Vassall, Jessica A.O. Rumfeldt, Ming Sze Tong, and Julia M. Bonner, as 
well as previously published data acquired by Peter B. Stathopulos (128); chemical denaturation 
of apo pWT SOD1 was performed by Jessica A.O. Rumfeldt; dimer 2-state data fitting was 
performed by Helen R. Broom, Kenrick A. Vassall, and Jessica A. O. Rumfeldt; monomer 2-
state data fitting was performed by Helen R. Broom and Kenrick A. Vassall, and 3-state data 
fitting using was performed by Helen R. Broom.   
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Overview 
Neurotoxic aggregation of mutant Cu, Zn-superoxide dismutase (SOD1) has been 
implicated in causing amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative 
disease.  It has been proposed that ALS-associated mutations in SOD1 promote the formation of 
neurotoxic aggregates by enhancing dissociation of mutant SOD1 homodimers to form 
aggregation-prone monomers.  We have previously investigated the thermodynamic effects of 
chemically and structurally diverse mutations on dimer interface stability for unmetallated (apo) 
SOD1 using isothermal titration calorimetry (ITC) and shown that the effects of the mutations 
generally propagate through the structure and compromise the strength of the dimer interface.  
Here we use these measurements of dimer interface stability combined with measurements of 
total unfolding by differential scanning calorimetry (DSC) and urea denaturation to assess the 
effects of mutations on both dimer interface and monomer stability.  We find that although all 
mutations characterized herein decrease the stability of the dimer interface, they have varying 
effects on the monomer stability ranging from slightly stabilizing to moderately destabilizing.  
These values reflect the true stability of the apo monomer; previous experiments commonly used 
a monomer construct with mutations in the dimer interface to assess the effects of disease-
associated mutations.  Using stability parameters to calculate the population of folded dimer, 
folded monomer intermediate, and unfolded monomer reveals that the mutations increase the 
population of a monomers at physiological temperature and pH.  Since apo monomers have an 
increased propensity to aggregate, these results are particularly pertinent for understanding toxic 
aggregation pathways involved in neurodegeneration. 
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3.1 Introduction 
Cu, Zn-superoxide dismutase (SOD1), a dimeric metalloenzyme, has become a model for 
understanding protein structure and function as well as folding and misfolding associated with 
disease (126).  In 1993, a genetic link was established between ALS and mutant forms of SOD1 
(8).  A characteristic feature of ALS is the presence of protein aggregates in motor neurons (21) 
and SOD1 has also been identified as a component of aggregates in SOD1-linked familial ALS 
and some sporadic ALS patients (26, 29, 231).  To date, over 170 predominantly missense 
mutations distributed throughout the protein have been linked to familial ALS 
(http://alsod.iop.kcl.ac.uk/home.aspx).  These mutations have an autosomal dominant pattern of 
inherence, and it is generally accepted that the mutations confer a toxic gain of function to 
SOD1, although the mechanisms of toxicity remain unclear (232).  Due to similarities in the 
clinical symptoms of fALS and sALS, common mechanisms are proposed for both forms of the 
disease (33, 233).  Thus, a major hypothesis in the field of ALS research is that mutations 
promote aggregation of SOD1, analogous to toxic misfolding of other proteins associated with 
various neurodegenerative diseases such as Huntington’s, Alzheimer’s, and prion disorders (52),   
leading to a cascade of toxic events that culminate in motor neuron death (3).  However, attempts 
to identify relationships between the effects of the mutations and ALS characteristics have 
shown that these effects are highly complex and not correlated with disease characteristics in a 
simple way (98, 229).   
The fully mature form of SOD1 (holoSS) is a homodimer that binds one zinc and one 
copper ion per subunit, has a very high melting temperature (~92 °C (128)), and can maintain 
enzymatic activity under strongly denaturing conditions (129).  Yet, while mature SOD1 is 
highly stable against denaturation, ALS-associated mutants have an increased tendency to be 
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metal deficient (99), which increases the dynamics of the protein (135).  Folding and 
thermodynamic stability analyses of mutant SOD1 proteins can reveal whether the mutations 
have adverse effects on protein stability and alter folding such that misfolding and aggregation 
become more favorable.  We have previously used differential scanning calorimetry (DSC) and 
chemical denaturation to determine the stability and unfolding mechanism of metallated (holo) 
and unmetallated (apo) disulfide oxidized (SS) pWT SOD1, and identified complex effects of 
several fALS-associated mutations (134, 143).  These studies and others have suggested that 
increased population of unmetallated monomeric forms of SOD1 may initiate toxic aggregation 
(99, 144, 193, 197–199, 226, 234, 235), implicating metal loss and dimer dissociation as key 
steps in the SOD1 aggregation pathway.   
ITC is an attractive method for analyzing binding energetics (203, 236).  In addition, 
combining ITC with DSC provides a method for dissecting the effects of mutations on dimer 
interface and monomer stability.  Strikingly, ITC data clearly show that diverse mutations all 
weaken dimer interface (Chapter 2).  In this chapter we expand on these findings and show that 
mutations have varying effects on monomer stability.  For most mutations, the effects on 
monomer stability are moderately to highly destabilizing, while some mutations actually increase 
monomer stability.  Thus, point mutations can have very different effects on the component 
stabilities of the SOD1 dimer.  These results highlight the importance of understanding not just 
total protein stability, but both interface and monomer stability, as it is the interplay between 
these two properties that determines whether or not a monomer intermediate is populated, and 
thus able to nucleate aggregation under physiological conditions.  
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Figure 3.1 Structural features of apo SOD1.  SOD1 is a homodimeric metalloenzyme.  Each 
monomer forms a Greek key β-barrel and contains a single disulfide bond (orange).  Structural 
studies have shown that in the absence of metal, zinc-binding loops (loop IV, green) and 
electrostatic loops (loop VII, blue) are disordered, and the protein is more flexible compared to 
the metal-bound form (135, 136).  The sites of ALS-associated mutations characterized herein 
are shown in red (PDB code 1HL4). 
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3.2 Materials and Methods 
3.2.1 Recombinant SOD1 expression and purification   
The human pWT SOD1 (pseudo wild-type with nonconserved Cys 6 and Cys 111 
replaced by Ala and Ser, respectively) (1, 98, 141) and mutant SOD1 were expressed using the 
plasmid vector pHSOD1ASlacI1 (204) in E. coli cells, purified and demetallated by dialysis 
against EDTA as described previously (128, 205).  Protein concentration was determined by 
absorbance at 280 nm using an extinction coefficient of 10,800 M
-1
 cm
-1
 for the SOD1 dimer 
(206).   
 
3.2.2 Differential Scanning Calorimetry 
DSC experiments were performed as described previously (128), using a LLP VP DSC 
(MicroCal Inc., Malvern Instruments Ltd.).  Samples contained ~0.05-3 mg mL
-1
 of protein in 20 
mM HEPES, pH 7.8.  Buffer versus buffer thermograms were subtracted from protein versus 
buffer thermograms and data were normalized to units of cal g
-1
 °C-1 before fitting.  As in 
previous studies (128, 134), the reversibility of unfolding for the apo SOD1 mutants was 
assessed by heating the sample to the end of the unfolding endotherm, followed immediately by 
cooling and subsequent re-scanning.  Reversibility was quantified by calculating the area under 
the unfolding endotherm for the first scan and second scan.  Samples were scanned at a rate of 1 
°C minute-1, unless otherwise specified.  
 
3.2.3 Isothermal Titration Calorimetry 
ITC experiments measuring the heat associated with apo SOD1 dimer (N2) dissociation  
to folded monomers (M), N2↔2M, as governed by the dissociation constant (Kd,N2↔2M), were 
81 
 
performed and data analyzed as described (207, 208) (Chapter 2).  For pWT and all SOD1 
mutations, experiments were performed at 37 °C where we found dissociation was increased 
relative to dissociation at room temperature (~23 °C).  Some mutations were sufficiently 
destabilizing that dissociation was also measureable at 25 °C, and in such cases the data could be 
readily compared with SEC measurements of dissociation.  Data from both ITC and SEC were in 
good agreement (Chapter 2). 
 
3.2.4 Analysis of calorimetry data  
Calorimetry data were analyzed using 2-state and 3-state models with various 
combination of parameters defined as fixed or fitted.  A 2-state unfolding model describing the 
transition from native folded dimer to unfolded monomers with no intermediate, N2↔2U, and a 
3-state model with the formation of a monomer intermediate, N2↔2M↔2U (143, 237, 238) 
(Tables 3.1, 3.2) were used.  For the 2-state model, individual thermograms were fit as described 
previously for apo SOD1 to Eq. 3.1 (128, 134): 
𝐶𝑝 = (𝐴 + 𝐵𝑇)(1 − 𝛼) + (𝐸 + 𝐹𝑇)𝛼 +
𝛽∆ℎ𝑐𝑎𝑙
2 (𝑇0.5)
𝑅𝑇2
𝛼(1−𝛼)
2−𝛼
 (Eq. 3.1) 
where Cp is the total specific heat capacity at temperature T (in Kelvin); A and B are the intercept 
and slope of the folded baseline, respectively; E and F are the intercept and slope of the unfolded 
baseline, respectively; R is the universal gas constant; β is the ratio of the van’t Hoff enthalpy 
(ΔHvH) to calorimetric enthalpy (ΔHcal) multiplied by the molecular weight (MW) of the SOD1 
dimer; Δhcal(T) is the specific calorimetric enthalpy (ΔHcal divided by the molecular weight) of 
unfolding at T; α is the extent of the unfolding reaction and T0.5 (or t0.5) is the temperature in 
Kelvin (or °C) at which half of the protein is unfolded (i.e α = 0.5).  Values of molecularity, n, 
were calculated using Eq. 3.2: 
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𝑛 =  
−∆𝐻𝑣𝐻
𝑠𝑙𝑜𝑝𝑒∗𝑅
+ 1 (Eq. 3.2) 
where ΔHvH is from the 2-state fit for a given thermogram and slope is the slope of a plot of 
lnPdimer versus 1/T0.5, where Pdimer is the protein concentration in M dimer (128, 239).  For each 
variant, the slope was determined using the data at all protein concentrations.  Representative 
plots of lnPdimer versus 1/T0.5 are shown in Fig. S3.1.   
For the dimer 3-state with monomer intermediate model, the data were fit to Eq. 3.3: 
𝐶𝑝 =  (
𝛽
1
∆ℎ𝑐𝑎𝑙,𝑁2↔2𝑀(𝑇1
′ ) +  𝛼2𝛽2∆ℎ𝑐𝑎𝑙,𝑀↔𝑈(𝑇1
′ )
𝑅𝑇2
) ∆ℎ𝑐𝑎𝑙,𝑁2↔2𝑀(𝑇1
′ )
𝛼1(1 − 𝛼1)
2 − 𝛼1
+ 
((
𝛽
1
∆ℎ𝑐𝑎𝑙,𝑁2↔2𝑀(𝑇1
′ ) + 𝛼2𝛽2∆ℎ𝑐𝑎𝑙,𝑀↔𝑈(𝑇1
′ )
𝑅𝑇2
)
𝛼1𝛼2(1 − 𝛼1)
2 − 𝛼1
+
𝛽
2
∆ℎ𝑐𝑎𝑙,𝑀↔𝑈(𝑇2
′ )
2𝑅𝑇2
𝛼1𝛼2(1 − 𝛼2)) 
∆ℎ𝑐𝑎𝑙,𝑀↔𝑈(𝑇2
′) + (1 − 𝛼1)(𝐴 + 𝐵𝑇) +  𝛼1(1 − 𝛼2)(𝐶 + 𝐷𝑇) + 𝛼1𝛼2(𝐸 + 𝐹𝑇) (Eq. 3.3) 
In Eq. 3.3, the subscripts 1 and 2 refer to the first transition, N2↔2M, and second transition, 
M↔U, respectively, both defined per M of dimer.  T1
’
 was set to 310 K (37 °C), corresponding to 
the temperature at which the thermodynamics of dimer dissociation were measured by ITC, thus 
allowing for these values to be fixed during data fitting (vide infra) (Fig. S3.2); T2
’
 was defined 
as the temperature at which the equilibrium constant, KMU, is equal to 1, and is thus 
independent of protein concentration; C and D are the intercept and slope, respectively, of the 
monomer intermediate baseline.  Due to the additional parameters in the 3-state model compared 
to the 2-state model, fitting individual thermograms to Eq. 3.3 resulted in high uncertainties in 
the fitted values.  Accordingly, multiple datasets obtained for different protein concentrations 
were fit globally with various parameters shared across the datasets as follows.  The slopes of the 
monomeric intermediate and unfolded monomer baselines were set equal to that of the native 
baseline (i.e., B=D=F; commonly normalized per M dimer), making the common assumption 
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that ΔCp of unfolding is temperature independent (Fig. S3.3) (219).  The intercepts of the 
intermediate and unfolded baselines were defined relative to the intercept of the native baseline 
according to temperature-independent values for ΔCp,N2↔2M (change in heat capacity upon dimer 
dissociation to monomeric intermediate) and ΔCp,M↔U (change in heat capacity upon monomeric 
intermediate unfolding): 
C= ΔCp,N2↔2M  + A (Eq. 3.3a) 
E= ΔCp,N2↔2M  + ΔCp, M↔U + A (Eq. 3.3b) 
ΔCp,N2↔2M was set to 1.7 kcal (mol dimer)
-1
 °C-1, the average value determined by Kirchoff 
analysis of ITC data for four SOD1 variants for which the enthalpy of dimer dissociation was 
measured as a function of temperature (Chapter 2, Fig. 2.3A).  Since ΔCp,N2↔2M + ΔCp,M↔U = 
ΔCp.N2↔2U (total ΔCp upon unfolding of apo SOD1 from folded dimer to unfolded monomers), 
the value of ΔCp,M↔U was set by subtracting ΔCp,N2↔2M from a ΔCp,N2↔2U of 3.30 kcal (mol 
dimer)
-1
 °C-1, which gives a value of 1.6 kcal (mol dimer)-1 °C-1 (0.8 kcal (mol monomer)-1 °C-1).  
ΔCp,N2↔2U of 3.30 kcal (mol dimer)
-1
 °C-1 was determined previously for apo SOD1 from 
Kirchoff analysis, structure-based calculations, and DSC data fitting of SOD1 variants (128).  
This approach is supported by the observation that the average ΔCp,N2↔2U values for apo SOD1 
variants are close to 3.30 kcal (mol dimer)
-1
 °C-1 (Table 3.2) (128, 134), and mutations typically 
cause minimal changes in ΔCp (240, 241) (Chapter 2).  For a more thorough discussion of our 
approach to 3-state fitting, refer to section 3.3.4.  All global fitting was performed using Matlab 
R2013b (The MathWorks Inc.). 
 
84 
 
3.2.5 Calculation of thermodynamic parameters using fitted values for 2-state and 3-state 
models 
Values for ΔG, ΔH, and ΔS were calculated from fitted DSC parameters according to the 
following equations:  
∆𝐺(𝑇) =  ∆𝐻(𝑇) − 𝑇∆𝑆(𝑇) (Eq. 3.4) 
∆𝐻(𝑇) =  ∆𝐻(𝑇𝑟𝑒𝑓) +  ∆𝐶𝑝(𝑇 − 𝑇𝑟𝑒𝑓) (Eq. 3.5) 
∆𝑆(𝑇) =  ∆𝑆(𝑇𝑟𝑒𝑓) + ∆𝐶𝑝ln (
𝑇
𝑇𝑟𝑒𝑓
) (Eq. 3.6) 
∆𝑆(𝑇𝑟𝑒𝑓) =  
∆𝐻(𝑇𝑟𝑒𝑓)−∆𝐺(𝑇𝑟𝑒𝑓)
𝑇𝑟𝑒𝑓
 (Eq. 3.7) 
where Tref is the reference temperature, T0.5 (or t0.5) for DSC 2-state fitting; for DSC 3-state 
fitting Tref = 310.15 K for dimer dissociation and T0.5 (or t0.5) for monomer unfolding; and 
ΔH(Tref), ΔS(Tref), and ΔG(Tref) are the corresponding enthalpy, entropy, and free energy, 
respectively, at the reference temperature. ΔG(Tref) was calculated using Eq. 3.8. 
∆𝐺(𝑇𝑟𝑒𝑓) = −𝑅𝑇𝑟𝑒𝑓𝑙𝑛𝐾(𝑇𝑟𝑒𝑓) (Eq. 3.8) 
For calculating stabilities obtained from 2-state and 3-state fitting, ΔCp values were set to 
the same temperature-independent values discussed above (Section 3.2.4).  For such calculations, 
ΔCp is commonly taken to be temperature-independent (219), and this assumption has been 
shown to be reasonable, particularly over short temperature ranges (58, 128, 242).  Accordingly, 
thermodynamic values were calculated at 51.2 °C (the average of all the t0.5 values in Table 3.1, 
tavg) and at physiological temperature, 37 °C.  Extrapolation errors are decreased when 
considering differences in stability, ΔΔGN2↔2U = (ΔGN2↔2U,WT - ΔGN2↔2U,mut), from values 
obtained using the same ΔCp (128, 243).  The calculated thermodynamic parameters were also 
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used to determine the fractions of different species (N2, M and U) (Fig. 3.7), as described 
previously (143, 173). 
  
3.2.6 Equilibrium urea denaturation curves at 37 °C 
Denaturation curve experiments were performed at 37 °C in 1 mM EDTA, 20 mM 
HEPES, pH 7.8.  Stock solutions of apo pWT were diluted 10-fold into different concentrations 
of urea and equilibrated at 37 °C for 10 hours.  Fluorescence was measured using a Fluorolog3-
22 spectrofluorometer (Horiba-Jobin-Yvon Spex Inc.) equipped with a thermostated cuvette 
holder with excitation and emission wavelengths of 282 and 360 nm, respectively.  
Thermodynamic parameters were obtained by globally fitting denaturation curves at 0.2, 0.8, 3, 
10, and 25 µM dimer using a 3-state dimer with a monomeric intermediate model as described in 
(143) using Microcal Origin 6.0 (Microcal Inc, Northampton, MA, USA).  Baselines were 
analyzed as follows and fixed during the global fitting.  The slope and intercept of the folded 
baseline were determined by linear regression using data between 0.3 and 1.8 M urea for the 25 
µM denaturation curve, where the population of native dimer is the largest.  These values were 
then normalized according to protein concentration.  The unfolded baseline slope and intercept 
were also determined individually for all protein concentrations by linear regression.  The 
fluorescence of the intermediate was determined by systematically changing the magnitude of 
the fluorescence to identify the value that corresponded to the lowest χ2, similar to previous 
denaturation curve analyses of apo pWT in guanidinium hydrochloride (134).  More specifically, 
the fluorescence of the intermediate was fixed to a value between 10 and 80% of the total 
amplitude of the transition.  The change in fluorescence of the intermediate with urea 
concentration was set to a value between that of the folded and unfolded protein according to the 
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magnitude of the intermediate signal; for example, when the fluorescence was set to 50% of the 
way through the transition, the slope of the intermediate was half way between the values for the 
folded and unfolded baselines.  In the global fitting for each intermediate fluorescence value, the 
four parameters ΔGN2↔2M, ΔGM↔U, and the dependence of the dimer interface and monomer 
stability on urea concentration (mN
2
↔2M and mM↔U, respectively) were shared across all protein 
concentrations and were allowed to float.  The lowest χ2 value for the fit was obtained with 
intermediate fluorescence and slope corresponding to 30% of the total amplitude of the 
transition.  
 
3.3 Results 
3.3.1 DSC reveals generally destabilizing but also some stabilizing effects of mutations on the 
total stability of apo SOD1 mutants 
DSC was used to measure the energetics of total protein unfolding.  Thermodynamic 
analysis requires reversibility of thermal unfolding.  As was seen for other apo SOD1 variants 
(128, 134), when scanning to the end of the unfolding endotherm, cooling and rescanning (Fig. 
3.2A), unfolding of the mutants studied here is highly reversible, generally 85-95%.  
Additionally, the DSC thermograms were not significantly affected by scan rate, which is 
evidence for equilibrium unfolding behaviour (Table 3.1) (128, 244).  Apo pWT SOD1 has a 
melting temperature, t0.5 (temperature at which half of the protein is unfolded), of ~59 °C (128), 
while the mutants generally have t0.5 values ranging from 10 to 15 °C lower than pWT, indicating 
marked destabilization (Table 3.1, Fig. 3.2).  Notable exceptions are H46R and V148I, which are 
slightly more stable than pWT with t0.5 values that are ~2 °C higher.  A similar change in the 
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apparent t0.5 has been reported previously for the irreversible unfolding of H46R in the WT 
SOD1 background (see Section 1.3.2) (245). 
 
3.3.2 Fitting of apo SOD1 thermal unfolding to dimer 2-state model  
Under constant pressure, heat flow is equal to the enthalpy of a system and, thus, can be 
directly measured using calorimetric techniques.  Enthalpy can also be determined indirectly by 
van’t Hoff analysis whereby the equilibrium constant for a given process (K) is determined at 
different temperatures to yield enthalpy (246, 247).  In simple cases, a plot of lnK versus 1/T is 
linear with a slope related to the enthalpy, referred to as the van’t Hoff enthalpy (∆HvH).  This 
type of analysis relies on a specific and appropriate model to define K correctly; thus, comparing 
the ∆HvH to the enthalpy directly measured by calorimetry (∆Hcal) can provide a way to assess 
the accuracy of the model used.  A common approach to analyzing the validity of a particular 
model is to calculate the ΔHvH/ΔHcal, which should be 1 if the model is correct.  However, we 
have found from many scans of different apo SOD1 variants that uncertainties in protein 
concentration (usually ~10%) and small amounts of protein aggregation can have a large impact 
on ΔHcal, which in turn can lead to some scatter in the ΔHvH/ΔHcal values.    A better approach to 
investigating the possibility of monomer formation during unfolding is by calculating the number 
of subunits in the cooperatively unfolding homo-oligomer, also known as the molecularity, n, 
which is related to ΔHvH (Materials and Methods Eq. 3.2, Fig. S3.1) (128, 239).  ΔHvH is 
relatively insensitive, compared to ΔHcal, to errors in protein concentration (128, 244, 248, 249).   
Furthermore, we have shown previously that the effects of aggregation on the 
thermodynamic analysis can be effectively eliminated by excluding high temperature data (i.e. 
excluding data at temperatures where exothermic aggregation can in some cases be significant), 
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and by calculating thermodynamic quantities using ΔHvH.  We are confident in the validity of 
this approach given that the average values for ΔCp,N2↔2U determined from the 2-state fits for all 
mutants, except A4V and V148G, are similar to the value of ΔCp,N2↔2U of 3.30 kcal (mol dimer)
-
1
 °C-1 determined for pWT using multiple experimental methods (Table 3.1, Materials and 
Methods) (128); exothermic aggregation would decrease the values of ΔCp,N2↔2U.  The lower 
value of ΔCp,N2↔2U for A4V and V148G is likely related to increased monomer formation, which 
is most pronounced for these mutants (vide infra).  Furthermore, while aggregation might in 
principle affect the shape of the endotherm at high temperatures, fitting different extents of the 
endotherm has very little effect on the determined total stability, described previously for dimer 
2-state fits (128), and for 3-state fits, described further below.   
The DSC data for the mutants were fit initially to a dimer 2-state unfolding model 
(N2↔2U), as done previously for pWT and other ALS-associated mutants (128, 134).  
Representative fits are shown in Fig. 3.2B, with fitted parameters summarized in Table 3.1.  At 
higher protein concentrations the data for most mutants are well fit by a dimer 2-state model, and 
the data follow similar trends to those reported for apo pWT and mutant SOD1 (Fig. 3.3) (128, 
134).  Furthermore, there is good agreement between stability measured by calorimetry and 
chemical denaturation for pWT (vide infra and Table 3.3) (134, 176, 177, 200).   
But at lower protein concentrations, clear deviations from 2-state behavior are observed.  
Increases in n from lower values at low protein concentration to ~2 at higher protein 
concentration, the value expected for 2-state unfolding of a dimeric protein, suggests that for 
most variants there is some formation of monomer at low protein concentrations due to mass 
action (Table 3.1).  For A4V, H46R, and V148G, the n values are considerably lower than 2 at 
all protein concentrations, indicating that the size of the cooperative unfolding unit is smaller for 
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these variants.  Thus, dimer dissociation and monomer unfolding occur over a broader 
temperature range, which points to non-2-state behavior (Fig. S3.2).   
Protein concentration dependence of t0.5 can further define when formation of monomer 
is occurring.  For various mutants, the t0.5 values increase with protein concentration as expected 
for a dimer 2-state transition.  The expected protein concentration dependence of t0.5 can be 
determined from the intersection of plots of ΔG versus t and –RTln 2Pdimer versus t, where R is 
the universal gas constant, Pdimer is the total dimer concentration in mol L
-1
, T is the temperature 
in Kelvin and t is the temperature in °C (Fig. 3.3) (128, 250).  In Fig. 3.3, representative ΔG 
versus t plots are shown in the upper left panel for pWT, A4T, and A4S, while plots of the 
predicted t0.5 versus protein concentration for various mutants compared to the fitted t0.5 values 
are shown in the remaining panels.   
For pWT, A4S, A4T, and V148I, the fitted t0.5 values show close agreement with 
predicted t0.5 values, while the fitted t0.5 values for A4V, H46R, V148G,  and to some extent 
G37R change less with protein concentration than predicted (128, 134).  Thus, for A4V, H46R 
and V148G, several observations point to a relatively high population of folded monomer during 
DSC scans.  Taken together, it can be seen that the 2-state model is accurate for many apo 
variants at higher protein concentration.  But at low protein concentration, and for some mutants 
other, more complex, unfolding models are required to characterize the energetics of apo SOD1 
unfolding (vide infra).     
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Figure 3.2 Fits of reversible unfolding for apo SOD1 variants to a dimer 2-state unfolding 
model.  In a typical DSC experiment, the protein sample is heated at a constant rate and the heat 
capacity (Cp) is monitored.  The temperature where half of the protein is unfolded is referred to 
as the melting temperature (t0.5).  After the first scan, the sample is cooled and rescanned to 
assess the reversibility of unfolding, a requisite for thermodynamic analysis of the process.  (A) 
The reversibility of the unfolding transitions was determined by performing two consecutive 
scans. The second scan (grey dashed line) was obtained immediately after cooling the sample 
following completion of the first scan (black solid line).  The reversibility, determined by 
integrating the area under the endotherm (ΔHcal) for the first scan and the second scan after 
subtraction of the baselines, is 95% or greater for all mutants except for A4V where it is ~85%.  
The native baseline was subtracted and datasets offset for purposes of comparison.  (B) Typical 
DSC thermograms with corresponding dimer 2-state fits for apo pWT SOD1 and a representative 
subset of mutants.  Data are presented as black solid lines while the corresponding dimer 2-state 
fits are presented as grey dashed lines.  Parameters obtained from the fits are summarized in 
Table 3.1.  Datasets were offset for purposes of comparison.  In both panels, the data were 
normalized for protein concentration (0.12-1.25 mg mL
-1
) and SOD1 variants are arranged from 
right to left in order of decreasing t0.5.   
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Figure 3.3 Predicted t0.5 for thermal unfolding of apo pWT and a subset of mutants.  In the 
top left panel, predicted values for t0.5 were calculated from the intersection of –RTln(2Pdimer) 
versus t (grey lines) and ΔG versus t (black lines) for pWT (solid black line), A4S (dashed black 
line), and A4T (dotted black line) (128, 250).  The line generated for 0.5 mg mL
-1
 (solid grey 
line) intersects each ΔG versus t plot at a lower temperature than the line generated for 5 mg mL-
1
 (dotted grey line).  The ΔG values were calculated using the average fitted parameters for the 2-
state dimer unfolding (Table 3.1).  Predicted t0.5 values (solid grey lines) from these calculations 
were then plotted as a function of protein concentration and compared to the actual fitted t0.5 
values (filled black squares) from Table 3.1. 
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Table 3.1 Thermodynamic parameters for dimer 2-state unfolding of apo SOD1.
 
SOD1 
variant 
[SOD1] 
(mg mL
-1
) 
t0.5
f
 
(°C) 
ΔCp,N2↔2U
g
 
(kcal (mol 
dimer)
-1 °C-1) 
 
ΔHvH(t0.5)
f
 
(kcal (mol 
dimer)
-1
) 
ΔGN2↔2U
g,h
 
(kcal 
(mol
 
dimer)
-1
) 
tavg
 
ΔGN2↔2U
g
 
(kcal 
(mol
 
dimer)
-1
) 
37 °C
 
ni 
pWT
a 
0.05 57.8 ± 0.6 3.71 106.5 ± 18.9 10.1 12.3 1.60 
pWT
a 
0.20 58.3 ± 0.1 2.95 112.8 ± 6.7 9.4 11.9 1.64 
pWT
a 
0.21 58.4 ± 0.1 3.74 116.8 ± 9.1 9.5 12.1 1.66 
pWT
a 
0.27 57.8 ± 0.0 3.85 115.4 ± 2.7 9.1 11.8 1.65 
pWT 0.40 58.6 ± 0.2 2.20 121.7 ±  6.3 9.3 12.1 1.69 
pWT
a 
0.44 59.1 ± 0.2 4.25 137.6 ± 9.4 9.7 13.1 1.78 
pWT 0.50 59.1 ± 0.0 3.32 130.0 ± 3.1 9.4 12.5 1.74 
pWT 0.50 59.2 ± 0.1 2.73 137.0 ± 6.6 9.6 13.0 1.78 
pWT 0.50 59.5 ± 0.0 2.23 129.7 ± 2.7 9.5 12.6 1.74 
pWT 0.52 58.4 ± 0.0 3.51 127.6 ± 2.8 9.2 12.3 1.72 
pWT 0.60 59.0 ± 0.1 1.08 127.0 ± 2.8 9.2 12.2 1.72 
pWT 0.73 59.4 ± 0.0 2.82 136.7 ± 1.9 9.5 12.8 1.78 
pWT
a 
0.73 58.8 ± 0.0 4.30 144.1 ± 2.5 9.4 13.2 1.82 
pWT
a 
1.42 60.0 ± 0.0 4.38 163.6 ± 2.4 9.9 14.3 1.93 
pWT
a 
1.50 60.3 ± 0.0 5.11 164.4 ± 4.0 10.0 14.4 1.93 
pWT
a 
2.99 61.3 ± 0.0 5.10 178.5 ± 1.4 10.4 15.3 2.01 
pWT
a 
3.00 61.9 ± 0.0 3.93 183.3 ± 1.9 10.8 15.8 2.04 
AVG
c 
n/a n/a 3.48 ± 0.5 n/a 10.6 ± 0.4  15.6 ± 0.5 n/a 
A4S 0.06 44.7 ± 0.1 2.81 132.2 ± 5.8 5.1 10.6 1.98 
A4S 0.13 45.8 ± 0.4 1.67 156.3 ± 11.6 4.7 11.1 2.16 
A4S 0.19 46.0 ± 0.3 2.85 140.8 ± 8.1 4.9 10.5 2.04 
A4S 0.57 47.8 ± 0.0 2.53 155.4 ± 0.9 4.9 10.9 2.15 
A4S 0.63 48.3 ± 0.0 4.45 159.0 ± 1.0 5.0 11.2 2.18 
AVG
c 
n/a n/a 2.86 ± 0.88 n/a 4.9 ± 0.1 10.9 ± 0.3 n/a 
A4T 0.08 40.6 ± 0.2 6.77 76.0 ± 6.0 4.7 8.3 1.77 
A4T 0.18 42.9 ± 0.1 3.98 116.3 ± 5.7 3.9 9.0 2.18 
A4T 0.20 43.0 ± 0.4 1.20 127.7 ± 18.9 3.6 9.2 2.29 
A4T 0.50 44.2 ± 0.3 2.34 133.9 ± 9.4 3.5 9.1 2.36 
A4T 1.00 45.9 ± 0.1 2.94 145.7 ± 2.1 3.7 9.6 2.48 
AVG
c
 n/a n/a 3.45 ± 1.85 n/a 3.7 ± 0.5 9.2 ± 0.5 n/a 
A4V 0.20 48.8 ± 1.6 -0.22 81.5 ± 17.2 6.6 9.2 1.43 
A4V 0.30 48.5 ± 0.1 1.73 82.4 ± 1.9 6.3 9.0 1.43 
A4V 0.40 49.3 ± 0.1 0.54 86.7 ± 3.5 6.3 9.0 1.46 
A4V 0.50 48.4 ± 0.1 2.50 77.5 ± 1.6 6.0 8.5 1.41 
A4V
d
 0.52 48.2 ± 0.1 3.46 78.1 ± 2.5 5.9 8.4 1.41 
A4V
e
 0.52 49.5 ± 0.2 1.24 80.1 ± 4.7 6.2 8.7 1.42 
A4V 1.00 48.9 ± 0.2 2.21 93.9 ± 3.5 5.5 8.7 1.50 
A4V 1.95 50.1 ± 0.0 1.88 120.6 ± 2.2 5.4 9.5 1.64  
AVG
c 
n/a n/a 1.67 ± 0.80 n/a 6.0 ± 0.5  9.0 ± 0.4 n/a 
E100G 0.20 49.5 ± 0.0 1.82 184.7 ±  10.2 6.4 12.2 2.19 
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E100G 0.50 51.0 ± 0.0 2.18 163.6 ± 0.9 6.6 12.4 2.24 
E100G 1.20 53.0 ± 0.0 2.40 156.9 ± 0.8 7.2 13.6 2.40 
AVG
c
 n/a n/a 2.13 ± 0.30 n/a 6.7 ± 0.4 12.8 ± 0.8 n/a 
G37R 0.11 48.5 ± 0.1  3.01 168.6 ± 2.5  6.2 12.7 2.12 
G37R 0.24 49.5 ± 0.0 2.64 171.3 ± 1.5 6.2 12.7 2.14 
G37R 0.40 51.2 ± 0.0 3.81 173.5 ± 0.4 6.8 13.1 2.16 
G37R 0.98 51.1 ± 0.0 3.59 180.8 ± 1.0 6.2 12.8 2.21 
G37R 1.92 52.2 ± 0.0 3.16 182.9 ± 0.5 6.3 12.9 2.22 
AVG
c
 n/a n/a 3.25 ± 0.47 n/a 6.4 ± 0.3 12.8 ± 0.2 n/a 
G93A
a
 0.10 45.6 ± 0.2  2.99 119.8 ± 8.3 5.4 10.2 1.96 
G93A
a
 0.12 46.6 ± 0.1 3.60 123.1 ± 8.3 5.6 10.4 1.99 
G93A
a
 0.50 49.1 ± 0.2 3.81 148.2 ± 5.0 5.6 11.1 2.18 
G93A
a
 0.50 49.0 ± 0.0 2.77 150.3 ± 2.4 5.5 11.2 2.20 
G93A
a
 0.50 49.0 ± 0.0 3.82 147.2 ± 0.9 5.6 11.1 2.18 
G93A
a
 0.50 48.0 ± 0.0 3.92 138.1 ± 2.1 5.2 10.4 2.10 
G93A
a
 1.00 49.1 ± 0.1 3.25 149.7 ± 2.1 5.1 10.8 2.19 
AVG
c
 n/a n/a 3.53 ± 0.44 n/a 5.4 ± 0.2 10.7 ± 0.3 n/a 
G93R
a
 0.21 47.0 ± 0.1 6.14 115.4 ± 3.7 5.5 9.9 2.39* 
G93R
a
 0.21 47.3 ± 0.0 5.73 123.7 ± 2.7 5.6 10.3 2.50* 
G93R
a
 0.40 48.7 ± 0.0 4.36 144.0 ± 2.4 5.6 11.0 2.74* 
AVG
c
 n/a n/a 5.39 ± 0.97 n/a 5.6 ± 0.0 10.4 ± 0.5 n/a 
G93S
a
 0.25 49.6 ± 0.1 2.60 146.4 ± 7.8 6.3 11.6 2.80* 
G93S
a
 0.29 50.0 ± 0.0 3.48 149.8 ± 4.1 6.4 11.8 2.84* 
G93S
a
 0.40 50.8 ± 0.0 2.13 158.6 ± 2.5 6.5 12.2 2.94* 
AVG
c
 n/a n/a 2.74 ± 0.69  n/a 6.4 ± 0.1 11.9 ± 0.3 n/a 
H43R 0.21 46.9 ± 0.1 3.60 123.1 ± 2.5 5.5 10.2 2.12* 
H43R 0.23 47.3 ± 0.0 2.80 120.6 ± 2.0 5.6 10.2 2.10* 
H43R 0.39 48.1 ± 0.0 3.07 128.8 ± 1.7 5.5 10.3 2.18* 
AVG
c
 n/a n/a 3.16 ± 0.46 n/a 5.5 ± 0.1 10.2 ± 0.1 n/a 
H46R 0.08 60.4 ± 0.3 4.81 90.0 ± 11.4 9.9 11.0 1.17 
H46R
 
0.17 60.9 ± 0.1 2.56 107.8 ± 2.0 10.0 11.8 1.21 
H46R 0.32 61.2 ± 0.0 3.31 120.2 ± 2.1 10.0 12.4 1.23 
H46R 0.39 61.0 ± 0.0 0.74 128.6 ± 2.1 10.1 12.9 1.25 
H46R 0.76 61.1 ± 0.0 5.18 139.2 ± 1.8 9.8 12.5 1.27 
AVG
c
 n/a n/a 3.32 ± 1.57 n/a 10.0 ± 0.1  12.1 ± 0.7 n/a 
I113T 0.08 43.4 ± 0.5 4.91 68.7 ± 16.8 5.8 8.7 1.53 
I113T
c 
0.10 45.3 ± 1.0 1.86 105.3 ± 18.1 5.6 9.8 1.82 
I113T 0.15 44.9 ± 0.4 3.03 94.4 ± 9.0 5.4 9.1 1.73 
I113T 0.21 45.0 ± 0.2 4.17 110.2 ± 5.8 4.9 9.3 1.85 
I113T
b
 0.40 46.0 ± 0.1 2.44 106.2 ± 4.0 4.9 9.1 1.82 
I113T
b
 0.50 47.1 ± 0.1 2.79 129.0 ± 4.1 4.9 9.9 2.00 
I113T
b
 0.75 46.4 ± 0.1 4.75 118.0 ± 3.9 4.5 9.1 1.91 
I113T 1.20 47.8 ± 0.0 3.35 138.5 ± 2.0 4.6 9.9 2.07 
AVG
c
 n/a n/a 3.41 ± 0.76 n/a 4.8 ± 0.3 9.6 ± 0.5 n/a 
V148G 0.12 46.1 ± 0.2 5.55 76.6 ± 5.6 6.2 9.0 0.71 
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V148G
 
0.23 48.3 ± 0.1 1.26 89.1 ± 0.7 6.3 9.3 0.59 
V148G 0.29 49.8 ± 0.0 -2.00 104.6 ± 2.0 6.6 10.0 0.64 
V148G 0.53 48.2 ± 0.0 0.07 91.5 ± 2.1 5.8 8.9 0.66 
V148G 0.92 46.8 ± 0.0 2.47 81.7 ± 2.9 5.1 8.0 0.73 
V148G 1.56 47.8 ± 0.3 -2.44 99.0 ± 1.0 4.8 8.4 0.70 
AVG
c
 n/a n/a 0.82 ± 3.0 n/a 5.6 ± 0.7 8.8 ± 0.5 n/a 
V148I 0.11 57.7 ± 0.1 6.67 108.8 ± 6.7 9.6 12.0 1.56 
V148I 0.26 59.2 ± 0.1 3.01 137.7 ± 3.0 10.1 13.5 1.71 
V148I 0.49 59.6 ± 0.1 6.37 141.4 ± 5.9 9.9 13.4 1.73 
V148I 0.53 59.6 ± 0.0 3.75 152.1 ± 1.7 10.1 14.1 1.78 
V148I 0.83 60.3 ± 0.0 3.38 166.9 ± 1.8 10.5 15.0 1.86 
V148I 2.33 61.2 ± 0.0 3.99 182.6 ± 1.1 10.6 15.7 1.94 
AVG
c
 n/a n/a 4.53 ± 1.58 n/a 10.1 ± 0.4 13.9 ± 1.3  n/a 
n/a = not applicable.   
Unless otherwise specified, all data were obtained at a scan rate of 1.0 °C minute-1.  Data for 
individual scans were fit to Eq. 3.1 as described in Materials and Methods. 
a
Data reported previously (128). 
b
Data reported previously (134).  
c
Values are averages and standard deviations calculated using thermograms with n ~ 2 or more. 
d 
Scan rate of 0.75 °C minute-1. 
e 
Scan rate was 1.5 °C minute-1. 
f 
Error estimates for individual thermograms are from the fitting program.  
g
Uncertainties were estimated from the standard deviations in the values obtained from the 
individual thermograms.  
h
tavg is 51.2 °C, the average value of t0.5 for all apo SOD1 variants. 
i
Molecularity values determined using Eq. 3.2 and Figure S3.1, as described in Materials and 
Methods. 
*Molecularity values are determined from the slope of a line with only three data points, and 
thus have a high level of uncertainty. 
Unpublished experiments were performed and the data analyzed by Helen R. Broom, Kenrick A. 
Vassall, Jessica A. O. Rumfeldt, Ming Sze Tong, and Julia M. Bonner. 
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3.3.3 ITC reveals that all mutations decrease the stability of the apo dimer interface.   
ITC was used to determine the thermodynamics of dimer dissociation, providing values 
for ∆HN
2
↔2M, Kd,N
2
↔2M, and corresponding ∆GN
2
↔2M.  In this chapter the ITC results have been 
combined with the DSC results, and so pertinent points from the ITC analyses will be 
summarized here before continuing with the combined analyses in the following sections.  While 
the effects of mutations on total stability range from highly destabilizing to moderately 
stabilizing, ITC experiments reveal that all mutations weaken the dimer interface (Chapter 2).   
ITC was also used to determine the temperature dependence of ∆HN
2
↔2M, ∆Cp,N
2
↔2M, and both 
the magnitude of ∆HN
2
↔2M and  ∆Cp,N
2
↔2M  were shown to be much higher than predictions based 
on surface area exposure upon dissociation would suggest (217, 218) (Chapter 2).  The 
∆Cp,N
2
↔2M and ∆Cp,M↔U were found to be similar, 1.7 ± 0.2 and 1.6 ± 0.8 kcal (mol dimer)
-1 °C-1, 
respectively, suggesting that there is considerable structural rearrangement upon dimer 
dissociation.  This interpretation is supported by the solution structure of the apo monomer 
variant, which contains mutations in the dimer interface that prevent dimerization.  This 
construct shows high levels of disorder in one half of the β-barrel and the largest loops (IV and 
VII, ~35 % of the sequence), and adopts what is referred to as an “open clam” structure (222).  
Chemical denaturation as a function of temperature under equilibrium and kinetic conditions has 
been performed on the apo monomer variant.  From these experiments the ∆Cp,M↔U was found to 
be even higher than what we have reported, 2.27 ± 0.69 kcal (mol dimer)
-1
 °C-1 (251).  In this 
method, the ∆GM↔U versus t curve obtained from these experiments was fit to a modified Gibbs-
Helmholtz equation to extract ∆HM↔U and ∆Cp,M↔U.  This approach will result in larger 
uncertainties in these parameters compared to the direct measurements reported herein.  
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Differences between the two ∆Cp,M↔U values may also be related to the effects of the added 
dimer interface mutations in the monomer variant construct used for comparison.     
Furthermore, our values for ∆Cp are consistent with chemical denaturation experiments, 
where the denaturant dependence of ∆GN
2
↔2M  and ∆GM↔U, also related to changes in exposed 
surface area, was determined to be 2.7 and 2.6 kcal (mol dimer)
-1
, respectively (134).  Addition 
of a stabilizing salt, Na2SO4, resulted in compaction of the monomer intermediate and an 
increase in the denaturant dependence of ∆GM↔U from 2.6 to 3.5 kcal (mol dimer)
-1
 (134).  Thus, 
there is substantial evidence that dimer dissociation is accompanied by a considerable amount of 
structural disruption, accounting for the high value of ∆Cp,N
2
↔2M. 
   
3.3.4 Fitting to 3-state dimer with monomeric intermediate model 
Given the evidence for non-2-state unfolding behavior in the DSC experiments (Fig. 3.3), 
and that ITC dilution experiments show measurable endothermic heats associated with dimer 
dissociation (Chapter 2, Fig. 2.2A), dimer dissociation and monomer unfolding appear decoupled 
quite prominently for a number of SOD1 variants, and to some extent for all variants at low 
protein concentrations.  The DSC data for all apo SOD1 variants were, therefore, also fit to a 
bimolecular 3-state dimer unfolding model with a monomeric intermediate (N2↔2M↔2U).  
Fitted data is shown in Fig. 3.4 and values obtained are summarized in Tables 3.2 and S3.1.  
For comparison, DSC data for apo A4V, H46R, and V148G, which exhibited the most 
pronounced 3-state unfolding behavior, were also fit to a unimolecular 2-state monomer 
unfolding model (M↔U), which would be applicable if the transition temperatures for each step 
in the 3-state mechanism were very different and if the majority of the heat effects reflected 
monomer unfolding (250, 252).  Fitting the DSC data for these three mutants to the 2-state 
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monomer unfolding model returned ΔHvH values that increased significantly with protein 
concentration, a finding that is inconsistent with unimolecular 2-state monomer unfolding (237) 
(Supplementary Methods, Section 3.5.1.1 and Table S3.2).  Thus, a 3-state model is more 
appropriate for describing apo unfolding. 
Fitting apo DSC data to a 3-state model with monomer intermediate allows the 
thermodynamics of both dimer dissociation and monomer unfolding to be quantified (Figs. 3.4, 
3.6, Table 3.2).  In order to define the larger number of parameters in this model, all data for a 
given apo variant were fit simultaneously, fixing the parameters for dimer dissociation, Kd,N2↔2M 
and Δhcal,N2↔2M, at 37 °C, to the values measured by ITC (Table 2.1) and the values for ΔCp to 
experimental values determined independently (Sections 3.2.4 and 3.3.3).  To allow for 
uncertainties in the concentration of protein undergoing thermal unfolding due to protein 
concentration measurements (~10%) and possible presence of small amounts of aggregated 
protein (128), the β1 and β2 were set equal to each other and allowed to vary, as was done 
previously for the 2-state fits (128, 134).  Thus, in fitting data to Eq. 3.3, the globally shared 
fitted parameters were T2
', Δhcal,M↔U(T2
'
), β1 = β2, and parameters defining the slope and intercept 
of the native baselines.  The data for all mutants are generally well fit using this method (Fig. 
3.4, Table 3.2).  As a control, mutants with more than 3 datasets were also globally fit without 
constraints from the ITC data (i.e., with Δhcal,N2↔2M and Kd,N2↔2M  at 37 °C also globally shared) 
and β1 and β2 fixed to the molecular weight of the dimer.  Using this method, the uncertainty in 
all values increased substantially.  Nevertheless, Kd,N2↔2M, and thus ∆GN2↔2M, values converged 
to those obtained by ITC (Table S3.1).  The agreement between fitted and experimentally 
determined Δhcal,N2↔2M and Kd,N2↔2M is particularly good for the few cases (I113T, A4V, and 
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V148G.) where this latter method resulted in low uncertainty in the fitted values.  Thus, our 
approach of fixing parameters defining dimer dissociation to those obtained by ITC is valid. 
In addition, a number of extra measures were used to assess the uncertainty in monomer 
stability as well as total protein stability.  In general, mutations have been found to have little 
effect on the ΔCp of global protein unfolding (ΔCp,N
2
↔2U) (128, 219, 240, 241).  Similarly, ITC 
experiments show that the ΔCp of dimer dissociation, ΔCp,N
2
↔2M, varies little upon mutation of 
SOD1 (Chapter 2, Fig. 2.3A).  Highly non-conservative substitutions at buried positions of 
hydrophobic residues by hydrophilic residues or vice versa have, however, been reported to 
change ΔCp by up to ~40% (253), and for one SOD1 variant, V148G, the ΔCp,N2↔2M was found 
to be slightly larger than the values obtained for the three other mutants analyzed (Chapter 2, Fig. 
2.3).  Because the ΔCp,N2↔2M could not be measured for all SOD1 variants, the data were also fit 
with the maximum ΔCp,N2↔2M obtained (2.2 kcal (mol dimer)
-1
 °C-1), corresponding to the 
estimated upper limits of mutational effects, to evaluate how changes in ΔCp impact monomer 
stability.  Increasing ΔCp,N2↔2M by ~0.6 kcal (mol dimer)
-1
 °C-1 had small effects on ΔGM↔U 
determined at tavg (on average ±0.1 kcal (mol monomer)
-1
) and at 37 °C (on average ±0.2 kcal 
(mol monomer)
-1
).  Because dimer stability was determined at 37 °C, changes in ΔCp,N2↔2M had 
no effect on ΔGN2↔2M (37 °C), but decreased GN2↔2M (tavg) by 0.2 kcal (mol dimer)
-1
.  Thus, for 
3-state fitting of DSC data it is reasonable to treat ΔCp as a constant, and changes appear to have 
no significant impact on monomer stability. 
The effects of aggregation at high temperature on ΔGN2↔2U were assessed by fitting 
varying amounts of data beyond the peak of the unfolding endotherm, from a maximum of the 
apparent end of the endotherm peak to a minimum of ~25% of the decreasing side of the 
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endotherm.  In the dimer 2-state fits, where ΔCp,N2↔2U is calculated from floating parameters that 
define the native and unfolded baselines, fitting the whole endotherm, including the post-
transition baseline can result in systematically low or negative ΔCp,N2↔2U values.  However, 
fitting various amounts of the endotherm to the 3-state model has very little impact on total 
stability, ±0.5-1.0 kcal (mol dimer)
-1
 at 37 °C and ±0.2-0.4 kcal (mol dimer-1) at tavg.  
Furthermore, similar stability values were obtained when ΔHvH and ΔHcal were set equal to each 
other (Table S3.1).  Based on these observations, effects of aggregation can be eliminated by 
excluding the high temperature data from the fit, and so aggregation at high temperature has little 
effect on measured stability.  The agreement between the DSC and ITC, as well as DSC and urea 
denaturation (vide infra), further supports the validity of our data fitting method (Tables 3.2, 
3.3). 
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Figure 3.4 Global fitting of apo SOD1 DSC data to the 3-state model.  Representative global 
fits of thermograms to the dimer 3-state with monomer intermediate model are shown.   The 
black solid lines represent the data, while the grey dashed lines correspond to the fit.  In each 
panel, scans at different protein concentrations are offset for clarity, with low concentrations at 
the bottom and high at the top.  The protein concentrations for each experiment are listed in 
Table 3.1, and the parameters obtained from the global fits of all mutants are summarized in 
Tables 3.2 and S3.1. 
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Table 3.2  Summary of thermodynamic parameters for apo SOD1 determined from global 3-state fits of DSC data. 
SOD1 
variant
a
 
∆HN
2
↔2M 
(kcal (mol 
dimer)
-1
) 
37 °Cb 
∆GN
2
↔2M 
(kcal (mol 
dimer)
-1
) 
37 °Cb 
t0.5, M↔U 
(°C)c 
 
∆HM↔U 
(kcal (mol 
monomer)
-1
) 
tavg
c,d
 
∆GM↔U 
(kcal (mol 
monomer)
-1
) 
37 °Ce,f 
∆GM↔U 
(kcal (mol 
monomer)
-1
) 
tavg
d, f
 
∆∆GM↔U 
(kcal (mol 
monomer)
-1
) 
tavg
d,g
 
pWT
c,h
 n/a 10.2 ± 0.7 n/a n/a 3.4 ± 0.5 n/a n/a 
pWT (30.8 ± 8.8)  (10.3 ± 0.5) 59.5 ± 0.9 44.0 ± 2.0 2.8 ± 0.6  1.2 ± 0.4 n/a 
V148I (11.4 ± 2.2) (8.9 ± 0.2) 60.1 ± 0.2 84.0 ± 1.2 5.7 ± 0.8 2.3 ± 0.4 -1.2 
G93S (17.6 ± 4.6) (8.4 ± 0.3) 49.2 ± 1.1 58.3 ± 3.7 2.0 ± 0.3  -0.4 ± 0.2 1.5 
H46R (16.2 ± 4.4) (8.4 ± 0.4) 62.5 ± 0.1 71.2 ± 1.1 5.3 ± 0.4 2.6 ± 0.2 -1.4 
E100G (16.0 ± 4.8) (8.0 ± 0.4) 48.0 ± 0.7 53.3 ± 8.4 1.6 ± 0.3 -0.5 ± 0.1 1.7 
G37R (7.8 ± 1.8) (7.6 ± 0.2) 50.3 ± 0.1 84.1 ± 2.8 3.2 ± 0.8 -0.2 ± 0.0 1.4 
H43R (23.0 ± 1.4) (7.5 ± 0.0) 47.6 ± 0.4 59.5 ± 5.2 1.7 ± 0.1 -0.7 ± 0.0 1.8 
G93A (14.0 ± 2.0) (7.2 ± 0.3) 47.4 ± 0.3 58.9 ± 4.7 1.7 ± 0.1 -0.7 ± 0.1 1.9 
I113T (30.2 ± 2.5) (7.1 ± 0.2) 46.7 ± 0.2 53.2 ± 3.7 1.4 ± 0.2 -0.7 ± 0.1 1.9 
A4T (39.2 ± 3.8) (7.1 ± 0.2) 43.6 ± 0.4 48.9 ± 9.6 0.8 ± 0.3 -1.1 ± 0.1 2.3 
A4S (9.0 ± 2.6) (7.0 ± 0.0) 46.3 ± 0.4 61.1 ± 10.0 1.5 ± 0.3 -0.9 ± 0.2 2.1 
G93R (45.6 ± 1.8) (6.7 ± 0.1) 49.1 ± 0.2 87.8 ± 7.7 3.1 ± 0.1 -0.6 ± 0.0 1.7 
A4V (37.2 ± 3.8) (6.4 ± 0.3) 50.9 ± 0.2 59.2 ± 3.4 2.3 ± 0.1 -0.1 ± 0.1 1.2 
V148G (50.6 ± 1.4)  (5.9 ± 0.3) 48.6 ± 0.0 67.8 ± 0.5 2.2 ± 0.1 -0.5 ± 0.0 1.7 
a
For each mutant, the scans at different protein concentrations used in the global fitting are those listed in Table 3.1, with the 
exception of pWT, where concentrations 0.20, 0.21, 0.40, 0.44, 0.85, 1.50, and 3.0 were fit; I113T where concentration 0.21 mg mL
-1
 
was omitted; A4V where concentration 0.52 mg mL
-1
 was omitted; and G93R mg mL
-1 
where concentration 0.21 was omitted.  
b
Numbers in the brackets were determined by ITC (Table 2.1) and fixed in the DSC 3-state fits. 
c
Errors determined from the fit. 
d
tavg is 51.2 °C, the average of all t0.5 values obtained from the 2-state fits. 
eΔGM↔U values calculated at physiological temperature.   
f
Error estimates were determined from the differences in values obtained from fits allowing ΔHvH/ΔHcal to deviate from unity, 
compared to values obtained when ΔHvH and ΔHcal were set equal, and values obtained using a higher ΔCp,N2↔2M (2.2 kcal (mol 
dimer)
-1
 °C-1) (Table S3.1). 
gΔΔG  = ΔGpWT - ΔGmutant, a positive value indicates lower stability of the mutant relative to pWT; values are calculated at tavg. 
hΔGN
2
↔2M  and ΔGM↔U were also determined by globally fitting urea denaturation curves at 37 °C to a 3-state model with monomeric 
intermediate.    
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3.3.5 Equilibrium urea denaturation at 37 °C of apo pWT 
In order to obtain an independent measure of stability, urea denaturation curves were 
determined for pWT at 37 °C as a function of protein concentration (Fig. 3.5).  We have used this 
approach previously for pWT at 25 °C to measure the total stability, ΔGN2↔2U, dissected into 
constituent ΔGN2↔2M and monomer stability, ΔGM↔U; similar analyses cannot be performed for 
mutants, however, owing to their lower stability (134).  The values of stability measured for 
pWT at 37 °C (Table 3.2) are consistent with values obtained previously by chemical 
denaturation at lower temperatures (134, 147, 177, 254), and with values determined at 37 °C by 
calorimetry (Tables 3.2, 3.3, S3.1).  The dimer interface stability is weakened at increased 
temperature, resulting in significant population of monomer at physiologically relevant 
temperature and pH (vide infra). 
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Figure 3.5 Equilibrium denaturation of apo pWT.  Equilibrium urea denaturation curves for 
apo pWT at dimer concentrations of 25 µM (pink circles), 10 µM (blue circles), 3 µM (green 
circles), 0.8 µM (red circles), and 0.2 µM (black circles).  Fluorescence data are scaled to aid 
comparison.  Solution conditions were 37 °C, 1 mM EDTA, 20 mM HEPES, pH 7.8.  Solid lines 
represent the global fit of all protein concentrations using the fluorescence value of the 
intermediate set to 30% of the total amplitude of the transition (see Materials and Methods) with 
fitted values of ΔGN2↔2M, ΔGM↔U, mN2↔2M, and mM↔U of 10.2 ± 0.7 kcal (mol dimer)
-1
, 3.4 ± 0.4 
kcal (mol monomer)
-1
, 0.4 ± 0.4 kcal (mol dimer)
-1
 (M urea)
-1
, and 1.8 ± 0.2 kcal (mol 
monomer)
-1
 (M urea)
-1
, respectively.  Changing the fluorescence of the intermediate from 10% to 
50% of the total amplitude changes the values of ΔGN2↔2M , ΔGM↔U , mN2↔2M and mM↔U by ± 1.0 
kcal (mol dimer)
-1
, ± 0.1 kcal (mol monomer)
-1
, ± 0.41 kcal (mol dimer)
-1
 M
-1
, and ± 0.1 kcal 
(mol monomer)
-1
 M
-1
,
 
respectively.  Experiments were performed and data analyzed by Jessica 
A. O. Rumfeldt. 
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3.3.6 Comparing monomer, dimer and total stabilities of apo SOD1 determined from 2-state 
and 3-state fitting 
Total protein stability and the constituent dimer and monomer stabilities obtained from 
the 3-state fits were compared to values for total stability obtained from the dimer 2-state fits at 
the tavg (Fig. 3.6A) and at physiological temperature (37 °C), and these results are summarized in 
Table 3.3.  For total unfolding, generally ΔGN2↔2U values for the 2-state fits with n values of ~2 
are similar to the values of ΔGN2↔2M↔2U from the global 3-state fits (Fig. 3.6A, Table 3.3).  This 
agreement between the 2-state and 3-state fits indicates that there is relatively little formation of 
monomer for pWT, A4S, A4T, E100G, G37R, G93S, G93A, H43R, and I113T and that 2-state 
fitting gives a reasonably accurate measure of stability (Fig. 3.6A).  The advantage of 3-state 
fitting though, even for apo variants that form low levels of monomer, is that the data can be 
used to dissect total stability into constituent dimer interface and monomer stabilities (Tables 3.2, 
3.3) and this method returns values for monomer stability that are consistent with previous 
measurements (Table 3.2) (176, 177, 188).  When the population of monomer is significant, as 
occurs when including DSC data at lower protein concentrations or when mutations either highly 
weaken the dimer interface (A4V, G93R, and V148G) or increase monomer stability (H46R and 
V148I), larger discrepancies in the stability determined by the dimer 2-state and 3-state fits are 
evident (Fig. 3.6A).  In these cases, fitting the data to a 2-state model will give inaccurate values.  
The total stabilities determined from the 3-state fits of the different apo SOD1 mutants 
vary greatly.  All the apo SOD1 mutants are destabilized relative to pWT, with total 
ΔΔGN
2
↔2M↔2U values on the order of ~4.3 to 8.9 kcal (mol dimer)
-1
, except for H46R and 
V148I, which are stabilized by 1.5 and 1.9  kcal (mol dimer)
-1
 (Table 3.3).  The contributions of 
dimer interface and monomer stability to overall changes in stability also vary markedly.  All the 
105 
 
mutations weaken dimerization, although to different extents (Chapter 2, Fig. 2.2), while the 
effects on monomer stability range from being significantly stabilizing for H46R and V148I to 
slightly or significantly destabilizing for the other mutants (Table 3.2).  Except for H46R and 
V148I, the destabilizing effects of mutations on monomer stability are relatively high, from ~1.5 
to 2.3 kcal (mol monomer)
-1
.  The molecular origin of the altered monomer stabilities likely 
varies considerably among the mutants.  The low monomer stability of H43R, G37R, the G93 
mutants, and E100G may be related to significant disruptions in beta sheet packing (255, 256), 
while for the dimer interface mutants A4S, T and V, and I113T, the low monomer stability could 
be the result of a combination of unfavorable burial of the polar moieties of serine and threonine 
into the hydrophobic core of the protein and steric effects (Fig. 3.1).  The other dimer interface 
mutations, V148G and V148I, have very different effects on monomer stability.  For the former, 
monomer stability is decreased, potentially owing to a loss of stabilizing interactions when valine 
is truncated to a glycine; while for the latter, the monomer is stabilized relative to pWT, which 
could be due to additional favourable hydrophobic interactions.  The increased stability for H46R 
relative to pWT is reminiscent of the stabilizing effects of mutations in functional residues within 
active sites of other proteins (257).  In the crystal structure of apo H46R (138), the guanidinium 
group of the arginine lies within the copper binding site and may stabilize the apo protein by 
mimicking, to some extent, the stabilizing effect of copper binding. 
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Figure 3.6 Comparing stabilities obtained from 3-state fitting of apo SOD1 variants.  (A)  
Total stability at tavg determined from 2-state (blue bars) and 3-state (red bars) fits of DSC data 
(Table 3.1 and Table 3.3).  Errors bars for total stability determined from 2-state fits are the 
standard deviation of multiple experiments at different protein concentrations (Table 3.1).  Error 
bars for total stability obtained from the 3-state fits were determined from the uncertainty in 
dimer interface stability, as determined by the standard deviation of multiple ITC experiments 
and monomer stability, as determined by different approaches to 3-state fitting (Table 3.2).  (B) 
Changes in monomer stability upon mutation are highly correlated (R=0.98) with changes in the 
t0.5’s of the disulfide reduced apo form of the protein.  Therefore, 3-state fitting returns 
reasonable values for ∆GM↔U.  Disulfide reduction has a large effect on the stability of the apo 
dimer interface, and thus this form of the protein is monomeric under physiological conditions.  
Limited stability data are available for reduced apo SOD1, owing to the irreversibility of 
unfolding for a number of mutations, but the ∆t0.5’s are a good indicator of the destabilizing 
effects of mutations (Chapter 4) (174).  
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Table 3.3 Comparisons of global stability determined from dimer 2-state and 3-state fits of apo SOD1. 
SOD1 
variant 
∆GN
2
↔2U 
(kcal (mol 
dimer)
-1
) 
37 °Ca 
∆G N
2
↔2U 
(kcal (mol 
dimer)
-1
) 
tavg °C
a
 
∆G N
2
↔2M↔2U 
(kcal (mol 
dimer)
-1
) 
37 °Cb 
∆G N
2
↔2M↔2U 
(kcal (mol 
dimer)
-1
) 
tavg °C
b
 
∆∆G N
2
↔2U 
(kcal (mol 
dimer)
-1
) 
tavg °C
c
 
∆∆G N
2
↔2M↔2U 
(kcal (mol 
dimer)
-1
) 
tavg °C
c
 
pWT
d
 n/a n/a 17.0 ± 1.2 n/a n/a n/a 
pWT 15.6 ± 0.5 10.6 ± 0.4 15.8 ± 1.3 11.0 ± 1.3 n/a n/a 
V148I 13.9 ± 1.3  10.1 ± 0.4 20.2 ± 1.6  12.9 ± 1.0 0.5 -1.9 
G93S 11.9 ± 0.3 6.4 ± 0.1 12.3 ± 0.7 6.7 ± 0.7 4.2 4.3 
H46R 12.1 ± 0.7 10.1 ± 0.1 18.9 ± 0.9 12.5 ± 0.8 0.5 -1.5 
E100G 12.8 ± 0.2 6.7 ± 0.4 11.1 ± 0.7 6.0 ± 0.6 3.9 5.1 
G37R 12.8 ± 0.2 6.4 ± 0.3 13.9 ± 1.6 6.5 ± 0.2 4.2 4.5 
H43R 10.2 ± 0.1 5.5 ± 0.1 18.9 ± 0.2 4.9 ± 0.0 5.1 6.1 
G93A 10.7 ± 0.4 5.4 ± 0.2 10.5 ± 0.4 5.0 ± 0.5 5.2 6.1 
I113T 9.6 ± 0.5 4.8 ± 0.3 9.8 ± 0.4 4.0 ± 0.4 5.8 7.0 
A4T 9.2 ± 0.5 3.7 ± 0.5 8.7 ± 0.6 2.9 ± 0.4 6.9 8.2 
A4S 10.9 ± 0.3 4.9 ± 0.1 10.1 ± 0.6 4.6 ± 0.4 5.7 6.7 
G93R 10.4 ± 0.5 5.6 ± 0.0 12.8 ± 0.2 3.2 ± 0.1 5.0 7.8 
A4V 9.0 ± 0.4 6.0 ± 0.5 10.9 ± 0.4 4.3 ± 0.5 4.6 6.8 
V148G 8.8 ± 0.5 5.6 ± 0.7 10.2 ± 0.4 2.2 ± 0.3 5.0 8.9 
n/a = not applicable. 
a
Uncertainties are the standard deviation of ΔGN22U values obtained from 2-state fits of the 
individual thermograms (Table 3.1).   
b
Uncertainties are calculated from uncertainties in dimer interface stability, determined by ITC, 
and monomer stability, determined by averaging the values obtained by various fitting methods 
(Tables 3.2, S3.1). 
cΔΔG  = ΔGpWT - ΔGmutant, a positive value indicates lower stability of the mutant relative to 
pWT; values are calculated at tavg. 
dΔGN
2
↔2M↔2U = ΔGN
2
↔2M  + 2ΔGM↔U.  ΔGN
2
↔2M and ΔGM↔U were determined by globally 
fitting urea denaturation curves at 37 °C to a 3-state model with monomeric intermediate.  
Uncertainties are from the fitting program.   
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3.3.7 Populations of N2, M, and U for apo SOD1 variants 
With knowledge of the dimer interface and monomer stabilities for different apo variants 
(Table 3.2), the fractions of N2, M and U can be calculated as a function of temperature for a 
given protein concentration (Fig. 3.6) (143, 173).  It is noteworthy that folded monomer is not 
significantly populated for pWT (<2%) at physiologically relevant temperature (37 °C), pH, and 
protein concentration (~40 µM (212)).  But, all of the mutants have markedly increased 
populations of folded monomer, ranging from 6% for V148I to 52% for V148G, and all but 
H46R and V148I have increased populations of unfolded monomer, ranging from 3% for V148G 
to 6% for A4T.  These results are of interest because monomeric species have been implicated in 
giving rise to toxic aggregates (see Discussion). 
Inspection of the populations of different species also provides insight into the different 
thermal unfolding mechanisms observed by DSC for the mutants.  The differences are a 
consequence of the relative effects of mutations both on dimer dissociation and on monomer 
stability (Table 3.2).  The observation of a monomer intermediate occurs when the dimer 
interface stability is low and/or the monomer stability is high.  For example, V148G has the most 
destabilized dimer interface, whereas H46R has significantly increased monomer stability.  Thus, 
for both of these mutants, there is a high population of monomer intermediate throughout the 
thermal unfolding transition (Fig. 3.7).  Although the other mutants examined also show a 
weakened dimer interface, the corresponding monomer stabilities are also substantially 
decreased and consequently the monomer intermediate is not as highly populated in DSC scans. 
Protein concentration also plays a role in the observation of monomer formation.  The 
relatively high concentrations required for DSC experiments result in decreased population of 
monomeric intermediate (as a percentage of total protein) and apparent 2-state unfolding (Fig. 
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3.7).  In contrast, monomer is more readily observed by ITC or chemical denaturation, both of 
which are typically performed at lower protein concentrations, which favour monomer formation 
(Chapter 2).  Therefore, it is important to consider the interplay between the interface and 
monomer stabilities in addition to solution conditions such as protein concentration as these will 
influence the observation of intermediate states. 
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Figure 3.7 Fractional populations of N2, M and U for apo SOD1 variants as a function of temperature.  In the panels on the left 
side, the total excess heat of unfolding (black lines) is dissected into the contributions from dimer dissociation (red lines) and 
monomer unfolding (blue lines) at protein concentrations, 0.10 mg mL
-1 
(0.32 M dimer) (dotted lines) and 1.0 mg mL-1 (32 M 
dimer) (solid lines).  In these panels, the folded and unfolded baselines are subtracted, leaving only the excess specific heat.  In the 
panels on the right side, the populations of the N2  (red lines), M (blue lines) and U (black lines) were calculated using the 
thermodynamic parameters obtained from fitting DSC data to a dimer 3-state model with monomeric intermediate with parameters for 
dimer dissociation determined by the ITC (Table 3.2, Materials and Methods).  Solid lines represent the populations at total protein 
concentrations of 1.0 mg mL
-1
 (32 M dimer), and dotted lines represent the populations at 0.10 mg mL-1 (0.32 M dimer).  As the 
temperature increases, the fraction of monomer increases, to varying extents, for all variants.   3-state unfolding behaviour is more 
readily detected when the transition from N2 to M becomes well resolved from the transition from M to U.  At 1.0 mg mL
-1
, the 
maximal fraction of monomer is <0.3 for pWT, H43R, and A4T, consistent with measured n values at comparable protein 
concentrations for these variants (Table 3.1), indicating predominantly dimer 2-state unfolding behaviour.  For mutants I113T and 
V148I, the maximal fraction of monomer is <0.4 at 1 mg mL
-1
, and the corresponding n values are low for experiments done at lower 
protein concentrations.  Thus, 3-state unfolding is more pronounced at lower protein concentrations.  A4V, H46R, and V148G exhibit 
the most 3-state unfolding behavior, as these mutants show the highest maximal fraction of monomer at 1 mg mL
-1
 (>0.6) and the 
lowest n-values.   At 0.10 mg mL
-1
, the maximal fraction of monomer is >0.5 for all variants indicating predominately 3-state 
unfolding behavior at lower protein concentration. 
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3.4 Discussion 
In this study, we have demonstrated a valuable new approach for characterizing ALS-
associated apo SOD1 mutants by combining ITC, chemical denaturation and DSC to obtain 
thermodynamic analyses of total protein stability, as well as constituent dimer interface and 
monomer stabilities.  Relatively few ITC studies have been performed on homodimeric proteins, 
and ITC has not previously been combined with DSC to dissect the components of total protein 
stability.  Here we show how this can be done, and we validate our approach by comparison to 
chemical denaturation data. 
ITC performed at physiological temperatures, where we find that dissociation is enhanced 
compared to lower temperatures, allows for accurate direct measurement of thermodynamic 
parameters (∆HN2↔2M and ∆GN2↔2M) (Chapter 2).  Using ITC data to constrain 3-state global fits 
of DSC data obtained for a range of protein concentrations then enables more accurate 
determination of monomer stability and total protein stability when the monomer becomes highly 
populated during unfolding (Fig. 3.6A, Tables 3.2, 3.3).  We find that calculations of 
molecularity for dimer 2-state fits of DSC scans provide a sensitive tool for monitoring monomer 
formation (Table 3.1), allowing for previously undetected monomer formation to be taken into 
account.  Molecularity values also provide an explanation for increases in ΔHvH with t0.5 (Table 
3.1), which should increase linearly with increases in t0.5 but are larger than expected for a dimer 
2-state model.  This observation can be attributed to a shift from ΔHvH values that are 
systematically low at low protein concentration, due to significant population of monomer, to 
higher values at higher protein concentrations that correspond to dimer unfolding (Table 3.1).  
The results reported here provide new insights into the molecular determinants of apo SOD1 
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folding, and the methods used should be broadly applicable to studying other oligomeric 
proteins.  
 
3.4.1 Many ALS mutations enhance dimer dissociation of apo SOD1 but have differing effects 
on monomer stability 
Direct analysis of dimer dissociation by ITC reveals that chemically and structurally 
diverse fALS-associated mutations promote the dissociation of apo SOD1 (Chapter 2).  These 
results are particularly interesting because the effects of mutations on the integrity of the dimer 
interface cannot be predicted readily based on inspection of the different structural contexts of 
the mutations.  Although the dimer interface mutations tend to have the largest deleterious 
effects, the consequences of mutations distant from the dimer interface propagate through the 
protein and weaken the interface.   
Previous indirect kinetic and equilibrium analyses of apo SOD1 have been conducted to 
assess the effects of mutations on dimer interface and monomer stabilities.  Together, these 
studies report similar trends to the results obtained here by calorimetry.  Mutations H46R, 
E100G, H43R, G93A, I113T, G93R, A4V, and V148G all destabilize the dimer interface (134, 
176, 177), although the ΔGN2↔2M of G93A was found to be very marginally increased relative to 
pWT in one study (177).  Consistent with our ITC experiments, A4V and V148G had the largest 
destabilizing effects on the interface (176, 177);  yet, the magnitude of these effects differ.  
Discrepancies between the different approaches may be due to differences in experimental 
conditions.  Previous experiments were performed at relatively low temperatures (<25 °C) (134, 
176, 177), where dissociation is less pronounced and mutational effects are smaller relative to the 
effects at 37 °C (Chapter 2).  Compared to the direct measurements of ΔGN2↔2M at 37 °C by ITC, 
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these previous experiments have high uncertainties due to long extrapolations (176, 177, 200), 
and the assumption of invariance in the rate constant for dimer association (176, 200).  The 
relative monomer stabilities of E100G, I113T, and G93R, determined by equilibrium 
denaturation at 25 °C, are, however, consistent with the relative monomer stabilities reported 
here (134), and the effects of mutations on monomer stability at tavg are highly correlated with 
changes in t0.5 of the reduced apo form (Fig. 3.6B), which is monomeric (98).  Although, the 
effects of mutations on the stability of the apo monomer variant, determined by kinetic analysis, 
were found to be more pronounced (176).  Taking into consideration the different SOD1 
constructs, experimental methodologies, and conditions, on the whole there is fairly good 
agreement between the different studies.   
It is worth mentioning that comparing mutational effects on stability at different 
temperatures requires knowledge of the curvature and amplitude of the ∆G versus t function.  
Mutations can in some cases affect this curvature in complex ways leading to large differences in 
stability relative to pWT.  For example, our studies show that G37R destabilizes the monomer at 
tavg by 1.4 kcal (mol monomer)
-1
(Table 3.2), but stabilizes the monomer by 0.4 kcal (mol 
monomer)
-1
 at 37 °C.  This large difference in relative stability at the different temperatures is 
due to the large ∆HM↔U value, which causes a large increase in the amplitude of the ∆G versus t 
function relative to pWT, in turn leading to high stability in the lower temperature range.  The 
same behaviour is observed for G93R and V148I mutants.  This finding emphasizes the 
difficulty in comparing relative stabilities obtained using different experimental approaches and 
measurement conditions.  To compare variations in reported relative stabilities, experiments 
should be performed under as close to identical conditions as possible.   
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3.4.2 Mutations increase population of monomeric species: implications for aggregation and 
ALS 
  Correlations between the properties of SOD1 mutants in vitro and ALS characteristics, 
such as disease duration and age of onset, have long been sought.  A number of studies have 
attempted to relate various measures of stability with disease duration, and, while there appears 
to be a correlation between total stability and disease duration for some mutants, there are also 
many outliers (200, 229, 230).  The results obtained here suggest that, rather than considering 
only total stability for such correlations, it is important also to account for the stabilities and 
populations of additional SOD1 species.  In particular, the fractions of both folded and unfolded 
monomer may be important, as these species have been suggested to be key precursors for 
aggregate formation (76, 99, 193, 199, 258).  Aggregation is generally enhanced by decreasing 
global or local protein stability and is thought to arise from fully or partially unfolded states (52).  
Here we show that the actual folded apo SOD1 monomer intermediate (i.e., not a mutant 
monomer model) has relatively low stability (Table 3.2) (134, 176, 177, 188).  Furthermore, the 
monomer is usually further destabilized by mutation (Table 3.2), and the expanded structure 
(Section 2.2.3) of folded monomeric apo SOD1 mutants may more readily allow for propagation 
of the destabilizing effects of mutations, increasing access to aggregation-prone states. 
All the mutants studied increase the fraction of folded monomers under physiologically 
relevant concentration, temperature, and pH (Fig. 3.7).  Since SOD1 aggregation has been 
reported to occur via a nucleation-dependent mechanism (99), even small increases in malleable 
monomers, which may promote nucleation, are important for accelerating aggregation.  These 
observations suggest that mutations promote different structural changes that may in turn 
promote aggregation in different ways (2, 181).  
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3.4.3 Conclusions 
Of central importance in understanding SOD1-mediated ALS is deciphering the 
mutation-driven mechanisms that may transform this protein into toxic aggregates.  Systematic 
thermodynamic analyses such as those reported herein are valuable not only for determining 
global stability but also for quantifying the stabilities and populations of species that may be 
important precursors to aggregation.  While many mutations, including ones distant from the 
dimer interface, decrease interface stability, and promote monomer formation, the effects on 
monomer stability are more complex.  Consequently, the relative amounts of folded and 
unfolded monomers populated under physiological conditions by different mutants will differ 
and may account for the complexity of aggregation mechanisms reported (2).  The new approach 
of using ITC combined with protein concentration dependence of DSC, provides detailed 
quantitative data on total, interface, and monomer stabilities for SOD1 mutants.  The results 
suggest that mutational effects on total stability of SOD1 are only part of the story; monomer and 
dimer interface stabilities are important additional factors central to understanding the origins of 
toxic SOD1 aggregation in ALS. 
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3.5 Supplementary Information 
3.5.1 Supplementary Methods  
3.5.1.1 Fitting of differential scanning calorimetry data to a 2-state monomer unfolding model   
In addition to the dimer 2-state unfolding and dimer 3-state with monomeric intermediate 
unfolding models, DSC data for apo A4V, H46R, and V148G were analyzed using a monomer 2-
state unfolding model describing a reversible transition from folded monomer (M) to unfolded 
monomers (U), M↔U (237).  Individual thermograms were fit to Eq. S3.1: 
𝐶𝑝 = (𝐴 + 𝐵𝑇)(1 − 𝛼) + (𝐸 + 𝐹𝑇)𝛼 +
𝛽∆ℎ𝑐𝑎𝑙
2 (𝑇0.5)𝛼(1−𝛼)
𝑅𝑇2
 (Eq. S3.1) 
where  Cp is the total specific heat absorbtion at temperature T (in Kelvin); A and E are the 
intercepts of the folded and unfolded baselines, respectively; B and F are the slopes of the folded 
and unfolded baselines, respectively; R is the universal gas constant; β is the ratio of van’t Hoff 
to calorimetric enthalpy multiplied by the molecular weight of the SOD dimer; Δhcal is the 
specific calorimetric enthalpy of unfolding at T; α is the extent of the unfolding reaction; and T0.5 
is the temperature at which unfolding is half complete (i.e α =0.5).  Fitting was performed using 
Microcal Origin 5.0 (Microcal Inc., Malvern Instruments). 
  
3.5.1.2 Predicting ΔCp,N2↔2M  based on changes in solvent accessible surface area (ΔASA)  
The polar and non-polar contributions to ΔASA (ΔASAp andΔASAnp, respectively) 
between dimer and dissociated monomers were determined using the crystallographic structures 
for both apo SOD1 wild-type (1HL4) using: 
ΔASAp = ASAmonA-p + ASAmonB-p – ASAdimer-p (Eq. S3.2a) 
ΔASAnp = ASAmonA-np + ASAmonB-np – ASAdimer-np (Eq. S3.2b) 
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where ASAmonA-p and ASAmonB-p are the polar, ASAmonA-np and ASAmonB-np are the non-polar solvent 
accessible surface areas of the folded monomers A and B,  respectively, which together make up 
the dimer in the crystal structure, and ASAdimer-p and ASAdimer-np are the polar and non-polar 
respectively, solvent accessible surface areas of the folded dimer.  These values were calculated 
using InterProSurf (259). 
The ΔCp,N2↔2M can be predicted using ΔASAp and ΔASAnp calculated above and the 
empirically derived equations: 
ΔCp,N2↔2M = -0.32 x ΔASAnp + 0.14 x ΔASAp (260) (Eq. S3.3a) 
ΔCp,N2↔2M = -0.45 x ΔASAnp + 0.26 x ΔASAp (261) (Eq. S3.3b) 
ΔCp,N2↔2M = -0.28 x ΔASAnp + 0.09 x ΔASAp (262) (Eq. S3.3c) 
ΔCp,N2↔2M = -0.51 x ΔASAnp + 0.21 x ΔASAp (263) (Eq. S3.3d) 
An average ΔCp,N2↔2M value of 0.45 ± 0.12 kcal (mol dimer)
-1
 °C-1 was determined based on 
equations S3.3a-S3.3d and using predicted ΔASAnp and ΔASAp of 1262 Å and 258 Å, respectively 
(173).   
 
  
119 
 
 
Figure S3.1 Plots of lnP versus 1/T0.5 used to determine molecularity, n, for apo SOD1 
variants.  Here the lnPdimer values are plotted versus 1/T0.5 values from the dimer 2-state fits for a 
representative set of apo variants (Table 3.1), and fit to a straight line using linear regression.  
Note that the midpoint of the thermal unfolding transition is a relatively well defined 
experimental value that is affected little in different unfolding models.  Data are plotted for 
H46R (red), V148I (blue), pWT (black), G37R (purple), A4V (green), and A4S (orange), 
ordered from most thermally stable to least stable variant and (left to right).  The slope values 
were used to determine n (summarized in Table 3.1) using Eq. 3.2, as described in the Material 
and Methods.  Values of n are related to the inverse of the slope values.  Of the representative set 
of mutants, the data for H46R and A4V have the steepest slopes, and hence the lowest average n 
values of ~1.3 and ~1.6, respectively, consistent with these mutants having higher populations of 
monomer (Fig. 3.6).  The lower slopes for the other variants correspond to higher n values 
approaching ~2, consistent with predominantly dimer unfolding.  When molecularities were 
calculated with ∆Hcal there was much more scatter in the data due to there being more 
experimental error in ∆Hcal (128, 244).  Taken together, the data are consistent with dimer 
unfolding with varying levels of monomer, in agreement with trends in t0.5 values with protein 
concentration (Fig. 3.3, Table 3.1). 
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Figure S3.2 3-state thermal denaturation of apo SOD1.  The total heat of unfolding (black 
curve) can be dissected into contributions from dimer dissociation (red curve) and monomer 
unfolding (blue curve).  In the 3-state global fitting approach taken herein, Kd,N2↔2M and 
Δhcal,N2↔2M , which characterize dimer dissociation, were set to the values determined by ITC at 
37 °C.  The slopes of the monomeric intermediate and unfolded monomer baselines were set 
equal to that of the native baseline, making the common assumption that ΔCp of unfolding is 
temperature independent (219).  The intercepts of the intermediate and unfolded baselines were 
defined relative to the intercept of the native baseline (solid grey line) according to temperature-
independent values for ΔCp,N2↔2M and ΔCp,M↔U determined by Kirchoff analysis (Materials and 
Methods).  Thus, the unfolded monomer and dimer baselines, grey dashed and dotted lines 
respectively, were defined based on ∆Cp,N2↔2M (X1) and ∆Cp,M↔U (X2); only T2
', Δhcal,M↔U(T2
'
), β1 
= β2, and parameters defining the slope and intercept of the native baselines (solid grey line) 
were set as globally shared floating parameters. 
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Table S3.1 Thermodynamic parameters for apo SOD1 determined from global 3-state fits. 
SOD1 
variant
a
 
∆HN
2
↔2M 
(kcal (mol  
dimer)
-1
) 
37 °Cb 
∆GN
2
↔2M 
(kcal (mol  
dimer)
-1
) 
37 °Cb 
t0.5, M↔U 
(°C)c 
 
∆HM↔U 
(kcal (mol 
monomer)
-1
) 
tavg
c,d
 
∆GM↔U 
(kcal (mol 
monomer)
-1
) 
37 °Ce,f 
∆GM↔U 
(kcal (mol 
monomer)
-1
) 
tavg
d, f
 
∆∆GM↔U 
(kcal (mol 
monomer)
-1
) 
tavg
d,g
 
pWT
c,i
 n/a 10.2 ± 0.7 n/a n/a 3.4 ± 0.5 n/a n/a 
pWT (30.8 ± 8.8)  (10.3 ± 0.5) 59.5 ± 0.9 44.0 ± 2.0 2.8 (1.9, 3.0) 1.2 (0.7, 1.3) n/a 
pWT
j
 8.8 ± 13.5 9.0 ± 11.8  58.4 ± 0.9 49.1 ± 6.7 3.0 1.10 n/a 
V148I (11.4 ± 2.2) (8.9 ± 0.2) 60.1 ± 0.2 84.0 ± 1.2 5.7 (4.2, 5.7) 2.3 (1.6, 2.4) -1.2 
V148I
j
 7.5 ± 3.8  7.7 ± 3.2 60.0 ± 0.1 79.9 ± 3.2 5.4 2.18 n/a 
G93S (17.6 ± 4.6) (8.4 ± 0.3) 49.2 ± 1.1 58.3 ± 3.7 2.0 (1.5, 2.0) -0.4 (-0.6, -0.3) 1.5 
H46R (16.2 ± 4.4) (8.4 ± 0.4) 62.5 ± 0.1 71.2 ± 1.1 5.3 (4.7, 5.4) 2.6 (2.3, 2.6) -1.4 
H46R
j
 25.0 ± 3.0 8.7 ± 3.1 62.8 ± 0.1 70.0 ± 1.9 5.3 2.5 n/a 
E100G (16.0 ± 4.8) (8.0 ± 0.4) 48.0 ± 0.7 53.3 ± 8.4 1.6 (2.1, 1.6) -0.5 (-0.3, -0.4) 1.7 
G37R (7.8 ± 1.8) (7.6 ± 0.2) 50.3 ± 0.1 84.1 ± 2.8 3.2 (3.0, 1.8) -0.2 (-0.3, -0.3) 1.4 
G37R
j
 42.7 ± 26.5  10.3 ± 15.6  46.7 ± 0.8 55.4 ± 21.6 1.5 -0.8 n/a 
H43R (23.0 ± 1.4) (7.5 ± 0.0) 47.6 ± 0.4 59.5 ± 5.2 1.7 (1.9, 1.7) -0.6 (-0.6, -0.6) 1.8 
G93A (14.0 ± 2.0) (7.2 ± 0.3) 47.4 ± 0.3 58.9 ± 4.7 1.7 (1.7, 1.7) -0.7 (-0.7, -0.6) 1.9 
G93A
j
 22.0 ± 10.6 8.1 ± 3.8 46.1 ± 0.7 50.8 ± 5.4   1.3 -0.8 n/a 
I113T (30.2 ± 2.5) (7.1 ± 0.2) 46.7 ± 0.2 53.2 ± 3.7 1.4 (1.7, 1.5) -0.7 (-0.7, -0.6) 1.9 
I113T
j
 27.2 ± 4.3 7.8 ± 1.3 45.7 ± 0.4 50.7 ± 1.7 1.2 -0.9 1.9 
A4T (39.2 ± 3.8) (7.1 ± 0.2) 43.6 ± 0.4 48.9 ± 9.6 0.8 (1.3, 0.9) -1.1 (-1.1, -1.0) 2.3 
A4T
j
 13.7 ± 46.3 10.4 ± 17.4 30.0 ± 6.4 42.9 ± 50.2 -0.8 -2.6 n/a 
A4S (9.0 ± 2.6) (7.0 ± 0.0) 46.3 ± 0.4 61.1 ± 10.0 1.5 (1.0, 1.1) -0.9 (-1.3, -1.2) 2.1 
A4S
j
 46.5 ± 14.0 9.0 ± 4.1 45.5 ± 1.7 45.0 ± 6.6 1.1 -0.8 n/a 
G93R (45.6 ± 1.8) (6.7 ± 0.1) 49.1 ± 0.2 87.8 ± 7.7 3.1 (2.9, 3.1) -0.6 (-0.5, -0.5) 1.7 
A4V (37.2 ± 3.8) (6.4 ± 0.3) 50.9 ± 0.2 59.2 ± 3.4 2.3 (2.4, 2.2) -0.1 (-0.1, -0.1) 1.2 
A4V
j
 35.9 ± 5.4 6.8 ± 2.2   51.0 ± 0.4 55.9 ± 3.6 2.3 0.0 n/a 
V148G (50.6 ± 1.4)  (5.9 ± 0.3) 48.6 ± 0.0 67.8 ± 0.5 2.2 (2.1, 2.3) -0.5 (-0.5, -0.5) 1.7 
V148G
j
 54.8 ± 0.4 5.7 ± 0.2 48.6 ± 0.0 65.7 ± 0.3 2.2 -0.5 n/a 
a
For each mutant, the scans at different protein concentrations used in the global fitting are those listed in Table 3.1, with the 
exception of pWT, where concentrations 0.20, 0.21, 0.40, 0.44, 0.85, 1.50, and 3.0 were fit; I113T where concentration 0.21 mg mL
-1
 
was omitted; A4V where concentration 0.52 mg mL
-1
 was omitted; and G93R mg mL
-1 
where concentration 0.21 was omitted. 
b
Numbers in the brackets were determined by ITC and fixed in the DSC 3-state fits. 
c
Errors are the uncertainty in fitted values. 
d
tavg is 51.2 °C, the average of all t0.5 values obtained from the 2-state fits. 
eΔGM↔U values calculated at physiological temperature.  
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fValues shown in bold are determined from fits allowing ΔHvH/ΔHcal to deviate from unity.  Data were also fit with ΔHvH and ΔHcal set 
equal, and these values are the first values shown in brackets.  Monomer stability was also determined using a higher ΔCp,N2↔2M (2.2 
kcal (mol dimer)
-1
 °C-1), and these values are the second values shown in brackets.  Uncertainties in monomer stability were 
approximated from the range of values obtained from these 3 different fitting procedures (Table 3.2). 
gΔΔG  = ΔGpWT - ΔGmutant, a positive value indicates lower stability of the mutant relative to pWT; values are calculated at tavg, where 
monomer stability is best defined. 
hΔGN
2
↔2M and ΔGM↔U were also determined by globally fitting urea denaturation curves at 37 °C to a 3-state model with monomeric 
intermediate. 
iΔGM↔U values obtained by fitting additional parameters ΔHN2↔2M and ΔGN2↔2M  (i.e., not fixing these parameters to the values 
obtained by ITC) and setting ΔHvH and ΔHcal equal, for mutants with more than 3 datasets.  This fitting method returns values with 
high uncertainty; therefore, the values from the fixed fits give more reliable comparison of relative stabilities. 
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Table S3.2 Thermodynamic parameters for monomer 2-state unfolding of apo SOD1. 
SOD1 
variant 
[SOD1] 
mg mL
-1
 
t0.5 
(°C)a 
∆Cp,M↔U 
(kcal (mol 
monomer)
-1
) 
∆HvH(t0.5) 
(kcal (mol 
monomer)
-1
)
 a
 
A4V 0.20 51.5 ± 1.4 -1.15 45.5 ± 10.6 
A4V 0.30 50.3 ± 0.6 0.02 56.6 ± 7.9 
A4V 0.40 50.6 ± 0.3 -0.47 56.9 ± 5.1 
A4V 0.50 50.8 ± 0.2 0.29 54.7 ± 2.5 
A4V 1.00 50.3 ± 0.4 0.26 65.9 ± 4.4 
A4V 1.95 51.5 ± 0.1 -0.18 79.3 ± 2.6 
     
H46R 0.08 61.6 ± 1.3 1.55 73.0 ± 18.8 
H46R 0.17 61.9 ± 0.3 0.71 74.6 ± 6.6 
H46R 0.32 62.2 ± 0.1 1.01 84.6 ± 2.2 
H46R 0.39 62.2 ± 0.2 0.27 86.6 ± 4.7 
H46R 0.76 62.2 ± 0.1 1.07 94.9 ± 2.5 
     
V148G 0.12 47.1 ± 0.5 5.19 44.7  ± 4.3 
V148G 0.23 51.1 ± 0.1 -1.68 62.3  ± 0.6 
V148G 0.29 52.3 ± 0.0 -3.07 52.4  ± 0.3 
V148G 0.53 49.8 ± 0.0 -0.76 61.0  ± 0.2 
V148G 0.92 49.2 ± 0.0 -0.71 59.2  ± 0.1 
V148G 1.56 48.4 ± 0.0 -0.51 55.6  ± 0.8 
a
Errors in fitted parameters are obtained from the fitting program. 
For A4V and H46R, data was obtained and fit by Kenrick A. Vassall. 
  
124 
 
Chapter 4 
Decreased stability and increased formation of soluble aggregates by 
immature SOD1 do not account for disease severity in ALS   
 
Author Contributions 
This chapter was published in the Proceedings of the National Academy of Sciences in 
2010, with the following authors: Kenrick A. Vassall*, Helen R. Broom* (published under my 
maiden name, Stubbs), Heather A. Primmer, Ming Sze Tong, Sarah M. Sullivan, Ryan Sobering, 
Sai Praveen Srinivasan, Lee-Ann K. Briere, Stanley D. Dunn, Wilfredo Colòn, and Elizabeth M. 
Meiering (174), and has been reproduced with permission.  
*Kenrick A. Vassall and Helen R. Broom contributed equally to this work.   
Kenrick A. Vassall, Helen R. Broom, Heather A. Primmer, Stanley D. Dunn, and 
Elizabeth M. Meiering designed experiments.  Plasmids containing wild type SOD1 (a construct 
containing the native free cysteines, refer to section 1.3.2), as well as SOD1 mutants with free 
cysteines were provided by Wilfredo Colòn.  Samples were prepared by Kenrick A. Vassall, 
Helen R. Broom, Heather A. Primmer, Ming Sze Tong, Sarah M. Sullivan and Sai Praveen 
Srinivasan.  Differential scanning calorimetry experiments were mainly performed by Kenrick 
A. Vassall with a subset being performed by Helen R. Broom; Helen R. Broom performed light 
scattering experiments; Stanley D. Dunn and Lee-Ann K. Briere performed the analytical 
ultracentrifugation experiments; Kenrick A. Vassall and Ryan Sobering performed circular-
dichroism experiments; and Heather A. Primmer performed the aggregation-prediction analysis.  
The manuscript was co-written by Kenrick A. Vassall, Helen R. Broom, Heather A. Primmer, 
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and Elizabeth M. Meiering.  We are grateful to Gian Tartaglia for assistance in using 
Zaggregator. 
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Overview 
Protein aggregation is a hallmark of many diseases, including amyotrophic lateral 
sclerosis (ALS), where aggregation of Cu, Zn-superoxide dismutase (SOD1) is implicated in 
causing neurodegeneration.  Recent studies have suggested that destabilization and aggregation 
of the most immature form of SOD1, the disulfide-reduced, unmetallated (apo) protein is 
particularly important in causing ALS.  We report herein in depth analyses of the effects of 
chemically and structurally diverse ALS-associated mutations on the stability and aggregation of 
reduced apo SOD1.  In contrast with previous studies, we find that various reduced apo SOD1 
mutants undergo highly reversible thermal denaturation with little aggregation, enabling 
quantitative thermodynamic stability analyses.  In the absence of ALS-associated mutations, 
reduced apo SOD1 is marginally stable but predominantly folded.  Mutations generally result in 
slight decreases to substantial increases in the fraction of unfolded protein.  Calorimetry, 
ultracentrifugation, and light scattering show that all mutations enhance aggregation propensity, 
with the effects varying widely, from subtle increases in most cases, to pronounced formation of 
40–100 nm soluble aggregates by A4V, a mutation that is associated with particularly short 
disease duration.  Interestingly, although there is a correlation between observed aggregation and 
stability, there is minimal to no correlation between observed aggregation, predicted aggregation 
propensity, and disease characteristics.  These findings suggest that reduced apo SOD1 does not 
play a dominant role in modulating disease.  Rather, additional and/or multiple forms of SOD1 
and additional biophysical and biological factors are needed to account for the toxicity of mutant 
SOD1 in ALS. 
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4.1 Introduction 
Mutations in Cu,Zn superoxide dismutase (SOD1) cause familial amyotrophic lateral 
sclerosis (fALS), a devastating and invariably fatal neurodegenerative disease.  Although 
accounting for only a small percentage of all ALS cases, SOD1 mutations represent one of the 
main known causes of the disease.  The similar symptoms and pathology of familial and sporadic 
ALS suggest common disease mechanisms and the potential for related therapeutic strategies 
(196, 232, 264).  The mechanisms by which mutant SOD1 cause ALS are not known; however, 
extensive evidence supports a toxic gain of function due to increased aggregation of mutant 
protein.   Misfolding and aggregation of diverse proteins are observed in numerous diseases, 
including other neurodegenerative diseases such as Alzheimer’s, Huntington’s and prion diseases 
(196, 264).  Amyloid is a type of aggregate structure formed by many disease-associated 
proteins, and perhaps by all proteins, often under destabilizing conditions (265).  Although there 
has been some controversy concerning the amyloid-like nature of large insoluble aggregates in 
mutant SOD1 mice models of ALS, amyloid aggregates are not observed in ALS patients (22, 
26, 266).  Here, we characterize the formation of small, soluble, non-amyloid aggregates by 
mutant SOD1.  
In its mature form, SOD1 is a highly stable, homodimeric protein, with each subunit 
binding one catalytic copper ion and one structural zinc ion, and containing one intramolecular 
disulfide bond as well as two non-conserved free cysteines (Fig. S4.1A).  Numerous in vivo and 
in vitro studies have shown that various immature, destabilized forms of SOD1 are prone to 
aggregate, and this is often enhanced by disease-associated mutations (76, 78, 128, 131, 144, 
184, 190, 267, 268).  Recently, attention has focused on aggregation of the most immature form 
of SOD1, in which the disulfide bond is reduced and no metals are bound, referred to here as the 
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reduced apo form.  Studies of various mutant-SOD1 ALS mice models have shown that small, 
soluble, misfolded forms of reduced apo SOD1 are enriched in the spinal cord and may be the 
common cytotoxic species that cause ALS (269, 270).  In addition, cell culture studies suggest 
that ALS-associated mutations can promote disulfide bond reduction and metal loss (194).  
Relatively little is known, though, about the properties of reduced apo SOD1, and how mutations 
affect these properties.  In vitro studies have shown that agitation and/or oxidation of reduced 
apo SOD1 results in the formation of large, insoluble, amyloid aggregates (76, 184).  However, 
the relevance of amyloid formation to ALS is questionable, and recent studies of mutant-SOD1 
mice models have shown that formation of aberrant intermolecular disulfide bonds and large 
insoluble aggregates by SOD1 becomes pronounced only occurs in the final, symptomatic stages 
of disease (268).  There is also extensive evidence that smaller, soluble aggregates are 
particularly neurotoxic (264).  Thus, it is of central importance to elucidate the properties of 
reduced apo SOD1s, and how these may relate to pathogenic mechanisms.   
We report here in depth analyses of the effects of chemically and structurally diverse 
ALS-associated mutations on the stability and aggregation of reduced apo SOD1, under 
physiologically relevant quiescent, reducing conditions.  The mutations are predominantly 
destabilizing, causing marked changes in the fraction of protein that is unfolded and increasing 
the propensity of the protein to form soluble aggregates.  However, the formation of these 
aggregates is not well correlated with disease duration. While the results suggest that aggregation 
of reduced apo SOD1 may play some role in disease, they do not support increased aggregation 
of reduced apo mutants as the dominant determinant of ALS duration.  Rather, multiple 
immature or aberrant forms of SOD1 are implicated in playing important roles in modulating 
disease.  
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4.2 Materials and Methods 
4.2.1 Expression and purification of mutant SOD1   
Disulfide-oxidized apo SOD1 proteins were prepared as described previously (134, 271).  
Reduced apo SOD1 was prepared by first unfolding the protein in 2 M guanidinium chloride 
(GdmCl), 20 mM HEPES, pH 7.8 for 30 min at ambient temperature with degassing.  Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP-HCl) was then added to a final concentration of 
10 mM with reduction occurring in an anaerobic environment for 1 hr.  Finally, samples were 
exchanged into buffer containing 1 mM TCEP-HCl, 20 mM HEPES pH 7.4 by successive 
dilutions and reconcentrations using a 3 kDa cutoff Nanosep centrifugal device (Pall 
Corporation). 
 
4.2.2 Differential scanning calorimetry   
DSC scans of apo SOD1 samples were performed as described elsewhere (128).  After 
subtraction of buffer versus buffer scans from protein versus buffer scans, disulfide-reduced apo 
SOD1 data were fit to a 2-state monomer unfolding model after normalizing for protein 
concentration (Supplementary Methods, Section 4.5.1).  
 
4.2.3 Analytical ultracentrifugation 
Sedimentation velocity and equilibrium experiments were conducted in the Biomolecular 
Interactions & Conformations Facility  (Shuclich School of Medicine & Dentistry, University of 
Western Ontario) using an Optima XL-A Analytical Ultracentrifuge (Beckman Coulter Inc.) with 
an An60Ti rotor and 2/6-channel cells with Epon-charcoal centerpieces.  Centrifugation was 
carried out at 20 °C with absorbance detection at either 252 or 280 nm.  Equilibrium data were 
130 
 
collected in radial step sizes of 0.002 cm and averaged over 10 readings.  Equilibrium data were 
fit to a single ideal species model (Supplementary Methods, Sections 4.5.3 and 4.5.4) using 
Prism 5 (GraphPad Software). 
 
4.2.4 Light scattering measurements 
Time average dynamic light scattering measurements were performed using a Zetasizer 
Nano ZS (Malvern Instruments Ltd.).  Particle size was determined from an average of 3 
correlation functions, each being the average of 5 consecutive 10 second data accumulations.  
Particle size was analyzed by the CONTIN method using Malvern software.  Samples were 
initially measured daily and then at increasing time intervals. 
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4.3 Results 
For most experiments herein, we employed a well-established pseudo wild-type (pWT) 
construct in order to facilitate measurements of stability and aggregation of reduced apo SOD1s 
and avoid complications caused by aberrant disulfide bond formation (76, 78, 126, 128, 144, 
255, 272).  In pWT, the nonconserved free cysteines at residues 6 and 111 are replaced by 
alanine and serine respectively, while the highly conserved cysteines at residues 57 and 146 are 
retained (Fig. S4.1A).  Cysteines 57 and 146 form a disulfide bond in mature forms of SOD1 but 
are reduced in the current study.  pWT is a suitable background because its activity, structure and 
stability are extremely similar to wild-type, and use of this background formerly enabled 
thermodynamic stability analyses for disulfide oxidized holo and apo SOD1s (128, 134, 143, 
144).  In various in vivo and in vitro studies, the free cysteines are frequently but not always 
observed to form aberrant disulfide bonds in aggregates, and they have been suggested to also 
play subtle roles in modulating noncovalent interactions during aggregation (76, 78, 131, 183, 
190, 267, 268).  These effects were controlled for here by analyzing the properties of mutations 
relative to the pWT background in the absence of disulfide bond formation.  In addition, we 
conducted some experiments using the wild-type (WT) background containing cysteines 6 and 
111; the results obtained are consistent with those obtained using pWT.   
All experiments on reduced apo SOD1s were conducted under physiologically relevant 
conditions of pH (20 mM HEPES, pH 7.4) and protein concentration (~30-60 µM monomer, 0.5-
1.0 mg mL
-1
) (131, 273), under reducing conditions (1 mM TCEP), with no agitation and sample 
incubation under anaerobic conditions.  The reduced status of the protein throughout all 
experiments was confirmed by iodoacetamide modification of the reduced cysteines followed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. S4.1B) (131). 
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4.3.1 In the absence of ALS-associated mutations, reduced apo SOD1 unfolds with high 
reversibility at well above physiological temperature   
The stability of reduced apo pWT and WT SOD1 were measured by differential scanning 
calorimetry (DSC) (Figs. 4.1A, B, 2D, Table S4.1), which shows that the temperature of 
maximum heat capacity (Cp), t0.5,app, is ~48 °C for both constructs.  The t0.5,app for reduced apo 
SOD1 is markedly lower compared to those for the more mature disulfide-oxidized apo and holo 
forms (Fig. 4.1A) (128, 144).  However, despite being significantly less stable, reduced apo pWT 
thermally unfolds with high reversibility, typically ~95 % (Fig. 4.1B), comparable to the 
reversibility for disulfide-oxidized forms of SOD1 (128, 134, 143).  The reversibility for the WT 
(Fig. 4.2D) is somewhat lower, at ~75%, likely due to the presence of the free thiols that have 
been shown previously to decrease reversibility due to the formation of aberrant disulfide bonds 
(141).  To minimize inaccuracies due to irreversibility, pWT was used for most of the further 
analyses.  
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Figure 4.1 Reversible thermal unfolding of reduced apo pWT SOD1.  (A) DSC scans of 
pWT SOD1 in the reduced apo form in 20 mM HEPES, 1 mM TCEP, pH 7.4 and the disulfide-
oxidized apo and holo forms in 20 mM HEPES, pH 7.8.  The dashed black line indicates 
physiological temperature of 37 °C.  (B) Consecutive thermal unfolding traces of disulfide-
oxidized apo pWT SOD1 in which the sample was heated (solid black line), cooled and heated 
again (dashed grey line).  (C) Change in apparent t0.5 of apo SOD1 in the disulfide-oxidized form 
(light shaded bars) and the disulfide-reduced form (dark shaded bars).  In all cases the mutations 
have a larger effect on the apparent t0.5 in the reduced apo form.  (D) Fraction of unfolded 
reduced apo mutant SOD1 at 37 °C.  The fraction of unfolded protein was calculated using the 
thermodynamic parameters (Table 4.1 and Supplementary Methods, Section 4.5.1). 
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4.3.2 Thermodynamic analysis under physiologically-relevant conditions shows reduced apo 
SOD1 undergoes a monomer 2-state unfolding transition and is predominantly folded 
High reversibility of unfolding is a prerequisite for thermodynamic analysis, which has 
not been reported previously for reduced apo SOD1. In previous studies, we showed that 
disulfide-oxidized apo and holo pWT SOD1 thermally unfold with high reversibility according 
to a 2-state dimer unfolding mechanism (128); however, reduction or mutation of the disulfide 
bond in apo SOD1 greatly weakens the dimer interface (147, 197, 273).  Measurements of 
thermal unfolding for reduced apo pWT are consistent with a monomer unfolding transition, 
showing no systematic shift in t0.5,app over ~20-fold range in protein concentration (7-152 µM, 
0.1-2.4 mg mL
-1
) (Fig. S4.2A).  The unfolding data for pWT are well fit using a 2-state monomer 
unfolding model (Table 4.1, Supplementary Methods, Section 4.5.1), with an average van’t Hoff 
to calorimetric enthalpy ratio (ΔHvH/ΔHcal) of 1.1 ± 0.2 (Table 4.1, Table S4.1) further 
confirming the applicability of the 2-state monomer model (237).  Similar fits are obtained for 
WT (Fig. 4.2E, Tables 4.1, S4.1).   
Calculation of the temperature dependence of stability requires knowledge of the change 
in heat capacity upon unfolding, ΔCp (Supplementary Methods, Section 4.5.2), which was 
determined by Kirchoff analysis (274) to be 1.1 ± 0.1 kcal mol
-1
 °C-1 for reduced apo pWT (Fig. 
S4.2B, C).  This value is relatively low compared to that expected for a protein of this size, ~2 
kcal mol
-1
 °C-1 (262, 275), suggesting that the reduced apo monomer may be less structured than 
a typical globular protein.  The Gibbs free energy of unfolding, ΔG, calculated from the 
thermodynamic parameters is 3.5 ± 0.1 and 1.8 ± 0.1 kcal mol
-1
 at 25 °C and 37 °C, respectively 
(Table 4.1).  Similar values were obtained for WT and are given in Table 4.1. 
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An independent measure of ΔG was obtained for pWT using CD-monitored equilibrium 
urea chemical denaturation and renaturation curves (Fig. S4.2D, E, Table 4.1).  These data are 
also well fit by a 2-state monomer unfolding transition, giving a ΔG of 4.0 ± 0.2 kcal mol-1 at 25 
°C, which is in reasonable agreement with the value obtained by DSC, and previous chemical 
denaturation experiments for reduced apo WT at pH 6.3 (147). 
Knowledge of ΔG enables calculation of the fraction of protein that is unfolded, fU 
(Supplementary Methods, Section 4.5.1).  For pWT at 37 °C, fU is ~0.05 (Fig. 4.1D), showing 
that the protein is predominantly (95 %) folded.  However, owing to the relatively low value of 
ΔG, fU is very sensitive to small perturbations in stability caused by mutation, as described 
below. 
  
136 
 
 
Figure 4.2 Reversibility and data fitting of reduced apo mutants.  The dashed black line 
indicates physiological temperature of 37 °C.  (A) Consecutive thermal unfolding endotherms of 
reduced apo mutants with low unfolding reversibility and (B) with high unfolding reversibility 
(scan one-solid black line; rescan-dashed grey line).  (C) DSC data fitting of the reduced apo 
mutants and pWT. Typical thermograms (solid black lines) with corresponding 2-state monomer 
fits (dashed grey lines) are shown.  (D) Consecutive thermal unfolding endotherms of WT and 
H46R
wt
 (scan one-solid black line; rescan-dashed grey line).  (E) DSC data fitting of WT and 
H46R
wt
 SODl.  Thermograms (solid black lines) with corresponding two-state monomer fits 
(dashed grey lines) are shown.  In each panel, the datasets are offset for clarity.  
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4.3.3 DSC reveals complex effects of ALS-associated mutations on the stability and 
aggregation propensity of reduced apo SOD1   
The effects of chemically and structurally diverse ALS-associated SOD1 mutations on 
both the disulfide-oxidized and reduced apo forms of the protein were also analyzed by DSC.  
The mutations include: A4V, T and S, and V148I, located in the dimer interface; G37R and 
H43R, affecting the packing of residues in the beta barrel; metal binding mutants H46R and 
G85R; G93R, S, A and D at a mutational hot-spot within a tight turn; and E100G located at the 
end of strand 6, which eliminates a salt bridge with K30 (Fig. S1A).  All of the mutants produced 
measurable thermograms (Figs. 4.2A, B, Table S4.2), except G93D.  
Based on lower t0.5,app values, the mutants are generally destabilized relative to pWT, 
except for H46R and V148I which have slightly increased stabilities (Fig. 4.1C, Table S4.2). 
Furthermore, in the reduced apo form all mutants except H46R, V148I and G85R have t0.5,app 
values at or below 37 °C (Tables 4.1, S4.2).  This is in contrast to the more mature disulfide-
oxidized apo form where the mutants all have t0.5,app values significantly higher than 37 °C (128, 
134).  Although it is difficult to directly compare the effects of the mutations on the 
thermodynamic stability of the oxidized to the reduced apo forms due to the change in 
quaternary structure, it is noteworthy that the changes in melting temperature are larger in the 
reduced apo form compared to the oxidized apo form (Fig. 4.1C, Table S4.2).  Similarly, the 
effects of mutations in non-metal binding mutants are larger in the oxidized apo forms than in the 
holo (metallated) forms (128), suggesting that the effects of mutations in SOD1 tend to 
propagate more as the protein becomes increasingly destabilized and folding becomes less 
cooperative.  Overall, the propensity of most reduced apo SOD1s to misfold/aggregate is evident 
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from the decreased reversibility of thermal unfolding traces (Fig. 4.2A), which is generally most 
pronounced in the significantly destabilized mutants. 
Nevertheless, the reversibility of thermal unfolding is remarkably high for several 
mutants: H46R, V148I, G85R, and E100G, enabling thermodynamic analysis using the 2-state 
monomer unfolding model (Figs. 4.2B, and C, Tables 4.1, S4.1).  Similar results were also 
obtained for H46R in the WT background (H46R
wt
, Figs. 4.2D and E, Tables 4.1 and S4.1).  The 
stability of pWT and H46R was also measured using chemical denaturation, again giving results 
consistent with those obtained by DSC (Figs. S4.2D and E, Table 4.1).  Using the fitted 
thermodynamic parameters, fU at 37 °C is calculated to be 0.05, 0.007, 0.03, 0.28, and 0.71 for 
pWT, H46R, V148I, G85R and E100G respectively (Fig. 4.1D, Supplementary Methods, Section 
4.5.1).  Thus, at physiological temperature the slightly stabilizing H46R and V148I mutants are 
predominantly folded (in fact, more so than pWT), but the proportion of unfolded protein is 
markedly increased for the other destabilizing mutants, with E100G being more unfolded than 
folded.  This differs significantly from the effects of the mutations in the disulfide-oxidized apo 
form where the proteins remain very predominantly folded (Table S4.2) (134). 
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Table 4.1  Summary of thermodynamic parameters for reduced apo SOD1s. 
Apo Reduced 
SOD1
a
 
t0.5  
(°C) 
∆HvH(37 °C) 
(kcal mol
-1
) 
∆𝐻𝑣𝐻
∆𝐻𝑐𝑎𝑙
 
∆Cp 
(kcal mol
-1°C-1) 
∆G(25 °C) 
(kcal mol
-1
)
b,c
 
∆G(37 °C) 
(kcal mol
-1
) 
∆∆G(37 °C) 
(kcal mol
-1
)
d
 
pWT 47.6 ± 0.5 50.5  ± 1.6 1.14 ± 0.15 0.72 ± 0.57 3.5 ± 0.1 1.8 ± 0.1 N/A 
     4.0 ± 0.2   
H46R 52.6  ± 0.5 56.1  ± 4.2 0.95 ± 0.08 -0.42 ± 0.84 4.9 ± 0.1 3.1 ± 0.1 1.3 
     5.1 ± 0.1   
V148I 51.0  ± 1.1 58.4  ± 2.6 0.93 ± 0.04 -2.62 ± 1.19 3.6 ± 0.1 2.2 ± 0.0 0.4 
G85R 40.7  ± 0.4 46.9  ± 1.8 1.06 ± 0.36 -0.11 ± 0.34 2.1 ± 0.1 0.6 ± 0.0 -1.2 
E100G 33.2  ± 1.2 47.3  ± 2.0 1.27 ± 0.06 0.79 ± 0.32 1.0 ± 0.1 -0.6 ± 0.2 -2.4 
WT 46.8  ± 0.4 57.2  ± 1.1 1.49 ± 0.27 1.01 ± 0.67 3.0 ± 0.0 1.6 ± 0.0 N/A 
H46R
wt
 52.7  ± 2.5 57.4  ± 5.4 0.76 ± 0.22 -1.59 ± 3.18 3.8 ± 0.5 2.4 ± 0.4 0.8 
N/A, not applicable 
All values are averages and standard deviations from at least three samples (Table S4.1), excluding WT and V148I, which are 
averages from two samples.  DSC experiments for pWT, H46R, G85R, and E100G were performed by Kenrick A. Vassall; DSC 
experiments for V148I, WT, and H46R
wt
 were performed by Helen R. Broom.   
a
All mutants are in the pWT background unless otherwise specified. 
b
Values are calculated using the thermodynamic parameters obtained from the monomer two-state model and a temperature 
independent ∆Cp of 1.1 ± 0.1 kcal mol
-1
 °C-1 (Fig. 4.2C). 
c
Values in italics are from monomer two-state unfolding fits of equilibrium urea chemical denaturation curves (Figs. S4.2D, E).  These 
experiments were performed by Kenrick A. Vassall and Ryan E. Sobering. 
d
∆∆G = ∆Gmutant - ∆GpWT 
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Although the thermal unfolding of these reduced apo SOD1s is highly reversible, there is 
some evidence in the DSC fitted parameters for increased aggregation propensity (128).  H46R, 
G85R and V148I have relatively low, mostly negative, fitted ΔCp’s, with average values of 0.42 
± 0.84, -2.62 ± 1.19 and -0.11 ± 0.34 kcal mol
-1
 °C-1 respectively (Table 4.1).  The negative 
average ΔCps for H46R and V148I are pronounced and consistent, suggesting the occurrence of 
exothermic aggregation as these mutants thermally unfold (128).  In contrast, E100G does not 
exhibit unusually low ΔCp values; however, the ΔHvH/ΔHcal ratios tend to be larger than 1 (1.3 ± 
0.1 on average), suggesting a larger cooperative unfolding unit, i.e. presence of aggregates (244).  
Overall, the DSC data are suggestive of subtle increases in aggregation of all mutant SOD1s.  
  
4.3.4 Analytical ultracentrifugation shows that reduced apo SOD1s are predominantly 
monomeric, and mutations slightly increase protein-protein interactions   
In order to further investigate the tendency of reduced apo SOD1s to aggregate, analytical 
ultracentrifugation (AUC) sedimentation velocity and equilibrium experiments were performed 
(Supplementary Methods, Sections 4.5.3 and 4.5.4).  Sedimentation velocity experiments can 
assess sample heterogeneity with high sensitivity.  Analysis of the velocity data for pWT and 
H43R revealed species with sedimentation coefficients of 1.5-2 S (Fig. S4.3), very similar to the 
values reported previously for reduced apo WT SOD1 (197).  The plots of boundary fraction 
versus sedimentation coefficient show only a modest slope, indicating no significant population 
of dimers or larger aggregated species for either pWT or H43R in these experiments. 
 Sedimentation equilibrium experiments at several rotor speeds (20,000, 25,000, 30,000 
and 35,000 rpm) were also performed to analyze the molecular weights (MWs) of the species 
present in solution.  Fitting of the equilibrium data for pWT, H43R, A4V, and E100G to a single 
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species model gave highly reproducible results (Table S4.3).  For the pWT protein, the fitted 
MW at lower rotor speeds is generally close to 15 kDa, just under the calculated mass of ~ 15.8 
kDa.  In contrast to the pWT, the fitted MWs for the A4V and E100G mutants are intermediate 
between monomer and dimer, while fits for the mutant H43R tend to give values closer to what 
would be expected for a dimer. Additionally, fitted MW values for all mutants markedly 
decrease with increased rotor speed (Table S4.3).  These results clearly indicate increased 
intermolecular association of the mutant proteins.  Attempts to fit the data to 2-state models for 
monomer/dimer, monomer/trimer and monomer/tetramer transitions gave poor fits with non-
random residuals, indicating that the association is likely more complex than a simple 2-state 
process.  Overall, the sedimentation equilibrium data indicate that the pWT protein remains 
predominantly monomeric during the lengthy period required for these studies, but that the 
mutants have an increased tendency to form small aggregated species.  These findings are 
consistent with the results of the DSC experiments.  
 
 4.3.5 Light scattering reveals markedly differences in aggregation of mutants upon prolonged 
incubation   
Dynamic light scattering (DLS) was used to monitor the size of particles in solution upon 
incubating samples at 37 °C (Figs. 4.3, S4.4 and S4.5A).  It is important to note that light 
scattering intensity is proportional to the sixth power of the diameter of the scattering particle, 
thus this technique is extremely sensitive to aggregate formation (276).  DLS analyses showed 
that all reduced apo SOD1 solutions were initially monodisperse, with a single species of 
hydrodynamic diameter ~5-6 nm.  This diameter is intermediate between those expected for a 
protein the size of SOD1 in the fully folded and unfolded states (277), consistent with the 
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relatively low ΔCp (see above), and suggesting that the folded reduced apo SOD1 may have an 
expanded structure. 
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Figure 4.3 Dynamic Light Scattering (DLS) data for reduced apo pWT and mutant SOD1. 
Particle size distributions for reduced apo pWT and mutants at 37 °C, pH 7.4, measured by 
dynamic light scattering over time, as indicated in hours (H).  
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Upon prolonged incubation, gradual formation of small amounts of soluble aggregates 
was observed, with distinct differences between mutants (Figs. 4.3, S4.4 and S4.5).  At one 
extreme, H46R and V148I show only very slight evidence for aggregation, with more than 99 % 
of the protein remaining as reduced monomers after ~300 hrs of incubation (Figs. 4.3D, S4.4D).  
In contrast, A4V, and H43R show the most pronounced evidence of soluble aggregates species 
(Figs. 4.3C, F).  A4V forms aggregates with hydrodynamic diameters of 40-60 nm within ~15 
hrs of incubation, and these approximately double in diameter and increase in abundance over ~2 
weeks.  H43R forms 100-1000 nm species within ~60 hours, which also increase in abundance 
with time.  For both mutants, at long incubation times the larger species dominate the scattering 
and the soluble monomers can no longer be observed.  However, the total intensity of scattered 
light continues to increase, indicating continued aggregation (Fig. S4.5B).  In general, the extent 
of aggregation of different mutants, as shown by the prominence of large species in the size 
distributions (Figs. 4.3, S4.4, 4.5A), is consistent with the extent of aggregation as indicated by 
total light scattering intensity (Figs. S4.5B-D).  Both observations give similar indications of the 
relative aggregation propensities of different mutants.  It should be noted, however, that lack of 
observation of the monomer peak does not indicate a predominantly aggregated sample.  If one 
considers a hypothetical mixture containing only 5 and 50 nm species, due to the dependence of 
light scattering intensity on the sixth power of the diameter, when 99 % of the intensity arises 
from the 50 nm species, this species will account for only 0.1 % by mass of the total protein in 
solution (276).  Therefore, the DLS data indicate only slight to moderate formation of soluble 
aggregates by reduced apo SOD1 variants, consistent with the DSC and centrifugation data.   
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4.4 Discussion 
The biophysical analyses conducted here show that ALS-associated mutations have the 
most pronounced effects on stability in the reduced apo form of SOD1, and enhance the 
formation of soluble aggregates.  These represent the first in depth analyses of reduced apo 
SOD1 stability and aggregation, and have important implications for understanding mechanisms 
of SOD1 aggregation that may be involved in ALS, considered further below.  
  
4.4.1 In the absence of ALS-associated mutations, reduced apo SOD1 is predominantly folded 
and has low aggregation propensity under physiologically relevant conditions   
The unfolding of pWT measured here by DSC and chemical denaturation is well fit by a 
reversible 2-state monomer unfolding transition, based on multiple DSC and chemical 
denaturation criteria (Figs. 4.2C, S4.2D,E, Table 4.1), and comparable results are obtained by 
DSC for WT (Fig. 4.2E, Table 4.1).  These results reveal that the ΔG of unfolding for reduced 
apo SOD1 at 37 °C, which has not been reported previously, is 1.8 ± 0.1 kcal mol-1 for pWT and 
1.6 ± 0.0 kcal mol
-1
 for WT.  Thus, at physiological temperature and pH the protein is 
predominantly folded, and shows very little tendency to aggregate.  
The very minimal aggregation observed here for monomeric reduced apo pWT and WT 
is particularly noteworthy given that previous studies have reported monomerization and loss of 
metals greatly enhance, or are required for, aggregation (76, 193).  Moreover, several studies 
have reported observations of amyloid formation by apo SOD1 in which the intramolecular 
disulfide bond was reduced or removed by mutagenesis (76, 78, 184).  A key difference between 
these and the current studies is their use of agitation rather than quiescent solution conditions.  It 
is well established that agitation promotes the aggregation of many proteins, often as amyloid 
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(76, 278, 279).  This is not well understood but likely involves interface effects and perhaps also 
accelerated oxidation of free thiols.   
The relevance of the formation of amyloid aggregates in previous studies of reduced apo 
SOD1 to ALS disease mechanisms is not clear.  Other forms of SOD1 have also been shown 
previously to form amyloid under destabilizing conditions caused by denaturant, sonication, 
trifluoroethanol or low pH (75, 76, 78, 255), and formation of intermolecular disulfide bonds 
(183).  In contrast, other studies under less extreme conditions have also reported evidence for 
distinct aggregation processes from native-like states (90, 99, 280).  Protein aggregation is 
generally strongly dependent on solution conditions, and many destabilizing and often non-
physiological conditions can result in the formation of amyloid.  In this regard, it should be noted 
that the amyloid-specific characteristic of green-gold Congo Red birefringence and ThT binding 
of aggregates is not observed in ALS (22, 266) and the intracellular SOD1-containing aggregates 
in fALS have a granule-coated rather than the smooth fibrillar structure characteristic of amyloid 
(26); thus, ALS is not a typical amyloid disease.   
A key aspect for in vitro studies of aggregation is to consider their relation to in vivo 
conditions.  Here we have used physiologically relevant conditions of temperature, pH, protein 
concentration and quiescence.  Importantly, the very minimal aggregation of reduced apo pWT 
and WT is consistent with cell culture and mice studies where wild-type SOD1 shows very little 
tendency to aggregate and mice do not develop ALS symptoms (268, 269).  This differs from 
observations for mutant SOD1s, which tend to aggregate more than WT in cell culture, and form 
small aggregated species in mice prior to the onset of symptoms followed by large disulfide-
linked aggregates in the final stages of disease (190, 268).  In contrast, in previous in vitro 
studies the comparable wild-type-like constructs not only formed amyloid (76, 78, 184) but in 
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some cases this was more pronounced than for ALS-associated mutants (184).  This suggests 
fundamentally different aggregation processes are being observed under different conditions.  
  
4.4.2 ALS-associated mutations have complex effects on stability and aggregation   
Under the physiologically relevant conditions used herein, we were able to measure the 
effects of many chemically and structurally diverse ALS-associated mutations on stability and 
aggregation propensity.  The effects on stability range from slightly stabilizing to slightly or 
significantly destabilizing (Fig. 4.1C, Tables 4.1, S4.2).  Consistent with previous studies on apo 
SOD1 where metal binding mutations had relatively small effects on t0.5,app (245), the metal 
binding mutants H46R and G85R are among the most stable mutants studied here.  In the 
disulfide-oxidized apo form, all the mutants have t0.5,app values well above physiological 
temperature; however, in the reduced apo form, most have t0.5,app values close to or lower than 37 
°C, indicating that they will be 50% or more unfolded at physiological temperature (Fig. 4.1D, 
Table S4.2).  The observation that decreases in melting temperatures tend to be largest in the 
reduced apo form implies that substantial increases in the population of unfolded conformations 
will also occur for many other mutants that have been found to have decreased t0.5,app in the 
disulfide-oxidized apo form (128, 134, 245).  Thus overall, many but not all ALS-associated 
mutations are likely to significantly increase the population of reduced apo unfolded monomers.   
Regardless of stability, the DSC, AUC and DLS experiments indicate that the reduced 
apo mutants generally have increased propensity to misfold/aggregate.  In particular, DLS results 
indicate that distinct sizes of small, soluble aggregates are observed for different mutants (Figs. 
4.3, S4.4, S4.5A).  Evidence for structural polymorphism of SOD1 aggregates was also reported 
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for agitation-induced aggregation (181).  These findings are intriguing as variations in aggregate 
structures may cause different disease phenotypes.  
 
4.4.3 Limited correlations between the properties of reduced apo mutant SOD1s and ALS 
characteristics implicate multiple forms of SOD1 in modulating disease  
Correlations between the properties of mutant SOD1 and ALS disease characteristics 
have been sought for many years and are critical for deciphering disease mechanisms.  Previous 
studies have reported evidence for a weak inverse correlation between oxidized apo SOD1 
stability and ALS disease duration (176, 200, 229), which improves when global or local protein 
characteristics such as charge (281) or hydrogen bonding (200) are considered.  The results for 
V148I suggest that increased hydrophobicity of the exposed dimer interface may be another 
significant modulator of aggregation.  A weak correlation is observed between reduced apo 
mutant SOD1 stability and disease duration (Figs. 4.4 and S4.6A), suggesting that the effects of 
the mutations on the stability of reduced apo SOD1 do not play a more significant role than their 
effects on oxidized apo in determining disease duration.  This implies that factors beyond 
stability, and multiple forms of SOD1, are important in modulating disease duration. 
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Figure 4.4 A correlation plot representing the relationship between reduced apo SOD1 
mutant stability, fALS disease durations, and observed and predicted aggregation.  The 
stability is determined by a change in apparent t0.5 of mutants compared to pWT and normalized, 
from 0 (least stable) to 1 (most stable).  Observed aggregation is based on DLS measurements as 
described in Fig. S4.5A.  Predicted aggregation based on the Chiti et al. 2003 method (282) was 
normalized from 0 (lowest propensity) to 1 (highest propensity).  Disease duration (229) is 
normalized from 0 (short) to 1 (long).  The aggregation-prediction analysis was performed by 
Heather A. Primmer. 
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There is a significant correlation (r = 0.78, Figs. 4.4, S4.6B) between observed 
aggregation and mutant destabilization, consistent with results of general studies of protein 
aggregation.  This has also been observed for more mature forms of SOD1 which tend to 
aggregate more readily when destabilized (128, 131, 144, 184).  The aggregation observed here 
is poorly correlated with nine different aggregation prediction models (Fig. S4.6E, SI Text).  The 
lack of correlations may be because most of these aggregation prediction algorithms were 
developed based on datasets of amyloid forming proteins and peptides.  As noted above, amyloid 
formation may differ significantly from the formation of the soluble, non-amyloid aggregates 
that are characterized here.  There is also no significant correlation between observed 
aggregation and ALS disease duration (Fig. 4.4, S4.6C).  Furthermore, the aggregation 
propensities of the SOD1 mutants predicted using the preceding methods are also poorly 
correlated with disease duration (Fig. S4.6D).  
Consideration of these correlations points to two key conclusions: neither the association 
of reduced apo SOD1 mutants into small soluble aggregates nor the predicted aggregation 
propensities of SOD1 mutants are able to account for fALS disease duration.  These key findings 
have two important implications: i) Multiple forms of SOD1 are likely to modulate disease 
characteristics and ii) amyloid formation is likely not an important factor in SOD1-associated 
fALS.  Further support for the first point is evidence that mutations enhance the population and 
aggregation of various immature forms of mutant SOD1, and the observation of multiple forms 
of SOD1 in aggregates in vivo (90, 126, 128, 196, 268, 280, 283).  The second point is further 
supported by evidence that fALS patient data fails to reveal any support for a role of amyloid in 
disease (22).  
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In conclusion, the results reported here provide novel and important data on the stability 
and soluble aggregate formation by reduced apo SOD1s, which should prove useful for further 
testing of ALS disease hypotheses.  The increased aggregation of reduced apo SOD1 upon 
mutation suggests that this form of the protein may play a role in causing disease.  However, the 
lack of strong correlations between reduced apo SOD1 stability and disease duration and 
between measured aggregation and disease duration, imply that the effects of mutations on 
reduced apo SOD1 are unlikely to be the dominant factor in modulating disease, and that 
multiple forms of the protein are involved.  Unravelling the complex aggregation processes that 
are likely to contribute to the syndrome of ALS (284) may ultimately lead to new and urgently 
needed approaches for treating this devastating disease. 
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4.5 Supplementary Information 
4.5.1 Analysis of Differential Scanning Calorimetry (DSC) thermal unfolding data  
Thermal unfolding scans for reduced apo SOD1 were fit to a 2-state monomer unfolding 
model (N↔U ) using the following Eq. 4.1 (237): 
𝐶𝑝(𝑇) = (𝐴 + 𝐵𝑇)(1 − 𝑓𝑢) +  (𝐶 + 𝐷𝑇)𝑓𝑢 +  
𝛽∆ℎ2(𝑇)𝑓𝑢(1−𝑓𝑢)
𝑅𝑇2
 (Eq. 4.1) 
where, Cp(T) is the total specific heat capacity, normalized per gram of protein, at temperature, T 
(in Kelvin), fU is the fraction of unfolded protein at T, R is the universal gas constant, ∆h(T) is the 
specific enthalpy of unfolding at T, A and B are the intercept and slope of the native baseline 
respectively, whereas C and D are the intercept and slope of the unfolded baseline respectively.  
β is a temperature-independent constant equal to the molecular weight of the dimer multiplied by 
the ratio of van’t Hoff to calorimetric enthalpies of unfolding, ΔHvH/ΔHcal.  The DSC data were 
fit to the approximate end of the unfolding transition due to the occurrence of downward sloping 
post-transition baselines, presumably due to exothermic aggregation of the unfolded protein at 
higher temperatures.   
The baselines for scans obtained in urea for the determination of the change in heat 
capacity upon unfolding, ΔCp, had higher variability, which created problems in obtaining 
consistent fitted values using Eq. 4.1.  Accordingly, scans in urea were analyzed using the 
commonly employed baseline subtraction with linear connect (which effectively removes the 
influence of the baselines), followed by fitting of the resulting excess specific heat capacity, 
Cp(T) normalized per mol of protein, to the MN2-state model, Eq. 4.2 (Microcal Origin version 
5.0) (128, 285–288):  
𝐶𝑝(𝑇) =  
𝛾∆𝐻2(𝑇)𝑓𝑢 (1−𝑓𝑢 )
𝑅𝑇2
 (Eq. 4.2) 
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where ΔH(T) is the enthalpy of unfolding at T, fU is the fraction of unfolded protein and γ is 
ΔHvH/ΔHcal.  Fitted parameters for reduced apo pWT datasets acquired in the absence of urea 
gave fitted parameters that were very similar to those obtained using Eq. 1 (<0.5 °C difference 
for t0.5 (temperature in °C at which fU = 0.5) and <10 % difference for ΔHvH and ΔHcal). 
 The fraction of unfolded protein can be determined from the equilibrium constant, K(t), at 
temperature, t (°C) using Eq. 4.3 and Eq. 4.4: 
𝑓𝑢 =  
−1+ √1+
8
𝑏
4
𝑏
 (Eq. 4.3) 
where, 𝑏 =  
𝐾(𝑡)
𝐾(𝑡0.5)
 (Eq. 4.4) 
 
4.5.2 Calculation of thermodynamic parameters at 37 °C  
ΔH(T), ΔS(T) and ΔG(T) of thermal unfolding were calculated at 37 °C (310.15 K) using 
a temperature independent ΔCp as previously described (128) using the following equations: 
∆𝐺(𝑇) =  ∆𝐻(𝑇) − 𝑇∆𝑆(𝑇) (Eq. 4.5) 
∆𝐻(𝑇) =  ∆𝐻(𝑇0.5) −  ∆𝐶𝑝(310.15 − 𝑇0.5) (Eq. 4.6) 
∆𝑆(𝑇) =  ∆𝑆(𝑇0.5) + ∆𝐶𝑝ln (
310.15
𝑇0.5
) (Eq. 4.7) 
∆𝑆(𝑇0.5) =  
∆𝐻(𝑇0.5)+ ∆𝐺(𝑇0.5)
𝑇0.5
 (Eq. 4.8) 
and ΔG(T0.5) = -RT0.5lnP (Eq. 4.9) 
where P is the protein concentration of monomer subunits and t0.5 is the temperature at which the 
protein is half unfolded. 
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4.5.3 Analytical ultracentrifugation 
Sedimentation velocity and equilibrium experiments were conducted at the Biomolecular 
Interactions & Conformations Facility (Shuclich School of Medicine & Dentistry, University of 
Western Ontario) using an Optima XL-A Analytical Ultracentrifuge (Beckman Coulter Inc.) with 
an An60Ti rotor and 2/6-channel cells with Epon-charcoal centerpieces.  Centrifugation was 
carried out at 20 °C, 20 mM HEPES, 1mM tris(2-carboxyethyl)phosphine (TCEP), pH 7.4, with 
absorbance detection at either 252 or 280 nm.  Equilibrium data were collected in radial step 
sizes of 0.002 cm and averaged over 10 readings.  Equilibrium data were fit to a single ideal 
species model (see below) using Prism 5 (GraphPad Software). 
 
4.5.4 Analysis of sedimentation equilibrium data 
Data were analyzed according to a single ideal species model as described elsewhere 
(289), according to Eq. 10: 
𝐴 =  𝐴𝑜𝑒𝑥𝑝 [
𝜔2
2𝑅𝑇
 𝑀𝑊𝑜𝑏𝑠(1 − ?̅?𝜌)(𝑥
2 − 𝑥𝑜
2) ] + 𝐼𝑜 (Eq. 4.10) 
where A is the absorbance at radius x, Ao is the absorbance at reference radius xo, ω is the angular 
velocity of the rotor, MWobs is the fitted molecular weight of the protein, ῡ is the partial specific 
volume of the protein, ρ is the density of the solvent, and Io is the baseline offset.   
 
4.5.5 Chemical renaturation and denaturation  
Chemical renaturation and denaturation equilibrium curves of reduced apo SOD1 were 
prepared as described elsewhere (134), except that urea was used as the denaturant instead of 
guanidinium chloride.  All samples contained 1 mM TCEP, 20 mM HEPES, pH 7.4 and were 
incubated for 24 hrs at 25 °C in an anaerobic environment before measuring circular dichroism 
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(CD) at 216 and 231 nm using a J715 spectropolarimeter (Jasco Research Ltd.).  Data were fit to 
a 2-state monomer unfolding model as described (290) according to Eq. 4.11: 
𝑌𝑜𝑏𝑠 =  
{(𝑌𝑁
𝑜− 𝑆𝑁[𝑢𝑟𝑒𝑎])− [(𝑌𝑁
𝑜− 𝑆𝑁[𝑢𝑟𝑒𝑎])− (𝑌𝑈
𝑜−𝑆𝑢[𝑢𝑟𝑒𝑎])]}𝑒
𝑚([𝑢𝑟𝑒𝑎]− 𝐶𝑚𝑖𝑑)
𝑅𝑇
1+𝑒
𝑚([𝑢𝑟𝑒𝑎]− 𝐶𝑚𝑖𝑑)
𝑅𝑇
 (Eq. 4.11) 
where, Yobs is the observed optical signal, YN
° and YU
°
 are the native and unfolded signals 
respectively, in the absence of urea, and SN and SU describe the dependence of the native and 
unfolded signals with urea respectively. m is a constant that describes the dependence of the free 
energy of unfolding ∆GU on urea concentration and Cmid is the concentration of urea at the 
midpoint of the curve, corresponding to the point at which fU = 0.5. 
 
4.5.6 Acquiring predicted aggregation propensities from a variety of known algorithms 
In order to further investigate aggregation mechanisms, the following methods were used 
to compare predicted mutant SOD1 aggregation with observed reduced apo mutant SOD1 
aggregation and disease duration: Chiti et al. (282) and Wang et al. (229) methods, and online 
algorithms including Zyggregator (http://www-vendruscolo.ch.cam.ac.uk) (291), PASTA 
(http://protein.bio.unipd.it/pasta2/) (292), Waltz (http://waltz.switchlab.org/) (293), TANGO 
(http://tango.crg.es/) (294), FoldAmyloid (http://bioinfo.protres.ru/fold-amyloid/) (295), and 
Profile3D (http://services.mbi.ucla.edu/zipperdb/) (296).  Predictions were made for pseudo WT 
(pWT) and all 12 mutants presented in this study.  Additionally, 13 extra mutants with disease 
duration averages based on 5 or more patients (229) were predicted and included in the 
correlations for disease duration.  All results were compared to pWT and no convincing 
correlations between predicted aggregation propensity and observed aggregation or familial 
amyotrophic sclerosis (fALS) disease duration were observed.  
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4.5.7 Supplementary Data 
 
Figure S4.1  (A) Ribbon representation of apo SOD1 (pdb code 1HL4) (139).  Each monomer 
binds one copper and one zinc (metals not shown).  The locations of C57 and C146, which form 
the intramolecular disulfide bond in each monomer, are shown in yellow.  The sites of the fALS-
associated mutations that were investigated in this study (A4, G37, H43, H46, G85, G93, E100, 
and V148) are shown in red.  The fALS mutations are dispersed throughout the structure of 
SOD1 and have a range of structural contexts. H46R and G85R (138, 297) alter metal binding, 
A4S, A4T, A4V, and V148 are located in the dimer interface, G93S, A, and R are in a tight turn, 
G37R and H43R disrupt packing in the β-barrel (255, 256), and E100G removes a salt bridge 
with K30 (143).  Residues C6 and C111 are mutated to A and S respectively, in the pWT 
construct and are shown in purple. The figure was rendered using VMD software 
(http://www.ks.uiuc.edu/).  (B) SDS-PAGE of reduced apo SOD1 before and after DSC 
experiments.  The gel contained 12% acrylamide and was visualized by staining with 
Coomassie Blue.  Lane 1 is a low molecular weight marker with molecular weights as indicated. 
Lanes 2 and 6 are disulfide-intact apo SOD1 controls, whereas lane 3 is apo SOD1 with disulfide 
reduced by β-mercaptoethanol. Lanes 4 and 5 are reduced apo SOD1 in 20 mM HEPES, 1 mM 
TCEP, pH 7.4 before and after DSC scanning, respectively.  These samples were treated with 
iodoacetamide prior to loading on the gel to prevent free cysteines from being oxidized on the 
gel (131). Samples, both before and after each experiment, were found to run much closer to the 
disulfide-reduced control in lane 3 than the oxidized controls in lanes 2 and 6, indicating that the 
samples remained fully reduced throughout each experiment.    
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Figure S4.2  (A) Protein concentration dependence of reduced apo pWT thermal unfolding. 
DSC endotherms were collected in 20mM HEPES, 1mMTCEP, pH 7.4 at different protein 
concentrations as indicated (in mg mL
-1
).  There is no concentration dependent shift to higher 
temperatures of unfolding, as expected for a monomer.  The data (solid black lines) over the >20-
fold concentration range are well fit (broken grey lines) by a monomer two-state unfolding 
model (Supplementary Methods, Section 4.5.1, Eq. S4.1).  Fitted parameters are given in Table 
S4.1.  (B) Kirchoff plot analysis of ΔCp. The ΔHvH values were obtained from two-state 
monomer fitting of pWT DSC data collected in the presence of urea (see D and E).  The ΔHvH 
data are well fit by linear regression (r = 0.967) giving a ΔCp value from the slope of 1.1 ± 0.1 
kcal mol
-1
 °C-1.  (C) Reduced apo pWT DSC scans in urea. Baselines generated by the linear 
connect method in Origin 5.0 (Microcal) were subtracted from raw data and normalized for 
protein concentration, prior to fitting data to a two-state monomer unfolding model 
(Supplementary Methods, Section 4.5.1, Eq. S4.1). Fits (broken grey lines) are shown for data 
(solid black lines) collected in 20 mM HEPES, 1 mM TCEP, pH 7.4 with 0.25, 0.5, 0.75, 0.875, 
1, and 1.25 M urea (Top to Bottom) as indicated.  ΔHvH values from the fits are plotted in Fig. 
S2A.  (D and E) Equilibrium urea renaturation and denaturation curves for reduced apo 
SOD1 at 25 °C.  Data for pWT are shown in blue and data for H46R are shown in black.  Protein 
concentrations for the curves are 8.5 μM (0.13 mg mL-1) (circles), 14 μM (0.22 mg mL-1) 
(triangles), and 24 μM (0.38 mg mL-1) (diamonds).   Denaturation and renaturation data are 
plotted as closed and open symbols, respectively.  CD data for each protein at (D) 216 nm and 
(E) 231 nm were globally fit to a two-state monomer unfolding model with Cmid  and m as shared 
parameters (Supplementary Methods, Section 4.5.5, Eq. S4.11). pWT and H46R yielded similar 
m values with the average being 2.49 ± 0.30 kcal mol
-1
, whereas the midpoint of denaturation 
(Cmid) for pWT was 1.63 ± 0.07 M and 2.04 ± 0.04 M for H46R, corresponding to ΔG of 4.0 ± 
0.2 kcal mol
-1
 and 5.1 ± 0.1 kcal mol
-1 
for pWT and H46R respectively (Table 4.1).  
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Figure S4.3 Van Holde–Weischet analysis (298) of sedimentation velocity analytical 
ultracentrifugation experiments for reduced apo pWT and H43R SOD1.  Experiments were 
conducted in 20 mM HEPES, 1 mM TCEP, pH 7.4 at 20 °C using an Optima XL-A Analytical 
Ultracentrifuge (Beckman Coulter Inc.) with an An60Ti rotor and two channel cells with Epon-
charcoal centerpieces and absorbance detection at 280 nm.  All velocity data were acquired at 
50,000 rpm with measurements (average of three readings) collected at radial step sizes of 0.003 
cm; scans were taken at 10 minute intervals for a total of 30 scans.  Data were analyzed using the 
program Sedfit (299).  The initial absorbances at 280 nm were 0.29 and 0.33 for pWT and H43R 
respectively.   
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Figure S4.4 Particle size distributions for apoSH A4S, A4T, G37R, H46R, wtH46R, G85R, 
G93A, G93R, and E100G as a function of incubation time in hours (H).  Samples contained 
1 mg mL
-1
 protein in 20mM HEPES, 1mM TCEP, pH 7.4.  The differing aggregation tendencies 
of each mutant are shown.  The monomer remains the dominant species and after incubating 
G85R, H46R, and wtH46R for ~300 H, whereas diminished monomer intensity and varying 
amounts of larger species form after incubating A4S, A4T, G37R, G93A, G93R and E100G 
under the same conditions.  There is no significant difference in the aggregation behavior of 
H46R in the pWT and WT background. 
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Figure S4.5 Summary of apoSH aggregation results. (A) To address reproducibility, each 
DLS experiment was repeated between two and five times and the percent of total light 
scattering intensity after incubation for ~300 H arising from species with a hydrodynamic 
diameter larger than 20 nm (dark blue bars) and 200 nm (light blue bars) was compared.  The 
reproducibility of each DLS experiment is reflected by the error bars.  (B–D) Change in light 
scattering intensity (in kilocounts per second (kcps)) as a function of incubation time is shown 
for all mutants studied.  All values plotted are an average of three measurements at each time 
point shown over the duration of the time course.  The data acquired for each mutant were 
categorized into three plots: (B) mutants that showed significant aggregation, (C) mutants that 
show evidence for slight to moderate increased aggregation tendencies, and (D) mutants that 
showed very little to no evidence of aggregation. 
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Figure S4.6 A correlation plot of reduced apo SOD1 mutant stability, observed 
aggregation, predicted aggregation propensity and disease duration.  Stability is represented 
as the change in t0.5,app for reduced apo SOD1 upon mutation.  Observed aggregation values are 
based on light scattering intensity at the end of each mutant SOD1 DLS time course (see Fig. 
S5A). Predicted aggregation was assessed for SOD1 mutants based on the Chiti et al. method 
(282).  Aggregation values are normalized in such a way that 1 represents the most aggregation 
and 0 represents the least aggregation.  Finally, disease duration is based on summarized data by 
Wang et al. (229) and is normalized so that 1 represents mutants with the longest disease 
durations and 0 represents mutants with the shortest disease durations.  (A) A poor correlation is 
observed between mutant reduced apo SOD1 stability and disease duration.  (B) Increased 
observed reduced apo SOD1 aggregation correlates well with a decrease in mutant stability.  
Disease duration is poorly correlated with observed reduced apo SOD1 aggregation (C) and 
predicted SOD1 aggregation (D).  (E) There is no correlation between observed and predicted 
aggregation (refer to Table S4.2). 
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a
Errors (±) from the fitting
 
program (Microcal Origin, version 5.0).  
b
Errors from individual fits could not be reliably determined because they are based on 
uncertainties in five independent variables.  
c
Errors derived using standard procedures (300) from errors in fitted Δhcal(t0.5) and β returned by 
the fitting program.  
Table S4.1 DSC monomer 2-state unfolding fitted parameters for disulfide-reduced apo SOD1s. 
ApoSH 
SOD1 
variants 
[Protein] 
(mg/mL) 
t0.5
a 
(°C) 
ΔCp(t0.5)
b 
(kcal (mol)
-1°C-1) 
ΔHvH(t0.5)
c
 
(kcal (mol)
-1
) 
ΔHcal(t0.5)
c 
(kcal (mol)
-1
) 
ΔHvH/ΔHcal 
 
pWT 0.11 47.3±0.1 1.12 63.5±1.7 47.9±0.8 1.33 
pWT 0.25 47.0±0.5 1.66 60.4±1.1 62.6±0.7 0.96 
pWT 0.42 47.4±0.3 0.88 63.2±2.8 52.4±1.9 1.21 
pWT 0.48 47.8±0.6 0.80 62.5±5.4 59.4±4.0 1.05 
pWT 0.53 47.5±0.0 0.71 60.2±0.6 60.2±0.4 1.00 
pWT 0.55 48.8±0.0 -0.27 60.6±0.7 59.8±0.4 1.01 
pWT 0.93 47.7±0.3 0.27 62.7±3.2 51.2±1.9 1.22 
pWT 2.30 47.5±0.1 0.61 59.8±1.7 44.6±0.8 1.34 
AVG
d 
 47.6 ±0.5 0.72±0.57 61.6±1.5 54.8±6.6 1.14±0.15 
       
H46R 0.33 52.3±0.1 -0.05 77.1±2.1 75.6±1.2 1.02 
H46R 0.48 52.5±0.0 0.17 70.5±0.8 80.9±0.1 0.87 
H46R 0.57 53.2±0.2 -1.39 70.5±2.9 73.2±1.6 0.96 
AVG
d 
 52.6±0.5 -0.42±0.84 72.7±3.8 76.5±4.0 0.95±0.08 
       
V148I 0.74 51.8±0.9 -3.46 56.6±9.4 58.4±3.8 0.97 
V148I 0.89 50.3±0.1 -1.77 60.3±1.3 67.0±0.8 0.90 
AVG
d
  51.0±1.1 -2.62±1.19 58.4±2.6 62.7±6.1 0.93±0.05 
       
G85R 0.17 40.6±2.0 -0.46 52.2±13.9 74.3±13.2 0.70 
G85R 0.38 40.4±0.6 0.22 50.9±3.8 47.1±2.5 1.08 
G85R 1.42 41.2±0.2 -0.11 49.3±1.5 35.0±0.7 1.41 
AVG
d 
 40.7±0.4 -0.11±0.34 50.8±1.5 52.3±20.2 1.06±0.36 
       
E100G 0.43 35.0±0.1 0.32 42.2±1.0 32.8±0.4 1.24 
E100G 0.49 32.7±1.1 0.87 45.5±6.8 37.9±4.8 1.20 
E100G 0.75 33.0±0.1 0.89 43.4±1.3 32.3±0.7 1.34 
E100G 0.80 32.1±0.1 1.07 42.1±1.2 32.6±0.5 1.29 
AVG
d 
 33.2±1.2 0.79±0.32 43.3±1.4 34.3±2.6 1.27±0.06 
       
WT 0.34 46.5±0.0 0.53 57.9±1.0 34.7±0.25 1.68 
WT 0.30 47.1±0.7 1.48 56.4±7.4 43.3±3.75 1.30 
AVG
d 
 46.8±0.4 1.01±0.67 57.2±1.1 39.0±6.1 1.49±0.27 
       
H46R
wt
 0.50 50.4±0.0  -1.86 55.5±0.9 64.9±0.63 0.86 
H46R
wt
 0.50 52.5±0.2 -0.40 63.6±1.6 70.9±1.26 0.90 
H46R
wt
 0.50 52.6±0.6 -0.77 64.4±6.0 85.2±5.19 0.76 
AVG
d 
 51.8±1.3 -1.01±0.76 61.2±4.9 73.7±10.4 0.84±0.07 
164 
 
d
Average and standard deviation. 
Data for pWT, H46R, G85R and E100G was obtained by Kenrick A. Vassall.  Data for WT, 
H46R
wt
, and V148I was obtained by Helen R. Broom. 
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Table S4.2 Stability and aggregation summary for disulfide-reduced apo SOD1s. 
ApoSH 
SOD1 
t0.5 
(disulfide 
reduced)
a
 
°C 
∆t0.5 
(disulfide 
reduced)
b
 
°C 
∆t0.5 
(disulfide 
oxidized)
b,c
 
°C 
Disease 
Duration 
(years)
d
 
Predicted 
Aggregation 
Propensity
e
 
Predicted 
Aggregation 
Propensity 
+ 
Instability
f
 
Observed 
Aggregation 
Propensity
g
 
H46R 52.8 ± 0.4 4.3 3.0 17.6 0.28 0.00 0.00 
V148I 50.0 ± 0.1 1.5 1.4 1.7 0.45 0.20 0.11 
pWT 48.5 ± 0.3 n/a n/a n/a 0.56 0.32 0.06 
G85R 41.2 ± 0.3 -7.3 -3.8 6.0 0.25 0.34 0.13 
A4V 36.3 ± 0.2 -12.2 -8.9 1.2 1.00 1.00 0.96 
H43R 35.4 ± 0.4 -13.1 -10.7 1.8 0.00 0.35 1.00 
G93R 35.4 ± 1.8 -13.1 -10.1 5.3 0.16 0.46 0.70 
E100G 35.3 ± 0.7 -13.2 -7.7 4.7 0.93 0.98 0.56 
G93A 34.6
h
 -14.9 -10.3 3.1 0.54 0.77 0.42 
G37R 33.5 ± 1.2 -15.0 -9.7 17.0 0.25 0.58 0.88 
G93S 33.4 ± 1.2 -15.1 -8.6 8.0 0.50 0.75 0.53 
A4S 32.5
h
 -16.0 -13.0 n/a 0.39 0.70 0.45 
A4V 30.9 ± 0.3 -17.6 -14.9 1.5 0.56 0.87 0.82 
n/a, not applicable 
a
Values are the apparent melting temperature where the observed Cp in the DSC scan is a 
maximum.  The values listed are the average of at least two independent measurements unless 
otherwise noted.  All experiments were performed by Kenrick A. Vassall, except V148I, which 
was performed by Helen R. Broom. 
b
Calculated as t0.5,app mutant – t0.5,app pWT, negative values indicate destabilization. 
c∆t0.5,app data for A4V, G85R, E100G, G93S, G93A G93R were obtained from (128, 134).  The 
∆t0.5,app data for H46R, V148I, H43R, G37R, A4S and A4T was obtained by Kenrick A. Vassall, 
except V148I which was obtained by Helen R. Broom.   
d
Average disease durations are from (229). 
e
Predicted aggregation propensities were calculated relative to pWT using the Chiti-Dobson 
method (282), and normalized using the methodology of Wang et al. (229), where 0 indicates 
low aggregation tendency and 1 indicates high aggregation tendency.  Calculations were 
performed by Heather A. Primmer. 
f∆t0.5,app incorporated into the predicted aggregation propensity as described by (229), and 
aggregation scores were normalized over a scale from 0 to 1.  Calculations were performed by 
Heather A. Primmer.   
g
Observed aggregation propensity is based on intensity statistics from DLS measurements as 
shown in Figure S4.5. 
h
t0.5,app based on one measurement. 
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Table S4.3 Single species model fitting of analytical ultracentrifugation sedimentation equilibrium data. 
Sample and Concentrations Best fit molecular weight (kDa) ± standard error at different rotor speeds 
ApoSH SOD1 [SOD1] 
mg mL
-1
 
20 000 rpm 25 000 rpm 30 000 rpm 35 000 rpm 
pWT 1.0 15.2 ± 0.4 15.0 ± 0.2 14.3 ± 0.2 13.5 ± 0.2 
pWT 1.0 14.3 ± 0.3 15.1 ± 0.3 15.2 ± 0.2 14.1 ± 0.1 
pWT 1.5 14.4 ± 0.3 15.6 ± 0.2 14.4 ± 0.1 12.4 ± 0.1 
E100G 0.8 22.5 ± 0.4 21.3 ± 0.2 19.3 ± 0.2 17.5 ± 0.1 
E100G 1.0 20.3 ± 0.4 19.3 ± 0.2 17.4 ± 0.2 16.6 ± 0.2 
E100G 1.5 20.2 ± 0.3 19.3 ± 0.2 17.8 ± 0.2 16.4 ± 0.1 
A4V 0.8 24.2 ± 0.6 21.1 ± 0.3 18.2 ± 0.2 16.5 ± 0.1 
H43R 1.0 36.6 ± 0.6 31.6 ± 0.6 23.2 ± 0.3 19.8 ± 0.2 
H43R 1.0 33.6 ± 0.4 28.4 ± 0.3 23.2 ± 0.2 20.5 ± 0.1 
Experiments were performed and data analyzed by Lee-Ann K. Briere and Stanley D. Dunn. 
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Chapter 5 
Further Aggregation Studies of Reduced Apo SOD1: 
 Increases in protein concentration  
or the addition of salt both promote aggregation 
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Overview 
In previous work (Chapter 4), we have characterized the stability of the most immature 
form of SOD1 (apoSH SOD1), which lacks both disulfide bonds and metals.  This form of the 
protein is mainly monomeric, with marginal stability that is greatly affected by ALS-associated 
mutations.  Surprisingly however, we found that apoSH SOD1 is remarkably resistant to 
aggregation under physiological-like conditions.  Static and dynamic light scattering (SLS and 
DLS, respectively) as well as analytical ultracentrifugation (AUC) reveal higher-order 
interactions occur between apoSH monomers, but of the 12 mutants invested, only one showed 
some evidence of aggregate formation.  In this chapter we demonstrate that apo aggregation is 
generally enhanced at higher protein concentration or in the presence of salt, and the 
mechanism(s) of aggregation have been characterized using a number of biophysical techniques 
including light scattering, atomic force microscopy (AFM), and Thioflavin-T (ThT) binding.  
Under conditions that promote aggregation, DLS and AFM experiments reveal that some 
mutants form small fibrils ranging from ~20-100 nm in length.  Other mutants aggregate less, but 
the aggregates that do form are longer (greater than 1000 nm).  Furthermore, ThT binding 
experiments suggest that the aggregates contain different degrees of internal β-structure.  Thus,    
mutations appear to promote aggregation in different ways and these findings may agree with 
nuclear magnetic resonance (NMR) experiments, which show that mutations have complex 
effects on the energy landscape of apoSH SOD1, and alter the mechanisms of association. 
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5.1 Introduction 
A characteristic feature of ALS is the presence of protein aggregates that accumulate in 
motor neurons (21) and SOD1 has been identified as a component of these aggregates in SOD1-
linked familial ALS and some sporadic ALS patients (26, 29, 231).  A major hypothesis in the 
field of ALS research is that mutations promote aggregation of SOD1, leading to a cascade of 
toxic events that culminate in motor neuron death (3).  However, attempts to identify 
relationships between the effects of the mutations and ALS characteristics have shown that these 
effects are highly complex and not correlated with disease characteristics in a simple way (98, 
229).   
Immature SOD1 (apoSH) is a marginally stable monomer (98), subsequent metal binding 
and disulfide bond formation result in dimerization and marked increase in stability (151) 
(Section 1.3.1).  The fully mature form of SOD1 (holoSS) has a melting temperature of ~92 °C 
(128), and can maintain enzymatic activity in strongly denaturing conditions (129).  Yet, while 
mature SOD1 is highly stable against denaturation, ALS-associated mutants have increased 
tendency to be metal deficient (99), which increases the dynamics of the protein (135).  Each 
SOD1 chain adopts an 8-stranded Greek key β-barrel structure with loops of differing length; the 
longest loops are referred to as the zinc-binding (Loop IV) and electrostatic loops (Loop VII).  
The zinc-binding loop contains the zinc-binding site, one of the cysteines in the intrasubunit 
disulfide bond, and residues involved in dimer interface formation (Fig. 1.5) (126, 130).  Thus, 
zinc binding, disulfide bond formation, and dimerization limit the flexibility of the zinc binding 
loop and significantly increase protein stability (131).  The electrostatic loop is important for 
SOD1 activity (133), and also for stabilizing the zinc-binding site (137).  Both zinc-binding and 
electrostatic loops contain many hydrogen bonding interactions, which are believed to stabilize 
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the protein by providing a network of connections between the loops and the metal binding sites 
(130).  Local unfolding of these loops and/or exposure of the edges of the β-barrel can participate 
in aberrant intermolecular interactions when metal binding is compromised (Section 1.3.6) (90, 
148).  In the absence of metal and disulfide bonds, vital interactions are lost causing the large 
loops to unravel and/or the dimer interface to be exposed, both of which could lead to aberrant 
intermolecular interactions (138).   
In recent years, there has been extensive research on the aggregation of apoSH SOD1, as 
this unstable and dynamic form of the protein has been proposed to be particularly likely to 
aggregate in disease (1, 76, 131, 174, 180, 195).  ApoSH SOD1 stability is relatively low 
compared to other globular proteins (1), far lower than more mature forms of SOD1 (Fig. 1.5) 
(128, 134),  and is the form of SOD1 most destabilized by mutations (98).  The thermal 
unfolding transition of apoSH starts to occur at only slightly above physiological temperature of 
37 °C; and, mutations can greatly increase the fraction of unfolded monomers (98).  Global 
destabilization by mutations is often accompanied by increases in local conformational dynamics 
and the energy landscape of apoSH appears to be complex (301).  Potentially owing to this 
complex energy landscape, in vitro, the extent and type of aggregation for apoSH varies greatly 
with experimental conditions (Fig. 1.7) and some conditions strongly enhance aggregation of 
even wild type (WT) apoSH (Section 1.3.6) (2).  In particular, denaturation and/or agitation of 
both WT and mutant apoSH can cause formation of various amyloid-like fibres (76, 179, 184).  
Recent studies have also shown that various forms of metal-free SOD1 can make amyloid-like 
fibres with smooth, unbranched morphologies under agitation conditions, and this occurs from 
the globally unfolded rather than the folded state (179).  In contrast, we have shown that under 
quiescent solution conditions, both WT and pWT apoSH show little tendency to aggregate, and 
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mutants exhibit increased but still low levels of aggregation (Chapter 4) (174).  These varying 
results suggest that the mode(s) of apoSH aggregation are particularly diverse and sensitive to 
varying conditions, due to the marginal stability of the protein and hence easily altered 
conformational properties.  The challenge in studying physiologically relevant apoSH 
aggregation is to find proper experimental conditions such that aggregation is observed, but not 
inappropriately promoted so as to favour amyloid formation given that ALS is not considered an 
amyloid disease (22). 
Here we show that by increasing the protein concentration and/or by adding 150 mM 
Na2SO4 or 150 mM NaCl, we observe differences in the aggregation propensity of diverse ALS-
associated apoSH SOD1 mutants.  By light scattering we see that some mutations promote rapid 
aggregation with little lag time, suggestive of aggregation from either the unfolded or native-like 
states, while others have more subtle effects on aggregation.  Atomic force microscopy (AFM) 
reveals that mutations leading to high levels of aggregation tend to promote aggregation 
pathway(s) that result in abundant levels of small aggregates.  AFM, in combination with 
Thioflavin-T (ThT) binding experiments, show that those apoSH mutants that exhibit lower 
aggregation propensity tend to form longer fibrils with more extensive β-structure.  Intriguingly, 
such structural polymorphisms exhibited by apoSH aggregates may be analogous to different 
“strains” observed in prion aggregation (23).  These results highlight how point mutations can 
have dramatic effects on the energy landscape of proteins, in particular marginally stable and 
highly dynamic proteins, and can modulate which aggregation pathways are either favoured or 
disfavoured. 
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5.2 Materials and Methods 
5.2.1 Preparation of apoSH SOD1 
ApoSH SOD1 was prepared from apo oxidized (apoSS) SOD1 as described previously 
(Chapter 4, Section 4.2.1) (174).  Reduction of the disulfide bond was verified by SDS-PAGE as 
described (Chapter 4, Fig S4.1) (174).  After reduction, 1 mg mL
-1
 apoSH samples were filtered 
using Anotop 10 filters with a 0.02 μm cut-off (GE Healthcare Life Sciences) to remove 
aggregates formed during the reduction procedure.  5 mg mL
-1
 samples could not be filtered 
using these filters, due to extensive sample loss; instead, samples were centrifuged at 16 300 rpm 
for 10 minutes to remove any large aggregates or dust particles.  Salt samples were prepared 
according to the normal protocol and then salt buffered in 20mM HEPES, 1mM TCEP was 
added to the apoSH samples after reduction.  During incubation, all samples were stored in a 
desiccator to avoid reoxidation.  Aggregation was monitored using a variety of techniques (vide 
infra), and all these experiments were performed on 45 μL aliquots removed from the apoSH 
sample starting immediately after filtration (t0) and approximately every 24 hours after t0.  To 
ensure that apoSH samples stayed reduced and that the samples’ aggregation state was preserved, 
each 45 μL aliquot was flash frozen in liquid nitrogen and stored at -80 °C for future analysis. 
 
5.2.2 Verifying the absence of metal for apoSH SOD1 samples 
 Preparation of apoSS SOD1 involves extensive dialysis of the protein against high 
concentrations of EDTA, which is later removed by further dialysis against EDTA-free buffer, as 
described (128, 134).  Some EDTA remains bound to apoSS (302), which can protect the protein 
from re-binding zinc or copper; zinc, in particular, is found in trace amounts on glassware and in 
chemical reagents used for reducing SOD1.  It is important to note that EDTA binding has been 
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found to have no effect on the stability of different forms of SOD1 determined by DSC (Broom, 
H.R., Doyle, C.M., and Meiering E.M., unpublished data).  Preparation of apoSH involves 
unfolding the protein in GdmCl to expose the intramolecular disulfide bond to reducing agent, 
TCEP, which effectively removes all bound EDTA from the protein.  As a result, apoSH is 
highly susceptible to re-metallation.  To avoid this problem, initially all glassware was soaked in 
nitric acid.  However, a high percentage of attempts to prepare metal free apoSH were 
nevertheless unsuccessful due to the presence of trace metals originating from reagents (Table 
S5.1).  Even trace levels of metal can accumulate in apoSH samples due to the protein’s very 
high affinity for metal (~6.8 x 10
-18
 M
-1
 and ~4.2 x 10
-14
 M
-1
 for copper and zinc, respectively) 
(303).  To avoid metal accumulation, all buffers were treated with Chelex® 100 (Bio-Rad 
Laboratories Ltd.) metal-binding resin.  Both approaches combined have proven to be effective 
at preventing metal contamination (Fig. 5.2, Table S5.1).  
 To verify that the protein did not become partially remetalled during reduction, a 
spectrophotometric metal-chelation assay using the chelator 4-(2-pyridylazo)rescorcinol (PAR)  
(Fig. 5.1) was performed.  The PAR assay was originally developed by Crow et al. (304) and 
Mulligan et al. (258), and later refined by Heather Primmer and Colleen Doyle to measure the 
metal content of SOD1, as described by Doyle, C.M., 2009, unpublished MSc. thesis (305).  
While the PAR assay was used to assess the metal content of samples used for experiments 
discussed in Chapter 4 (174), metal analysis was not described and so will be described here.  
PAR is a dye that binds transition metals with high affinity, resulting in a red shift in the 
absorbance spectrum of PAR from 415 nm to approximately 500 nm, depending on the metal 
(258, 304, 306).  The molar absorbance coefficient of copper and zinc-bound PAR is very high, 
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36 300 and 69 200 M
-1
 cm
-1
, respectively; thus, PAR is a sensitive indicator of metal ion 
concentration (304).     
 
Figure 5.1 The molecular structure of apo and metal bound PAR.  Copper and zinc binding 
to PAR is facilitated by the pyridyl nitrogen, one of the nitrogens within the azo moiety, and the 
oxygen of the 2-phenolate group within the resorcinol moiety.  PAR binds copper in a 1:1 ratio 
and zinc in a 2:1 ratio when there is at least a 2.5-fold excess of PAR with respect to metal.  The 
affinity of PAR for both metals is high, 7.7 x 10
-11
 and 2.6 x 10
-15
 M
-1
 for the [PAR]2-zinc and 
[PAR]-copper complexes, respectively (304).   
 
 PAR2-zinc and PAR-copper complexes exhibit different absorbance spectra (258, 304, 
305).  Either copper or zinc binding causes the absorbance at 490 and 520 nm to increase linearly 
with metal concentration relative to apo PAR.  When copper binds to PAR, the increase in 
absorbance at both wavelengths is the same; however, when zinc binds the increase in 
absorbance at 490 is greater than at 520 nm (258).  These differences in the absorbance spectra 
can be exploited to simultaneously quantify the amount of copper and zinc bound to SOD1 (Fig. 
5.2).  To do so, 45 μL of apoSH SOD1 was added to a mixture of PAR, GdmCl, and HEPES, pH 
7.4 (final concentrations 100 μM PAR, 6 M GdmCl, and 20 mM HEPES) as described (305), and 
the absorbance spectrum was measured.  Spectral deconvolution software, SpectraLab 
(http://cyp3a4.ucsd.edu/spectralab.html), developed by Dmitri Davydov, was used to 
deconvolute the [PAR], [PAR]2-zinc and [PAR]-copper components of the experimental 
spectrum (307).  This was done by fitting the experimental absorbance spectrum with a set of 
absorbance spectra standards for [PAR], [PAR]2-zinc and [PAR]-copper, which returns 
multiplication factors for each standard that relate to the weighting of each component in the 
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experimental spectrum.  These multiplication factors can be used to calculate the levels of copper 
and zinc in the sample. 
 The metal content in apoSH samples prepared for NMR experiments was determined by 
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) at the Analytical 
Laboratory for Environmental Science Research and Training, University of Toronto.  The PAR 
and ICP-AES experiments confirm that the combined approach of soaking all glassware in nitric 
acid and treating buffers with Chelex® 100 resin prevents metal contamination.   
176 
 
 
Figure 5.2 The PAR assay provides a sensitive method for determining metal content of 
apoSH samples.  (A) The absorbance spectra of free PAR (solid black line), [PAR]-copper 
(dotted black line), and [PAR]2-zinc (dashed black line) are shown.  The changes observed in the 
[PAR]-copper and [PAR]2-zinc spectra are due to the presence of 5 μM metal.  Addition of a 
metal-free apoSH results in an absorbance spectrum that resembles free PAR (dotted blue line).  
An increase in absorbance at 490 and 520 nm indicates that the sample contains metal (solid red 
line).  As illustrated in (B), metal contamination was a large issue between 2009 and 2012, with 
numerous apoSH samples becoming highly metallated with zinc.  Red bars reflect the average 
percentage of metal found in apoSH samples, and error bars are the standard deviation.  After 
subsequently switching to the combined approach of soaking all glassware in nitric acid and 
treating all buffers with Chelex® 100 resin, very few samples were found to contain metal.    
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5.2.3 Light scattering experiments 
Light scattering measurements were made according to the protocol described previously 
(Chapter 4, Section 4.2.4) (174).  The intensity of light scattered (I) depends on the size and 
concentration of particles in solution.  Fluctuations in light scattering intensity as a function of 
time (I(t)) depend on the translational diffusion coefficient (Dc) of the particles in solution (276, 
308).  According to the laws of Brownian motion, large particles diffuse at a slower rate than 
small particles.  Dc relates to the hydrodynamic diameter (Dh), the diameter of a sphere that 
diffuses at the same rate as the particle being measured, according to the Stokes-Einstein 
equation (Eq. 5.1), 
𝐷𝑐 =
𝐾𝑇
3𝜋𝜂𝐷ℎ
 (Eq. 5.1) 
where, K is the Boltzmann constant, T is the temperature, and η is the viscosity of the sample.  
Dc is determined from an autocorrelation function, which measures the correlation of I(t) with 
itself after a series of delay times (τ) (276, 308).  For a monodisperse sample, the decay in 
autocorrelation is related the translational diffusion of particles within the sample according to 
Eq. 5.2, 
|𝑔(𝜏)| = exp(−𝑞𝐷𝑐𝜏) (Eq. 5.2) 
where g(τ) represents the exponential decay in autocorrelation and q is the light scattering vector, 
defined according to Eq. 5.3, 
𝑞 =
4𝜋𝜂sin (
Ɵ
2
)
𝜆
 (Eq. 5.3) 
where Ɵ is the light scattering angle and λ is the wavelength of the light (309).  For polydisperse 
samples, the decay in autocorrelation of the signal will be polyexponential. 
The PDI is related to the width (σ), or standard deviation, of the particle size distribution 
(Eq. 5.4) (310, 311). 
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𝑃𝐷𝐼 =  
𝜎2
𝑍𝑑
2 (Eq. 5.4) 
This parameter is obtained from fitting the autocorrelation function using the Cumulants method 
(311–313), which assumes the sample is monodisperse and the decay in autocorrelation is single 
exponential (311).  The size obtained from this approach is referred to as the Z-average (Zd), and 
represents the average Dh of all particles in solution.  Therefore, the Zd is only an accurate 
quantity when the sample is monodisperse (311, 314).  In principal, monodisperse  samples show 
PDI values less than 0.1 (308, 310, 315).  For polydisperse samples, the Cumulants method of 
fitting is not valid and a multi-exponential fitting approach is required.  This method is referred 
to as the CONTIN method (276, 311, 313).  It is worth nothing that because many different 
distributions of species can lead to the same decay in autocorrelation when the sample is 
polydisperse, it is not possible to get precise distributions of similarly sized species that are not 
resolved by DLS.  Therefore, PDI values provide an assessment of polydispersity, but not 
composition of the sample (316).  
 
5.2.4 Seeding experiments 
 To test for seeding-induced aggregation of apoSH pWT and H43R, 45 μL aliquots of 
A4V and H43R samples left to incubate at 1 mg mL
-1
, pH 7.4, 37 °C for ~300 hours and found to 
form aggregates by light scattering measurements, were added to 1 mL of freshly reduced and 
filtered apoSH samples.  In the first experiment, A4V and evaporation-induced H43R amyloid 
aggregates were added to non-aggregated pWT; in the second experiment evaporation-induced 
H43R amyloid aggregates and as an additional control, H43R previously incubated at 1 mg mL
-1
, 
pH 7.4, 37 °C for ~300 hours, that did not undergo evaporation-induced aggregation (herein 
referred to as non-amyloid aggregates), were also added to non-aggregated H43R.  H43R does 
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not readily aggregate in the absence of evaporation-induced effects on the sample; therefore, this 
control provided a way to assess the effects of adding previously incubated and frozen apoSH 
samples on aggregation that are unrelated to the presence of aggregates in the sample.  
   
5.2.5 AFM experiments 
To prepare the AFM samples, 45 μL of apoSH solution was deposited on freshly cleaved 
mica, with a 0.15 mm thickness and 22 mm diameter (SPI Supplies, Structure Probe Ltd.).  The 
sample was incubated on the bench at room temperature for 5 minutes to let the protein adhere to 
the mica surface.  The excess solution was drawn off the surface of the mica by capillary action 
using a Kimwipe and then washed four times with 45 µL of milli-Q water using a micropipette.  
Between each rinse, the excess water was drawn off with a Kimwipe.  Samples were then dried 
under a stream of air and then stored in a plastic Petri dish inside a desiccator to prevent dust or 
moisture accumulation. 
Images were obtained using a JPK Nanowizard II atomic force microscope (JPK 
Instruments) in intermittent contact mode, where vertical deflection of the cantilever was 
recorded and used to reconstruct an image of the sample.  For all experiments, monolithic silicon 
AFM tips with a radius of curvature less than 8 nm, force constant of 42 Nm
-1
, and resonance 
frequency of 320 kHz were used (NCH type, Nanoworld Innovative Technologies).  Multiple 
lower resolution 10 x 10 μm images were taken first (512 x 512 or 1024 x 1024 pixels) followed 
by multiple higher resolution 3 x 3 or 5 x 5 μm images (1024 x 1024 or 2048 x 2048 pixels).  
AFM images were analyzed using Scanning Probe Image Processor (SPIP) software , Particle 
and Pore Analysis (Image Metrology), to determine the length, breadth, height, volume, and 
aspect ratio of the particles detected as well as sample properties such as percent surface 
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coverage, which can be used to compare the extents of aggregate formation in different samples, 
and sample roughness, which assess how evenly distributed the protein is on the mica.  Average 
coverage estimates obtained by SPIP were also used to gage the extent of aggregation of the 
different samples.  Coverage is calculated by dividing the sample area (monomers and 
aggregates) by the total image area.  Samples containing many aggregates will generally exhibit 
higher coverage on the mica.   
SPIP software returns a number of different measures of particle size, which have 
differing accuracies depending on the aggregate morphology.  Fiber length is defined as the 
longest segment within the aggregate skeleton and is found by reducing the particle to a width of 
one pixel and measuring the longest distance from end to end.  The skeleton length, on the other 
hand, includes also all branches of the fibril (Fig. 5.3).  Fiber width is calculated by dividing the 
total aggregate area by the fiber length.  For particles that are highly spherical, the fiber and 
skeleton length will be an underestimate of the true length as there will be a significant loss in 
size at the ends of the aggregate when it is shrunk to one pixel in width (Fig. 5.3).  In such cases, 
fiber width is then overestimated.  This was found to be the case for apoSH particles; therefore, a 
different measure of length was used.  Length estimates are determined simply by the end to end 
distance of the particle and breadth is defined as half the distance in the perpendicular direction.  
To obtain an estimate of the number of monomers within each particle, the volume obtained by 
SPIP software was divided by the volume of the apo monomer, ~18.8 nm
3
, calculated from the 
crystal structure of the apoSS dimer (1HL4) using the Volume, Area, Dihedral Angle Reporter 
(VADAR) (317).  There is currently no crystal structure of the apoSH monomer. 
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Figure 5.3 Aggregate morphology influences the accuracy of different size measurements.  
The measured area of the aggregates (blue) is calculated using SPIP, Particle and Pore Analysis 
software and is based on the number of pixels within the aggregate image (refer to SPIP manual 
at http://www.imagemet.com/).  Fiber length is the longest segment of the aggregate reduced to a 
width of 1 pixel, shown as a solid black line in (A) and (B).  (A) For the branched fibril, fiber 
length is the sum of segments a, b, c, and d.  Skeleton length is the sum of all segments, a, b, c, d, 
e, and f.  (B) For small, more spherical aggregates, reducing the aggregate width to 1 pixel 
causes a significant loss in aggregate length and an underestimate of the aggregate length.  Since 
the majority of SOD1 particles resembled the type shown in (B), length as opposed to fiber 
length was used.  
 
5.2.6 ThT binding experiments 
Aggregated apoSH samples (45 μL aliquots) were diluted into ThT buffer, final 
concentration 25 μM ThT, 50 mM glycine, pH 9.0, as described (144).  The final concentration 
of total protein was 32 μM and 160 μM for samples incubated at 1 mg mL-1 and 5 mg mL-1, 
respectively.  Fluorescence spectra from 455-575 nm were obtained immediately after dilution of 
the apoSH samples using first a Photon Technology International QuantaMaster 4 (Horiba-Jobin-
Yvon Spex Inc.) (Fig. 5.6), and then a Fluorolog3-22 spectrofluorometer (Horiba-Jobin-Yvon 
Spex Inc.) (all other experiments), with an excitation wavelength of 440 nm.  Excitation and 
emission slit widths of 1 and 5 nm, respectively were used.  The spectra are the accumulated 
average of 5 scans. 
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5.3 Results 
5.3.1 DLS experiments suggest higher order interactions between apoSH monomers at 1 mg 
mL
-1
, pH 7.4, 37 °C 
Under quiescent, physiologically relevant conditions (1 mg mL
-1
, pH 7.4, 37 °C), we have 
reported previously that reduced apo SOD1 (apoSH) shows increased tendency to form soluble 
aggregates, but that for most variants prolonged incubation does not result in high levels of 
aggregation (Chapter 4) (174).  Light scattering offers a powerful method for detecting very 
small amounts of aggregated species, as the light scattering intensity is proportional to the Dh
6
, 
where Dh is the hydrodynamic diameter (Eq. 5.1) (276).  Intensity distributions, such as those 
reported in Figs. 4.3 and S4.4, weight particles according to the amount of light they scatter, 
hence will always emphasize larger particles, and such distributions can be misleading when 
trying to assess how much protein has aggregated.  Number distributions however, weight 
particles according to their concentration in solution, and thus provide a more intuitive estimate 
of aggregation propensity.   
Empirical calculations based on the polypeptide chain length show that the Dh of folded 
and unfolded apoSH SOD1 is ~4.2 and 7.8 nm, respectively (277).  At 37 °C pWT, WT, H46R, 
and V148I, are predominantly folded (174); therefore, DLS measurements of a monodisperse 
sample should result in intensity and number distributions centred at ~4 nm, corresponding to the 
folded monomer.  The DLS measurements obtained at t0 for these variants show Dh,I and Dh,N 
values are consistent with the empirical calculations (average ~5.5 nm and ~3.1 nm, 
respectively) (Table 5.1).  For destabilized mutants, especially those with t0.5 values close to or 
lower than 37 °C (Fig. 4.1C, Table S4.2), the Dh,I and Dh,N of a monodisperse sample should be 
larger, between 4 and 8 nm.  As expected for these mutants, the Dh,I values at t0 were found to be 
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larger (average ~7.2 nm) (Fig. 5.4, Table 5.1).  While the Dh,N values are generally smaller than 4 
nm, destabilized mutants exhibit higher Dh,N values than pWT and stabilized mutants, consistent 
with the trend observed for Dh,I values (Table 5.1).  Differences in Dh,I and Dh,N can arise when 
samples are not monodisperse.  For instance, when both folded and unfolded monomers are 
populated and/or when particles larger than the apoSH monomer begin to form in solution.  A 
single dimer, assuming it has double the volume of the monomer, will scatter ~5 times more 
light.  Following similar logic, a trimer ~15 times more light compared to the monomer (318, 
319).  Thus, even low levels of higher order species will make larger contributions to the 
intensity distribution compared to the number distribution.  Unfolded protein and/or higher order 
oligomers present at t0 are unresolved by DLS measurements, and the result is a broad peak that 
emphasizes larger particles in the intensity distribution and smaller, more abundant particles in 
the number distribution.  Interestingly, differences in Dh,I and Dh,N at t0 are largest for A4V (~5 
nm), and E100G, which is less stable and more unfolded 37 °C shows a smaller difference Dh,I 
and Dh,N values at t0 (~3 nm).  This finding suggests that the larger difference in these values 
observed for A4V may be due to the formation of higher order species, consistent with the higher 
aggregation propensity of this mutant (vide infra). 
The PDI values, which exceed the value expected for a monodisperse sample (>0.1) also 
provide further confirmation that apoSH samples are not monodisperse at t0.  The PDI is also 
generally increased relative to pWT at t0 for the destabilizing mutants, consistent with increases 
in the amount of globally unfolded protein, although we cannot rule out that destabilizing 
mutations may promote formation of higher order species such as dimers and trimers.   
Under physiological-like conditions, light scattering intensity (Fig. S5.1), as well as  
intensity distributions plotted with number distributions as a function of time (Figs. 5.4 and S5.2) 
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reveal that, most apoSH variants aggregate very little when incubated for ~300 hours.  The 
notable exception is A4V, where light scattering intensity and both Dh,I and Dh,N values increase 
with time.  However, the average Dh,N after ~300 hours of incubation (t300) shows a high level of 
uncertainty (Table 5.1), demonstrating that not enough aggregates have formed in solution to 
give reliable estimates of their size by number distribution (Table S5.2).  pWT, WT, and 
stabilizing mutations H46R and V148I show very little change in Dh,I and Dh,N over time (Fig. 
5.1, Table 5.1).  Yet, for destabilizing mutants (A4S, A4T, A4V, E100G, G37R, G93A, G93R, 
G92S, and V148G), the difference in Dh,I and Dh,N increases after prolonged incubation at 37 °C, 
due to increases in Dh,I.  The exceptions are G85R, H43R which behave similar to pWT, WT, 
H46R, and V148I.  Furthermore, aside from A4V, the Dh,N values are very similar after 
incubation to values obtained at t0, which suggests that the concentration of various species does 
not change much over the course of the incubation period.  Although, for all variants, including 
pWT and WT, prolonged incubation results in an increase in the PDI, indicating that apoSH 
samples become more polydisperse over time, which could be due to the presence of very small 
amounts of aggregated protein.  
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Figure 5.4 DLS shows that apoSH variants aggregate little at 1 mg mL
-1
, pH 7.4, 37 °C.  All 
samples were incubated in 1 mM TCEP, 20 mM HEPES.  Intensity distributions are indicated by 
the solid lines and number distributions by the dotted lines.  DLS measurements were taken 
approximately every 24 hours, with t0 at the bottom of each panel and the last time point, greater 
than 300 hours, at the top.  Intensity distributions emphasize larger particles in solution; 
therefore, the centre of the peak is shifted to the right compared to the number distribution.  The 
number distributions, which are proportional to the concentration of different species in solution, 
indicate that only for A4V does the concentration of these larger species become abundant after 
incubation for more than ~300 hours.  
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Table 5.1 DLS data summary for apoSH SOD1 variants at 1 mg mL
-1
, pH 7.4, 37 °C. 
 t = 0 t > 300 
ApoSH 
SOD1 
variant 
PDI
a
 
PDI width
b
 
 
 
 
(nm) 
Intensity 
Distribution 
Hydrodynamic 
Diameter
c
 
(nm) 
Number 
Distribution 
Hydrodynamic 
Diameter
c
 
(nm) 
PDI
a
 
PDI width
b
 
 
 
(nm) 
Intensity 
Distribution 
Hydrodynamic 
Diameter
c
 
(nm) 
Number 
Distribution 
Hydrodynamic 
Diameter
c
 
(nm) 
pWT 0.205 2.146 5.383 3.131 0.267 5.231 5.228 3.449 
 0.025 0.250 0.332 0.387 0.083 5.657 0.253 0.398 
WT 0.245 2.672 5.848 3.061 0.348 85.11 5.462 3.397 
 0.038 0.874 1.059 0.959 0.160 251.6 0.853 0.694 
A4S 0.251 3.532 8.103 3.302 0.750 24.35 80.46 3.449 
 0.014 0.134 1.622 1.744 0.041 2.141 4.640 0.626 
A4T 0.250 3.991 7.190 4.419 1.0 45.24 241.8 4.544 
 0.020 0.327 0.202 0.686 0.0 5.109 6.424 0.334 
A4V 0.224 5.566 8.593 3.807 0.312 29.55 63.46 15.40 
 0.043 9.779 1.452 1.376 0.119 10.88 15.38 14.70 
E100G 0.230 2.595 6.432 3.548 0.461 86.19 123.5 4.003 
 0.014 0.151 0.739 0.706 0.163 52.04 353.4 0.357 
G37R 0.300 48.10 5.058 3.499 0.909 149.0 596.6 3.467 
 0.078 109.5 0.711 0.442 0.141 34.49 134.2 0.864 
G85R 0.179 2.516 5.812 3.644 0.271 43.79 5.584 4.095 
 0.045 0.373 0.259 0.673 0.060 67.39 0.715 0.206 
G93A 0.224 3.315 7.683 3.841 0.621 122.9 171.8 4.190 
 0.049 0.851 1.300 1.286 0.245 142.5 248.9 0.766 
G93R 0.240 3.732 7.563 3.971 0.598 26.87 151.1 11.60 
 0.056 1.155 0.806 1.053 0.334 9.509 104.2 11.58 
G93S 0.239 3.226 7.136 3.899 0.502 30.34 84.11 3.880 
 0.024 0.548 0.708 0.930 0.143 46.08 85.18 1.598 
H43R 0.215 3.547 8.603 4.046 0.344 51.18 6.640 3.735 
 0.049 0.650 0.457 0.885 0.110 150.6 0.651 1.503 
H46R 0.186 2.149 5.671 3.086 0.192 5.428 6.113 3.525 
 0.019 0.433 0.863 0.498 0.035 8.757 0.461 0.558 
H46R
wt
 0.227 20.13 5.109 2.825 0.496 1063 95.32 3.371 
  0.089 37.77 0.501 0.905 0.307 2061 273.3 0.403 
V148G 0.291 10.37 6.646 3.928 0.567 191.1 291.5 3.955 
 0.117 13.20 0.522 1.343 0.138 197.1 316.3 1.083 
V148I 0.178 1.868 5.262 3.380 0.471 94.69 5.179 3.681 
 0.029 0.130 0.472 0.348 0.210 110.2 0.333 0.471 
Bold and italicized values are the averages and standard deviations, respectively, resulting from 
multiple experiments (shown in Table S5.2). 
a
PDI is obtained using the Cumulants method of fitting the autocorrelation function (Eq. 5.4).  
Values larger than 0.1 are indicative of polydispersity (i.e., the sample contains more than one 
species in solution).  High PDI values result in larger peak widths, and thus greater distribution 
of sizes reported. 
b
Peak width reflects the range of sizes obtained from the intensity distribution and is related to 
the PDI according to Eq. 5.4. 
c
The sizes reported correspond to the main peak in the distributions. 
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5.3.2 Sample evaporation may promote aggregation 
 The initial aggregation experiments (Chapter 4) performed on apoSH variants involved 
incubating the samples in glass vials that were difficult to seal effectively.  As a result, prolonged 
incubation at 37 °C resulted in partial sample evaporation in some cases, the extent of which 
differed (Figs. 5.5, 5.6).  Evaporation-induced aggregation of H43R may account for the 
discrepancy between the aggregation propensity previously published (Chapter 4) and in Chapter 
5 for this mutant.  Subsequent aggregation experiments with H43R in vials that sealed more 
effectively failed to reproduce the initial finding that H43R has a high aggregation propensity 
and forms aggregates larger than those formed by A4V (98).  In an attempt to explain these 
different results, subsequent analysis of other samples, which appeared to aggregate after a long 
lag time when the sample volume was low, were performed (Fig. 5.5).  While, the samples 
stayed mainly reduced throughout the incubation period, we cannot rule out the possibility that 
other effects, such as partial sample degradation, are also a factor accounting for the differences 
in aggregation behaviour observed for these samples. 
 Amyloid formation occurs through a nucleation-dependent mechanism characterized by a 
lag time, during which the critical nucleus forms, followed by rapid fibril growth (320).  Surfaces 
can play a large role in facilitating the formation of the initial nucleus (321–327).  For example, 
proteins that are amyloidogenic also tend to be amphiphilic and concentrate at hydrophobic-
hydrophilic interfaces such as the air-water interface and lower the surface tension of water (322, 
324–326, 328).  This phenomenon can catalyze the formation of amyloid because it increases the 
effective concentration of protein at the interface, as well as force the protein into a β-
conformation where hydrophobic segments within the protein align with the hydrophobic surface 
(322, 328).  Proteins that are only marginally stable, such as apoSH SOD1, may be more likely 
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to undergo surface-induced structural changes that result in the protein becoming trapped in an 
amyloidogenic state.  Sample evaporation causes the concentration and surface-area to volume 
ratio to increase, both of which can elevate the levels of protein in the amyloidogenic state.  
Above a critical concentration amyloid fibril formation will dominate over other association 
pathways.   
 AFM experiments confirm that under certain conditions apoSH mutants can form fibrillar 
aggregates with smooth and twisted fibril morphology typical of amyloid fibrils (Figs. 5.6, S5.3-
S5.6) (89).  ThT binding experiments on these fibrillar H43R aggregates indicate that they 
contain extensive β-structure resembling amyloid (Fig. 5.6).  It could be that the marginal 
stability and conformational flexibility of apoSH SOD1 may allow it to adopt different 
conformations that can access different aggregation pathways.  Given the limited number of 
samples that exhibited this type of aggregation, it is unclear whether or not these samples 
represent different points within the same amyloid aggregation mechanism or differing 
mechanisms altogether.  While amyloid formation by SOD1 is generally not believed to be 
relevant to disease (22), these findings highlight the importance of understanding factors that can 
influence in vitro aggregation experiments. 
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Figure 5.5 DLS and AFM reveal that sample evaporation can promote fibril formation at 
pH 7.4, 37 °C and initial concentration of 1 mg mL-1.  All samples were incubated in 1 mM 
TCEP, 20 mM HEPES.  (A) SLS experiments show that evaporation-induced aggregation occurs 
after a lag time of ~100 hours.  (B) DLS experiments show that sample evaporation promoted 
protein aggregation.  As in Fig. 5.4, DLS measurements were taken approximately every 24 
hours, with t0 at the bottom of the panels and the last time point, >300 hours, at the top.  Intensity 
distributions (solid lines) emphasize larger particles in solution; the number distributions (dotted 
lines) emphasize smaller particles in solution.  At later time points, both intensity and number 
distributions shift to larger species, as aggregates become abundant in solution after a 
considerable lag time (~100, 150, and 300 hours for H43R, G85R, and V148I, respectively).  (C) 
AFM images partially evaporated apoSH H43R, G85R, and V148I confirm that sample 
evaporation can lead to fibril formation.  In all panels, the white bars correspond to 1 µm.  The 
extent of this process was most pronounced for H43R, which formed thick fibrils with a twisted 
morphology.  Fibril formation was less extensive in the other samples.  G85R formed fibrils of 
similar lengths to H43R, but that were much thinner while V148I formed fibrils that were both 
thinner and shorter than those formed by H43R.  These differences appear consistent with DLS 
data, which indicates that aggregation started earlier in the H43R sample compared to G85R and 
V148I.  These mutants may also exhibit intrinsically different amyloid-forming propensities, 
although based on the Chiti et al., prediction algorithm (282), the amyloid-forming propensities 
for H43R, G85R, and V148I are low (Fig. 4.4).  For all images of these samples refer to Figs. 
S5.3-S5.5. 
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Figure 5.6 ThT binding experiments reveal that evaporation-induced H43R aggregates 
resemble amyloid.  (A) ThT fluorescence experiments on non-evaporated apoSH samples are 
shown.  ThT rapidly associates with fibrils composed of cross β-sheets common to amyloid, 
resulting in an increase in its fluorescence intensity at 482 nm (329–332).  Three mutants that 
displayed differing aggregation behaviour when incubated at 1 mg mL
-1
, pH 7.4, and 37 °C were 
selected.  For all samples, four time points were measured.  The initial time points (t0) are shown 
by the dotted line and lightest colours and the later time points are shown by progressively darker 
colours and lines with increasing dash length.  The final time points are indicated by the darkest 
colours and solid lines.  A4V (red), which aggregates the most showed the largest increase in 
ThT fluorescence over time; G93R (blue) showed a slight tendency to aggregate and a small 
change in ThT fluorescence; and H46R (green) a very little tendency to aggregate and very little 
change in ThT fluorescence.  These changes in fluorescence intensity at 482 nm are however 
very small, even for A4V, compared to the changes expected upon ThT binding to amyloid 
fibrils (329–332).  (B) ThT fluorescence for partially evaporated H43R samples at different time 
points are shown.  The initial time points (t0) are indicated by the dotted line and lightest colours 
and the later time points are shown by progressively darker colours and lines with increasing 
dash length.  The final time point is indicated by the darkest colour and solid line.  In both panels 
the solid black line represents the fluorescence intensity of free ThT in sample buffer (1 mM 
TCEP, 20 mM HEPES) (Materials and Methods, Section 5.2.6). 
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5.3.3 Seeding and Cross-seeding do not promote aggregation of apoSH pWT and H43R 
 Light scattering data shows that, while most apoSH variants undergo very little 
aggregation at 1 mg mL
-1
, pH 7.4, and 37 °C, low levels of aggregation occur.  These results 
suggest that either these intermolecular interactions are not highly stabilizing and/or not enough 
collisions between proteins occur at 1 mg mL
-1
 to facilitate particle growth.  Often 
conformational changes in the native state are required to initiate aggregation and the rate at 
which proteins aggregate depends on the concentration of protein in an aggregation-prone state 
(53).  Once aggregation-promoting nuclei (seeds) are formed, they can recruit protein resulting in 
aggregate growth.  The addition of seeds, therefore, can increase the rate of aggregation by 
providing a surface that supports addition of aggregation-prone monomers.  There is some 
controversy regarding the degree of specificity of aggregation, and different specificity 
requirements have been demonstrated for different proteins and modes of aggregation.  One 
study found that sequences with more than 70 percent identity were capable of co-aggregating 
(333); on the other hand, there is strong evidence that even single point mutations in the prion 
protein (PrP) can create transmission barriers that limit propagation of the misfolded protein 
(334, 335).  Protein inclusions formed in vivo also tend to be highly homogenous (336).  In 
contrast, other studies have shown that different proteins with low sequence similarity are 
capable of co-aggregating (337–339).     
 In an attempt to accelerate aggregation of apoSH, two seeding experiments were 
performed.  In the first experiments, A4V aggregates and H43R amyloid aggregates were added 
to freshly prepared pWT samples, to assess potential differences in cross-seeding efficiency (Fig. 
5.7A, C, E, G).  It was hypothesized that the different morphologies of the aggregates may lead 
to very different abilities to induce aggregation of pWT.  Given the presence of aggregates in 
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these samples and the high sequence identity between the different SOD1 variants, the hope was 
that increasing the concentration of aggregation nuclei would promote aggregation.  As ALS-
linked SOD1 mutations are autosomal dominant, the effects of mutant protein on the aggregation 
properties of the wild-type protein are pertinent to the understanding of disease mechanisms (3). 
As shown in Fig. 5.7A, C, E, G, the addition of A4V seeds and H43R amyloid seeds 
resulted in little aggregation.  These results suggest that either the concentration of aggregation 
nuclei was too low to induce aggregation in these samples, or that the efficiency of co-
aggregation between these samples was low due to high sequence and/or conformational 
specificity requirements.  A second experiment was performed in which H43R amyloid seeds 
were added to non-aggregated H43R.  An aliquot of an H43R sample that did not undergo 
evaporation-induced aggregation was also added to a sample of non-aggregated H43R as a 
control (Materials and Methods, Section 5.2.4), herein referred to as non-amyloid seeds even 
though this sample contained very few aggregates (Fig. 5.7B, D, F, H).  Like the first 
experiment, neither the addition of amyloid or non-amyloid seeds led to any dramatic change in 
aggregation behaviour.  The sample containing amyloid aggregates did exhibit an increase in 
light scattering intensity with time, although the standard deviation in the measurements were 
high, and by DLS it is evident that the concentration of aggregates was low (Fig. 5.7B, F).  It is 
possible that these seeding experiments were not successful because the concentration of 
aggregates added was too low to initiate aggregation.  Or it could be that the end stage amyloid 
aggregates are less effective at inducing aggregation of apoSH compared to smaller oligomers.  
Now that we have established better experimental conditions for measuring apoSH aggregation 
(vide infra), it will be valuable to return to these experiments to assess the cross-seeding ability 
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of different apoSH mutants as well as the different seeding properties of early versus late stage 
aggregates. 
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Figure 5.7 Light scattering measurements show that addition of aggregates as seeds does 
not induce further aggregation at 1 mg mL
-1
, pH 7.4, 37 °C.  All samples were incubated in 1 
mM TCEP, 20 mM HEPES.  Seeding and cross-seeding experiments with pWT (panels A, C, E, 
G) and H43R (panels B, D, F, H) were carried out in an attempt to induce aggregation.  In all of 
these experiments, 45 μL aliquots of samples left to incubate at 1 mg mL-1, pH 7.4, 37 °C for 
~300 hours were added to non-aggregated samples (Materials and Methods, Section 5.2.4).  (A) 
SLS shows that neither the addition of A4V aggregates (red squares) or H43R amyloid 
aggregates (blue squares), to pWT, incubating at 1 mg mL
-1
, pH 7.4, 37 °C, results in much 
change in light scattering intensity over time compared to the sample with no aggregates added 
(black squares).  Error bars reflect the standard deviation of three measurements at each time 
point.  (C, E, and G) DLS data for pWT containing no added aggregates, pWT containing A4V 
aggregates, and pWT containing H43R amyloid aggregates are shown, respectively.  In these 
experiments, aggregates were added after the initial measurement, which is why only one peak 
was observed in the intensity distribution (solid lines) at t0.  After aggregates were added, their 
presence was evident in the intensity distribution, but their concentration in the sample was too 
low to get reliable size estimates.  (B) SLS shows that the addition of H43R amyloid aggregates 
(blue squares) to non-aggregated H43R, incubating at 1 mg mL
-1
, pH 7.4, 37 °C, results in a 
marginal change in light scattering intensity compared to the sample with no aggregates added 
(black squares).  As an additional control, H43R previously incubated at 1 mg mL
-1
, pH 7.4, 37 
°C for ~300 hours, that did not undergo evaporation-induced aggregation (herein referred to as 
non-amyloid aggregates), was also added to non-aggregated H43R (red squares).  H43R does not 
readily aggregate in the absence of evaporation-induced effects on the sample; therefore as 
expected, the changes in light scattering intensity of this sample compared to H43R with no 
aggregates added (black squares) are similar.  Error bars reflect the standard deviation of three 
measurements at each time point.  (D, F, and H) DLS data for H43R with no added aggregates, 
H43R containing H43R amyloid aggregates, and H43R containing non-amyloid aggregates are 
shown, respectively.  In all seeding and cross-seeding experiments, DLS data indicates that very 
little additional aggregation takes place after the addition of aggregates to the sample.  While the 
intensity distributions (solid lines) show that there are aggregates in solution, the number 
distributions (dotted lines) indicate that concentrations of these species remain very small.  DLS 
measurements were taken approximately every 24 hours, with t0 at the bottom of the panels and 
the last time point, >300 hours, at the top.  
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5.3.4   Light scattering shows that apoSH variants exhibit increased aggregation at higher 
concentration 
 Aggregation experiments were performed under the same conditions as described in 
Section 5.3.1, but at higher protein concentration to further promote intermolecular interactions 
and so observe more measureable levels of aggregation.  To this end, only destabilized mutants 
A4V, G37R, G93A, G93R, and G93S were selected, as they were expected to have higher 
aggregation propensities at higher protein concentration.  For apoSH mutants more stable than 
pWT, it was thought that increasing the concentration of the sample alone would not be enough 
to promote aggregation; therefore, 150 mM Na2SO4, known to enhance aggregation (Section 
5.3.7), was also added to V148I to assess if this mutant would aggregate via a similar mechanism 
when provided with an extra push. 
 SLS measurements show that for pWT, G93A, and G93S at increased protein 
concentration the light scattering intensity does not change significantly with time, suggesting 
low levels of aggregation even at higher protein concentration (Fig. 5.8).  For V148I in 150 mM 
Na2SO4, the average light scattering intensity does not change greatly with time; however, the 
uncertainty in later measurements is very high, pointing to the presence of small amounts of 
large particles in solution.  On the other hand, A4V, G37R and G93R exhibit notably increased 
level of aggregation at higher protein concentration (Fig. 5.9).  These mutants aggregate with no 
discernible lag time, suggesting that the energetic barrier between the unfolded or native state(s) 
and aggregation-prone state(s) is low.  Consistent with experiments at 1 mg mL
-1
, A4V 
aggregates more than all other variants when incubated at 5 mg mL
-1
, rapidly forming aggregates 
that over time become too large to be analyzed quantitatively by light scattering, as shown by the 
decrease in light scattering intensity after ~50 hours of incubation.  SLS is an excellent method 
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for determining differences in aggregation; yet, it is less suited for assessing subtle changes in 
intermolecular association for samples that undergo much less aggregation, for which DLS is a 
more powerful tool. 
At higher protein concentration, Dh,I and Dh,N values at t0 for pWT and V148I are 
consistent with the empirical estimate of ~4 nm for folded monomer (Fig. 5.9, Table 5.2) (277).  
For A4V, G37R and G93R, Dh,I was measured to be 20.1, 9.3, and 9.0 nm, respectively at t0, 
~1.5-12 nm larger compared to measurements obtained for 1 mg mL
-1
 samples, corresponding to 
sizes larger than expected for monomeric apoSH SOD1.  Although, the Dh,N values for these 
mutants are lower, 4.6, 5.3, and 5.4 nm, respectively, they are still increased for 5 mg mL
-1
 
compared to 1 mg mL
-1
 samples.  The other destabilizing mutants, G93A and G93S, exhibit less 
change in Dh,I and Dh,N values with protein concentration, and they are more consistent with the 
expected Dh values of ~4-8 nm for a mixture of unfolded and folded monomers stated above 
(277), 7.0 and 5.0 nm, respectively, for G93A and 6.9 and 4.0 nm, respectively, for G93S.  The 
Dh,N values at t0 are less influenced by small increases in associated species, although for pWT 
and all mutants they increased slightly at high protein concentration.  The PDI at t0 is also higher 
for pWT and all mutants at 5 mg mL
-1
, compared to 1 mg mL
-1
, providing further evidence of 
increased oligomerization at higher concentration.  Taken together, t0 DLS measurements reveal 
that some mutants, A4V, G93R, and G37R, show increased aggregation, while other mutants, 
G93A, G93S, and V148I in 150 mM Na2SO4, display similar aggregation compared to pWT.  On 
the whole, however, higher order interactions are more apparent at higher protein concentration 
for all apoSH variants studied.    
After ~300 hours of incubation, all the 5 mg mL
-1
 samples, except for V148I, show an 
increased discrepancy in Dh,I and Dh,N relative to measurements at t0.  Dh,I and Dh,N  differ the 
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most for pWT, G93A, and G93S with differences ranging from ~400-1200 nm, due to increases 
in Dh,I but not Dh,N  (Table 5.2).  For V148I in 150 mM Na2SO4, the Dh,I  and Dh,N values are 
fairly similar, and relatively unchanged with time.  A4V displayed the most aggregation at 5 mg 
mL
-1
; light scattering was only measureable up to 120 hours after which based on visual 
inspection the protein had formed large aggregates beyond the DLS detection limit (>1000 nm) 
(Fig 5.9).  Furthermore, pWT, A4V, G93A, G93S, and V148I in 150 mM Na2SO4 samples 
similarly exhibit a large increase in PDI with incubation time leading to large uncertainty in Dh,I 
values after ~300 hours (Table 5.2).  Taken together, these results suggest that large aggregates 
form in these samples, which scatter a large amount of light but, except for A4V, remain low in 
concentration.  Thus, size estimates by DLS are difficult.   
On the other hand, G37R and G93R exhibit smaller discrepancies in Dh,I and Dh,N at ~t300, 
although still larger relative to t0 measurements.  Both values increase with time, pointing to a 
clear increase in the concentration of aggregates.  A4V, G37R and G93R also show large 
increases in the Dh,N  values measured after t300 for 5 mg mL
-1
 compared to 1 mg mL
-1
 samples, 
indicating more aggregation higher concentrations.  Furthermore, the PDI values for G37R and 
G93R samples decrease with incubation time, indicating that the samples become more 
monodisperse, which may be due to an increase in aggregate concentration and a decrease in the 
monomer and oligomer concentration.  The other apoSH variants showed little change in Dh,N at 
t300 compared to t0 as well as t300 measurements at lower protein concentration, but the PDI 
increased with protein concentration.   
SLS and DLS data together indicate that different apoSH variants demonstrate different 
aggregation behaviour.  Changes in total light scattering intensity, Dh, and PDI measurements 
indicate that at increased protein concentration, intermolecular interactions are enhanced leading 
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to clearly increased levels of aggregation in A4V, G93R and G37R samples.  Alternatively, 
while at higher concentration intermolecular interactions are also enhanced in pWT, G93A, 
G93S and V148I in Na2SO4 samples, they do not lead to extensive aggregation.  Rather, some 
aggregates may form but they remain low in concentration.   
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Figure 5.8 SLS reveals different levels of aggregation for apoSH variants incubated at 
higher concentration (5 mg mL
-1
, pH 7.4, 37 °C).  All samples were incubated in 1 mM TCEP, 
20 mM HEPES.  At higher protein concentration, aggregation becomes more favourable for 
some mutants.  A4V, the only mutant plotted on the right hand axis (red squares), aggregated the 
most and was only measurable by light scattering for ~120 hours.  After this point the aggregates 
were too large to be detected.  G37R (green triangles) and G93R (blue circles) also aggregated 
with very little detectible lag time.  Incubation at higher protein concentration however, does not 
lead to much change in light scatter intensity over time for pWT, G93A, and G93S (black 
squares, purple squares and orange circles, respectively).  V148I (pink triangles), a mutant more 
stable than pWT, was incubated at higher concentration with the addition of 150 mM Na2SO4, 
which promotes aggregation (Section 5.3.7).  In this case, the light scattering intensity fluctuated 
greatly between the measurements giving rise to large standard deviations in the measurements.  
This finding indicates that large particles are present in solution, yet these species are not 
abundant.  Error bars represent the standard deviation of three measurements at each time point. 
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Figure 5.9 DLS also reveals different levels of aggregation for apoSH variants incubated at 
higher concentration (5 mg mL
-1
, pH 7.4, 37 °C).  All samples were incubated in 1 mM TCEP, 
20 mM HEPES.  At increased protein concentration A4V shows the highest aggregation 
propensity. At t0 there is a large discrepancy in the size reported by intensity and number 
distribution, suggesting that aggregates form immediately.  After ~24 hours most of the sample 
formed aggregates of similar size to those observed at 1 mg mL
-1
; however, larger aggregates are 
also apparent.  Subsequent measurements revealed that a significant amount of protein had 
formed aggregates too large to be detected by DLS, resulting in poor estimates of particle size.  
After ~120 hours the sample was not measureable by DLS.  G37R and G93R showed much 
higher levels of aggregation at higher concentration, forming aggregates similar in size to those 
formed by A4V and 1 mg mL
-1
 as indicated by the shift in intensity and number distributions to 
larger values.  DLS measurements of G93A, G93S, and V148I incubated with 150 mM Na2SO4 
over time reveal that the majority of particles in solution exhibit little change in size. 
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Table 5.2 DLS data summary for apoSH SOD1 variants at 5 mg mL
-1
, pH 7.4, 37 °C. 
 t = 0 t > 300 
ApoSH 
SOD1 
variant 
PDI
a
 
PDI width 
 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
PDI
a
 
PDI width 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
pWT 0.363 7.785 4.620 3.340 0.926 65.05 707.1 3.845 
 0.053 2.993 0.041 0.115 0.104 11.39 404.5 0.080 
A4V
d
 0.374 27.00 20.15 4.616 1.0 1679 514.9 36.00 
 0.150 25.92 11.08 1.288 0.0 322.4 221.7 22.36 
G37R 0.404 7.876 9.252 5.317 0.242 22.26 60.06 24.23 
 0.017 0.453 0.072 0.365 0.014 0.676 1.920 2.190 
G93A 0.321 62.11 7.030 4.961 0.931 285.1 1256 3.910 
 0.036 54.47 0.050 0.178 0.120 49.43 445.1 0.529 
G93R 0.327 37.70 9.025 5.352 0.215 14.33 35.81 15.98 
 0.078 48.06 0.684 0.716 0.014 0.435 0.655 0.917 
G93S 0.806 38.76 6.852 3.977 0.833 32.16 398.6 5.664 
 0.045 11.59 0.199 1.184 0.068 5.263 72.75 0.431 
V148I 0.330 10.29 5.568 4.066 1.0 5551 4.774 4.378 
Na2SO4 0.026 4.689 0.258 0.221 0.0 3028 0.728 0.344 
Bold and italicized values are the averages and standard deviations respectively resulting from 
three measurements of a single sample (shown in Table S5.3). 
a
PDI is obtained from the Cumulants method of fitting the autocorrelation function (Eq. 5.4).  
Values larger than 0.1 are indicative of polydispersity (i.e., the sample contains more than one 
species in solution).  High PDI values result in larger peak widths and greater uncertainty in the 
sizes reported. 
b
Peak width reflects the uncertainty in the hydrodynamic diameter obtained from the intensity 
distribution and is related to the PDI according to Eq. 5.4. 
c
The sizes reported correspond to the main peak in the distributions. 
d
A4V aggregated readily at higher protein concentration, leading to the formation of aggregates 
visible by the eye.  Such aggregates diffuse too slowly to be measureable by DLS, thus the 
sample could only be measured for ~120 hours. 
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5.3.5 AFM images of aggregated apoSH variants point to different modes of aggregation 
 DLS experiments reveal that apoSH variants exhibit increased aggregation at increased 
protein concentration, but the extent to which aggregation is promoted differs.  For simplicity the 
apoSH variants were categorized into two groups, the first containing variants that undergo little 
change in light scattering intensity and average particle size with time, pWT, G93A, G93S, and 
V148I in 150 mM Na2SO4, and the second containing the variants with more pronounced 
aggregation, A4V, G93R and G37R (Figs. 5.8 and 5.9, Table 5.2).  To account for these 
differences between the two groups, the properties of the aggregates formed were investigated by 
AFM imaging. 
 As shown in Figs. 5.10 and 5.11, the size and morphology of the aggregates differs 
between the two groups of apoSH variants.  Consistent with the light scattering data, the pWT 
sample contained the fewest aggregates, yet there is evidence indicating low levels of fibril 
formation (Figs. 5.11, 5.12, S5.6).  SPIP software was used to estimate aggregate length, breadth, 
height, aspect ratio and volume (Section 5.2.5); and estimates of particle volume were compared 
to the crystal structure volume of the apoSS SOD1 dimer to ascertain how many monomers 
associate to form the aggregates, assuming no significant volume changes in the monomer upon 
association (Fig. 5.13).  These values are summarized in Table 5.3.   
Given the asymmetry of the data, median rather than average values were used to 
compare the data obtained for different apoSH variants (340).  The median length and breadth 
estimates (Fig. 5.13, Table 5.3) of the pWT particles deposited on mica were ~20 nm and ~12 
nm, respectively, larger than the size of the size of the dominant species, the apoSH monomer, 
reported by DLS (Table 5.2).  By AFM the majority of measured particle heights range from 0.2-
0.5 nm, smaller than the approximate diameter of the apo monomer (~3.3 nm), determined from 
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estimates of the apoSS volume (37.5 nm
3
) (317).  This apparent flattening may be due to the 
protein unfolding at the mica surface (341).  Furthermore, apoSH monomers, oligomers, and 
aggregates may bind to the mica surface in different ways, and certain species may be more 
easily washed away during sample preparation.  This process may also vary between different 
samples.  It is also worth noting that the distributions of length, breadth, and monomers per 
particle can convey misleading information regarding the number of aggregates in solution, 
particularly for samples containing large aggregates, such as A4V.  Formation of these large 
assemblies will decrease the levels of smaller fibrils, generating regions of low aggregate 
density.  Because it is not possible to exhaustively image the entire mica surface, it can be 
challenging to interpret differences in the absolute number of particles detected between two 
samples, but comparing the shapes of the distributions is meaningful.  Given these caveats, there 
is good agreement between DLS and AFM results.    
For pWT, the majority of particles detected are composed of ~1 to 4 monomers.  This 
finding is consistent with DLS results that suggest pWT may form low levels of small oligomers 
that are not distinguishable from the monomer but broaden the Dh distributions.  As indicated by 
the median aspect ratio of 1.4 (Table 5.3), the pWT particles in general resemble flattened 
spheres.  For the few particles larger than 200 nm, the average aspect ratio is larger consistent 
with fibril formation.  The low average coverage estimates also indicate that very little 
aggregation has occurred, as was evident by light scattering. 
By AFM, aggregation is more apparent for all mutants analyzed (Figs. 5.10 and 5.11).  
Even those mutants categorized into group one that showed less aggregation by light scattering, 
G93A, G93S, and V148I, exhibited larger median length and breadth estimates, and more 
particles larger than 200 nm compared to pWT (Fig. 5.13, Table 5.3).  The median length and 
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breadth estimates, ranged from 22-39 nm and 15-25 nm, respectively, indicating higher levels of 
larger particles relative to pWT.  Likewise, volume estimates indicate that more particles 
containing ~10 monomers are observed for these mutants compared to pWT.  Thus, the long 
fibrils observed in the AFM images, most notably for G93A (Figs. 5.10, 5.11, and S5.10) and 
V148I (Figs. 5.10, 5.11, and S5.13), are considered outliers given their low concentration, and 
have little impact on the shapes of the size distributions (Fig. 5.13).  Yet, the presence of these 
fibrils is reflected in the larger median aspect ratios of particles greater than 200 nm in length 
(~2-5) (Table 5.3).  It is noteworthy that the lengths of fibrils that are not linearly displayed on 
the mica will be underestimated and the breadths overestimated; therefore, the aspect ratios 
(length divided by breadth) will similarly be underestimated.   
Given the large size of these long fibrils (>1000 nm), they would scatter a great deal of 
light and thus be evident in the Dh,I, but not Dh,N, distributions; although, given the low 
concentration of these long fibrils they may not be observed in all measurements and give rise to 
large standard deviation in SLS measurements.  Both of these observations are evident in the 
light scattering data for group one apoSH variants.  Taken together, the larger average length and 
breadth estimates for G93A, G93S, and V148I, together with the higher average coverage, point 
to enhanced aggregation propensity relative to pWT, consistent with light scattering data.   
AFM imaging confirms that the second group of apoSH variants aggregate considerably 
more than the first (Figs. 5.10, 5.11, 5.13, S5.7, S5.9, S5.11).  For these mutants, median length 
and breadth estimates ranged from 24-48 nm and 14-30 nm, respectively (Table 5.3), and were 
highest for A4V and G93R.  Also, aggregates composed of up to 100 monomers were detected 
relatively frequently, most notably for A4V and G93R (Fig. 5.13).  Particles with lengths greater 
than 200 nm tend to be numerous in group two compared to group one samples (Table 5.3).  
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Interestingly, while these mutants aggregate more than those in the first group by both DLS and 
AFM, there does not appear to be evidence for the formation of long fibrils observed in G93A 
and V148I samples.  The aspect ratios of aggregates formed by A4V, G37R and G93R are only 
slightly higher for the particles greater than 200 nm, which suggests that long fibril formation is 
rare.  Group two mutants also show higher values for average coverage of the aggregates (Table 
5.3), which also points to higher levels of aggregation for these samples.   
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Figure 5.10 AFM reveals that different apoSH variants form aggregates of differing sizes 
and morphologies when incubated at higher concentration (5 mg mL
-1
).  AFM images of 
apoSH variants incubated for ~300 hours, except A4V which was only incubated for ~120 hours.  
Images are 5 x 5 μm and white bars indicate 1 μm.  Consistent with DLS results, pWT showed 
the lowest levels of aggregate formation, although some fibrils are apparent.  Samples that 
exhibited the highest levels of aggregation, A4V, G37R, and G93R formed numerous particles 
~25-80 nm in length.  Samples that displayed lower aggregation propensity, G93A, G93S and 
V148I, formed a small number of long fibrils, greater than 1 μm.  For all images, the aggregates 
are so large that they mask the presence of small particles resembling monomers and oligomers.  
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To better illustrate the morphological differences in the aggregates and the presence of these 
small oligomers refer to refer to Figs. 5.11 and Fig. 5.12.  For all images of these samples refer to 
Figs. S5.6-S5.13. 
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Figure 5.11 Close-up AFM images of different apoSH variants incubated at higher 
concentration (5 mg mL
-1
) reveal the abundance of monomers and small oligomers.  Here 2 
x 2 µm images of apoSH samples incubated at 5 mg mL
-1
 are shown.  White bars indicate 500 
nm.  For images of aggregated G37R, refer to Fig. 5.14. 
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Figure 5.12 Size estimates of small oligomers that are abundant in the AFM images of 
apoSH variants incubated at high concentration (5 mg mL
-1
).  Numerous small particles 
representing monomers and small oligomers 10-20 nm in length are evident in the background of 
the 5 x 5 µm images shown in Fig. 5.11.  The presence of these particles is clear when 
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comparing the images to those obtained for cleaved mica (top images).  In this figure, centre 
images are 2 x 2 µm and white bars represent 500 nm.  White boxes represent the regions that 
are shown close-up (~580 x 580 nm) in the right and left panels, and in these images white bars 
represent 100 nm.   Size estimates were calculated by hand using JPK Data Processing Software 
(JPK Instruments AG).   
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Figure 5.13 AFM measurements of aggregated apoSH SOD1 variants represented as box 
and whisker superimposed on violin plots.  In each panel, the median of the data is shown by a 
horizontal line in the middle of the box and the box represents the first to third quartile of the 
data (i.e., the middle 50% of the data).  The whiskers extend 1.5 times the interquartile range 
from the edges of the box and all points outside this range, which are considered outliers, are 
shown individually as red circles.  Violin plots were superimposed on the box and whisker plots 
to illustrate the density of the data.  Length, breadth, and aspect ratio distributions (top right, top 
left, and bottom left panels, respectively) show that the median of the data is shifted to higher 
values for all mutants compared to pWT.  Furthermore, the mutant distributions are broader and 
there are more large particles considered outliers.  Distributions showing the number of 
monomers within the particles (lower right panel) are also broader for all mutants.  Although the 
resolution of these distributions is lower than the others due to the higher uncertainty in the data, 
they reveal large populations of particles ~1-2 monomers for all samples and for pWT, G93A, 
and V148I, these particles are the most abundant particles detected.  For G37R and G93S, the 
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median is shifted to slightly higher values, although the majority of particles observed are very 
small (>10 monomers).  Only for A4V and G93R are particles containing more than 10 
monomers the most abundant.  
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5.3.6 AFM images of apoSH G37R at t0 and t300 reveal that the distribution of particles shifts 
to higher order oligomers with time 
To assess the progression of aggregate growth, G37R at t0 was also imaged (Figs. 5.14, 
S5.8, S5.9).  The median length and breadth estimates at t0 were ~20 and 13 nm, respectively.  
Volume estimates indicate that the majority of particles observed are monomers, dimers and 
small amounts of oligomers containing ~10 monomers.   At ~t300, the median length and breadth 
estimates were 24 and 14 nm, respectively; thus, aggregates grew more in length than breadth 
(Figs. 5.14, 5.15, and Table 5.3).  Although image analysis reveals that the aspect ratio of the 
particles changes little with incubation time (Table 5.3), the images clearly show that G37R 
particles are more fibrillar at t300.  It is likely that image processing results in an over-estimation 
of particle breadth, as these small fibrils adopt different, non-linear conformations on the mica 
surface.  At t300, the monomers per particle distribution shifts to dimers and higher order 
oligomers.  However, the small fibrils evident at t300 appeared to coalesce on the mica, resulting 
in their detection as very large particles, reducing the apparent proportion of small fibrils which 
resemble those formed by A4V and G93R.  Due to the coalescence of these small fibrils, 
differences in the length, breadth, monomer per particle, and aspect ratio distributions at t0 and 
t300 are smaller than would be if these small fibrils were consistently detected as individual 
particles. 
Taken together, AFM imaging provides further evidence that apoSH forms small 
oligomers even prior to prolonged incubation at 5 mg mL
-1
, pH 7.4, 37 °C, providing a 
rationalization for the high PDI values observed by DLS.  While image statistics reveal subtle 
shifts in the particle size distributions to higher values, by eye it is evident that small fibrils are 
abundant, as observed for A4V and G93R samples. 
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Figure 5.14 AFM reveals that apoSH G37R forms small oligomers at t0 that appear to 
transition to longer fibrils abundant at t300.  AFM images of G37R at t0 (prior to incubation) 
and at ~t300 (after ~300 hours of incubation at 5 mg mL
-1
, pH 7.4, 37 °C) indicate abundant levels 
of small particles representing monomers and small oligomers with volumes consistent with ~10 
monomers.  After incubation for ~300 hours, small fibrils become evident.  Top panels are 5 x 5 
µm and bottom panels are close-up (2 x 2 µm) images of the top panels.  White bars indicate 1 
µm.  For all images of these samples refer to Figs. S5.8 and S5.9. 
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Figure 5.15 AFM measurements of apoSH G37R at t0 and t300 represented as box and 
whisker superimposed on violin plots.  In each panel, the median of the data is shown by a 
horizontal line in the middle of the box and the box represents the first to third quartile of the 
data (i.e., the middle 50% of the data).  The whiskers extend 1.5 times the interquartile range 
from the edges of the box and all points outside this range, which are considered outliers, are 
shown individually as red circles.  Violin plots were superimposed on the box and whisker plots 
to illustrate the density of the data.  Length and breadth distributions (top right and top left 
panels, respectively) show that the median of the data shifts to higher values for t300 samples 
compared to t0 samples.  Furthermore, more outliers are present in the t300 distributions due to the 
formation of large clumps of small fibrils (Figs. 5.10, 5.11, S5.9, and S5.10).  The aspect ratio 
distributions (lower left panel) appear fairly consistent between t0 and t300 samples, possibly 
owing to the non-linear conformation of the fibrils present at t300 on the mica surface.  
Distributions showing the number of monomers within the particles (lower right panel) reveal 
that monomers and small oligomers (containing <10 monomers) are the dominant species at t0.  
At t300, there is an increase in the number of particles containing >100 monomers, although 
monomers and small oligomers remain the dominant species. 
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Table 5.3 AFM image statistics of apoSH variants incubated at 5 mg mL
-1
, pH 7.4, 37 °C. 
Red Apo 
SOD1
a
 
Median Length 
(nm)
b
 
Median Breadth 
(nm)
b
 
Average Height 
(nm)
b
 
Number of 
Large Particles 
(>200 nm)
c
 
Median  
Aspect Ratio
b,d
 
Median Aspect 
Ratio of Large 
Particles 
(>200nm)
 b,d,e
 
Average 
Coverage 
(%)
f
 
Average 
Roughness 
(nm)
g
 
pWT 19.6 (14.7-25.2) 12.4 (10.4-15.9) 0.26 (0.21-0.32) 1 1.38 (1.33-1.63) 3.91 (3.05-6.50)  0.30 ± 0.55 0.12 ± 0.03  
A4V 46.9 (26.0-83.0) 30.7 (17.0-49.8) 0.44 (0.24-0.70) 58 1.50 (1.33-1.81) 1.71 (1.44-2.14) 8.85 ± 4.39 1.19 ± 0.47 
G37R t0 16.4 (12.6-28.4) 9.9 (7.3-19.4) 0.21 (0.16-0.32) 1 1.54 (1.33-1.99) 3.37 (2.97-3.77) 1.86 ± 0.91  0.26 ± 0.05 
G37R 24.3 (17.0-39.3) 13.9 (10.8-21.8) 0.24 (0.18-0.31) 55 1.50 (1.33-1.89) 2.23 (1.72-2.79) 9.72 ± 2.03  0.26 ± 0.06 
G93A 30.1 (19.9-55.4) 16.4 (10.9-39.4) 0.15 (0.12-0.20) 48 1.57 (1.33-2.04) 3.37 (2.38-4.90) 4.98 ± 2.65  0.22 ± 0.25 
G93R 48.1 (28.2-80.4) 27.5 (17.9-44.1) 0.50 (0.32-0.67) 117 1.57 (1.33-1.97) 2.02 (1.63-2.54) 14.1 ± 7.14 0.30 ± 0.12 
G93S 39.1 (24.5-58.8) 24.3 (14.7-41.5) 0.13 (0.10-0.18) 9 1.50 (1.33-1.88) 2.29 (1.71-3.30) 7.61 ± 4.55 0.20 ± 0.09 
V148I+ 
Na2SO4 
21.6 (17.0-55.4) 14.7 (10.8-39.1) 0.14 (0.12-017) 14 1.42 (1.33-1.71) 2.86 (2.04-3.99) 2.61 ± 1.49 0.16 ± 0.04 
a
All apoSH SOD1 samples were incubated for over 300 hours at 37 °C before being deposited on the mica and imaged.  The exception 
is G37R labelled t0, which was not incubated.  
bData represents the median and first to third quartile range in brackets of SPIP measurements obtained from all AFM images.  Due to 
asymmetry in the values, the median rather than the average is shown.  
c
The number of large particles was calculated by summing the total number of particles over 200 nm and diving that number by the 
number of images obtained for that sample.  Thus, values represent the average number of particles detected per image.  In cases 
where very few large aggregates were detected and normalization according to the number of images obtained resulted in a number 
between 0 and 1, the value was rounded to 1.   
d
The aspect ratio equals the particle length divided by breadth. 
e
The aspect ratio of particles with lengths greater than 200 nm. 
f
The coverage is the area taken up by aggregates divided by the total area.  Values represent the average and standard deviation of all 
images. 
g
The roughness is average vertical deviation from the mica surface.  Values represent the average and standard deviation of all images.  
Average roughness should be comparable to particle height if the particles are deposited evenly on the mica surface. 
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5.3.7 Aggregates formed by different apoSH variants exhibit differences in ThT binding. 
 The structure of the apoSH aggregates formed at 5 mg mL
-1
 was investigated further with 
ThT binding experiments.  Since its discovery in 1959, ThT binding has become one of the most 
widely used methods for detecting amyloid structures (331).  Upon binding to amyloid, ThT 
exhibits a shift in excitation and emission maximum from 385 to 450 nm and 445 to 482 nm, 
respectively, and a several orders of magnitude increase in fluorescence intensity (see also 
Section 5.3.2) (329–332).  This increase in fluorescence intensity has been attributed to the 
molecular properties of free versus amyloid-bound ThT.  ThT is a benzothiazole that contains a 
combination of polar and hydrophobic regions (Fig. 5.16).   
 
Figure 5.16 Molecular structure of ThT.  Free ThT in solution can undergo rotation, as 
indicated by the red arrow.  Immobilization of ThT occurs upon interaction with amyloid fibrils 
resulting in an increase in fluorescence intensity at 482 nm. 
 
In solution the benzylamine and benzathiole rings are able to rotate, which rapidly quenches the 
excited state.  But when ThT binds to amyloid structures, free rotation of these rings is inhibited 
and the excited state is preserved (331, 342).  ThT appears to bind to diverse amyloid fibrils 
suggesting that common structural properties within the fibrils are recognized, although the exact 
mechanism of ThT binding is only beginning to be understood.  The consensus is that ThT binds 
to the surface of amyloid fibrils between the grooves created by sidechains, usually aromatic and 
hydrophobic side chains, in an orientation that is parallel to the fibril axis (331, 343, 344).  
Highly charged fibrils tend to exhibit very low levels of ThT binding (331, 345).  Furthermore, 
ThT does not generally interact strongly with misfolded protein, soluble oligomers, or 
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amorphous aggregates, thus it has some specificity for extended β-sheet structure (346, 347).  
However, there is evidence for ThT binding to the hydrophobic pockets within non-fibrillar, 
globular proteins; therefore, when using ThT has to investigate the structure of aggregated 
protein, it is necessary to demonstrate that increases in ThT fluorescence are not a consequence 
of binding to the native protein (331).  As discussed previously, little ThT fluorescence was 
observed for samples containing very few aggregates (Fig. 5.6A), which demonstrates that ThT 
does not bind to non-aggregated apoSH SOD1. 
The aggregates formed by the apoSH variants incubated at higher concentration 
displayed differences in ThT-binding (Fig. 5.17); interestingly, these differences cannot be 
explained simply by the presence of more aggregates, suggesting that there are differences in the 
degree and nature of extended β-sheet structure in different aggregates.  ThT fluorescence was 
highest for V148I in 150 mM Na2SO4, even though light scattering and AFM indicate that low 
levels of long fibrils are present in this sample (Section 5.3.5).  G93A, which also forms low 
amounts of long fibrils exhibited an increase in ThT fluorescence comparable to A4V, which 
aggregates more than all other mutants investigated (Figs. 5.8, 5.9).  G93S exhibited very little 
increase in ThT fluorescence, even lower than pWT, suggesting that there are lower levels of 
long fibrils in this sample compared to V148I in 150 mM Na2SO4, G93A, and pWT.   
Of the mutants that extensively aggregate, G93R caused the largest change in ThT 
fluorescence; A4V caused a modest change in ThT fluorescence while for G37R the change was 
even smaller.  While AFM indicates that the lengths of A4V and G93R fibrils were comparable, 
differences in ThT fluorescence may be due to coalescence of the fibrils in the A4V sample, 
reducing the availability of ThT-binding sites, and fibrils formed by G37R were smaller than 
those formed by A4V and G93R (Figs. 5.10, 5.11, 5.13, S5.7, S5.9, S5.11, Table 5.3).  Such a 
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finding would be consistent with previous work showing that ThT fluorescence is often lower for 
oligomers and amorphous aggregates (346, 347).  Interestingly, the ThT fluorescence maximum 
for G93R, A4V, and G37R is blue-shifted by roughly 5 nm, which may also be an indicator of 
different features underlying the structure of these aggregates compared to those formed by 
pWT, G93A, G93S, and V148I. 
Taken together, ThT fluorescence appears to depend on both the concentration of fibrils 
and the specific structural features within the aggregates.  These experiments indicate that V148I 
in 150 mM Na2SO4, and to a lesser extent G93A, form amyloid-like aggregates with an extended 
β-sheet that result in large increases in ThT fluorescence, even though their concentration is low 
in solution.  Other mutants, such as A4V and G93R, with high levels of aggregated protein cause 
some increase in ThT fluorescence, but the effect is far less pronounced, which suggests that the 
underlying structures of the aggregates are different. 
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Figure 5.17 Differences in ThT fluorescence upon binding apoSH aggregates formed at 
high concentration (5 mg mL
-1
) points to structural differences in the aggregates.  
Aggregates formed by apoSH incubated at 5 mg mL
-1
 display differences in ThT fluorescence, 
which suggest that the β-sheet content of these aggregates differs.  Free ThT in 1 mM TCEP, 
20mM HEPES buffer does not fluoresce at 482 nm (black), but upon binding to aggregates 
containing an extended β-sheet there is a dramatic increase in fluorescence.  Thus the increase in 
fluorescence intensity is related to both the levels of aggregates as well as the specific structural 
features that lead to difference enhancements in fluorescence intensity.  These experiments show 
that all aggregates increase the intensity of ThT fluorescence, albeit to different extents, 
indicating that they all contain some degree of β-sheet.  Aggregates formed by V148I in 150 mM 
Na2SO4 have the highest degree of internal β-structure, resembling amyloid.  The fluorescence 
intensity increase is lower for the other mutants, even those that extensively aggregate, G93R 
(blue) and A4V (green).  
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5.3.8 Light scattering experiments reveal that Na2SO4 and NaCl can increase the aggregation 
propensity of apoSH SOD1 variants 
 Another approach to generating higher levels of aggregation is to add salt to the sample 
buffer.  The effects of different salts on protein stability can be highly complex and protein 
specific, but general trends have emerged from numerous years of work (69, 348–351).  Protein 
association can be enhanced by the addition of salt through various general effects, such as 
screening charged regions of the protein and reducing electrostatic repulsion between proteins, 
reducing protein stability by decreasing the strength of salt bridges and/or by binding to the 
partially charged polypeptide backbone.  Salts can also affect protein stability in non-specific 
ways according to their position in the Hofmeister series; anions have stronger effects than 
cations (348).  The Hofmeister series for anions is as follows:  
SCN
-
 > ClO4 > I
-
 > ClO3
-
 > Br
-
 > NO3
-
 > Cl
-
 > CH3CO
2-
 > HPO4
2-
 > SO4
2- 
Chaotropic anions are on the left and destabilize the native state and solubilize proteins, whereas 
kosmotropic anions on the right stabilize the native state and decrease protein solubility.  The Cl
-
 
ion is considered the midpoint of the series, with neither chaotropic or kosmotropic properties 
(69, 348, 349, 351).  The difference between chaotropes and kosmotropes arises from their 
interactions with native and unfolded proteins.  Chaotropes, or denaturants, bind more to the 
unfolded state and promote unfolding.  Kosmotropes on the other hand, are excluded from the 
solvent surrounding the protein and the degree of exclusion is in proportion to the solvent 
exposed surface area of the protein.  Therefore, when the protein is unfolded there is a larger 
degree of exclusion, which increases the energy of the unfolded state relative to the folded state 
and favours protein folding and further assembly (69).   
225 
 
Since the isoelectric point of apoSH SOD1 is pH 5.7 (352, 353), it will have a net 
negative charge at physiological pH, which may be a factor limiting aggregation in the absence 
of salt.  Na2SO4, previously shown to enhance irreversible thermal denaturation of apoSH (K.A. 
Vassall and E.M. Meiering, unpublished data), and NaCl were therefore added to the samples to 
try to promote aggregation at 1 mg mL
-1
.  This approach is not unreasonable, given that the 
intracellular ionic strength is ~100-200 mM (354). 
For these experiments a subset of destabilized mutants were selected, as they were 
expected to be more likely to aggregate at 37 °C compared to more stable, and thus more folded, 
variants.  For pWT, E100G, H43R, and V148G, neither the addition of 150 mM Na2SO4 nor 150 
mM NaCl caused the light scattering intensity to change markedly with time, similar to samples 
containing no added salt.  Thus, the aggregation propensity of these variants remains low in both 
salts (Fig. 5.18).  For E100G in NaCl, H43R in Na2SO4, and V148G in Na2SO4, the average light 
scattering intensity did not change greatly with time; however, the uncertainty in a number of 
measurements is very high, pointing to the presence of small amounts of large particles in 
solution (Section 5.3.4).  On the other hand, A4V and G93R exhibit considerably higher levels of 
aggregation in Na2SO4 and NaCl, with the former promoting aggregation more than the latter, 
based on the absolute light scattering intensity after ~t300 (Fig. 5.18).  This finding is consistent 
with aggregation experiments in the absence of salt that show A4V and G93R aggregate more 
than other apoSH variants (Section 5.3.4).  Similar to aggregation experiments at 5 mg mL
-1
, in 
both Na2SO4 and NaCl A4V and G93R aggregate with little apparent lag time, suggesting 
aggregation from the native state or a low energetic barrier between the native and aggregation-
prone state(s). 
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To assess whether the increased aggregation propensity observed in the presence of 
Na2SO4 was due to increased ionic strength, aggregation was also monitored for samples 
containing a higher NaCl concentration (450 mM) (Fig. 5.18, Table 5.4).  From this one 
experiment, it appears that Na2SO4 retains the ability to promote aggregation over NaCl, even 
when ionic strength differences are accounted for.  If aggregation was promoted primarily by 
charge screening, then the effects of different salts at the same ionic strength would be identical.  
In fact, increasing the concentration of NaCl actually decreased aggregation to levels observed 
for salt free samples (Fig. 5.18), which is consistent with other work that suggests protein 
aggregation has a bell-shaped dependence on salt (355).  Although, additional experiments are 
required to confirm the validity of these results, it appears that the kosmotropic properties of 
Na2SO4 exert an enhancing effect on aggregation of A4V and G93R.  G93S was also found to 
aggregate more in Na2SO4, yet the light scattering intensity plateaued at a lower level compared 
to A4V and G93R samples indicating the effect of Na2SO4 on G93S aggregation is less 
pronounced. 
At t0, the Dh,I and Dh,N for pWT are ~5.3 and 2.8 nm, respectively in Na2SO4 and ~5.8 and 
3.0 nm, respectively in NaCl (Fig. 5.19A), which are fairly close to values obtained for samples 
with no added salt, 5.4 and 3.1, respectively (Table 5.4).  Relative to pWT, mutants exhibit a 1.0-
3.1 nm, 2.2-4.7 nm, and 1.0-3.6 nm increase in the Dh,I at t0 for salt free, Na2SO4, and NaCl 
containing samples, respectively, and this increase was most pronounced for A4V and G93R 
Na2SO4 and NaCl samples.  The differences in Dh,N between pWT and mutant samples are 
smaller and generally within the margin of uncertainty in the measurements, which is not 
surprising given that Dh,I is more sensitive to subtle changes in the levels of oligomers, as 
discussed previously.   
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After ~300 hours of incubation, both the Dh,I and Dh,N increase for all A4V and G93R 
samples, however the increase is larger and standard deviation in the values considerably lower 
for samples containing Na2SO4 and NaCl (Fig. 5.17B, Table 5.4).  For G93S and V148G Na2SO4 
samples, only Dh,I increases significantly with time and is much larger than Dh,N (Fig. 5.19B, 
Table 5.4).  Therefore, Na2SO4 has a marginal effect on aggregation propensity of G93S and 
V148G, while NaCl has little effect.  For pWT, H43R, and E100G, little change was observed in 
Dh,I and Dh,N values over time in both salt free and salt containing buffers. 
When incubated in Na2SO4 and NaCl, A4V and G93R samples show a slight decrease in 
average PDI with time.  Alternatively, the change in PDI with time generally increases for all 
other samples, and for H43R, G93S, and V148G the increase is most pronounced for samples 
containing Na2SO4 and NaCl (Table 5.4).  Thus, as discussed above, samples that form 
aggregates appear to become more monodisperse with time, while samples that aggregate little 
tend to become more polydisperse with time.    
It is further evident from these results that different apoSH mutants display very different 
aggregation propensities.  Aggregation is enhanced by Na2SO4, and to a lesser extent NaCl; 
however, the addition of salt does not result in clearly increased aggregation of all apoSH 
variants.  As was observed for aggregation experiments at 5 mg mL
-1
, A4V and G93R undergo 
much higher levels of aggregation in Na2SO4 and NaCl compared to the other mutants under all 
conditions.  
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Figure 5.18 SLS reveals that mutants tend to exhibit increased aggregation propensity 
when incubated in salt.  For all panels, apoSH variants were incubated in buffer, 1 mM TCEP, 
20mM HEPES, pH 7.4, with either no salt (blue diamonds), 150 mM Na2SO4 (red squares), or 
150 mM NaCl (green triangles).  In the panel labelled G93R equal ionic strength, the 
concentration of NaCl was 450 mM.  Na2SO4 promotes aggregation of all mutants, but the effect 
was most pronounced for A4V, G93R, and G93S.  NaCl only appears to enhance aggregation of 
A4V and G93R, and the effect is lower compared to Na2SO4.  Error bars represent the standard 
deviation of three measurements at each time point. 
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Figure 5.19 DLS experiments indicate that Na2SO4 and NaCl promote aggregate formation, 
most notably for A4V and G93R mutants.  Sample conditions are the same as those described 
in Fig. 5.18.  (A) The effect of salt on the size of particles in solution is shown for mutants that 
displayed little increase in light scattering intensity with incubation time.  For these apoSH 
variants, DLS indicates that very low levels of aggregation are observed under all conditions.  
(B) The effect of salt on the size of particles in solution is shown for mutants that displayed an 
increase in light scattering intensity with incubation time (Fig. 5.18).  For A4V and G93R, 
aggregation is enhanced in 150 mM Na2SO4 and NaCl as indicated by the shift in intensity (solid 
lines) and number distributions (dotted lines) to larger values.  While G93S showed an increase 
in light scattering intensity with incubation time in 150 mM Na2SO4 (Fig. 5.18), DLS data 
indicates that the aggregates formed never become the most abundant species.  At t0 there is a 
difference in the size reported by intensity and number distribution for all samples, which 
suggests that the samples exhibit some degree of heterogeneity.  Table 5.4 provides a summary 
of DLS data shown here.   
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Table 5.4 DLS data summary for apoSH SOD1 variants at 1 mg mL
-1
, pH 7.4, 37 °C, 150 mM salt. 
 t = 0 t > 300 
ApoSH 
SOD1 
variant 
PDI
a
 
PDI width 
 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
PDI
a
 
PDI width 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
pWT 0.205 2.146 5.383 3.131 0.267 5.231 5.228 3.449 
No Salt 0.025 0.250 0.332 0.387 0.083 5.657 0.253 0.398 
pWT 0.240 2.197 5.262 2.816 0.236 61.37 5.551 3.292 
Na2SO4 0.023 0.093 0.502 0.541 0.066 79.72 0.888 1.050 
pWT 0.228 2.298 5.800 3.013 0.350 127.9 5.350 3.522 
NaCl 0.031 0.273 0.117 0.980 0.135 214.9 0.213 0.619 
A4V 0.224 5.566 8.593 3.807 0.312 29.55 63.46 15.40 
No Salt 0.043 9.779 1.452 1.376 0.119 10.88 15.38 14.70 
A4V 0.273 4.665 9.907 4.446 0.212 33.47 90.67 43.77 
Na2SO4 0.024 0.540 0.804 2.712 0.022 4.221 8.127 6.920 
A4V 0.269 4.418 9.239 3.907 0.211 31.79 86.95 43.86 
NaCl 0.015 0.268 0.409 1.466 0.013 1.610 3.608 3.869 
E100G 0.230 2.595 6.432 3.548 0.461 86.19 123.5 4.003 
No Salt 0.014 0.151 0.739 0.706 0.163 52.04 353.4 0.357 
E100G 0.267 3.937 8.087 4.756 0.390 105.8 6.566 5.821 
Na2SO4 0.013 0.298 0.477 0.405 0.058 86.10 0.112 0.078 
E100G 0.217 2.820 7.309 3.763 0.414 162.2 5.876 3.645 
NaCl 0.033 0.154 0.354 1.132 0.049 174.3 0.214 1.548 
G93R 0.240 3.732 7.563 3.971 0.598 26.87 151.1 11.60 
No Salt 0.056 1.155 0.806 1.053 0.334 9.509 104.2 11.58 
G93R 0.257 14.51 9.754 4.390 0.233 36.20 96.74 40.40 
Na2SO4 0.035 29.85 0.920 1.633 0.030 6.532 16.03 6.737 
G93R 0.254 4.889 9.355 4.297 0.245 30.78 83.08 35.06 
NaCl 0.037 1.813 1.326 1.378 0.018 3.004 9.362 7.290 
G93R
d
 0.285 71.70 8.259 4.968 0.337 56.19 142.2 34.19 
NaCl 0.038 116.6 1.266 0.676 0.044 5.427 10.12 22.31 
G93S 0.239 3.226 7.136 3.899 0.502 30.34 84.11 3.880 
No Salt 0.024 0.548 0.708 0.930 0.143 46.08 85.18 1.598 
G93S 0.239 4.570 8.312 3.944 0.629 214.8 331.8 4.354 
Na2SO4 0.023 1.851 0.346 1.660 0.264 19.22 17.33 2.296 
G93S 0.236 61.46 6.788 4.136 0.704 837.6 6.287 5.099 
NaCl 0.050 101.5 1.105 0.503 0.143 353.3 0.186 0.558 
H43R 0.215 3.547 8.603 4.046 0.344 51.18 6.640 3.735 
No Salt 0.049 0.650 0.457 0.885 0.110 150.6 0.651 1.503 
H43R 0.255 3.745 9.258 3.595 0.763 908.9 6.760 5.359 
Na2SO4 0.014 0.183 1.138 1.754 0.286 995.7 0.416 0.162 
H43R 0.233 2.984 8.104 4.658 0.255 12.72 6.604 3.460 
NaCl 0.003 0.202 0.551 0.371 0.007 13.23 0.177 1.941 
V148G 0.291 10.37 6.646 3.928 0.567 191.1 291.5 3.955 
No Salt 0.117 13.20 0.522 1.343 0.138 197.1 316.3 1.083 
V148G 0.319 4.906 7.458 2.761 0.877 1247 280.1 5.759 
Na2SO4 0.012 0.296 0.490 1.014 0.145 904.4 197.9 0.274 
V148G 0.238 11.13 6.803 4.533 0.741 414.1 725.3 4.879 
NaCl 0.105 11.56 0.673 0.389 0.081 161.5 53.00 0.991 
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Bold and italicized values are the averages and standard deviations, respectively resulting from 
multiple experiments (shown in Table S5.4).  
a
PDI is obtained from the Cumulants method of fitting the autocorrelation function (Eq. 5.4).  
Values larger than 0.1 are indicative of polydispersity (i.e., the sample contains than one species 
in solution).  High PDI values result in larger peak widths, and thus greater uncertainty in the 
sizes reported. 
b
Peak width reflects the uncertainty in the hydrodynamic diameter obtained from the intensity 
distribution and is related to the PDI according to Eq. 5.4. 
c
The sizes reported correspond to the main peak in the distributions 
d
Ionic strength of this sample was identical to Na2SO4 samples. 
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5.3.9 AFM imaging shows that Na2SO4 and NaCl promote fibrillization of A4V, G93R and 
G93S 
 To account for the increase in light scattering intensity observed for A4V, G93R, and 
G93S in Na2SO4 and to a lesser extent NaCl, AFM was again used to assess the size and 
morphology of the aggregates formed.  The absolute light scattering intensity will increase if the 
size and/or number of aggregates increase.  As shown in Fig. 5.19, DLS experiments suggest that 
the size of the aggregates does increase, shown by the increase in Dh,N, and the magnitude is 
similar for both A4V and G93R samples in Na2SO4 and NaCl.  The same increase in Dh,N was 
not observed for G93S in Na2SO4 and NaCl sample, but an increase in Dh,I as well as an increase 
in light scattering intensity was evident, which together point to lower levels of aggregate 
formation.  The Dh,I and Dh,N distributions are, however, quite broad and may not reflect subtle 
differences in the size of the particles formed under the different conditions.  AFM, on the other 
hand, provides a more powerful technique for assessing these differences. 
 AFM imaging confirms that Na2SO4 and NaCl generally promote fibrillization of A4V, 
G93R, and G93S (Figs. 5.20-5.22, S5.14-S5.23).  For both A4V and G93R, median length and 
breadth estimates indicate that longer and thicker fibrils form in Na2SO4 and NaCl, and size 
estimates are fairly consistent with DLS data given the caveats mentioned previously (Figs. 5.20-
5.22, S5.14-S5.21, Tables 5.4, 5.5).  For both A4V and G93R, particles larger than 200 nm are 
more numerous in samples containing salt (Figs. 5.20, 5.21), and the average coverage estimates 
for these samples are also generally higher (Table 5.5).     
At 1 mg mL
-1
, the average aspect ratio of these larger aggregates appear similar in salt 
free and salt containing buffers; yet, far fewer of these larger aggregates are detected in salt free 
buffer which leads to less accurate size statistics.  Comparing the average aspect ratios of the 
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larger aggregates formed in Na2SO4 and NaCl with those formed at higher protein concentration 
(5 mg mL
-1
) in salt free buffer, it is evident that A4V and G93R aggregates formed in salt have 
higher aspect ratios than those formed at 5 mg mL
-1
 in the absence of salt (Section 5.3.5).  Thus, 
salt appears to promote aggregation and more specifically growth in the length of fibrils (Figs. 
5.20-5.22, Table 5.5).    
G93S appears to form formed fewer, but much longer fibrils in Na2SO4 and to a lesser 
extent in NaCl (Figs. 5.20, 5.21, S5.22, S5.23), compared to A4V and G93R.  Given that salt free 
and NaCl containing samples exhibited similar levels of aggregation by light scattering, only 
Na2SO4 and NaCl samples were imaged.  Although the median length and breadth estimates 
suggest that most particles in solution are quite small (12-30 nm in length), there are a fair 
number of aggregates larger than 200 nm detected in both samples.  The large aggregates formed 
in Na2SO4 tend to have the highest aspect ratios (Fig. 5.19, Table 5.5), even larger than 
aggregates formed at 5 mg mL
-1
 in salt free buffer.  These long fibrils also tend to form branches 
that are suggestive of either secondary nucleation sites, or bundling of fibrils together.  G93S 
fibrils formed in NaCl also showed evidence of branching and/or bundling, although to a lesser 
extent (Figs. 5.20, 5.21, S5.23).   
Thus, it can be concluded that aggregates formed in salt are more fibrillar compared to 
those formed in the absence of salt.  The morphology of A4V and G93R aggregates formed in 
Na2SO4 and NaCl were similar, although the aspect ratios of G93R aggregates longer than 200 
nm were found to be higher.  For G93S, Na2SO4 and to a lesser extent NaCl induced formation of 
fibrils much longer with several branches, although overall much lower levels of aggregation 
were observed compared to A4V and G93R.  This trend is familiar; at 5 mg mL
-1
, apoSH 
mutants that displayed lower aggregation propensity formed longer aggregates (Section 5.3.5).  It 
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could be that such mutants form more stable interactions that lead to the formation of longer 
fibrils.   
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Figure 5.20 AFM reveals that A4V, G93R, and G93S form aggregates of differing sizes and 
morphologies in Na2SO4 and NaCl.  AFM images of apoSH variants incubated in salt free, 
Na2SO4, and NaCl for ~300 hours.  All images are 5 x 5 µm and white bars indicate 1 μm.  Only 
samples exhibiting high levels of aggregation by light scattering were imaged.  Since salt free 
and NaCl G93S samples showed similar levels of aggregation by light scattering, only the later 
was imaged.  Consistent with DLS results, less aggregation was observed for salt free samples.  
SPIP software indicates that fibrils formed in salt tend to be longer than those formed in salt free 
buffer (Fig. 5.25).  For all images of these samples refer to Figs. S5.14-S5.23. 
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Figure 5.21 Close-up AFM images of different apoSH variants incubated in salt free, 
Na2SO4, and NaCl buffer reveal the abundance of monomers, small oligomers, and larger 
aggregates with diverse morphologies.  Close-up images of those shown in Fig. 5.20 reveal 
small particles resembling monomers and small oligomers are abundant.  Aggregates formed in 
salt tend to be more fibrillar, with the longest fibrils formed by G93S in Na2SO4.  These images 
are 2 x 2 µm and white bars indicate 500 nm.  
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Figure 5.22 AFM measurements of aggregated apoSH variants in salt free, Na2SO4, and 
NaCl represented as box and whisker superimposed on violin plots.  In each panel, the 
median of the data is shown by a horizontal line in the middle of the box and the box represents 
the first to third quartile of the data (i.e., the middle 50% of the data).  The whiskers extend 1.5 
times the interquartile range from the edges of the box and all points outside this range, which 
are considered outliers, are shown individually as red circles.  Violin plots were superimposed on 
the box and whisker plots to illustrate the density of the data.  Length, breadth, and aspect ratio 
distributions (top right, top left, and bottom left panels, respectively) show that the median of the 
data is shifted to higher values for samples containing Na2SO4 and NaCl.  Furthermore, particle 
length and breadth estimates were larger for A4V and G93R compared to G93S, which is 
consistent with light scattering results that point to higher aggregation propensity of A4V and 
G93R   Furthermore, the A4V and G93R distributions are broader than G93S distributions.  For 
G93S, in all distributions there are more large particles considered outliers (red dots), which can 
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be accounted for by the presence of long fibrils in the images.  Distributions showing the number 
of monomer per particle indicate that the majority of particles detected have volumes consistent 
with ~1-5 monomers for salt free A4V and G93R samples, as well as G93S Na2SO4 and NaCl 
samples.  For A4V and G93R Na2SO4 and NaCl samples, these distributions become broader as 
more particles contain 10-100 monomers are detected.   
241 
 
Table 5.5.  AFM image statistics of aggregated apoSH variants at 1 mg mL
-1
, pH 7.4, 37 °C, 150 mM salt. 
Red Apo 
SOD1
a
 
Median Length 
(nm)
b
 
Median Breadth 
(nm)
 b
 
Median Height 
(nm)
 b
 
Number of 
Large Particles 
(>200 nm)
c
 
Median Aspect 
Ratio
 b,d
 
Median Aspect 
Ratio of Large 
Particles 
(>200nm)
 b,d,e
 
Average 
Coverage 
(%)
f
 
Average 
Roughness 
(nm)
g
 
A4V  
no salt 
21.9 (14.9-55.0) 12.4 (9.8-33.9) 0.12 (0.10-0.39)  5 1.56 (1.33-2.22)  2.01 (2.47-3.07)  1.32 ± 1.96 0.19 ± 0.18 
A4V 
Na2SO4 
48.2 (24.9-85.7) 29.7 (12.4-48.6) 0.12 (0.10-0.28) 109 1.67 (1.35-2.28) 2.03 (1.57-2.76) 16.4 ± 7.48 0.55 ± 0.33 
A4V 
NaCl 
55.4 (24.5-97.6) 36.8 (8.6-51.9) 0.33 (0.12-0.45) 167 1.81 (1.38-2.51) 2.11 (1.63-2.80) 13.4 ± 3.50 0.30 ± 0.08 
G93R  
no salt 
22.0 (14.9-34.2) 7.8 (5.5-13.9) 0.16 (0.11-0.54) 7 2.29 (1.71-3.20) 3.69 (2.74-4.97) 4.39 ± 1.04  0.17 ± 0.00 
G93R 
Na2SO4 
t22 
15.3 (9.8-36.0) 9.0 (5.4-22.1) 0.31 (0.20-0.50) 0 1.57 (1.33-2.00) 1.93 (1.75-3.71) 0.35 ± 0.06  0.13 ± 0.05 
G93R 
Na2SO4 
t143 
68.4 (34.5-
119.2) 
33.2 (21.0-41.3) 0.64 (0.41-0.50) 61 2.23 (1.61-3.18) 4.73 (3.38-5.64) 3.02 ± 0.29 0.19 ± 0.00 
G93R 
Na2SO4  
35.9 (19.6-73.5) 22.6 (10.2-43.3) 0.25 (0.16-0.53) 78 1.70 (1.38-2.22) 2.87 (2.12-3.75) 8.31 ± 6.06 0.27 ± 0.11 
G93R 
NaCl 
27.0 (15.2-51.3) 16.7 (6.8-28.0) 0.16 (0.11-0.54) 52 1.75 (1.38-2.34) 2.25 (1.70-3.32) 6.11 ± 6.62  0.30 ± 0.29 
G93S 
Na2SO4 
17.2 (12.4-27.1) 9.3 (5.9-16.3) 0.10 (0.07-0.12) 30 1.71 (1.38-2.28) 5.09 (3.32-8.19) 2.68 ± 0.80 0.15 ± 0.05 
 G93S 
NaCl 
20.9 (16.1-31.3) 14.7 (10.4-20.8) 0.32 (0.21-0.46) 17 1.41 (1.27-1.74) 2.19 (1.62-2.79) 6.51 ± 2.34 0.30 ± 0.11 
a
All apoSH SOD1 samples were incubated for over 300 hours at 37 °C before being deposited on the mica and imaged.  The exception 
is G93R in 150 mM Na2SO4 labelled t22 and t143, where samples were incubated for 22 and 143 hours respectively. 
 bData represents the median and first to third quartile range in brackets of SPIP measurements obtained from all AFM images.  Due to 
asymmetry in the values, the median rather than the average is shown.  
c
The number of large particles was calculated by summing the total number of particles over 200 nm and diving that number by the 
number of images obtained for that sample.  Thus, values represent the average number of particles detected per image.  In cases 
where very few large aggregates were detected and normalization according to the number of images obtained resulted in a number 
between 0 and 1, the value was rounded to 1.   
d
The aspect ratio equals the particle length divided by breadth. 
e
The aspect ratio of particles with lengths greater than 200 nm. 
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f
The percent coverage is the area taken up by aggregates divided by the total area.  Values represent the average and standard 
deviation of all images. 
g
The roughness is average vertical deviation from the mica surface.  Values represent the average and standard deviation of all images.  
Average roughness should be comparable to particle height if the particles are deposited evenly on the mica surface. 
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5.3.10 ApoSH G93R in Na2SO4 initially forms small fibrils that lengthen over time 
 Samples from the early, middle, and end stages of apoSH G93R aggregation in Na2SO4 
were imaged by AFM to assess changes in aggregate structure that coincide with increases in 
light scattering intensity (Figs. 5.20, S5.18-S5.20).  As shown in Fig. 5.20, small fibrils have 
already begun to form in the first 22 hours of incubation.  The median length and breadth 
estimates of the particles are ~15 nm and 9 nm, respectively, and volume estimates suggest that 
the majority of particles in solution are monomers with some oligomers present as well (Fig. 
5.21).  This result indicates that oligomerization begins rapidly in Na2SO4, consistent with SLS 
data that shows little detectible lag time before light scattering intensity increases (Fig. 5.16).  As 
mentioned previously, detection of more than one species in solution after only 22 hours of 
incubation may account for the high PDI values obtained by DLS before aggregates become 
abundant (Section 5.3.7).   
After 143 hours of incubation, the median length and breadth of particles increases to ~68 
nm and 33 nm, respectively.  The distributions of the length, breadth, and number of monomers 
per particle broaden, pointing to an increase in the proportion of larger particles.  Furthermore, 
the aggregates become more elongated, as indicated by the increase in aspect ratio, which is even 
more pronounced for particles longer than 200 nm (Table 5.5).  Interestingly, at 143 hours of 
incubation the fibrils appear to have reached their maximum size.  At 234 hours, aggregate sizes 
and aspect ratios are comparable to estimates at 143 hours (Fig. 5.17).  Nevertheless, the average 
coverage of the sample on the mica surface increases with time; therefore, the increase in light 
scatter intensity between 143 to 234 hours of incubation appears not to be due to further 
aggregate growth, but rather an increase in abundance of these fibrils.    
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Figure 5.23 AFM images of apoSH G93R in 150 mM Na2SO4 as a function of time.  ApoSH 
G93R was imaged at different time points over the course of the incubation period.  The top, 
middle, and bottom panels correspond to 22, 143, and 234 hours of incubation, respectively.  
These times correspond to initial nucleation, exponential, and plateau phases of the aggregation 
mechanism (Fig. 5.18).  All images are 5 x 5 μm and white bars indicate 1 μm.  For all images of 
these samples refer to Figs. S5.17-S5.20. 
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Figure 5.24 Close-up AFM images of apoSH G93R in Na2SO4 as a function of time.  Close-
up images of those shown in Fig. 5.23 reveal small particles resembling monomers and small 
oligomers as well as longer fibrils are abundant.  The left, middle, and right panels correspond to 
22, 143, and 234 hours of incubation, respectively, corresponding to the initial nucleation, 
exponential, and plateau phases of the aggregation mechanism (Fig. 5.18).  Size estimates were 
calculated by hand using JPK Data Processing Software (JPK Instruments AG).  All images are 2 
x 2 μm and white bars indicate 500 nm.  For all images of these samples refer to Figs. S5.18-
S5.20. 
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Figure 5.25 AFM measurements of apoSH G93R incubated in Na2SO4 for 22 143, and 234 
hours represented as box and whisker superimposed on violin plots.  In each panel, the 
median of the data is shown by a horizontal line in the middle of the box and the box represents 
the first to third quartile of the data (i.e., the middle 50% of the data).  The whiskers extend 1.5 
times the interquartile range from the edges of the box and all points outside this range, which 
are considered outliers, are shown individually as red circles.  Violin plots were superimposed on 
the box and whisker plots to illustrate the density of the data.  Length, breadth, and aspect ratio 
distributions (top right, top left, and bottom left panels, respectively) show that the median of the 
data is shifted to higher values for samples for t143 compared to t0 samples.  After t143 aggregate 
growth is less apparent.  Distributions showing the number of monomer per particle (lower right 
panel) indicate that the majority of particles detected at t22 range from ~1-10 monomers and over 
time the proportion of particles containing 10-100 monomers increases. 
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5.3.11 Fibrils formed in salt compared to salt free samples display increases in ThT binding 
 ThT binding experiments were performed on a subset of mutants that exhibited different 
aggregation propensities in salt to further investigate structural differences in the aggregates 
formed.  The mutants selected were A4V and G93R, which both exhibit high levels of 
aggregation in salt; G93S which aggregates slightly in Na2SO4, but much less in NaCl; and 
E100G which aggregates very little under all conditions.  As discussed in Section 5.3.6, upon 
binding to aggregates that contain an extended β-sheet, ThT exhibits a shift in excitation and 
emission maximum from 385 to 450 nm and 445 to 482 nm, respectively, and a several orders of 
magnitude increase in fluorescence intensity (329–332).  Thus, differences in ThT binding 
properties can point to differences in the underlying structure within the aggregates.   
In general, samples containing Na2SO4 displayed the highest levels of ThT fluorescence.  
Fluorescence was lower in NaCl samples and even lower in the salt free samples (Fig. 5.26), 
consistent with the level of aggregation observed by light scattering and AFM.  G93R samples 
were the exception to this trend; all displayed similar levels of ThT fluorescence.  As shown in 
section 5.3.6, apoSH variants that form long fibrils at 5 mg mL
-1
, in the absence of salt, display 
high levels of ThT fluorescence, even though the concentration of these aggregates is low.  Thus, 
ThT fluorescence is highly sensitive to aggregates with amyloid-like properties.  
Although the distribution of sizes is large, AFM experiments suggest that A4V fibrils 
formed in Na2SO4 and NaCl are longer than those formed in the absence of salt.  G93S in 
Na2SO4 formed fibrils much longer than those observed in A4V and G93R samples (Fig. 5.22).  
Given that G93S aggregates formed in Na2SO4 display the highest levels of ThT fluorescence, 
even though these fibrils are not highly abundant suggests that the longer fibrils may contain 
more extensive β-sheet structure.  All E100G samples, as well as salt free and containing G93S 
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samples, which displayed little change in light scattering intensity over time, showed the smallest 
increases in ThT fluorescence consistent with low levels of aggregation.  These results highlight 
the advantages of combining light scattering and ThT-binding experiments.  Fibrils longer than 
1000 nm are difficult to detect by light scattering, especially if present at low concentrations.  On 
the other hand, ThT-binding appears to be highly sensitive to detecting low levels of these fibrils.  
When both changes in light scattering intensity are small and ThT fluorescence is low, it can be 
concluded that little aggregation takes place.     
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Figure 5.26 ThT fluorescence is generally enhanced for aggregates formed in salt compared 
to salt free samples.  ThT binding experiments were performed on aggregates formed in salt 
free, 150 mM Na2SO4, and 150 mM NaCl buffer (1 mM TCEP, 20 mM HEPES, pH 7.4).  The 
black line indicates the fluorescence of free ThT in 1 mM TCEP, 20 mM HEPES, pH 7.4, and 
neither Na2SO4 nor NaCl changed the ThT fluorescence spectrum (data not shown).  Free ThT in 
pH 7.4 buffer shows very little fluorescence at 482 nm, but upon binding to aggregates 
containing an extended β-sheet there is a dramatic increase in fluorescence.  These experiments 
show that all aggregates increase the intensity of ThT fluorescence, albeit to different extents, 
indicating that they all contain some degree of β-sheet.  The mutants selected ranged from those 
that aggregate extensively, A4V (green) and G93R (blue), as well as mutants that undergo much 
less aggregation, G93S (pink) and E100G (orange).  Salt free, Na2SO4, and NaCl samples are 
indicated by solid, dashed, and dotted lines, respectively.   
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5.4  Discussion 
A number of different groups have undertaken a range of strategies to study aggregation 
of immature forms of SOD1, as discussed in Section 1.3.6.  Our group has found apoSH is 
generally fairly resistant to aggregation under physiological-like solution conditions (174).  To 
speed up the process, other groups have used agitation, or other means to destabilize the protein 
and generate higher levels of aggregation on an experimentally tractable time scale.  Given that 
the initial conformation of a protein often dictates the types of aggregation pathways accessible 
(94, 356), and in particular that unfolded SOD1 will form amyloid fibrils under destabilizing 
conditions (Section 5.3.2) (179), we have attempted here to measure aggregation under 
conditions that are physiologically relevant.  Initial attempts to induce aggregation by adding 
aggregate seeds were unsuccessful, suggesting that either higher levels of seeds are required to 
initiate aggregation and/or that apoSH mutants tend to exhibit specificity in the intermolecular 
interactions that lead to aggregate formation.  Differences in aggregation behaviour of different 
apoSH mutants became observable when the concentration of the sample was increased and/or 
salt was added to the buffer.  We hypothesized that both of these changes would encourage 
protein association without dramatically altering the stability, and thus initial conformation of 
apoSH. 
 
5.4.1 ApoSH variants form intermolecular interactions that can support aggregation at higher 
than physiological concentration  
Light scattering, and AFM experiments indicate that interactions between apoSH variants 
are generally enhanced at increasing protein concentrations or in the presence of salt.  Here only 
salt free experiments will be discussed and in the following sections the effects of salt will be 
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elaborated on.  As reported previously (Chapter 4) (174), apoSH pWT and stabilized mutants, 
H46R and V148I, unfold at temperatures well above 37 °C (48-53 °C) and so will be mainly 
folded at physiological (and incubation) temperature.  Destabilizing mutations A4V, T, S, 
E100G, G93A, R, S, and V148G unfold at temperatures in the range of 31-40 °C; therefore, a 
considerably higher level of unfolded protein will be present at 37 °C (174).  DLS measurements 
reveal that apoSH variants incubated at 1 mg mL
-1
 exhibit Dh,I and Dh,N values that are consistent 
with mixtures of folded and unfold apoSH (Tables 5.1, S5.2) (277).  The difference in Dh,I and 
Dh,N values at t0 was larger for the destabilized mutants, which could indicate oligomerization.  
The PDI values obtained at t0 are also high for all variants and even higher for destabilized 
mutants, which is consistent with increases in the population of unfolded protein although could 
also be due to enhanced oligomerization (Tables 5.1, S5.2).  
Incubation for ~300 hours (t300) at 1 mg mL
-1
, pH 7.4, 37 °C leads to little change in light 
scattering intensity for most apoSH variants (Fig. S5.1); A4V, the most common North 
American fALS mutation with particularly short disease duration (7, 8), showed the greatest 
change in light scattering intensity with time and consistently aggregates more than other 
variants under all conditions explored (vide infra), but interestingly is not the most destabilized 
mutant (174).  The Dh,I and Dh,N values for pWT, stabilizing mutants H46R and V148I, and 
destabilized mutants G85R and H43R, did not change significantly with time.  The other 
destabilized mutants (A4T, S, E100G, G37R, G85R, G93A, S, and V148G) exhibited an increase 
in Dh,I but not Dh,N; only for A4V and G93R were changes in Dh,N observed (Figs. 5.4, S5.2, 
Tables 5.1, S5.2).  All variants exhibit an increase in PDI with incubation time; thus, some 
aggregates do form at 1 mg mL
-1
, but their concentrations remain very low (Tables 5.1, S5.2).  
These results were very surprising given the marginal stability of apoSH and the numerous 
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studies suggesting that this form of the protein is the form that exhibits the greatest manifestation 
of mutation effects and is most highly, and very, prone to aggregate (76, 131, 147, 180, 184, 
195).   
The differences in aggregation propensity between SOD1 variants became more 
pronounced at higher protein concentration (5 mg mL
-1
) (Figs. 5.8, 5.9).  For some (pWT, G93A, 
G93S, and V148I) the light scattering intensity did not change significantly over the incubation 
period, while for others (A4V, G37R, and G93R) the light scattering intensity increased rapidly.  
For convenience the mutants were categorized as group one, lower aggregation propensity, and 
group two, higher aggregation propensity.  Interestingly, these differences in aggregation 
propensity could not be accounted for based merely on protein stability differences; G93A and 
G93S unfold at lower temperatures, with apparent melting temperatures of ~34.6 and 33.4 °C, 
respectively, than A4V and G93R, 36.3 and 35.4 °C, respectively.  G37R is even less stable, 
unfolding at 33.4 °C (Table S4.2) (174).  SLS revealed that mutants categorized in group two 
appear to aggregate with little lag time, signifying aggregation either from the unfolded or 
native-like state (Fig. 5.8).  However, DLS measurements, which are able to detect subtle 
changes in intermolecular interactions, reveal that all variants exhibit an increase in 
intermolecular interactions at higher protein concentration.  First, Dh,N values at t0 are between 
0.1 and 1.8 nm larger at 5 mg mL
-1
 compared to 1 mg mL
-1
, which points to an increase in 
concentration of small oligomers (Tables 5.1, 5.2, S5.2, S5.3).  It is noteworthy that for mutants 
with higher aggregation propensity, group two, there is a 1.5-12 nm increase in the Dh,I at t0.  
Secondly, the PDI values at t0 are larger for 5 mg mL
-1
 samples compared to 1 mg mL
-1
 samples.  
Thus, t0 measurements suggest that intermolecular interactions are promoted at increased protein 
concentration.  This hypothesis was further supported by AFM imaging of freshly prepared (i.e., 
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non-incubated) G37R.  The majority of particles detected were monomers, and oligomers 
containing up to 10 monomers (Figs. 5.14, 5.15).  In general, the behaviour exhibited by apoSH 
variants resembles the type of reversible aggregation described below (Section 5.4.5) whereby 
proteins in their native or native-like states interact weakly and these interactions are promoted at 
higher protein concentration. 
 
5.4.2 Native and non-native dimerization of apoSH 
 Recent advances in NMR spectroscopy have made it possible to detect alternative, 
potentially misfolded, conformations of a protein that are populated by as little as ~0.5% (357).  
Our collaborators, Dr. Ashok Sekhar and Dr. Lewis Kay at the University of Toronto, have 
performed a combination of Chemical Exchange Saturation Energy Transfer (CEST) and Carr-
Purcell-Meiboom-Gill (CPMG) NMR relaxation experiments (357–359), to assess the energy 
landscape of apoSH SOD1, in particular any misfolded conformations that may account for the 
higher aggregation propensity of apoSH compared to more mature forms of SOD1 that display 
an extremely low tendency to aggregate (301).  The results of these experiments indicate that the 
energy landscape of apoSH is rugged; multiple conformations and oligomerization states form 
transiently, which likely have important consequences for the mechanism(s) of aggregation (vide 
infra, Fig. 5.28).  NMR analyses of apoSH pWT reveals that the β-barrel is largely intact, but the 
absence of defined structure in zinc-binding and electrostatic loops (IV and VII, respectively) 
enables promiscuous interactions that may underlie the first steps in the aggregation pathway.   
Combined CEST and CPMG experiments revealed four apoSH conformers in 
equilibrium with the native state (Fig. 5.28).  Two of the conformers locally fold into states that 
resemble more mature forms of SOD1, the first forming the native dimer (Process I) and the 
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second forming the α-helix in the electrostatic loop that is important for zinc binding (Process 
II).  The other two conformers are non-native dimers that form through interactions between 
residues in the native dimer interface and the electrostatic loop.  The first non-native dimer 
(Process III) resembles the native dimer and is similar in stability with one of the monomers 
rotated by 180 °.  Thus, the residues buried in this non-native interface are very similar to those 
buried in the native interface.  The second non-native dimer (Process IV) forms through 
interactions between residues that form the native dimer interface of one monomer (β1, β8, the 
zinc-binding loop (loop IV), and loop VI) and the zinc-binding and electrostatic loops of another.  
Unlike the other dimers described, the second non-native dimer is asymmetric; one of the 
monomers is rotated 90° relative to the other.  Such interactions between the β-barrel and the 
long loops are not unlike the type of interactions observed in crystallographic studies of oxidized 
apo and part-metallated SOD1 fibrils (90, 136, 138).  The Kd’s of the apoSH native and non-
native dimer formation are ~100 ± 50 mM at 37 °C, which confirms that at 5 mg mL-1, ~0.5-
1.8% of the protein exists as a dimer.  While these levels are very low, light scattering is 
particularly sensitive to detecting larger particles (i.e. apoSH dimers will scatter 5 times more 
light) and under these conditions dimeric apoSH will scatter ~2.5-8.5% of the incident light 
beam.   
 These results indicate that apoSH can interconvert between a number of states with little 
change in monomer conformation, which may account for the heterogeneity of apoSH samples 
that give rise to differences in Dh,I and Dh,N as well as the high PDI values at t0 (Figs. 5.27, 5.28).  
Furthermore, we observe that aggregation of apoSH proceeds with very little detectable lag time 
(vide infra) (Figs. 5.8, 5.18), which also suggests that little conformational change in apoSH is 
required to initiate aggregation (53).  Interestingly, the native dimer interface is involved in the 
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formation of all 3 types of dimers, and in only one case is it exposed after dimer formation.  We 
speculate that formation of symmetric dimers could be protective due to the burial of 
hydrophobic residues exposed in the apoSH monomer (see Chapter 2) (173).  On the other hand, 
formation of the assymmetic non-native dimer may facilitate further assembly because the native 
dimer interface residues remain exposed (Fig. 5.27).  While it is too early to assess how native 
and non-native dimer formation relate to aggregate formation, the observation that apoSH can 
rapidly convert to different oligomeric forms, may account for the complex aggregation 
behaviour observed.  If particular types of association are more favoured by certain mutations 
compared to others, this in turn may lead to differences in aggregation propensity and aggregate 
morphology (Fig 5.28) (52, 356, 360). 
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Figure 5.27 Asymmetric dimer formation can serve as template for further aggregate 
growth.  The asymmetric dimer (Process IV) can serve as a template for addition of monomers 
and other dimers to form oligomers.  The pathway shown in the middle involves the apoSH 
monomer forming the asymmetric non-native dimer (Process IV), which then associates with 
another non-native asymmetric dimer to form a tetramer.  The process is then repeated to form 
an octamer.  Alternatively, the asymmetric dimer can recruit other dimers, such as the native 
dimer (left) or the symmetric non-native dimer (right) to form different tetramers (301).  
Oligomers were built using HADDOCK docking software (361).     
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5.4.3 At increased protein concentration apoSH variants exhibit differences in aggregation 
behaviour 
After ~t300, the differences in Dh,I and Dh,N values are generally more pronounced for 5 
mg mL
-1
 samples compared to 1 mg mL
-1
 samples.  This discrepancy is most notable for group 
one mutants, which form low levels of large aggregates leading to pronounced increases in Dh,I 
but not Dh,N.  At higher protein concentration, large differences in Dh,I and Dh,N were also evident 
for A4V, which first forms a mixture of small fibrils resembling those observed in G37R and 
G93R samples as well as much larger aggregates, described further below.  Similar to 
experiments at 1 mg mL
-1
, for all group one mutants and A4V, there is a large increase in PDI 
with time, which further points to an increase in sample heterogeneity, and for group one 
variants, indicates low levels of aggregate formation given that monomers remain the most 
abundant species at the end of the incubation period.  Group two mutants show smaller 
differences in Dh,I and Dh,N values at t300, consistent with aggregates being more abundant in 
these samples.  As well, for this group the PDI decreases with incubation time.  Together these 
results indicate that group two samples become more uniform with time as the levels of 
monomers and oligomers present at t0 may decrease, while the concentration of aggregates 
increases with time.  
AFM experiments on aggregated apoSH variants, incubated at 5 mg mL
-1
, were 
performed to assess aggregate morphologies.  As only very low levels of aggregation occur for 
most variants when incubated at 1 mg mL
-1
, only 5 mg mL
-1
 samples were imaged.  For apoSH 
pWT, the majority of particles detected were small, consistent with volume estimates of the 
monomer, dimer, and oligomers containing up to ~4 monomers (Fig. 5.13, Table 5.3).  
Aggregates larger than 200 nm in length were rarely observed; yet, the very few that were 
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resembled the long fibrils formed by group one mutants, G93A, G93S, and V148I (in 150 mM 
Na2SO4) (Figs. 5.10, 5.11).  For these mutants, the detected particles exhibited slightly larger 
length and breadth estimates (Fig. 5.12, Table 5.3).  Additionally, more particles larger than 200 
nm in length were detected, and these particles showed larger aspect ratios.  Nevertheless, most 
particles in these samples were small (i.e., 1-10 monomers), indicating that the long fibrils 
detected are very low in concentration.  Taken together, AFM results confirm that large 
uncertainties in SLS data, discrepancies in Dh,I and Dh,N, as well as high PDI values observed in 
group one samples, are likely due to the presence of low levels of long fibrils.  
Mutants that showed the highest levels of aggregation at 5 mg mL
-1
 by light scattering, 
A4V, G37R, and G93R (group two), similarly were found to contain far more aggregates by 
AFM (Fig. 5.11).  In the most extreme case, small A4V aggregates, like those formed by G37R 
and G93R, appear to coalesce into large amorphous-like aggregates (Figs. 5.10, 5.11, S5.7).  The 
presence of these large aggregates may explain the large decrease in light scattering intensity 
between 50 and 120 hours of incubation, as large aggregates form from the soluble monomers 
and/or small aggregates and are invisible to this technique.  Average length and breadth 
estimates, as well as the relative proportion of particles containing more than 10 dimers were 
larger compared to group one variants.  Interestingly, while group two mutants aggregate far 
more than group one, there is no evidence of long fibrils, which suggests that there may be 
structural differences in the aggregates formed by the different groups that affect the maximum 
length of the aggregates.  Group one aggregates appeared to resemble flexible, worm-like fibrils 
that have been observed in aggregation studies of β-lactoglobulin, hen-egg-white lysozyme, and 
mouse PrP (362–364).  ThT binding experiments also suggest there may be differences in the 
underlying secondary structure of the aggregates (Fig. 5.17).  Since ThT fluorescence depends 
259 
 
both on aggregate concentration and β-sheet content, the results can be difficult to interpret.  In 
general though, differences in fluorescence intensity appear to relate to aggregate length, with 
those mutants forming the longest fibrils (i.e., V148I) exhibiting the largest increase in ThT 
fluorescence (Fig. 5.17).   
 
5.4.4 Salt has diverse effects on the aggregation propensity of apoSH 
 It is clear from the aggregation experiments described above that increasing the protein 
concentration alone does not noticeably increase aggregation of all apoSH SOD1 mutants.  One 
factor limiting aggregation may be the net negative charge of apoSH at neutral pH (352, 353).  If 
this negative charge inhibits aggregation, the addition of salt should screen the repulsive charge 
between apoSH monomers and promote aggregation.  Salts tend to have complex effects on 
protein aggregation that depend on how they affect the balance of hydrophobic and electrostatic 
interactions between proteins (348, 349, 355, 365).  In addition to screening charges, they can 
also change the hydration of proteins, affecting the ensemble of conformations a protein is able 
to access (348–351).  The effects of salt on the aggregation of other marginally stable proteins, 
α-synuclein (366), yeast prion protein (sup35) (367), mammalian prion protein (PrP) (355), and 
amyloid-β (365), as well as globular proteins β2-microglobulin (368), and human 
immunoglobulin G1 (369), has been an area of active research.  We hypothesized that both 
Na2SO4, which encourages protein folding and association through the Hofmeister effect (348), 
and NaCl, which has less impact on protein hydration but can screen electrostatic interactions, 
would promote aggregation through a combination of these complex effects.  Light scattering 
measurements, however, showed that pWT, E100G, H43R, and V148G remain fairly resistant to 
aggregation in Na2SO4 and NaCl.  In contrast, A4V, G93R, and G93S aggregate more in the 
260 
 
presence of salt, and in all three cases, the effects were most pronounced for samples containing 
Na2SO4.  A4V and G93R in both Na2SO4 and NaCl and G93S in Na2SO4 aggregated with little 
detectable lag time suggesting a low energy barrier to aggregation, as described above.  Given 
that Na2SO4 has been shown to increase the stability of the apoSS monomer (134), the 
population of unfolded apoSH would be reduced in Na2SO4 at 37 °C.  Thus, aggregation for these 
mutants is likely occurring from native-like, folded, rather than unfolded states (53).  For pWT, 
DLS data reveal that the addition of salt has little effect on the Dh,I and Dh,N at t0.  Interesting 
though, the Dh,I values reported for all mutants were increased relative to pWT ranging by 1-3 
nm, 2-5 nm, and 1-4 nm for salt free, Na2SO4, and NaCl samples, respectively, and the increases 
were most pronounced for A4V and G93R samples containing salt (Table 5.4).  Salt 
concentration-dependent increases in the Dh,I have also been observed for mammalian PrP, and 
were proposed to be due to anion-specific binding that causes conformational changes that in 
turn promote oligomer formation (355).     
 Over time, relatively large increases in both Dh,I and Dh,N  values were evident for A4V 
and G93R samples containing salt, but not for salt free samples.  For G93S and V148G Na2SO4 
samples, only Dh,I increased significantly with time and was much larger than Dh,N.  In contrast, 
there was little change in Dh,I and Dh,N values for G93S and V148G salt free and NaCl samples, 
as well as all pWT, E100G, and H43R samples.  A slight decrease in PDI values with time for 
A4V and G93R samples containing salt is also consistent with higher levels of aggregation, 
compared to all other samples, including A4V and G93R in the absence of salt, that exhibit an 
increase in PDI with incubation time.  Again we see that conditions suitable for promoting 
aggregation of some mutants, notably A4V, G93R, and to a lesser extent G93S, did not 
obviously increase the observed aggregation of other mutants.  The effects of Na2SO4 and NaCl 
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on the aggregation propensity of apoSH reported here are consistent with the numerous studies 
of the Hofmeister effect on protein aggregation (348–351, 367, 369, 370).  Strong kosmotropes, 
such as Na2SO4, tend to promote aggregation by encouraging association (367, 369, 370).   
By AFM we see that Na2SO4 and NaCl promote fibrillization of A4V, G93R, and G93S 
samples (Figs. 5.20, 5.21, Table 5.5).  For all three mutants, the largest aggregates (those with 
lengths longer than 200 nm) formed in salt exhibit larger aspect ratios compared to those formed 
at higher protein concentration in salt free buffer (Tables 5.4, 5.5).  It is noteworthy that images 
of G93R in Na2SO4 taken over the course of the aggregation experiment reveal that fibril 
elongation occurs up to the midpoint of the exponential growth phase at which point fibrils 
appear to stop growing (Figs. 5.23, 5.24, S5.18-S5.20).  Alternatively, G93S, which exhibited 
lower levels of aggregation in salt compared to A4V and G93R, formed the longest fibrils and 
some of these fibrils also appear to either bundle together and/or form branches indicative of 
secondary nucleation sites (Figs. 5.20, 5.21, S5.22, S5.23).  The fibrils formed by G93S in 
Na2SO4, and to a lesser extent NaCl, resembled those formed by G93A at 5 mg mL
-1
 in salt free 
buffer and V148I at 5 mg mL
-1
 in 150 mM Na2SO4, but interestingly were not observed for G93S 
at 5 mg mL
-1
 in salt free buffer, although further experiments are required to assess whether the 
internal structure of these aggregates are similar.   
Aggregation experiments in salt exhibit similar trends to those reported for experiments 
at high protein concentration in the absence of salt; mutants that exhibit low levels of 
aggregation as indicated by slight changes in light scattering intensity with time, large 
uncertainties in the measurements, and increases in Dh,I but not Dh,N tend to form low levels of 
long fibrils.  On the other hand, mutants with higher aggregation propensity form smaller fibrils 
that are more abundant.  Without exhaustively imaging all regions of the mica surface, it is 
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difficult to relate the quantity of fibrils in the image (sample coverage) to the levels in solution, 
yet it is clear that the coverage is higher for samples that exhibit higher aggregation by light 
scattering.  Thus, the combination of longer, as well as more numerous, fibrils in samples 
containing salt may be the cause of the higher light scattering intensity observed for these 
samples (Fig. 5.18).  Similar trends were observed for Sup35, where kosmotropic salts induced 
rapid aggregation, but the aggregates formed were less robust and found to fragment (370).  
Lower overall aggregation of Sup35 was evident in chaotropic salts, these conditions promoted 
the formation of stronger aggregates that were more rigid and longer.  Though we have not yet 
explored the effects of chaotropic salts on apoSH aggregation, the results are analogous to the 
effects of mutations on the type of aggregation behaviour observed.  Mutants that rapidly 
aggregate tend to form small fibrils.  On the other hand, mutants that exhibit lower levels of 
aggregation form long fibrils that may form branches or bundle but tend not to fragment.  
 ThT binding experiments were performed on A4V, G93R, G93S, and E100G samples 
incubated for ~300 hours in salt free, Na2SO4, and NaCl buffers to probe the differences in 
structure that may account for the differences in aggregation behaviour exhibited (Fig. 5.26).  In 
general, samples containing Na2SO4 showed the largest increase in ThT fluorescence, which was 
most pronounced for G93S aggregates formed in Na2SO4.  Thus, again we see that mutants that 
form long fibrils (i.e., with the highest aspect ratios) even at low levels, display the highest levels 
of ThT fluorescence (Section 5.3.6, Fig. 5.17).       
 Light scattering, AFM, and ThT binding experiments reveal that Na2SO4 and NaCl 
promote aggregation of some, but not all, apoSH mutants.  The effects of salt on the levels of 
apoSH aggregation correlate with the abilities of the different anions to stabilize and encourage 
protein association, according to the Hofmeister series (i.e., SO4
2-
 promotes aggregation more 
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than Cl
-1
).  Our findings are also consistent with other studies of other marginally stable proteins 
have shown that different salts and even the same salt at different concentrations can cause the 
same protein to form aggregates with very different morphologies (355, 364, 370).   
 
5.4.5 ApoSH exhibits different modes of aggregation that vary with mutation and solution 
conditions       
Many proteins can undergo multiple types of aggregation, characterized both by different 
rates of aggregate formation as well as diverse arrays of aggregate morphologies (371–374).  In 
many cases, the more malleable the protein, the higher the number of aggregation-prone 
conformations that can be generated and in turn the higher the diversity of aggregate structures 
formed (94, 356).   
Proteins can reversibly aggregate from native or native-like states that form weak 
interactions that in turn lead to formation of dimers and small oligomers, often observed only at 
increased protein concentration (371, 375).  The dynamic equilibrium established between 
monomers and oligomers is governed by the thermodynamic stability of each state (53); higher 
order species will only become abundant at protein concentrations above the equilibrium 
dissociation constant (Kd) (375).  For apoSH pWT, a rough estimate of the Kd for native and non-
native dimer formation has been obtained by NMR (Section 5.4.2) (301); more experiments are 
in progress to assess how mutations modulate the energetics of native and non-native 
dimerization.  Preliminary studies reveal that the A4V mutation, located in the dimer interface, 
abolishes both native and non-native dimerization (301); therefore, mutations may play pivotal 
roles in modulating the accessibility of different oligomerization pathways.  Given evidence that 
a number of different oligomers form reversibly from the native state (Section 5.4.2), it is 
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possible that they could initiate different interactions that may become irreversible, as has been 
observed for amyloid-forming proteins (94, 360).  Irreversible aggregation generally involves 
more substantial conformational changes and the formation of aggregates that do not readily 
dissociate unless exposed to high levels of chemical denaturant (371, 375).  In such cases, partial 
protein unfolding leads to the exposure of segments capable of forming new, and often very 
strong, hydrogen-bonding or hydrophobic interactions.  Partial unfolding can occur preceding or, 
often at higher protein concentrations, after association (375).  The complex mechanism(s) 
underlying irreversible aggregation tend to be governed more by the rates of association and are 
therefore, under kinetic rather than thermodynamic control (92).  The rates of unfolding and 
association are highly dependent on protein conformation and solution conditions.  Changing the 
interactions between proteins has a large impact on the rate of each step in the aggregation 
process.  Furthermore, structural changes often only need to involve a small proportion of 
monomer in order to facilitate irreversible aggregation and often these conformational changes 
involve an increase in β-structure (371).  Irreversible species often can grow via different 
mechanisms, for example, through monomer addition to existing aggregates and/or through 
coalescence of aggregates.   It is important to note that reversible and irreversible aggregation 
pathways are not necessarily mutually exclusive; reversible aggregates can convert to 
irreversible species upon conformational changes in the protein (375). 
For apoSH, low levels of oligomers may be present at t0, but in most cases these 
oligomers do not transition into larger aggregates at 1 mg mL
-1
.  Increasing the concentration of 
the sample to 5 mg mL
-1
 and/or adding Na2SO4 and NaCl leads to higher levels of oligomer 
formation and substantial changes in the rates of aggregation for some but not all mutants,  
which is consistent with our current understanding of how both primary sequence and 
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environmental conditions can alter the aggregation of proteins.  Conformational heterogeneity 
leading to polymorphism in aggregate structure has been commonly observed for other 
aggregation-prone proteins and has been proposed to underlie the species barrier in prion 
diseases and the severity of different amyloid strains (sections 1.2.1, 1.2.2) (83, 89, 97, 356).  
Mutations modulate the structural features of the fibres, resulting in distinct, or common, 
protease-resistant cores under different conditions (Section 1.3.6) (181, 185).  NMR also reveals 
that A4V and G85R have very different effects on the energy landscape of apoSH (301).  In 
some cases, mutations appear to promote rapid formation of small aggregates that are unable to 
grow very long, potentially due to their low stability and high frangibility, while in other cases 
mutations, under the same conditions, disfavour rapid aggregation and instead promote the 
formation of long fibrils with extensive β-sheet content (Fig. 5.24).  Given the low levels of these 
long fibrils, we speculate that more extensive conformational changes are required to facilitate 
growth.  By experimenting with a number of different solution conditions, but without promoting 
aggregation too aggressively (e.g., sonication, agitation) (75, 76, 180, 192), we have been able to 
see different effects of ALS-mutations on the aggregation propensity of apoSH, and gain 
valuable insights mechanisms of SOD1 aggregation that may be involved in disease. 
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Figure 5.28 Monomeric apoSH is in equilibrium with native and non-native conformations 
that can represent templates for different aggregation pathways.  On the left are the 
conformations of native apoSH (blue) shown by NMR to be transiently populated.  Some states 
exhibit features similar to the native state of holoSS SOD1, referred to as mature conformations, 
and include native dimerization (top right) and electrostatic loop helix formation (bottom right).  
The other dimers formed do not resemble holoSS and arise from “non-native association” (top 
left and bottom left structures) (301).  The heterogeneity of conformations formed by apoSH 
may account for the different types of aggregates formed (shown on the left).  Mutations may 
modulate the energy landscape of apoSH, such that certain local folding and/or association 
pathways are favoured over others and this in turn may dictate the type of aggregates formed.  
DLS, AFM, and ThT binding experiments reveal that some mutations lead to low levels of 
aggregation, where aggregates formed exhibit substantial increases in β-content and undergo 
little fragmentation (top right AFM images).  Other mutations promote rapid aggregation that 
leads to abundant small aggregates that in some cases coalesce but rarely form long fibrils 
(bottom right AFM images). 
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5.5 Supplementary Data 
 
Figure S5.1 SLS reveals that most apoSH variants undergo very little aggregation at 1 mg 
mL
-1
, pH 7.4, 37 °C.  All samples were incubated in 1 mM TCEP, 20 mM HEPES.  (A) Most 
apoSH variants aggregate little when incubated at 1 mg mL
-1
, pH 7.4, 37 °C, as indicated by little 
change in light scattering intensity (discussed in Chapter 4).  A4V (red triangles) and to a lesser 
extent A4T (purple squares), G37R (purple diamonds), and G93R (peach triangles) samples 
exhibit an increase in light scattering intensity over the incubation period; however, DLS reveals 
that the aggregates formed remain low in concentration with the exception of A4V.  (B) A4V 
was left to aggregate for approximately 400 hours (blue diamonds) at which point the aggregates 
formed were filtered from the sample and the experiment was restarted (red diamonds).  
Filtration and removal of aggregated protein decreases the concentration of the sample, as 
suggested by the decrease in initial counts between the first and restart experiments; however, 
aggregation proceeds in the restarted experiment at the same rate as the first.  Experiments 
shown in both panels are single representative aggregation experiments.  Error bars reflect the 
standard deviation in light scattering intensity measurements made in triplicate every ~24 hours.  
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Figure S5.2 DLS reveals that most apoSH variants, incubated at 1 mg mL
-1
, pH 7.4, 37 °C, 
show very little increase in size.  All samples were incubated in 1 mM TCEP, 20 mM HEPES.  
Intensity distributions are indicated by the solid line and number distributions by the dotted line.  
DLS measurements were taken approximately every 24 hours, with t0 at the bottom of the page 
and the last time point, greater than 300 hours, at the top.  Intensity distributions emphasize 
larger particles in solution; therefore, the centre of the peak is shifted slightly to larger values.  
The number distributions, which reflect the concentration of different species in solution, 
indicate small particles corresponding to monomers and possibly small oligomers are the most 
abundant species after incubation for greater than 300 hours.  Data obtained from the DLS 
experiments shown in Figures 5.4 and S5.2 are summarized in Table S5.2.  
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Figure S5.3 AFM images of partially evaporated apoSH H43R after ~130 and 300 hours of 
incubation at, pH 7.4, 37 °C.  AFM images confirm that sample evaporation can lead to fibril 
formation.  In all panels, the white bars correspond to 1 µm.  (A) and (B) are 3 x 3 and 15 x15 
µm images of samples incubated for ~130 hours, respectively.  (C) and (D) are 3 x 3 and 15 x 15 
images µm of samples incubated for ~300 hours, respectively.  Fibrils are present at 130 hours of 
incubation, even before the peak representing small particles is no longer detected by DLS (Fig. 
5.5), but become more numerous and coiled together after 300 hours of incubation.   
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Figure S5.4 AFM images of partially evaporated apoSH G85R after ~300 hours of 
incubation at pH 7.4, 37 °C.  AFM images confirm that sample evaporation can lead to fibril 
formation.  All panels are 5 x 5 μm images and the white bars correspond to 1 µm.  Evaporation 
can induce formation of long, thin fibrils that appear coiled together in regions.  There is also 
evidence of spherical, amorphous-like aggregates that may be fibrils clumped together as they 
often appear to have fibrillar components emerging from them.   
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Figure S5.5 AFM images of partially evaporated apoSH V148I after ~300 hours of 
incubation at pH 7.4, 37 °C.  AFM images confirm that sample evaporation can lead to fibril 
formation.  (A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars 
correspond to 1 µm.  Fibrils formed in the partially evaporated V148I sample are shorter than 
those formed by H43R and G85R, which is consistent with DLS data indicating that aggregation 
did not begin as early in this sample. 
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Figure S5.6 Images of apoSH pWT incubated for ~300 hours at 5 mg mL
-1
, pH 7.4, 37 °C. 
(A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 
µm. 
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Figure S5.7 Images of apoSH A4V incubated for ~120 hours at 5 mg mL
-1
, pH 7.4, 37 °C. 
(A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 
µm. 
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Figure S5.8 Images of apoSH G37R at t0 (5 mg mL
-1
, pH 7.4, 37 °C).  All images are 5 x 5 μm 
and the white bars correspond to 1 µm. 
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Figure S5.9 Images of apoSH G37R at ~t300 (5 mg mL
-1
, pH 7.4, 37 °C).  (A) and (B) show 5 
x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
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Figure S5.10 Images of apoSH G93A at ~t300 (5 mg mL
-1
, pH 7.4, 37 °C).  (A) and (B) show 5 
x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
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Figure S5.11 Images of apoSH G93R at ~t300 (5 mg mL
-1
, pH 7.4, 37 °C).  (A) and (B) show 5 
x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
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Figure S5.12 Images of apoSH G93S at ~t300 (5 mg mL
-1
, pH 7.4, 37 °C).  (A) and (B) show 5 
x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
  
286 
 
 
  
287 
 
 
 
Figure S5.13 Images of apoSH V148I at ~t300 (5 mg mL
-1
, pH 7.4, 37 °C, 150 mM Na2SO4).  
(A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 
µm. 
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Figure S5.14 Images of apoSH A4V at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C).  (A) and (B) show 5 x 
5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
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Figure S5.15 Images of apoSH A4V at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM Na2SO4).  
(A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 
µm. 
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Figure S5.16 Images of apoSH A4V at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM NaCl).  (A) 
and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
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Figure S5.17 Images of apoSH G93R at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C).  All images are 5 x 
5 μm and the white bars correspond to 1 µm. 
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Figure S5.18 Images of apoSH G93R at ~t22 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM Na2SO4).  
All images are 5 x 5 μm and the white bars correspond to 1 µm. 
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Figure S5.19 Images of apoSH G93R at ~t143 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM Na2SO4).  
All images are 5 x 5 μm and the white bars correspond to 1 µm. 
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Figure S5.20 Images of apoSH G93R at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM Na2SO4). 
(A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 
µm. 
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Figure S5.21 Images of apoSH G93R at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM NaCl).  (A) 
and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 µm. 
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Figure S5.22 Images of apoSH G93S at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM Na2SO4). 
(A) and (B) show 5 x 5 and 10 x 10 μm images, respectively, and the white bars correspond to 1 
µm. 
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Figure S5.23 Images of apoSH G93S at ~t300 (1 mg mL
-1
, pH 7.4, 37 °C, 150 mM NaCl). All 
images are 5 x 5 μm and the white bars correspond to 1 µm. 
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Table S5.1 Metal content of apoSH samples. 
ApoSH sample
a
 Date Prepared
b
 
Copper content 
%
c
 
Zinc Content 
%
c
 
pWT 03/07/09 -0.01 7.28 
pWT 03/07/09 0.00 7.59 
pWT 03/07/09 0.00 5.99 
A4V 16/07/09 -0.01 4.88 
E100G 31/07/09 0.00 2.98 
pWT 09/08/09 0.01 10.14 
G85R 02/02/10 0.00 7.50 
G85R 02/02/10 0.00 7.15 
G93A 22/04/10 0.04 10.11 
G93A 22/04/10 0.01 7.09 
A4S 20/05/10 0.00 16.81 
V148I 25/05/10 0.02 9.96 
G37R 27/05/10 0.01 9.64 
A4S 21/06/10 0.00 8.08 
A4S 24/06/10 0.00 31.91 
A4T 24/06/10 0.02 40.86 
A4T  24/06/10 0.04 87.31 
V148I 09/09/10 -0.20 8.30 
V148I 09/09/10 -0.20 7.65 
H46R 15/09/10 -0.21 24.69 
A4S 12/10/10 0.03 21.43 
G85R 18/10/10 0.01 18.25 
A4T 25/10/10 0.01 8.10 
H46R 28/10/10 0.00 10.10 
A4S 07/11/10 0.05 19.70 
G93R 08/11/10 0.02 9.96 
G93S 11/11/10 0.01 14.52 
E100G 15/11/10 -0.20 18.20 
G93S  15/11/10 -0.20 11.67 
G93S 15/11/10 -0.21 12.21 
G93R 18/11/10 -0.21 13.74 
pWT 10/05/11 -0.23 8.23 
AS 20/07/11 -0.20 2.72 
pWT + A4V seeds 20/07/11 -0.20 2.58 
pWT + H43R seeds 20/07/11 -0.21 2.36 
H43R 08/11/11 -0.20 24.85 
A4V 22/05/12 -0.14 12.22 
H43R 29/05/12 -0.21 6.87 
H43R  01/08/12 -0.19 5.97 
H43R 01/08/12 -0.19 6.19 
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H43R 01/08/12 -0.21 5.84 
H43R 07/01/13 -0.18 2.74 
H43R 07/01/13 -1.75 3.27 
A4V no salt 04/06/13 0.00 0.31 
A4V Na2SO4 04/06/13 0.00 -0.09 
A4V NaCl 04/06/13 0.00 0.09 
G93R no salt 20/06/13 0.00 0.91 
G93R Na2SO4 20/06/13 0.00 0.67 
G93R NaCl 20/06/13 0.00 0.71 
E100G no salt 07/07/13 0.00 -0.64 
E100G Na2SO4 07/07/13 0.00 -0.80 
E100G NaCl 07/07/13 0.00 -0.04 
AS no salt 22/10/13 0.00 -0.79 
AS Na2SO4 22/10/13 0.00 0.17 
AS NaCl 22/10/13 0.00 -0.75 
H43R no salt 29/10/13 0.00 -0.01 
H43R Na2SO4 29/10/13 0.01 -1.64 
H43R NaCl 29/10/13 0.00 -0.63 
A4V Na2SO4 26/11/13 0.00 0.30 
A4V NaCl 26/11/13 0.00 0.12 
G93R no salt 08/01/14 0.00 0.56 
G93R Na2SO4 08/01/14 0.00 -0.67 
G93R NaCl 08/01/14 0.00 0.63 
G93S no salt 22/01/14 0.00 0.32 
G93S Na2SO4 22/01/14 0.00 -0.36 
G93S NaCl 22/01/14 0.00 0.64 
a
Samples analyzed for metal content.  Samples highlighted in red contain too much metal for 
results to be interpreted.  Samples containing less than 10 % metal were used. 
b
The date the sample was prepared listed as day, month, year.  Samples prepared in 2013-2014 
had much less metal contamination than samples prepared before. 
c
Metal concentration divided by apoSH concentration. 
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Table S5.2 All DLS data for apoSH SOD1 variants at 1 mg mL
-1
, pH 7.4, 37 °C. 
 t = 0 t > 300 
ApoSH 
SOD1 
variant 
PDI
a
 
PDI width 
 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
PDI
a
 
PDI width 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
pWT 0.154 1.761 5.094 3.314 0.215 2.768 5.084 3.256 
 0.187 1.986 5.473 2.436 0.252 2.644 5.384 3.216 
 0.206 2.117 5.445 3.345 0.176 1.911 4.875 3.182 
 0.224 2.552 5.757 3.104 0.243 2.520 5.337 3.028 
 0.223 2.310 5.517 3.503 0.237 2.452 5.566 3.478 
 0.235 2.468 5.560 3.582 0.224 2.349 5.045 3.336 
 0.170 1.777 5.144 3.082 0.315 7.762 4.875 3.122 
 0.203 1.914 4.627 2.687 0.204 2.241 5.404 3.095 
 0.219 2.148 5.169 3.045 0.219 2.458 5.626 3.930 
 0.233 2.284 5.392 2.741 0.450 7.483 5.252 4.320 
 0.203 2.210 5.565 3.737 0.404 6.354 5.290 3.583 
 0.198 2.226 5.849 3.000 0.264 21.83 4.994 3.839 
Avg. 0.205 2.146 5.383 3.131 0.267 5.231 5.228 3.449 
Stdev. 0.025 0.250 0.332 0.387 0.083 5.657 0.253 0.398 
WT 0.211 2.570 6.724 4.617 0.754 631.5 4.393 3.574 
 0.243 2.719 6.104 3.209 0.442 52.54 5.140 4.053 
 0.257 2.861 5.333 3.049 0.826 1008 4.661 4.049 
 0.219 2.609 6.427 4.330 0.279 4.229 5.085 3.232 
 0.220 2.662 6.402 4.568 0.347 14.40 5.040 3.863 
 0.219 2.583 5.138 3.450 0.336 4.768 5.201 3.706 
 0.246 2.188 5.539 3.074 0.239 11.93 4.726 3.059 
 0.222 2.211 6.015 1.189 0.290 3.787 5.756 4.062 
 0.201 2.367 5.926 1.970 0.300 4.096 5.350 3.418 
 0.264 2.076 5.937 2.549 0.223 2.643 5.521 4.247 
 0.245 2.070 4.458 2.797 0.248 3.034 4.873 3.232 
 0.213 2.078 4.822 3.344 0.308 5.045 5.606 3.603 
 0.226 2.233 6.614 2.067 0.344 4.946 5.219 2.705 
 0.212 2.085 5.181 2.429 0.236 2.776 5.823 3.323 
 0.221 2.173 4.769 2.666 0.198 2.368 6.978 4.439 
 0.239 2.245 5.276 3.196 0.256 3.126 8.325 1.903 
 0.267 2.143 9.593 1.431 0.230 5.783 5.271 2.269 
 0.240 2.193 5.131 2.770 0.321 4.461 5.042 3.492 
 0.324 4.658 5.801 3.239 0.383 6.073 5.090 3.604 
 0.322 4.584 5.752 4.147 0.382 6.096 5.739 2.012 
 0.330 4.803 5.870 4.194 0.362 5.639 5.869 3.484 
Avg. 0.245 2.672 5.848 3.061 0.348 85.11 5.462 3.397 
Stdev. 0.038 0.874 1.059 0.959 0.160 251.6 0.853 0.694 
A4S 0.236 3.378 7.546 4.752 0.704 21.93 83.96 3.047 
 0.255 3.626 6.834 3.787 0.781 26.00 82.23 3.130 
 0.263 3.592 9.930 1.366 0.765 25.12 75.20 4.171 
Avg. 0.251 3.532 8.103 3.302 0.750 24.35 80.463 3.449 
Stdev. 0.014 0.134 1.622 1.744 0.041 2.141 4.640 0.626 
A4T 0.242 4.399 6.911 4.810 1.0 40.06 235.9 4.280 
 0.214 4.386 7.014 3.710 1.0 41.25 247.1 4.561 
 0.265 3.964 7.419 4.982 1.0 40.49 233.4 4.729 
 0.255 3.659 7.370 4.212 1.0 49.61 249.9 4.442 
 0.262 3.736 7.284 5.215 1.0 50.60 244.1 5.090 
 0.263 3.802 7.142 3.582 1.0 49.41 240.4 4.163 
Avg. 0.250 3.991 7.190 4.419 1.0 45.24 241.8 4.544 
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Stdev. 0.020 0.327 0.202 0.686 0.0 5.109 6.424 0.334 
A4V 0.264 3.399 7.243 3.660 0.248 38.17 102.4 42.02 
 0.240 3.017 6.044 3.961 0.261 39.26 94.19 45.83 
 0.212 2.730 6.639 3.609 0.261 38.76 108.0 35.61 
 0.258 4.434 10.43 1.292 0.269 24.40 65.40 7.532 
 0.264 4.300 11.08 1.351 0.259 23.58 61.19 29.59 
 0.271 4.489 10.58 3.084 0.261 23.48 62.64 6.666 
 0.245 3.519 7.430 4.566 0.244 22.53 60.54 30.47 
 0.187 2.939 7.601 3.953 0.243 22.73 61.09 31.40 
 0.147 2.784 8.562 4.845 0.234 22.38 60.24 33.35 
 0.277 4.807 11.25 1.667 0.268 22.20 58.60 4.422 
 0.263 4.273 10.29 3.925 0.262 21.73 56.88 5.631 
 0.258 4.204 10.28 1.676 0.263 21.75 57.87 5.102 
 0.102 3.227 7.885 3.954 0.279 22.26 57.00 4.859 
 0.236 3.443 7.987 4.704 0.272 22.36 59.08 5.266 
 0.216 3.351 7.185 4.585 0.294 22.92 61.80 5.065 
 0.208 3.435 9.099 5.966 0.251 23.11 60.24 33.65 
 0.152 2.963 8.497 5.745 0.256 23.05 60.73 5.231 
 0.203 3.263 9.623 1.637 0.240 22.12 59.80 6.988 
 0.212 3.462 8.300 4.866 0.212 40.00 46.91 4.915 
 0.223 3.561 8.698 4.868 0.384 25.70 54.33 6.238 
 0.222 3.584 8.396 5.063 0.457 29.63 50.18 4.807 
 0.234 3.554 7.700 4.856 0.570 59.04 54.46 4.556 
 0.239 3.450 8.439 3.370 0.662 50.77 54.61 6.255 
 0.248 51.40 6.992 4.164 0.528 47.26 54.93 4.240 
Avg. 0.224 5.566 8.593 3.807 0.312 29.55 63.46 15.40 
Stdev. 0.043 9.779 1.452 1.376 0.119 10.88 15.38 14.70 
E100G 0.226 2.451 6.325 4.355 0.275 88.37 5.716 3.956 
 0.232 2.536 6.406 3.829 0.379 97.29 5.127 3.857 
 0.230 2.330 5.947 3.026 0.441 8.945 6.064 4.100 
 0.243 2.715 5.622 3.495 0.765 101.7 5.730 3.192 
 0.245 2.675 5.699 3.138 0.692 176.3 1066 3.951 
 0.234 2.530 5.851 3.106 0.479 116.8 5.444 4.160 
 0.240 2.825 7.392 2.429 0.405 114.5 5.576 4.047 
 0.223 2.700 7.533 3.893 0.340 21.61 5.740 4.292 
 0.200 2.595 7.111 4.664 0.376 50.16 5.884 4.469 
Avg. 0.230 2.595 6.432 3.548 0.461 86.19 123.5 4.003 
Stdev. 0.014 0.151 0.739 0.706 0.163 52.04 353.4 0.357 
G37R 0.288 3.880 5.272 3.892 0.720 181.4 831.6 4.405 
 0.282 3.638 5.088 3.153 0.736 189.1 488.0 3.173 
 0.285 3.510 4.698 3.380 1.0 169.2 600.2 4.174 
 0.454 271.7 4.019 3.068 1.0 118.2 497.9 3.895 
 0.243 2.946 5.086 3.318 1.0 115.2 501.0 2.076 
 0.250 2.980 6.184 4.185 1.0 120.9 660.6 3.080 
Avg. 0.300 48.10 5.058 3.499 0.909 149.0 596.6 3.467 
Stdev. 0.078 109.5 0.711 0.442 0.141 34.49 134.2 0.864 
G85R 0.162 2.106 5.954 2.876 0.319 121.6 5.130 4.151 
 0.230 2.835 5.970 3.926 0.204 5.954 6.408 4.267 
 0.144 2.606 5.513 4.129 0.291 3.824 5.213 3.866 
Avg. 0.179 2.516 5.812 3.644 0.271 43.79 5.584 4.095 
Stdev. 0.045 0.373 0.259 0.673 0.060 67.39 0.715 0.206 
G93A 0.215 2.893 8.418 2.800 0.467 187.2 6.049 1.775 
 0.245 3.033 7.849 4.265 0.516 277.2 5.917 4.133 
 0.226 3.087 7.834 4.390 0.469 391.0 678.3 4.367 
 0.220 3.188 7.520 5.850 0.378 204.6 5.947 3.581 
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 0.240 3.309 6.950 4.722 0.479 306.8 5.968 3.390 
 0.253 3.505 6.848 4.176 0.374 99.95 5.906 3.592 
 0.305 4.794 7.864 4.804 0.581 11.95 5.938 4.369 
 0.256 3.984 8.658 4.645 0.559 11.28 6.215 4.570 
 0.265 3.974 7.131 3.527 0.558 11.21 6.145 4.604 
 0.241 3.567 7.208 3.781 0.206 48.47 5.925 3.755 
 0.237 3.730 7.766 4.592 0.555 504.4 6.052 4.411 
 0.254 3.518 9.433 1.170 0.372 6.035 6.813 4.165 
 0.252 4.388 8.604 4.976 0.600 13.02 155.2 4.063 
 0.177 2.991 8.522 4.805 0.563 11.87 174.3 4.390 
 0.177 2.993 8.394 4.279 0.545 11.40 6.536 4.402 
 0.238 3.771 8.996 2.139 0.933 29.15 218.9 5.331 
 0.265 3.995 7.965 3.792 0.943 29.80 235.3 5.508 
 0.244 3.952 9.847 1.515 0.950 29.86 195.3 4.984 
 0.155 1.782 5.180 4.865 1.0 135.0 502.1 4.035 
 0.126 1.607 5.085 1.517 1.0 141.4 732.0 4.513 
 0.107 1.561 5.270 4.054 1.0 119.8 643.6 4.062 
Avg. 0.224 3.315 7.683 3.841 0.621 122.9 171.8 4.190 
Stdev. 0.049 0.851 1.300 1.286 0.245 142.5 248.9 0.766 
G93R 0.160 2.349 6.847 3.726 1.0 49.44 322.6 4.392 
 0.159 2.379 6.415 4.068 1.0 43.14 256.6 4.643 
 0.155 2.380 7.108 4.528 1.0 43.91 261.7 4.640 
 0.210 2.730 6.581 3.309 0.783 20.32 181.5 5.224 
 0.211 2.730 7.196 3.900 0.710 17.32 256.7 4.602 
 0.195 2.621 7.500 1.774 0.610 20.47 170.5 4.730 
 0.184 2.720 7.123 4.131 0.952 28.38 260.9 4.582 
 0.235 3.044 6.314 4.302 0.978 29.8 257.9 4.619 
 0.217 2.781 7.005 2.811 0.983 29.92 260.1 4.510 
 0.311 5.046 7.158 4.683 0.579 27.62 50.63 2.548 
 0.287 4.563 8.698 4.423 0.491 27.71 47.91 4.358 
 0.304 4.922 8.430 3.920 0.419 23.43 50.59 3.735 
 0.303 5.060 8.315 4.699 0.174 21.23 61.72 34.43 
 0.275 4.607 8.628 5.552 0.194 22.23 63.47 31.05 
 0.274 4.595 8.161 4.723 0.173 21.1 61.68 33.95 
 0.239 5.241 7.820 3.719 0.240 20.18 51.52 22.48 
 0.317 4.998 8.247 1.722 0.244 19.14 53.81 23.16 
 0.287 4.410 8.589 5.484 0.238 18.32 50.13 11.12 
Avg. 0.240 3.732 7.563 3.971 0.598 26.87 151.1 11.60 
Stdev. 0.056 1.155 0.806 1.053 0.334 9.509 104.2 11.58 
G93S 0.223 3.075 7.135 4.276 0.597 12.98 169.5 5.275 
 0.266 3.939 8.133 3.513 0.597 13.00 164.8 2.251 
 0.267 3.820 7.767 2.220 0.617 13.57 150.7 4.588 
 0.234 3.148 6.376 4.711 0.239 124.3 6.439 5.130 
 0.236 2.797 6.421 4.044 0.461 8.520 6.603 1.498 
 0.207 2.574 6.981 4.630 0.500 9.658 6.643 4.536 
Avg. 0.239 3.226 7.136 3.899 0.502 30.34 84.11 3.880 
Stdev. 0.024 0.548 0.708 0.930 0.143 46.08 85.18 1.598 
H43R 0.218 3.527 8.509 3.780 0.208 4.024 6.858 1.250 
 0.210 3.452 8.629 4.568 0.246 3.031 6.388 4.354 
 0.236 3.727 7.961 5.190 0.238 3.135 6.321 4.428 
 0.263 4.582 8.303 4.564 0.508 529.2 5.259 3.509 
 0.178 3.171 9.463 3.433 0.314 4.489 6.208 4.508 
 0.201 3.354 9.280 5.306 0.284 12.80 5.948 4.544 
 0.140 2.703 8.262 4.735 0.247 21.10 7.519 1.209 
 0.158 2.754 8.513 3.259 0.325 4.869 7.336 6.267 
 0.155 2.808 8.606 2.215 0.335 4.684 7.008 4.838 
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 0.272 4.257 8.542 4.146 0.516 10.13 6.655 3.699 
 0.260 3.722 8.104 3.725 0.445 8.075 6.900 4.032 
 0.284 4.510 9.064 3.627 0.461 8.592 7.280 2.187 
Avg. 0.215 3.547 8.603 4.046 0.344 51.18 6.640 3.735 
Stdev. 0.049 0.650 0.457 0.885 0.110 150.6 0.651 1.503 
H46R 0.208 2.844 7.065 3.994 0.218 2.713 5.999 4.026 
 0.208 2.667 6.463 3.600 0.227 3.244 6.010 3.998 
 0.202 2.593 6.855 2.424 0.216 2.503 6.926 3.723 
 0.158 1.712 5.053 3.171 0.206 2.478 5.636 3.524 
 0.176 1.970 5.088 3.124 0.125 1.900 6.229 3.246 
 0.179 2.088 5.363 3.131 0.184 2.195 6.517 2.219 
 0.191 1.848 5.096 2.500 0.146 28.76 5.392 3.921 
 0.161 1.791 4.968 3.069 0.213 2.647 6.368 3.395 
 0.188 1.825 5.084 2.760 0.190 2.415 5.944 3.673 
Avg. 0.186 2.149 5.671 3.086 0.192 5.428 6.113 3.525 
Stdev. 0.019 0.433 0.863 0.498 0.035 8.757 0.461 0.558 
H46R
wt
 0.133 1.598 4.991 3.245 0.511 427.8 4.104 3.116 
 
0.175 1.766 5.269 1.722 0.299 90.06 3.965 3.246 
 0.109 1.386 4.650 2.750 0.170 3.494 4.700 3.344 
 0.218 2.459 5.154 3.428 0.438 130.0 4.504 3.121 
 0.222 2.378 5.801 3.604 1.0 6197 4.150 4.113 
 0.217 2.331 5.947 2.315 1.0 2345 824.0 3.932 
 0.263 43.94 5.005 1.189 0.490 122.9 4.372 3.301 
 0.299 11.38 4.541 3.361 0.230 90.15 4.173 3.321 
 0.405 113.9 4.619 3.808 0.327 162.9 3.905 2.842 
Avg. 0.227 20.13 5.109 2.825 0.496 1063 95.32 3.371 
Stdev. 0.089 37.77 0.501 0.905 0.307 2061 273.3 0.403 
V148G 0.272 3.780 6.998 4.654 0.484 366.2 504.6 3.655 
 0.250 3.337 7.294 1.205 0.637 366.1 542.7 4.017 
 0.237 3.138 6.969 4.215 0.814 380.6 678.7 4.008 
 0.130 36.99 5.947 4.516 0.498 9.429 9.704 2.113 
 0.434 7.644 6.459 4.583 0.443 11.79 6.209 4.565 
 0.422 7.301 6.210 4.393 0.525 12.33 6.758 5.372 
Avg. 0.291 10.37 6.646 3.928 0.567 191.1 291.5 3.955 
Stdev. 0.117 13.20 0.522 1.343 0.138 197.1 316.3 1.083 
V148I 0.221 2.050 4.493 2.734 0.656 14.31 4.876 3.840 
 0.175 1.778 4.909 3.288 0.496 14.07 4.961 3.907 
 0.210 1.936 4.662 3.053 0.378 51.49 5.269 4.331 
 0.186 1.869 5.581 3.922 0.409 149.6 4.993 3.543 
 0.146 1.690 5.425 3.347 0.308 29.22 5.252 3.346 
 0.149 1.683 5.195 3.317 0.265 3.443 5.976 2.648 
 0.136 1.856 5.667 3.661 0.443 264.5 5.017 3.881 
 0.190 1.980 5.736 3.576 0.342 43.21 5.265 3.775 
 0.190 1.973 5.689 3.520 0.938 282.4 5.000 3.859 
Avg. 0.178 1.868 5.262 3.380 0.471 94.69 5.179 3.681 
Stdev. 0.029 0.130 0.472 0.348 0.210 110.2 0.333 0.471 
Bold and italicized values are the averages and standard deviations, respectively. 
a
PDI is obtained from the Cumulants method of fitting the autocorrelation function (Eq. 5.4).  
Values larger than 0.1 are indicative of polydispersity (i.e., the sample contains than one species 
in solution).  High PDI values result in larger peak widths, and thus greater uncertainty in the 
sizes reported. 
b
Peak width reflects the uncertainty in the hydrodynamic diameter obtained from the intensity 
distribution and is related to the PDI according to Eq. 5.4. 
c
The sizes reported correspond to the main peak in the distributions.  
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Table S5.3 All DLS data for apoSH SOD1 variants at 5 mg mL
-1
, pH 7.4, 37 °C. 
 t = 0 t > 300 
ApoSH 
SOD1 
variant 
PDI
a
 
PDI width 
 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
PDI
a
 
PDI width 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
pWT 0.302 11.230 4.627 3.473 0.970 64.64 529.7 3.937 
 0.403 6.299 4.575 3.278 1.000 53.88 1170 3.793 
 0.383 5.826 4.657 3.270 0.807 76.64 421.5 3.804 
Avg. 0.363 7.785 4.620 3.340 0.926 65.05 707.1 3.845 
Stdev. 0.053 2.993 0.041 0.115 0.104 11.39 404.5 0.080 
A4V 0.200 56.91 19.80 4.218 1.0 1314 770.3 11.38 
 0.460 11.25 9.252 6.056 1.0 1924 401.6 55.03 
 0.461 12.83 31.40 3.573 1.0 1800 372.8 41.60 
Avg. 0.374 27.00 20.15 4.616 1.0 1679 514.9 36.00 
Stdev. 0.150 25.92 11.08 1.288 0.0 322.4 221.7 22.36 
G37R 0.397 7.685 9.205 5.039 0.233 22.31 62.22 26.67 
 0.391 7.550 9.216 5.731 0.234 21.56 58.54 22.43 
 0.423 8.394 9.335 5.181 0.258 22.91 59.43 23.58 
Avg. 0.404 7.876 9.252 5.317 0.242 22.26 60.06 24.23 
Stdev. 0.017 0.453 0.072 0.365 0.014 0.676 1.920 2.190 
G93A 0.325 125.0 6.974 4.848 0.793 318.9 802.3 4.520 
 0.355 29.75 7.069 4.869 1.000 228.4 1692 3.601 
 0.283 31.59 7.046 5.166 1.000 308.1 1275 3.608 
Avg. 0.321 62.11 7.030 4.961 0.931 285.1 1256 3.910 
Stdev. 0.036 54.47 0.050 0.178 0.120 49.43 445.1 0.529 
G93R 0.269 93.17 8.389 4.713 0.209 14.16 35.06 16.83 
 0.296 11.56 8.939 6.126 0.206 14.00 36.10 16.11 
 0.415 8.376 9.748 5.216 0.231 14.82 36.27 15.01 
Avg. 0.327 37.70 9.025 5.352 0.215 14.33 35.81 15.98 
Stdev. 0.078 48.06 0.684 0.716 0.014 0.435 0.655 0.917 
G93S 0.777 34.99 507.6 4.765 0.758 37.94 337.6 5.767 
 0.783 29.53 654.9 4.551 0.851 30.91 479.1 6.034 
 0.857 51.77 485.7 2.615 0.891 27.64 379.0 5.191 
Avg. 0.806 38.76 549.4 3.977 0.833 32.16 398.6 5.664 
Stdev. 0.045 11.59 92.02 1.184 0.068 5.263 72.75 0.431 
V148I 0.300 11.47 5.863 4.320 1.0 7548 4.446 4.349 
Na2SO4 0.344 14.27 5.386 3.956 1.0 7038 4.268 4.050 
 0.347 5.119 5.454 3.922 1.0 2067 5.608 4.736 
Avg. 0.330 10.29 5.568 4.066 1.0 5551 4.774 4.378 
Stdev. 0.026 4.689 0.258 0.221 0.0 3028 0.728 0.344 
Bold and italicized values are the averages and standard deviations, respectively. 
a
PDI obtained from the Cumulants method of fitting the autocorrelation function (Eq. 5.4).  
Values larger than 0.1 are indicative of polydispersity (i.e., the sample contains than one species 
in solution).  High PDI values result in larger peak widths, and thus greater uncertainty in the 
sizes reported. 
b
Peak width reflects the uncertainty in the hydrodynamic diameter obtained from the intensity 
distribution and is related to the PDI according to Eq. 5.4. 
c
The sizes reported correspond to the main peak in the distributions.  
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Table S5.4 All DLS data for apoSH SOD1 variants at 1 mg mL
-1
, pH 7.4, 37 °C, 150 mM salt. 
 t = 0 t > 300 
ApoSH 
SOD1 
variant 
PDI
a
 
PDI width 
 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
PDI
a
 
PDI width 
 
 
(nm)
b
 
Intensity 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
Number 
Distribution 
Hydrodynamic 
Radius 
(nm)
c
 
pWT 0.154 1.761 5.094 3.314 0.215 2.768 5.084 3.256 
No Salt 0.187 1.986 5.473 2.436 0.252 2.644 5.384 3.216 
 0.206 2.117 5.445 3.345 0.176 1.911 4.875 3.182 
 0.224 2.552 5.757 3.104 0.243 2.520 5.337 3.028 
 0.223 2.310 5.517 3.503 0.237 2.452 5.566 3.478 
 0.235 2.468 5.560 3.582 0.224 2.349 5.045 3.336 
 0.170 1.777 5.144 3.082 0.315 7.762 4.875 3.122 
 0.203 1.914 4.627 2.687 0.204 2.241 5.404 3.095 
 0.219 2.148 5.169 3.045 0.219 2.458 5.626 3.930 
 0.233 2.284 5.392 2.741 0.450 7.483 5.252 4.320 
 0.203 2.210 5.565 3.737 0.404 6.354 5.290 3.583 
 0.198 2.226 5.849 3.000 0.264 21.83 4.994 3.839 
Avg. 0.205 2.146 5.383 3.131 0.267 5.231 5.228 3.449 
Stdev. 0.025 0.250 0.332 0.387 0.083 5.657 0.253 0.398 
pWT 0.224 2.099 4.773 2.196 0.270 152.8 4.615 2.678 
Na2SO4 0.229 2.207 5.776 3.187 0.160 6.411 6.381 4.505 
 0.266 2.284 5.237 3.066 0.278 24.91 5.656 2.694 
Avg. 0.240 2.197 5.262 2.816 0.236 61.37 5.551 3.292 
Stdev. 0.023 0.093 0.502 0.541 0.066 79.72 0.888 1.050 
pWT 0.261 2.476 5.666 2.287 0.371 5.578 5.573 4.180 
NaCl 0.225 2.434 5.880 2.623 0.473 376.0 5.329 2.950 
 0.199 1.984 5.853 4.128 0.205 2.198 5.149 3.436 
Avg. 0.228 2.298 5.800 3.013 0.350 127.9 5.350 3.522 
Stdev. 0.031 0.273 0.117 0.980 0.135 214.9 0.213 0.619 
A4V 0.264 3.399 7.243 3.660 0.248 38.17 102.4 42.02 
No Salt 0.240 3.017 6.044 3.961 0.261 39.26 94.19 45.83 
 0.212 2.730 6.639 3.609 0.261 38.76 108.0 35.61 
 0.258 4.434 10.43 1.292 0.269 24.40 65.40 7.532 
 0.264 4.300 11.08 1.351 0.259 23.58 61.19 29.59 
 0.271 4.489 10.58 3.084 0.261 23.48 62.64 6.666 
 0.245 3.519 7.430 4.566 0.244 22.53 60.54 30.47 
 0.187 2.939 7.601 3.953 0.243 22.73 61.09 31.40 
 0.147 2.784 8.562 4.845 0.234 22.38 60.24 33.35 
 0.277 4.807 11.25 1.667 0.268 22.20 58.60 4.422 
 0.263 4.273 10.29 3.925 0.262 21.73 56.88 5.631 
 0.258 4.204 10.28 1.676 0.263 21.75 57.87 5.102 
 0.102 3.227 7.885 3.954 0.279 22.26 57.00 4.859 
 0.236 3.443 7.987 4.704 0.272 22.36 59.08 5.266 
 0.216 3.351 7.185 4.585 0.294 22.92 61.80 5.065 
 0.208 3.435 9.099 5.966 0.251 23.11 60.24 33.65 
 0.152 2.963 8.497 5.745 0.256 23.05 60.73 5.231 
 0.203 3.263 9.623 1.637 0.240 22.12 59.80 6.988 
 0.212 3.462 8.300 4.866 0.212 40.00 46.91 4.915 
 0.223 3.561 8.698 4.868 0.384 25.70 54.33 6.238 
 0.222 3.584 8.396 5.063 0.457 29.63 50.18 4.807 
 0.234 3.554 7.700 4.856 0.570 59.04 54.46 4.556 
 0.239 3.450 8.439 3.370 0.662 50.77 54.61 6.255 
 0.248 51.40 6.992 4.164 0.528 47.26 54.93 4.240 
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Avg. 0.224 5.566 8.593 3.807 0.312 29.55 63.46 15.40 
Stdev. 0.043 9.779 1.452 1.376 0.119 10.88 15.38 14.70 
A4V 0.277 4.878 9.349 5.038 0.224 36.96 101.6 47.79 
Na2SO4 0.290 5.125 9.522 5.629 0.228 37.62 98.08 48.46 
 0.292 5.094 10.69 1.241 0.227 36.95 92.27 49.11 
 0.292 4.918 9.093 5.145 0.201 30.23 84.60 37.04 
 0.238 3.855 9.677 1.346 0.219 31.28 86.95 33.01 
 0.248 4.122 11.11 8.274 0.172 27.79 80.54 47.19 
Avg. 0.273 4.665 9.907 4.446 0.212 33.47 90.67 43.77 
Stdev. 0.024 0.540 0.804 2.712 0.022 4.221 8.127 6.920 
A4V 0.264 4.480 9.663 4.254 0.198 31.51 83.28 44.61 
NaCl 0.277 4.614 9.050 4.798 0.197 29.80 84.64 39.65 
 0.284 4.676 8.921 4.760 0.206 30.01 83.55 39.82 
 0.283 4.570 9.228 3.127 0.217 33.47 91.84 48.46 
 0.256 4.105 9.795 1.298 0.221 32.72 89.83 42.56 
 0.249 4.060 8.779 5.205 0.229 33.23 88.54 48.03 
Avg. 0.269 4.418 9.239 3.907 0.211 31.79 86.95 43.86 
Stdev. 0.015 0.268 0.409 1.466 0.013 1.610 3.608 3.869 
E100G 0.226 2.451 6.325 4.355 0.275 88.37 5.716 3.956 
No Salt 0.232 2.536 6.406 3.829 0.379 97.29 5.127 3.857 
 0.230 2.330 5.947 3.026 0.441 8.945 6.064 4.100 
 0.243 2.715 5.622 3.495 0.765 101.7 5.730 3.192 
 0.245 2.675 5.699 3.138 0.692 176.3 1066 3.951 
 0.234 2.530 5.851 3.106 0.479 116.8 5.444 4.160 
 0.240 2.825 7.392 2.429 0.405 114.5 5.576 4.047 
 0.223 2.700 7.533 3.893 0.340 21.61 5.740 4.292 
 0.200 2.595 7.111 4.664 0.376 50.16 5.884 4.469 
Avg. 0.230 2.595 6.432 3.548 0.461 86.19 123.5 4.003 
Stdev. 0.014 0.151 0.739 0.706 0.163 52.04 353.4 0.357 
E100G 0.263 3.597 7.812 5.145 0.377 203.9 6.550 5.907 
Na2SO4 0.282 4.154 7.811 4.337 0.340 42.63 6.685 5.756 
 0.257 4.060 8.637 4.787 0.454 71.00 6.463 5.801 
Avg. 0.267 3.937 8.087 4.756 0.390 105.8 6.566 5.821 
Stdev. 0.013 0.298 0.477 0.405 0.058 86.10 0.112 0.078 
E100G 0.232 2.870 6.901 4.082 0.457 362.9 5.878 4.897 
NaCl 0.240 2.943 7.529 2.505 0.424 48.71 5.661 1.914 
 0.179 2.647 7.498 4.701 0.361 74.94 6.088 4.124 
Avg. 0.217 2.820 7.309 3.763 0.414 162.2 5.876 3.645 
Stdev. 0.033 0.154 0.354 1.132 0.049 174.3 0.214 1.548 
G93R 0.160 2.349 6.847 3.726 1.0 49.44 322.6 4.392 
No Salt 0.159 2.379 6.415 4.068 1.0 43.14 256.6 4.643 
 0.155 2.380 7.108 4.528 1.0 43.91 261.7 4.640 
 0.210 2.730 6.581 3.309 0.783 20.32 181.5 5.224 
 0.211 2.730 7.196 3.900 0.710 17.32 256.7 4.602 
 0.195 2.621 7.500 1.774 0.610 20.47 170.5 4.730 
 0.184 2.720 7.123 4.131 0.952 28.38 260.9 4.582 
 0.235 3.044 6.314 4.302 0.978 29.80 257.9 4.619 
 0.217 2.781 7.005 2.811 0.983 29.92 260.1 4.510 
 0.311 5.046 7.158 4.683 0.579 27.62 50.63 2.548 
 0.287 4.563 8.698 4.423 0.491 27.71 47.91 4.358 
 0.304 4.922 8.430 3.920 0.419 23.43 50.59 3.735 
 0.303 5.060 8.315 4.699 0.174 21.23 61.72 34.43 
 0.275 4.607 8.628 5.552 0.194 22.23 63.47 31.05 
 0.274 4.595 8.161 4.723 0.173 21.10 61.68 33.95 
 0.239 5.241 7.820 3.719 0.240 20.18 51.52 22.48 
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 0.317 4.998 8.247 1.722 0.244 19.14 53.81 23.16 
 0.287 4.410 8.589 5.484 0.238 18.32 50.13 11.12 
Avg. 0.240 3.732 7.563 3.971 0.598 26.87 151.1 11.60 
Stdev. 0.056 1.155 0.806 1.053 0.334 9.509 104.2 11.58 
G93R 0.265 4.592 10.36 4.525 0.185 29.25 82.94 47.32 
Na2SO4 0.286 5.169 10.32 5.872 0.189 27.32 78.10 38.18 
 0.311 5.837 11.32 1.460 0.214 28.02 79.34 29.25 
 0.267 4.467 9.279 5.040 0.267 42.04 94.20 47.93 
 0.248 4.026 10.09 5.363 0.245 37.15 95.44 45.46 
 0.217 3.765 9.670 6.282 0.245 37.29 100.4 42.93 
 0.197 94.09 8.081 3.874 0.267 45.57 127.6 33.01 
 0.273 4.583 9.076 4.947 0.248 40.12 111.7 35.20 
 0.247 4.033 9.594 2.150 0.236 39.01 100.9 44.35 
Avg. 0.257 14.51 9.754 4.390 0.233 36.20 96.74 40.40 
Stdev. 0.035 29.85 0.920 1.633 0.030 6.532 16.03 6.737 
G93R 0.327 8.550 7.037 5.091 0.263 28.68 78.68 28.15 
NaCl 0.240 4.128 9.990 4.400 0.256 28.10 71.46 34.31 
 0.235 3.979 9.323 5.539 0.262 28.45 76.63 25.18 
 0.257 4.651 11.05 1.792 0.236 35.86 97.46 41.29 
 0.237 4.132 9.095 5.175 0.227 32.12 88.34 37.80 
 0.227 3.893 9.637 3.786 0.225 31.49 85.88 43.63 
Avg. 0.254 4.889 9.355 4.297 0.245 30.78 83.08 35.06 
Stdev. 0.037 1.813 1.326 1.378 0.018 3.004 9.362 7.290 
G93R
a
 0.322 206.3 6.924 4.618 0.387 62.38 132.5 58.88 
NaCl 0.285 4.565 8.413 5.747 0.302 52.25 141.5 28.18 
 0.247 4.245 9.441 4.539 0.322 53.94 152.7 15.50 
Avg. 0.285 71.70 8.259 4.968 0.337 56.19 142.2 34.19 
Stdev. 0.038 116.6 1.266 0.676 0.044 5.427 10.12 22.31 
G93S 0.223 3.075 7.135 4.276 0.597 12.98 169.5 5.275 
No Salt 0.266 3.939 8.133 3.513 0.597 13.00 164.8 2.251 
 0.267 3.820 7.767 2.220 0.617 13.57 150.7 4.588 
 0.234 3.148 6.376 4.711 0.239 124.3 6.439 5.130 
 0.236 2.797 6.421 4.044 0.461 8.520 6.603 1.498 
 0.207 2.574 6.981 4.630 0.500 9.658 6.643 4.536 
Avg. 0.239 3.226 7.136 3.899 0.502 30.34 84.11 3.880 
Stdev. 0.024 0.548 0.708 0.930 0.143 46.08 85.18 1.598 
G93S 0.247 6.680 8.012 5.020 0.934 230.9 333.8 6.320 
Na2SO4 0.213 3.217 8.234 4.780 0.468 219.9 348.1 1.830 
 0.258 3.814 8.690 2.032 0.486 193.5 313.6 4.911 
Avg. 0.239 4.570 8.312 3.944 0.629 214.8 331.8 4.354 
Stdev. 0.023 1.851 0.346 1.660 0.264 19.22 17.33 2.296 
G93S 0.292 178.6 5.553 4.096 0.823 1193 6.457 5.675 
NaCl 0.222 3.088 7.129 3.654 0.745 833.2 6.314 5.063 
 0.194 2.679 7.683 4.658 0.545 486.5 6.089 4.560 
Avg. 0.236 61.46 6.788 4.136 0.704 837.6 6.287 5.099 
Stdev. 0.050 101.5 1.105 0.503 0.143 353.3 0.186 0.558 
H43R 0.218 3.527 8.509 3.780 0.208 4.024 6.858 1.250 
No Salt 0.210 3.452 8.629 4.568 0.246 3.031 6.388 4.354 
 0.236 3.727 7.961 5.190 0.238 3.135 6.321 4.428 
 0.263 4.582 8.303 4.564 0.508 529.2 5.259 3.509 
 0.178 3.171 9.463 3.433 0.314 4.489 6.208 4.508 
 0.201 3.354 9.280 5.306 0.284 12.80 5.948 4.544 
 0.140 2.703 8.262 4.735 0.247 21.10 7.519 1.209 
 0.158 2.754 8.513 3.259 0.325 4.869 7.336 6.267 
 0.155 2.808 8.606 2.215 0.335 4.684 7.008 4.838 
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 0.272 4.257 8.542 4.146 0.516 10.13 6.655 3.699 
 0.260 3.722 8.104 3.725 0.445 8.075 6.900 4.032 
 0.284 4.510 9.064 3.627 0.461 8.592 7.280 2.187 
Avg. 0.215 3.547 8.603 4.046 0.344 51.18 6.640 3.735 
Stdev. 0.049 0.650 0.457 0.885 0.110 150.6 0.651 1.503 
H43R 0.252 3.956 8.543 4.350 1.0 2049 6.318 5.173 
Na2SO4 0.243 3.633 10.57 1.590 0.843 467.0 6.818 5.462 
 0.271 3.645 8.661 4.844 0.445 210.6 7.143 5.443 
Avg. 0.255 3.745 9.258 3.595 0.763 908.9 6.760 5.359 
Stdev. 0.014 0.183 1.138 1.754 0.286 995.7 0.416 0.162 
H43R 0.235 3.214 8.741 4.856 0.263 27.99 6.411 4.809 
NaCl 0.230 2.902 7.794 4.889 0.249 5.500 6.641 4.336 
 0.234 2.837 7.778 4.230 0.253 4.668 6.760 1.235 
Avg. 0.233 2.984 8.104 4.658 0.255 12.72 6.604 3.460 
Stdev. 0.003 0.202 0.551 0.371 0.007 13.23 0.177 1.941 
V148G 0.272 3.780 6.998 4.654 0.484 366.2 504.6 3.655 
No Salt 0.250 3.337 7.294 1.205 0.637 366.1 542.7 4.017 
 0.237 3.138 6.969 4.215 0.814 380.6 678.7 4.008 
 0.130 36.99 5.947 4.516 0.498 9.429 9.704 2.113 
 0.434 7.644 6.459 4.583 0.443 11.79 6.209 4.565 
 0.422 7.301 6.210 4.393 0.525 12.33 6.758 5.372 
Avg. 0.291 10.37 6.646 3.928 0.567 191.1 291.5 3.955 
Stdev. 0.117 13.20 0.522 1.343 0.138 197.1 316.3 1.083 
V148G 0.329 5.161 7.706 1.687 0.994 1685 169.5 6.013 
Na2SO4 0.321 4.975 7.774 2.893 0.922 1849 162.2 5.794 
 0.306 4.581 6.894 3.702 0.714 207.0 508.6 5.469 
Avg. 0.319 4.906 7.458 2.761 0.877 1247 280.1 5.759 
Stdev. 0.012 0.296 0.490 1.014 0.145 904.4 197.9 0.274 
V148G 0.117 24.47 6.632 4.801 0.647 600.3 710.6 4.893 
NaCl 0.299 4.377 6.233 4.087 0.791 329.4 784.1 3.881 
 0.297 4.527 7.545 4.712 0.784 312.6 681.2 5.862 
Avg. 0.238 11.13 6.803 4.533 0.741 414.1 725.3 4.879 
Stdev. 0.105 11.56 0.673 0.389 0.081 161.5 53.00 0.991 
Bold and italicized values are the averages and standard deviations, respectively.  Salt free 
samples are the same as those shown in Table S5.2.  
a
PDI is obtained from the Cumulants method of fitting the autocorrelation function (Eq. 5.4).  
Values larger than 0.1 are indicative of polydispersity (i.e., the sample contains than one species 
in solution).  High PDI values result in larger peak widths, and thus greater uncertainty in the 
sizes reported. 
b
Peak width reflects the uncertainty in the hydrodynamic diameter obtained from the intensity 
distribution and is related to the PDI according to Eq. 5.4. 
c
The sizes reported correspond to the main peak in the distributions. 
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Chapter 6 
Summary and Future Work 
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The focus of this work has been on immature forms of SOD1, apoSS and apoSH, due to 
their diminished stability and ostensibly higher aggregation propensity relative to the fully 
mature holoSS form (99, 134, 144, 147, 174, 184, 193, 195, 198, 226, 376), and our results have 
uncovered important characteristics of immature SOD1 that may lead to misfolding of an 
otherwise extremely stable and compact protein (128).  
 
6.1. Key findings from studies of apoSS dimer and monomer stabilities and implications of 
these findings for disease 
A prevailing hypothesis in the field of ALS research has been that fALS-associated 
mutations destabilize the SOD1 dimer interface, leading to an increase in monomeric SOD1 that 
can nucleate aggregation (134, 143, 175, 193, 197–199).  Until now however, this hypothesis 
was based on measurements of a few mutants made at lower than physiological temperature 
(176, 177, 200), as well as molecular dynamic simulations (175, 201, 202), and direct 
measurement of the effects of mutations at 37 °C had not been done.  We have demonstrated here 
that ITC is a powerful, and to date underutilized, tool for characterizing the thermodynamics of 
protein association, and have clearly shown that the effects of numerous, structurally diverse, 
mutations propagate through the structure and weaken the dimer interface.  Importantly, we find 
that apoSS dimer stability is significantly reduced, and potentially more easily perturbed, at 
physiological temperature (37 °C) compared to lower temperatures (134, 177, 193, 197).  
Furthermore, we have determined that apoSS dissociation is characterized by a high ∆Cp,d; thus, 
the dissociation enthalpy is strongly temperature-dependent, and as a result, dissociation is 
increasingly favorable and measurable by ITC at higher temperature due to the increased heat of 
dissociation.  This high ∆Cp,d points to a significant structural disruption in the monomer that 
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accompanies dimer dissociation, and this finding provides key information for understanding the 
mechanisms and energetics underlying normal maturation of SOD1, as well as toxic SOD1 
misfolding pathways associated with disease.  Our results indicate that dimerization may be a 
powerful deterrent of misfolding by structuring regions of the monomer that may otherwise form 
aberrant intermolecular interactions (90, 138). 
A strategy for combating aggregation of SOD1 has long been sought, and attempts have 
been made to engineer chemical cross-links across the dimer interface or find small molecules 
capable of binding to and stabilizing the dimer interface (377–380).  These strategies are 
analogous to the approach employed to combat aggregation of transthyretin (TTR), where 
mutations linked to familial amyloid polyneuropathy (FAP) induce conformational changes that 
promote dissociation of the native tetramer, leading to formation of partially folded monomers 
that can self-assemble into amyloid fibrils (215).  Past attempts to design drugs to stabilize 
apoSS SOD1 have focused on stabilizing the dimer interface against dissociation by designing 
drugs to bind in the hydrophobic cavity within the interface created by Val 7, Gly 147, and Val 
148 (380, 381), but there binding specificity for the dimer interface has been found to be low 
(378, 380), and their effectiveness at limiting aggregation has been controversial (378).  Our 
results demonstrate that changes in local stability introduced by mutations have a ripple effect 
through apoSS, and these results may open up additional avenues for drug exploration. By the 
same principle, small molecules that stabilize one region of the protein may have an impact on 
the dimer interface and prevent dissociation.  Given the high connectivity of the dimer interface 
and active site, small molecules able to bind to the active site with high specificity and mimic the 
effects of metal may result in stabilization of the entire dimeric structure. 
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By combining ITC measurements of dimer interface stability with DSC measurements of 
total stability, we have been able to distinguish the effects of mutations on the different 
components of total stability.  With knowledge of the dimer interface and monomer stability 
values for different apoSS variants (Table 3.2), the fractions of N2, M and U can be calculated as 
a function of temperature for a given protein concentration, which provides a powerful method 
for determining the state(s) likely to be populated under physiological conditions.  We have 
found that mutations have differing effects on monomer stability, ranging from slightly 
stabilizing to significantly destabilizing, and this finding is important for elucidating mechanisms 
of mutant SOD1 aggregation and may be particularly helpful for designing strategies for 
stabilizing mutant SOD1. 
 
6.2 Future studies on apoSS SOD1  
 Other members of the Meiering group have used NMR to gain information on the local 
stability and conformational flexibility of holoSS SOD1 variants.  Colleen Doyle has used amide 
proton temperature coefficients to probe alternative conformations that are close in energy to the 
native state (Doyle, C. M. and Meiering E.M., unpublished data) (305).  These experiments 
report on regions of the protein more likely to undergo conformational fluctuations, and 
performed at different temperatures provide a way to visualize the unfolding process.  Dr. Jessica 
Rumfeldt has also performed amide exchange experiments to assess local dynamics of holoSS 
variants (Rumfeldt, J. A. O., and Meiering E.M., unpublished data) (382).  These experiments on 
apoSS, would provide important information on the regions of the structure that may become 
disrupted when the protein dissociates.  As reported in Chapter 2, we observe very different ∆Hd 
values for different apoSS variants, and this result may point to different degrees of local 
315 
 
unfolding that accompany dissociation in each case.  Thus, probing the energy landscape using 
NMR techniques may provide an explanation for these differences.  Given that apoSS monomers 
are thought to be highly prone to nucleating aggregation, such experiments would provide 
valuable information on the conformations of misfolded SOD1, which is highly relevant to 
unraveling the mechanism(s) of SOD1 aggregation (vide infra). 
 In addition, ITC could be used to gather information on the thermodynamics of metal 
binding to apoSS SOD1.  Previous attempts to characterize metal binding using a variety of 
techniques were made difficult due to the presence of EDTA bound to the protein.  We have now 
established an effective protocol for removing this bound EDTA by first unfolding the protein in 
GdmCl and then exchanging the protein out of GdmCl into metal and EDTA-free buffer.  Data 
obtained from these experiments would provide important clues as to the maturation process of 
SOD1 in the cell and whether mutations affect this process.  Banci and colleagues have 
established that zinc binding precedes and facilitates interaction with CCS (161); thus, mutations 
that disrupt zinc binding will also indirectly disrupt copper binding.  While this proposal that 
metal binding is disrupted in mutant SOD1 is not new (283, 304), to the best of my knowledge, 
measurements of the thermodynamics of metal binding for a large number of SOD1 mutants 
have not been performed.  It is possible however, that metal binding to apoSS may be too tight to 
be measured by ITC.  If the equilibrium constant for association (Ka) is greater than 10
9
, the 
binding curve will be too steep for accurate fitting of the data (383).  For a given process to be 
measureable by ITC, c, defined according to Eq. 6.1 should be between 10 and 1000 (208, 383, 
384), 
𝑐 = 𝐾𝑎[𝑃𝑑𝑖𝑚𝑒𝑟]𝑛 (Eq. 6.1) 
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where Ka is the association constant; Pdimer is the concentration of the protein in the reaction cell; 
and n is the stoichiometry of the reaction (385).  Past kinetic folding experiments revealed that 
the kd’s of zinc binding to monomeric and dimeric apoSS pWT are 100 ± 122 pM and 22 ± 35 
pM, respectively at 20 °C (145).  ITC has been used to measure the energetics of zinc binding to 
apoSS WT SOD1 and found the kd  to be 100 nM at 25 °C, and the ∆Cp to be -0.67 kcal mol
-1
 °C, 
indicating substantial conformational changes upon metal binding (386).  Given that mutations 
have been proposed to weaken metal binding, it may be possible to measure the thermodynamics 
of metal binding to mutant SOD1 by experimenting with different protein concentrations and 
temperatures.  As mentioned in Chapter 2, large ∆Cp values lead to large changes in ∆H with 
temperature; given the magnitude and sign of ∆Cp, metal binding may be increasingly 
measureable at lower temperature for a number of mutants. 
 
6.3 Key findings from studies of apoSH aggregation and implications of these findings for 
disease  
Previous studies in the Meiering lab had also concentrated on characterizing the stability 
of various apoSH SOD1 variants (174); since 2010 the focus of further work on apoSH has been 
on characterizing the aggregation of apoSH in vitro, under experimental conditions that closely 
resemble physiological protein concentration, temperature, and pH (Chapter 4 and 5).  We found 
that under these conditions (1 mg mL
-1
, 37 °C, pH 7.4) that apoSH is remarkably resistant to 
aggregation, despite its marginal stability (Chapter 4).  When incubated for ~300 hours at 1 mg 
mL
-1
, pH 7.4, 37 °C, little change in light scattering intensity was observed for most apoSH 
variants with A4V, the most common North American fALS mutation with particularly short 
disease duration (7, 8), the exception (174).  These results were very surprising given the 
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marginal stability of apoSH and the numerous studies suggesting that this form of the protein is 
the form that exhibits the greatest manifestation of mutation effects (76, 131, 147, 180, 184, 
195).  We therefore explored other conditions that we believed would encourage protein 
association, without significantly altering the levels of unfolded protein.     
The differences in aggregation propensity between SOD1 variants were more pronounced 
at higher protein concentration (5 mg mL
-1
).  DLS measurements at t0 suggest that intermolecular 
interactions are promoted for all mutants at increased protein concentration.  Moreover, for the 
most aggregation-prone mutants Dh,I and Dh,N values at t0 were higher at 5 mg mL
-1
 compared to 
1 mg mL
-1
, which may points to an increase in concentration of small oligomers.  By AFM we 
were able to determine that the majority of particles detected were monomers and dimers, with 
low levels of oligomers also being observed.  For some apoSH variants, pWT, G93A, G93S, and 
V148I, low levels of aggregation occur but monomers, dimers and small oligomers remained the 
dominant species in solution, as shown by the fairly consistent light scattering intensity, 
increases in the PDI, as well as increases in Dh,I but not Dh,N, over the incubation period.  AFM 
and ThT-binding experiments confirmed that long fibrils with increased β-structure were present 
in solution, but these species did not become highly abundant.  For other mutants, A4V, G37R, 
and G93R, extensive aggregation was observed, as shown by the rapid increase in the light 
scattering intensity with little lag time, increases in both Dh,I and Dh,N, as well as decreases in the 
PDI.  Such aggregation behaviour is indicative of a low energy barrier between the unfolded, 
native, and aggregation-prone state(s) (53, 320).  Interestingly these mutants with higher 
aggregation propensity appear unable to form long fibrils, which suggest that there are structural 
differences in the aggregates formed by the mutants that affect their abilities to grow.  
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Furthermore, these differences in aggregation propensity and aggregate morphology could not be 
accounted for based merely on protein stability differences.   
We also found large differences in the aggregation propensity of apoSH mutants with the 
addition of Na2SO4 and NaCl to the samples.  Light scattering measurements showed that pWT, 
E100G, H43R, and V148G remain fairly resistant to aggregation in Na2SO4 and NaCl.  While the 
aggregation propensities of A4V, G93R, and G93S were influenced by the addition of salt, and 
in all three cases, the effects were most pronounced for samples containing Na2SO4.  A4V and 
G93R in both Na2SO4 and NaCl and G93S in Na2SO4 aggregated with little detectable lag time 
suggesting a low energy barrier to aggregation, as described above.  The Dh,I values reported for 
all mutants were increased relative to pWT and the increases were most pronounced for A4V and 
G93R samples containing salt.  Therefore, even prior to incubation at 37 °C, changes in Dh,I 
reveal that Na2SO4, and to a lesser extent NaCl, promote intermolecular interactions and the 
effects are most obvious for A4V and G93R, which both consistently exhibit higher aggregation 
propensities under all conditions explored.  As was observed for samples incubated at 5 mg mL
-
1
, mutants, such as A4V and G93R, that aggregated significantly in salt exhibited increases in 
both Dh,I and Dh,N and decreases in the PDI over the course of the incubation period.  Again we 
see though that conditions suitable for promoting aggregation of some mutants, notably A4V, 
G93R, and to a lesser extent G93S, are not suitable for promoting aggregation of other mutants.  
The same increases in light scattering intensity, and both Dh,I and Dh,N, as well as a decrease in 
PDI with incubation time were not observed for pWT, E100G, H43R, and V148G.  By AFM as 
well, we see that Na2SO4 and NaCl promote the formation of longer and thicker fibrils in A4V, 
G93R, and G93S samples and for all three mutants, the largest aggregates (those with lengths 
longer than 200 nm) formed in salt exhibit aspect ratios greater than those formed at higher 
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protein concentration in salt free buffer.  These results suggest that Na2SO4 and NaCl promote 
fibrillization of A4V, G93R, and G93S.  It is interesting to note that G93S, which exhibited 
lower levels of aggregation in salt compared to A4V and G93R, formed the longest fibrils and 
exhibited the highest ThT fluorescence of all aggregates formed in salt, despite being less 
abundant.  Images of G93R in Na2SO4 taken over the course of the aggregation experiment 
reveal that fibril elongation occurs up to the midpoint of the exponential growth phase at which 
point fibrils stop growing; thus, they never reach lengths observed for G93S suggestive of 
different aggregation pathways observed for the two mutants. 
Taken together, light scattering, AFM, and ThT binding experiments reveal that Na2SO4 
and NaCl promote aggregation of some, but not all, apoSH mutants.  The effects of salt on the 
levels of apoSH aggregation correlate with the abilities of the different anions to stabilize and 
encourage protein association, according to the Hofmeister series (348–351).  Estimates of fibril 
size reveal that they are longer in salt, but the distributions are too broad to distinguish 
differences between those formed in Na2SO4 and NaCl.  Similar observations are evident for 
G93S, which formed even longer aggregates in both Na2SO4 and NaCl.  Based on these results, 
and recent NMR experiments (301) it appears that point mutations have a large impact on the 
energy landscape of apoSH, and thus govern the type of aggregation behaviour observed, while 
different solution conditions may modulate the extent to which the protein proceeds down the 
aggregation pathway. 
These findings are highly relevant to disease given that various mutant-SOD1 ALS mice 
models have shown that small, soluble, misfolded forms of apoSH SOD1 are enriched in the 
spinal cord and may be the common cytotoxic species that cause ALS (269, 270).  Given that 
mutations have a large effect on the conformation and aggregation propensity of apoSH, these 
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differences may help elucidate the structural characteristics of different SOD1 variants to 
account for differing disease phenotypes.  In ALS and a number of diseases such as Parkinson’s, 
Alzheimer’s, and Huntington’s, neurodegeneration spreads through interconnected regions of the 
central nervous system (10, 15).  Misfolded SOD1 is targeted for degradation via the ubiquitin 
pathway, and mutations in SOD1 may disrupt this process and in turn impair the proteasomal 
degradation pathway (27, 28).  It has been shown that SOD1 can be excreted via a variety of 
distinct pathways (Chapter 1, section 1.1) and immunization targeting extracellular SOD1 has 
been found to increase the lifespan of transgenic mice expressing mutant SOD1 (45).  Once 
transported to the extracellular environment, misfolded SOD1 conformers and/or SOD1 
aggregates less than 0.4 μm in diameter (10, 40) can be taken up by neighbouring cells and seed 
aggregation of endogenous wildtype and mutant SOD1 (39).  These processes have been found 
to be highly protein-specific and differences in the rate of cell to cell transfer of these aggregate 
seeds may underlie the rate of disease progression and partially account for the differences in 
pathology observed (40).  Furthermore, labile SOD1 aggregates have been proposed to be more 
toxic due to their higher transmissibility (40).  We have observed significant differences in both 
the aggregation propensity and morphological features of apoSH aggregates and these findings 
may be highly relevant to unraveling the complex mechanisms underlying ALS toxicity.  A 
remaining challenge for ALS research lies in uncovering the initial event(s) that lead to disease 
and the toxic species, misfolded or oligomeric protein, responsible for disease onset.  While it is 
likely that multiple forms of SOD1 are relevant to disease, the experiments presented here reveal 
how significantly the energy landscape of apoSH is altered by fALS-associated mutations such 
that particular aggregation pathways are either accessible or inaccessible depending on the 
mutation.  Mutations may affect any number of processes including folding, proper interaction 
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with CCS (161), interaction with protein degradation machinery and/or components of secretory 
vesicles (27, 28, 44), rates of aggregation and properties of aggregates formed (Chapter 5), as 
well as aberrant interactions with cellular components such as the mitochondria (12, 387); thus 
studies aimed at uncovering the different properties of mutant SOD1 will be highly important for 
determining the initial events that begin the cascade of toxic events that culminate in disease.  
 
6.4 Future studies on apoSH SOD1 
 Our approach thus far has been to consider a range of different experimental conditions in 
order to generate measurable levels of aggregation without significantly altering the 
conformation of apoSH, which is commonly done to accelerate the process (76, 78, 181, 188, 
192).  Now that suitable conditions for measuring aggregation have been established, numerous 
additional experiments to characterize the mechanisms of apoSH aggregation are possible.  First 
of all, aggregation data for more apoSH mutants will be important for elucidating trends that can 
account for the complex aggregation behaviour observed.  We have noted that apoSH stability 
cannot alone account for the complexity of aggregation behaviour.  Likewise, the different 
mechanisms of apoSH aggregation cannot be explained by the structural contexts of the 
mutations; for example, G93A and G93R exhibit very different aggregation behaviour.  As we 
highlighted in Chapter 2, it is important to account for both dimer and monomer stabilities to 
determine which states are likely formed in vivo.  While apoSH is mainly monomeric, DLS, 
AFM, and NMR suggest very low levels of dimer formation.  It is also interesting to note that 
A4V and G93R mutations, which render apoSH highly prone to aggregation under all conditions 
explored, also have large effects on the apoSS dimer interface stability (Chapter 2).  Thus, these 
mutations may similarly reduce native apoSH dimerization, which may promote other aberrant 
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interactions.  NMR experiments, such as those described in section 5.4.2, on additional mutants 
may provide important information on how mutations modulate the types of interactions between 
apoSH monomers and may shed light on the critical aberrant interactions that are required to 
support aggregation.  By AFM we detect particles with volumes consistent with apoSH 
monomers, dimers and small oligomers during the initial, growth, and plateau phases in the 
aggregation mechanism, yet it is unclear whether dimerization is essential step in nucleation or 
protective against aggregation.  Further characterization of the stability of apoSH under 
conditions shown to promote aggregation will also be important for determining the apoSH 
states important for aggregation. 
 Our experiments also reveal that different apoSH aggregates exhibit differences in 
secondary structure.  Further ThT fluorescence experiments performed on early and late-stage 
aggregates may point to important structural changes that facilitate a particular type of 
aggregation versus another.  Additional dyes such as 8-anilinonaphthalene-1-sulfonic acid 
(ANS), which exhibits an increase in fluorescence in the presence of hydrophobic residues (388), 
may also provide valuable information on the different structural features of apoSH aggregates.  
Protease digestion experiments can also be used to assess whether the cores of morphologically 
different aggregates are formed by different regions of the SOD1 structure, as was observed for 
agitation-induced aggregation of apoSH SOD1 (181).   
 Another important avenue to explore is how the aggregates formed in vitro relate to those 
formed in vivo.  Many different antibodies have been developed to recognize particular specific 
features of misfolded SOD1 (12).  These antibodies have been extremely useful for detecting 
misfolded SOD1 in aggregates isolated from ALS patients, but given the wide range of epitopes 
that are recognized by different antibodies they have also generated controversy regarding the 
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role of SOD1 in sALS (22, 33, 199, 389).  We now have a better appreciation for the effects of 
mutations on the conformation of SOD1, in particular on the metal free forms of the protein.  In 
collaboration with Dr. Christine Vande Velde, antibody binding experiments on holoSS, apoSS, 
non-aggregated apoSH, and aggregated apoSH will provide valuable insights into the different 
structural features recognized and determine why particular antibodies recognize SOD1 in sALS 
aggregates while others do not.  Other preliminary experiments with the Vande Velde group 
have shown that mutant non-aggregated and aggregated apoSH bind to the mitochondria isolated 
from the cerebral cord and/or liver of rodents (Fig. 6.1).  Mitochondria have been considered a 
target of misfolded and aggregated SOD1 toxicity (12).  Currently, these experiments have only 
been performed using a polyclonal SOD1 antibody that recognizes unfolded SOD1, but such 
experiments with different antibodies that recognize diverse structural features will be important 
for assessing the form(s) of SOD1 involved in toxicity.  Thus, using the knowledge gained from 
in vitro biophysical experiments on the folding and aggregation mechanism of various forms of 
SOD1, to design in vivo experiments with the specific aim of elucidating the role of different 
forms of SOD1 in disease will provide a powerful approach for unraveling the complex 
mechanisms that initiate toxicity and inevitably contribute to disease.   
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Figure 6.1 Mutant apoSH binds to rat mitochondria.  The affinity of different forms of SOD1 
for the mitochondria surface was assessed using western blots.  In these experiments, 
mitochondria are isolated from the spinal cords or liver of experimental rats.  Different SOD1 
samples are then incubated with the mitochondria at 37 °C for 20 minutes.  The samples are then 
centrifuged to remove the excess protein and then a west blot is run.  For these experiments, 
SOD1 was probed using a polyclonal antibody that recognizes unfolded SOD1 (Cell Signalling 
Technology, New England Biolabs Ltd.).  These experiments indicate that mutant apoSH binds 
to the mitochondria, apoSH pWT is only detected at very low levels, and metal bound SOD1 is 
not detected at all.  It is important to note that the Cell Signalling SOD1 polyclonal antibody may 
not recognize more folded forms of the protein; thus, identical experiments using different 
antibodies capable of recognizing folded SOD1 are required to confirm that mutant apoSH 
SOD1 is uniquely capable of becoming localized to the mitochondria.   
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